Gene "Gene synonym" Ensembl "Gene description" Uniprot Chromosome Position "Protein class" "Biological process" "Molecular function" "Disease involvement" Evidence "HPA evidence" "UniProt evidence" "NeXtProt evidence" "MS evidence" "RNA tissue specificity" "RNA tissue distribution" "RNA tissue specificity score" "RNA tissue specific NX" "RNA cell line specificity" "RNA cell line distribution" "RNA cell line specificity score" "RNA cell line specific NX" "RNA cancer specificity" "RNA cancer distribution" "RNA cancer specificity score" "RNA cancer specific FPKM" "RNA brain regional specificity" "RNA brain regional distribution" "RNA brain regional specificity score" "RNA brain regional specific NX" "RNA blood cell specificity" "RNA blood cell distribution" "RNA blood cell specificity score" "RNA blood cell specific NX" "RNA blood lineage specificity" "RNA blood lineage distribution" "RNA blood lineage specificity score" "RNA blood lineage specific NX" "RNA mouse brain regional specificity" "RNA mouse brain regional distribution" "RNA mouse brain regional specificity score" "RNA mouse brain regional specific pTPM" "RNA pig brain regional specificity" "RNA pig brain regional distribution" "RNA pig brain regional specificity score" "RNA pig brain regional specific pTPM" Antibody "Reliability (IH)" "Reliability (Mouse Brain)" "Reliability (IF)" "Subcellular location" "Secretome location" "Blood concentration - Conc. blood IM [pg/L]" "Blood concentration - Conc. blood MS [pg/L]" "Subcellular main location" "Subcellular additional location" "Antibody RRID" "Pathology prognostics - Breast cancer" "Pathology prognostics - Cervical cancer" "Pathology prognostics - Colorectal cancer" "Pathology prognostics - Endometrial cancer" "Pathology prognostics - Glioma" "Pathology prognostics - Head and neck cancer" "Pathology prognostics - Liver cancer" "Pathology prognostics - Lung cancer" "Pathology prognostics - Melanoma" "Pathology prognostics - Ovarian cancer" "Pathology prognostics - Pancreatic cancer" "Pathology prognostics - Prostate cancer" "Pathology prognostics - Renal cancer" "Pathology prognostics - Stomach cancer" "Pathology prognostics - Testis cancer" "Pathology prognostics - Thyroid cancer" "Pathology prognostics - Urothelial cancer" "Tissue RNA - adipose tissue [NX]" "Tissue RNA - adrenal gland [NX]" "Tissue RNA - amygdala [NX]" "Tissue RNA - appendix [NX]" "Tissue RNA - basal ganglia [NX]" "Tissue RNA - bone marrow [NX]" "Tissue RNA - breast [NX]" "Tissue RNA - cerebellum [NX]" "Tissue RNA - cerebral cortex [NX]" "Tissue RNA - cervix, uterine [NX]" "Tissue RNA - colon [NX]" "Tissue RNA - corpus callosum [NX]" "Tissue RNA - ductus deferens [NX]" "Tissue RNA - duodenum [NX]" "Tissue RNA - endometrium 1 [NX]" "Tissue RNA - epididymis [NX]" "Tissue RNA - esophagus [NX]" "Tissue RNA - fallopian tube [NX]" "Tissue RNA - gallbladder [NX]" "Tissue RNA - heart muscle [NX]" "Tissue RNA - hippocampal formation [NX]" "Tissue RNA - hypothalamus [NX]" "Tissue RNA - kidney [NX]" "Tissue RNA - liver [NX]" "Tissue RNA - lung [NX]" "Tissue RNA - lymph node [NX]" "Tissue RNA - midbrain [NX]" "Tissue RNA - olfactory region [NX]" "Tissue RNA - ovary [NX]" "Tissue RNA - pancreas [NX]" "Tissue RNA - parathyroid gland [NX]" "Tissue RNA - pituitary gland [NX]" "Tissue RNA - placenta [NX]" "Tissue RNA - pons and medulla [NX]" "Tissue RNA - prostate [NX]" "Tissue RNA - rectum [NX]" "Tissue RNA - retina [NX]" "Tissue RNA - salivary gland [NX]" "Tissue RNA - seminal vesicle [NX]" "Tissue RNA - skeletal muscle [NX]" "Tissue RNA - skin 1 [NX]" "Tissue RNA - small intestine [NX]" "Tissue RNA - smooth muscle [NX]" "Tissue RNA - spinal cord [NX]" "Tissue RNA - spleen [NX]" "Tissue RNA - stomach 1 [NX]" "Tissue RNA - testis [NX]" "Tissue RNA - thalamus [NX]" "Tissue RNA - thymus [NX]" "Tissue RNA - thyroid gland [NX]" "Tissue RNA - tongue [NX]" "Tissue RNA - tonsil [NX]" "Tissue RNA - urinary bladder [NX]" "Tissue RNA - vagina [NX]" "Tissue RNA - B-cells [NX]" "Tissue RNA - dendritic cells [NX]" "Tissue RNA - granulocytes [NX]" "Tissue RNA - monocytes [NX]" "Tissue RNA - NK-cells [NX]" "Tissue RNA - T-cells [NX]" "Tissue RNA - total PBMC [NX]" "Cell RNA - A-431 [NX]" "Cell RNA - A549 [NX]" "Cell RNA - AF22 [NX]" "Cell RNA - AN3-CA [NX]" "Cell RNA - ASC diff [NX]" "Cell RNA - ASC TERT1 [NX]" "Cell RNA - BEWO [NX]" "Cell RNA - BJ [NX]" "Cell RNA - BJ hTERT+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ [NX]" "Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]" "Cell RNA - CACO-2 [NX]" "Cell RNA - CAPAN-2 [NX]" "Cell RNA - Daudi [NX]" "Cell RNA - EFO-21 [NX]" "Cell RNA - fHDF/TERT166 [NX]" "Cell RNA - HaCaT [NX]" "Cell RNA - HAP1 [NX]" "Cell RNA - HBEC3-KT [NX]" "Cell RNA - HBF TERT88 [NX]" "Cell RNA - HDLM-2 [NX]" "Cell RNA - HEK 293 [NX]" "Cell RNA - HEL [NX]" "Cell RNA - HeLa [NX]" "Cell RNA - Hep G2 [NX]" "Cell RNA - HHSteC [NX]" "Cell RNA - HL-60 [NX]" "Cell RNA - HMC-1 [NX]" "Cell RNA - HSkMC [NX]" "Cell RNA - hTCEpi [NX]" "Cell RNA - hTEC/SVTERT24-B [NX]" "Cell RNA - hTERT-HME1 [NX]" "Cell RNA - HUVEC TERT2 [NX]" "Cell RNA - K-562 [NX]" "Cell RNA - Karpas-707 [NX]" "Cell RNA - LHCN-M2 [NX]" "Cell RNA - MCF7 [NX]" "Cell RNA - MOLT-4 [NX]" "Cell RNA - NB-4 [NX]" "Cell RNA - NTERA-2 [NX]" "Cell RNA - PC-3 [NX]" "Cell RNA - REH [NX]" "Cell RNA - RH-30 [NX]" "Cell RNA - RPMI-8226 [NX]" "Cell RNA - RPTEC TERT1 [NX]" "Cell RNA - RT4 [NX]" "Cell RNA - SCLC-21H [NX]" "Cell RNA - SH-SY5Y [NX]" "Cell RNA - SiHa [NX]" "Cell RNA - SK-BR-3 [NX]" "Cell RNA - SK-MEL-30 [NX]" "Cell RNA - T-47d [NX]" "Cell RNA - THP-1 [NX]" "Cell RNA - TIME [NX]" "Cell RNA - U-138 MG [NX]" "Cell RNA - U-2 OS [NX]" "Cell RNA - U-2197 [NX]" "Cell RNA - U-251 MG [NX]" "Cell RNA - U-266/70 [NX]" "Cell RNA - U-266/84 [NX]" "Cell RNA - U-698 [NX]" "Cell RNA - U-87 MG [NX]" "Cell RNA - U-937 [NX]" "Cell RNA - WM-115 [NX]" "Blood RNA - basophil [NX]" "Blood RNA - classical monocyte [NX]" "Blood RNA - eosinophil [NX]" "Blood RNA - gdT-cell [NX]" "Blood RNA - intermediate monocyte [NX]" "Blood RNA - MAIT T-cell [NX]" "Blood RNA - memory B-cell [NX]" "Blood RNA - memory CD4 T-cell [NX]" "Blood RNA - memory CD8 T-cell [NX]" "Blood RNA - myeloid DC [NX]" "Blood RNA - naive B-cell [NX]" "Blood RNA - naive CD4 T-cell [NX]" "Blood RNA - naive CD8 T-cell [NX]" "Blood RNA - neutrophil [NX]" "Blood RNA - NK-cell [NX]" "Blood RNA - non-classical monocyte [NX]" "Blood RNA - plasmacytoid DC [NX]" "Blood RNA - T-reg [NX]" "Blood RNA - total PBMC [NX]" "Brain RNA - amygdala [NX]" "Brain RNA - basal ganglia [NX]" "Brain RNA - cerebellum [NX]" "Brain RNA - cerebral cortex [NX]" "Brain RNA - hippocampal formation [NX]" "Brain RNA - hypothalamus [NX]" "Brain RNA - midbrain [NX]" "Brain RNA - olfactory region [NX]" "Brain RNA - pons and medulla [NX]" "Brain RNA - thalamus [NX]" ABCC1 "GS-X, MRP, MRP1" ENSG00000103222 "ATP binding cassette subfamily C member 1" P33527 16 15949577-16143074 "Cancer-related genes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, Transporters" Transport Hydrolase "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "EFO-21: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.5;eosinophil: 3.1;T-reg: 2.1" "Group enriched" "Detected in many" 7 "granulocytes: 7.5;T-cells: 2.1" "Low region specificity" "Detected in all" HPA002380 Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA002380: AB_1844432" "unprognostic (9.97e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-2)" "unprognostic (2.94e-1)" "unprognostic (4.89e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (5.42e-5)" "unprognostic (3.42e-1)" "unprognostic (3.31e-1)" "unprognostic (4.07e-2)" "unprognostic (9.78e-3)" "unprognostic (7.19e-2)" "prognostic unfavourable (1.55e-6)" "unprognostic (1.84e-1)" "unprognostic (1.15e-1)" "unprognostic (1.43e-2)" "unprognostic (1.80e-2)" 8.9 8.2 2.4 8.3 3.1 8.4 9.6 4.4 5.0 8.3 10.7 2.6 15.5 3.5 10.5 12.7 14.7 5.6 9.6 8.0 2.1 2.4 4.5 1.6 10.9 12.2 3.0 2.1 6.8 5.8 18.4 4.2 5.2 4.1 9.6 4.1 12.0 16.9 10.9 20.8 6.6 8.2 16.4 4.0 9.2 10.9 15.1 2.3 26.8 15.7 12.6 15.6 15.3 11.8 0.7 0.5 7.5 0.5 0.4 2.1 0.2 2.2 24.2 0.1 6.3 5.6 3.5 1.3 7.1 8.7 6.2 6.4 3.8 17.5 6.6 38.2 13.7 6.5 2.0 7.0 4.7 11.5 2.2 8.1 14.2 14.0 16.7 2.9 21.1 7.3 4.7 1.8 1.0 6.8 8.2 3.4 1.9 4.5 5.2 2.7 3.8 3.6 18.5 3.6 3.2 2.3 8.2 3.5 5.8 9.0 9.8 2.4 3.4 1.5 0.6 0.4 1.4 5.1 5.7 6.3 3.2 2.2 3.2 3.0 0.7 7.5 0.1 3.1 0.6 0.4 0.6 0.7 0.5 0.6 0.5 0.3 0.6 0.6 0.0 0.4 0.5 0.3 2.1 0.2 2.4 3.1 4.4 5.0 2.1 2.4 3.0 2.1 4.1 2.3 ABCC3 "cMOAT2, EST90757, MLP2, MOAT-D, MRP3" ENSG00000108846 "ATP binding cassette subfamily C member 3" O15438 17 50634777-50692252 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 53.5;liver: 66.2" "Cell line enhanced" "Detected in many" "A549: 33.9;CAPAN-2: 25.9;HeLa: 14.3;RPTEC TERT1: 14.8;RT4: 14.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 6.2;non-classical monocyte: 7.6" "Lineage enriched" "Detected in many" 5 "monocytes: 7.6" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "CAB037136, HPA048483" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB037136: AB_477165, HPA048483: " "unprognostic (1.57e-2)" "unprognostic (1.60e-1)" "unprognostic (1.53e-1)" "unprognostic (1.65e-2)" "unprognostic (9.67e-3)" "unprognostic (6.19e-3)" "unprognostic (7.44e-3)" "unprognostic (8.20e-2)" "unprognostic (3.18e-1)" "unprognostic (5.13e-2)" "prognostic unfavourable (9.57e-4)" "unprognostic (1.60e-3)" "prognostic unfavourable (4.68e-6)" "unprognostic (3.42e-1)" "unprognostic (4.77e-2)" "unprognostic (4.44e-2)" "unprognostic (1.57e-3)" 3.5 36.0 0.4 17.0 0.4 0.5 7.7 0.3 0.4 1.9 23.9 0.8 14.1 10.3 1.6 4.6 5.3 1.0 53.5 0.8 0.4 0.4 13.5 66.2 9.0 10.3 0.6 0.0 1.0 22.2 1.7 0.8 3.5 1.5 5.4 7.7 0.8 4.7 23.6 0.4 4.8 37.0 2.5 4.6 4.9 12.8 1.0 0.0 0.8 4.5 7.0 7.9 7.1 3.5 0.0 1.6 1.3 7.6 0.3 0.5 7.4 2.4 33.9 0.0 0.1 1.9 3.0 0.0 4.5 5.7 0.3 0.3 1.8 25.9 0.0 3.5 8.8 6.2 0.0 0.4 0.4 0.0 0.0 0.7 14.3 10.3 7.7 0.0 0.0 3.4 2.5 1.3 2.8 0.6 0.0 0.0 3.5 7.9 0.0 0.0 0.0 4.5 0.0 0.0 0.1 14.8 14.7 0.0 0.3 8.2 1.4 0.0 1.1 0.0 7.5 0.2 1.5 0.1 3.6 0.0 0.0 0.0 3.7 0.0 0.3 0.3 2.8 0.0 0.0 6.2 0.0 0.0 0.1 0.0 1.6 0.0 0.0 0.0 1.3 0.3 7.6 0.2 0.5 7.4 0.4 0.4 0.3 0.4 0.4 0.4 0.6 0.0 1.5 0.0 ABCC6 "ARA, EST349056, MLP1, MRP6, PXE, URG7" ENSG00000091262 "ATP binding cassette subfamily C member 6" O95255 16 16148928-16223522 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Sensory transduction, Transport, Vision" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 27.4" "Cell line enriched" "Detected in some" 8 "Hep G2: 37.7" "Cancer enhanced" "Detected in many" "liver cancer: 16.7" "Cell type enriched" "Detected in some" 5 "classical monocyte: 7.3" "Lineage enriched" "Detected in many" 5 "monocytes: 7.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA038105 Supported "Plasma membrane" "Plasma membrane" "HPA038105: " "unprognostic (1.32e-1)" "unprognostic (1.11e-1)" "unprognostic (5.98e-2)" "unprognostic (3.15e-2)" "unprognostic (1.59e-1)" "unprognostic (3.09e-1)" "prognostic favourable (3.82e-4)" "unprognostic (6.54e-3)" "unprognostic (3.64e-1)" "unprognostic (9.10e-2)" "unprognostic (1.30e-1)" "unprognostic (1.65e-1)" "unprognostic (1.12e-3)" "unprognostic (3.42e-1)" "unprognostic (2.00e-1)" "unprognostic (4.91e-2)" "unprognostic (1.41e-1)" 2.3 1.4 0.2 0.0 0.2 0.0 1.1 0.0 0.0 0.1 1.5 7.0 0.0 0.0 0.0 0.3 1.2 0.8 0.1 0.1 9.0 27.4 2.8 0.0 0.2 0.1 6.7 0.5 0.1 0.0 0.7 1.2 6.7 0.2 1.7 0.0 3.7 0.0 0.2 0.1 2.2 0.0 2.2 0.0 0.0 0.0 0.2 0.9 1.3 7.3 0.6 0.1 1.2 0.0 0.9 0.4 0.0 0.0 0.5 1.1 0.0 0.2 0.5 0.9 3.7 1.4 0.0 0.5 0.0 0.0 0.4 0.0 0.3 0.0 0.4 1.1 0.1 37.7 0.2 0.0 0.2 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.9 0.2 0.0 0.0 0.0 0.0 1.3 0.0 0.1 0.6 0.0 0.4 0.1 4.8 3.1 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 1.0 7.3 0.3 0.0 1.0 0.0 0.0 0.1 0.0 0.9 0.2 0.1 0.1 1.3 0.6 0.1 0.1 0.0 1.2 AC004691.2 ENSG00000250424 7 30852273-30923812 "Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in some" "Cell line enhanced" "Detected in some" "A549: 1.3;ASC diff: 1.1;SH-SY5Y: 1.9;SK-BR-3: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA019206, HPA030130" Approved Approved "Plasma membrane" "Plasma membrane" "HPA019206: AB_1844965, HPA030130: AB_10601565" "unprognostic (2.15e-1)" "unprognostic (3.12e-1)" "unprognostic (1.83e-1)" "unprognostic (1.66e-1)" "unprognostic (2.72e-4)" "unprognostic (5.13e-2)" "unprognostic (3.44e-2)" "unprognostic (2.15e-1)" "unprognostic (2.88e-2)" "unprognostic (3.76e-1)" "unprognostic (2.49e-1)" "unprognostic (3.71e-2)" 0.8 0.2 0.0 0.0 0.4 0.2 0.6 0.0 0.3 1.1 1.3 1.4 1.4 1.5 0.7 2.4 3.1 0.8 0.0 0.1 0.5 0.0 1.1 0.0 0.0 0.6 2.2 0.0 0.3 0.0 0.7 0.2 0.7 1.2 0.4 0.3 0.4 2.3 0.0 0.0 0.9 0.1 0.7 0.0 1.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 1.3 0.0 0.4 1.1 0.0 0.0 0.0 0.0 0.0 0.4 0.6 0.6 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 1.2 0.0 0.3 0.0 0.0 0.0 0.0 0.3 0.0 0.5 0.6 0.0 0.3 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 ADAM12 "MCMPMltna, MLTN" ENSG00000148848 "ADAM metallopeptidase domain 12" O43184 10 126012381-126388455 "Predicted membrane proteins, Predicted secreted proteins, Transporters" "Cell adhesion" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 50 "placenta: 487.4" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 46.4;hTEC/SVTERT24-B: 29.2;U-2197: 28.8;U-251 MG: 25.7;U-87 MG: 22.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Cell type enriched" "Detected in some" 5 "MAIT T-cell: 9.8" "Lineage enriched" "Detected in single" 98 "T-cells: 9.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "HPA030866, HPA030867, HPA030868" Enhanced Supported "Plasma membrane" "Secreted in female reproductive system" "Plasma membrane" "HPA030866: , HPA030867: AB_10602428, HPA030868: " "unprognostic (3.35e-1)" "unprognostic (1.05e-3)" "unprognostic (3.52e-2)" "unprognostic (2.47e-2)" "unprognostic (3.34e-2)" "unprognostic (2.16e-1)" "unprognostic (2.91e-6)" "unprognostic (2.17e-2)" "unprognostic (4.85e-2)" "unprognostic (1.30e-2)" "unprognostic (2.53e-2)" "unprognostic (1.09e-1)" "prognostic unfavourable (2.39e-14)" "unprognostic (3.11e-3)" "unprognostic (9.06e-3)" "unprognostic (4.70e-3)" "unprognostic (3.47e-3)" 6.0 0.0 0.6 2.1 2.8 0.0 5.9 0.6 0.6 8.0 0.5 0.5 0.4 0.0 2.6 0.5 0.5 0.1 4.6 0.7 0.6 0.7 1.0 0.4 1.1 1.0 0.8 0.5 8.2 0.6 0.0 1.1 487.4 0.8 0.7 0.1 0.9 1.1 0.4 0.5 0.3 0.4 1.5 0.7 0.5 0.1 0.7 0.6 0.5 0.4 0.5 1.2 4.5 0.8 0.0 0.0 0.0 0.0 0.0 9.8 0.1 4.9 0.7 2.0 0.0 5.9 12.2 0.0 12.9 1.0 4.4 11.1 0.0 0.0 0.0 0.0 46.4 0.0 0.0 0.4 4.8 0.5 0.1 0.0 7.9 0.0 0.9 0.0 10.3 14.9 0.0 29.2 0.9 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.8 0.0 1.5 1.3 0.1 13.3 0.1 8.8 1.5 0.0 0.2 0.0 0.0 0.0 15.9 5.3 28.8 25.7 0.0 0.1 0.0 22.1 0.0 9.8 0.0 0.0 0.0 0.5 0.0 9.8 0.0 0.4 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.1 0.6 2.8 0.6 0.6 0.6 0.7 0.8 0.5 0.8 0.6 ADAMTS1 "C3-C5, KIAA1346, METH1" ENSG00000154734 "ADAM metallopeptidase with thrombospondin type 1 motif 1" Q9UHI8 21 26835747-26845409 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins, Transporters" "Heparin-binding, Hydrolase, Metalloprotease, Protease" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 112.8" "Cell line enhanced" "Detected in many" "ASC diff: 60.9;BJ: 71.0;hTEC/SVTERT24-B: 49.0;hTERT-HME1: 44.6;RPTEC TERT1: 41.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "gdT-cell: 8.0;NK-cell: 9.0" "Group enriched" "Detected in many" 85 "NK-cells: 9.0;T-cells: 8.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in some" "CAB016394, HPA031498" Uncertain Approved "Plasma membrane" "Secreted to extracellular matrix" 1900000 "Plasma membrane" "CAB016394: AB_626637, HPA031498: " "unprognostic (6.82e-2)" "unprognostic (1.35e-1)" "unprognostic (1.21e-1)" "unprognostic (1.64e-1)" "unprognostic (1.18e-2)" "prognostic unfavourable (5.13e-4)" "unprognostic (1.03e-1)" "unprognostic (3.28e-1)" "unprognostic (2.37e-2)" "unprognostic (5.39e-2)" "unprognostic (1.75e-1)" "unprognostic (4.55e-2)" "unprognostic (9.70e-3)" "unprognostic (8.27e-3)" "unprognostic (1.12e-1)" "unprognostic (6.76e-2)" "unprognostic (1.57e-1)" 70.6 13.4 8.2 18.7 14.0 0.7 29.0 6.3 9.2 22.0 18.2 9.5 4.8 3.3 27.7 25.8 30.0 45.8 62.3 40.9 7.6 4.8 15.4 22.8 25.0 10.9 12.7 3.7 112.8 9.3 6.3 7.6 56.8 13.2 23.3 16.5 7.8 5.8 8.1 25.7 6.1 16.2 46.4 10.2 7.2 16.8 12.8 11.4 0.0 14.3 18.1 2.7 32.7 45.3 0.0 0.0 0.0 0.0 9.0 8.0 1.4 0.0 0.0 1.1 0.0 60.9 15.1 3.7 71.0 24.8 12.3 8.1 0.0 0.0 0.0 4.9 22.5 1.3 0.8 3.6 21.7 0.0 22.6 0.0 7.4 0.0 11.7 2.8 0.0 16.9 0.0 49.0 44.6 5.0 1.2 0.0 36.4 0.0 0.3 0.0 4.0 2.8 0.0 28.1 0.2 41.6 4.0 0.0 5.5 3.3 0.0 0.3 0.1 0.7 5.1 17.5 0.9 27.2 10.5 0.1 0.0 0.0 14.4 0.0 5.3 0.0 0.0 0.0 8.0 0.0 0.8 0.0 0.3 0.6 0.0 0.0 0.0 1.5 0.0 9.0 0.0 0.0 0.0 1.4 8.2 14.0 6.3 9.2 7.6 4.8 12.7 3.7 13.2 11.4 ADD3 ADDL ENSG00000148700 "Adducin 3" Q9UEY8 10 109996368-110135565 "Disease related genes, Predicted intracellular proteins" "Actin-binding, Calmodulin-binding" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 71.4;ASC TERT1: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB009797, HPA035696" Supported Supported "Plasma membrane" 29000 "Plasma membrane" "CAB009797: AB_2223583, HPA035696: " "unprognostic (2.66e-1)" "unprognostic (2.63e-2)" "unprognostic (1.46e-3)" "unprognostic (1.64e-1)" "unprognostic (2.65e-2)" "unprognostic (1.75e-2)" "unprognostic (1.57e-3)" "unprognostic (6.42e-2)" "unprognostic (5.73e-2)" "unprognostic (2.37e-2)" "unprognostic (7.58e-2)" "unprognostic (9.12e-2)" "unprognostic (2.34e-3)" "unprognostic (1.36e-1)" "unprognostic (4.03e-1)" "unprognostic (3.68e-2)" "unprognostic (5.92e-2)" 22.9 9.4 65.7 15.9 46.8 15.8 40.4 29.6 44.4 27.2 26.0 44.1 20.1 32.4 11.8 28.7 17.1 22.4 31.9 26.1 63.3 29.9 45.7 11.4 16.2 29.5 37.5 42.8 20.3 31.3 10.4 15.0 14.9 41.1 15.4 30.5 22.3 25.7 16.6 5.1 17.6 37.7 13.4 54.5 17.1 28.6 21.7 52.7 24.0 41.9 9.3 29.1 21.3 22.0 20.7 9.0 46.8 11.5 25.6 35.2 31.2 7.0 1.4 10.5 4.5 71.4 67.2 4.6 9.0 24.4 6.0 11.3 15.3 23.0 22.5 10.8 13.8 2.4 9.5 6.4 9.1 2.2 10.7 2.0 7.4 10.5 8.1 7.5 17.1 32.6 3.1 14.4 0.6 8.4 5.6 12.4 10.3 0.2 8.0 6.8 6.5 3.6 6.8 13.6 1.1 15.1 3.6 1.6 16.8 6.6 2.2 15.4 2.7 2.6 2.0 3.6 10.3 7.5 2.0 17.6 7.7 21.0 10.8 3.8 6.1 46.8 10.4 37.2 28.2 9.7 22.7 20.7 30.3 24.4 9.0 16.3 35.2 28.1 18.2 25.6 11.5 6.0 27.4 31.2 65.7 46.8 29.6 44.4 63.3 29.9 37.5 42.8 41.1 52.7 ADORA1 RDC7 ENSG00000163485 "Adenosine A1 receptor" P30542 1 203090654-203167405 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.7" "Cell line enhanced" "Detected in some" "CACO-2: 19.3;MCF7: 11.6;RH-30: 31.9;RPTEC TERT1: 15.5;SK-BR-3: 17.3;U-138 MG: 10.4" "Cancer enhanced" "Detected in many" "glioma: 24.5" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044383 Supported "Plasma membrane" "Plasma membrane" "HPA044383: " "unprognostic (3.93e-3)" "unprognostic (8.16e-2)" "unprognostic (6.16e-2)" "unprognostic (2.38e-3)" "unprognostic (2.25e-2)" "unprognostic (2.34e-1)" "unprognostic (4.64e-2)" "unprognostic (4.17e-2)" "unprognostic (3.04e-1)" "unprognostic (4.80e-3)" "unprognostic (1.42e-1)" "unprognostic (2.98e-1)" "unprognostic (2.96e-3)" "unprognostic (1.54e-1)" "unprognostic (1.27e-1)" "unprognostic (4.13e-2)" "unprognostic (5.76e-4)" 4.5 1.0 19.7 2.6 21.7 0.8 6.1 9.7 38.7 1.1 1.6 27.4 0.0 2.0 2.0 1.6 1.6 2.0 1.8 13.8 19.8 12.1 4.2 1.0 2.8 1.4 22.8 13.4 0.8 15.5 15.5 0.9 8.9 25.0 1.2 1.6 1.8 8.9 1.3 2.0 1.9 1.8 1.3 20.7 7.4 1.6 16.3 15.9 0.0 3.2 0.0 1.4 3.4 0.3 0.0 0.6 0.0 0.1 0.0 0.0 0.1 0.1 1.4 0.3 0.1 0.1 0.8 0.1 0.9 1.4 0.3 0.2 19.3 0.3 0.0 4.4 3.5 0.0 0.3 0.0 0.1 0.0 0.5 0.0 0.2 0.0 0.3 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.0 0.0 3.0 11.6 0.0 0.0 5.0 0.0 0.0 31.9 1.0 15.5 0.0 0.3 0.3 2.1 17.3 0.2 1.0 0.4 0.0 10.4 5.3 0.0 5.6 0.0 0.0 0.0 5.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 19.7 21.7 9.7 25.7 19.8 12.1 22.8 13.4 25.0 15.9 ADRA1B ENSG00000170214 "Adrenoceptor alpha 1B" P35368 5 159865080-159972544 "Cancer-related genes, FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.6;liver: 20.3;lymphoid tissue: 17.4" "Cell line enhanced" "Detected in some" "EFO-21: 13.0;HaCaT: 6.6;TIME: 11.0;U-2 OS: 9.2;U-251 MG: 7.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA074416 Supported "Plasma membrane" "Plasma membrane" "HPA074416: " "unprognostic (4.93e-3)" "unprognostic (2.94e-2)" "unprognostic (1.79e-1)" "prognostic unfavourable (6.00e-5)" "prognostic unfavourable (6.98e-4)" "unprognostic (4.08e-3)" "unprognostic (1.67e-3)" "unprognostic (1.68e-1)" "unprognostic (6.12e-2)" "prognostic favourable (2.67e-4)" "unprognostic (2.28e-1)" "unprognostic (1.37e-1)" "prognostic unfavourable (1.40e-6)" "unprognostic (5.24e-4)" "unprognostic (2.54e-1)" "prognostic favourable (3.19e-5)" "unprognostic (1.59e-2)" 5.3 2.9 5.3 0.9 9.0 0.4 2.3 1.3 21.6 0.9 1.2 0.7 0.8 1.2 1.5 3.6 1.1 3.6 1.3 3.3 6.2 5.8 7.4 20.3 4.7 2.3 1.2 13.9 6.2 0.8 1.0 0.8 1.1 5.2 1.6 1.1 0.9 1.0 1.9 1.6 1.3 1.7 1.2 0.9 17.4 0.9 0.8 0.5 0.0 2.0 0.0 1.1 0.8 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 4.7 0.3 0.0 2.4 0.9 0.1 0.5 0.2 0.6 0.3 0.0 4.2 0.0 13.0 3.8 6.6 0.0 0.5 0.3 0.0 0.3 0.0 1.6 0.0 5.0 0.0 0.0 2.8 0.0 0.0 0.2 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.1 0.6 0.0 0.7 0.0 4.5 0.0 0.4 0.0 0.0 0.3 0.4 0.1 0.0 11.0 0.1 9.2 0.0 7.0 0.0 0.0 0.0 3.3 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.3 9.0 1.3 21.6 6.2 5.8 1.2 13.9 5.2 0.5 AL355315.1 ENSG00000249967 10 97584374-97673910 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 22.2;liver: 15.1" "Cell line enhanced" "Detected in some" "AN3-CA: 3.6;EFO-21: 3.9;HaCaT: 1.9;HBEC3-KT: 2.9;HBF TERT88: 2.0;T-47d: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "NK-cell: 1.0" "Lineage enhanced" "Detected in single" "NK-cells: 1.0" HPA076857 Uncertain "Plasma membrane" "Plasma membrane" "HPA076857: " 2.4 1.1 1.9 0.3 2.3 0.3 1.0 4.6 3.3 1.9 0.9 5.5 0.6 0.3 1.1 2.5 0.8 2.7 2.3 4.9 2.6 1.0 22.2 15.1 0.8 0.3 6.4 3.3 0.8 2.4 5.7 0.9 0.6 4.8 0.8 0.3 2.1 0.8 3.9 2.2 0.9 0.8 0.8 5.5 0.9 0.9 0.9 4.6 0.0 0.8 2.5 0.4 1.0 0.9 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.1 0.0 0.6 3.6 0.0 1.2 0.0 0.0 0.4 0.0 1.2 0.0 0.0 0.0 3.9 0.6 1.9 0.0 2.9 2.0 0.0 0.2 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.2 1.1 0.0 0.7 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 1.9 2.3 4.6 2.3 2.6 1.0 6.4 3.3 4.8 4.6 ALK CD246 ENSG00000171094 "ALK receptor tyrosine kinase" Q9UM73 2 29192774-29921566 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 8.1;pituitary gland: 17.9" "Cell line enriched" "Detected in some" 6 "SH-SY5Y: 26.4" "Group enriched" "Detected in some" 5 "glioma: 1.0;melanoma: 1.5;ovarian cancer: 0.7;thyroid cancer: 1.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA010694 Approved Supported "Plasma membrane" "Plasma membrane" "HPA010694: AB_1078133" "unprognostic (4.96e-2)" "unprognostic (1.11e-2)" "unprognostic (1.45e-1)" "unprognostic (4.56e-7)" "unprognostic (7.17e-2)" "unprognostic (1.71e-1)" "unprognostic (9.07e-3)" "unprognostic (6.29e-3)" "unprognostic (1.18e-1)" "unprognostic (1.01e-1)" "unprognostic (2.67e-4)" "unprognostic (3.70e-2)" "unprognostic (2.06e-2)" "unprognostic (7.15e-2)" "unprognostic (1.98e-1)" "unprognostic (1.38e-1)" "unprognostic (3.61e-2)" 1.8 3.1 3.6 1.2 4.4 0.3 1.1 0.5 8.1 0.7 2.1 2.0 0.0 0.7 0.5 0.5 0.6 0.5 1.2 0.4 3.4 4.9 0.4 0.5 1.1 0.5 2.7 4.2 0.6 0.4 0.4 17.9 0.5 5.5 0.5 1.2 2.4 0.9 0.8 0.3 0.9 1.5 0.9 2.1 0.5 0.8 4.9 0.9 0.0 1.6 0.0 0.3 0.6 1.2 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.4 0.0 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 3.5 0.0 0.0 0.1 0.3 26.4 0.0 0.0 0.6 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 3.1 0.0 4.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.6 4.4 0.5 5.9 3.4 4.9 2.7 4.2 5.5 0.9 ALPI ENSG00000163295 "Alkaline phosphatase, intestinal" P09923 2 232456123-232460032 "Enzymes, Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 406 "intestine: 133.2" "Cell line enriched" "Detected in some" 12 "CACO-2: 12.4" "Cancer enhanced" "Detected in many" "liver cancer: 4.7" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA038764: , HPA038765: , HPA051699: " "unprognostic (1.01e-1)" "unprognostic (7.71e-2)" "unprognostic (4.14e-2)" "unprognostic (1.47e-1)" "unprognostic (9.57e-4)" "unprognostic (8.07e-2)" "unprognostic (1.71e-1)" "unprognostic (9.99e-2)" 0.1 0.1 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.1 63.0 0.0 0.0 57.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.1 1.3 0.0 0.1 0.0 0.1 0.1 133.2 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 12.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 ALPP ENSG00000163283 "Alkaline phosphatase, placental" P05187 2 232378534-232382889 "Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins" Hydrolase "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 17 "placenta: 240.2" "Group enriched" "Detected in some" 6 "HaCaT: 86.1;SiHa: 23.7" "Cancer enhanced" "Detected in many" "endometrial cancer: 15.3" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "CAB026327, HPA038764, HPA038765, HPA051699" Enhanced Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB026327: , HPA038764: , HPA038765: , HPA051699: " "unprognostic (4.86e-2)" "unprognostic (5.19e-3)" "unprognostic (6.67e-3)" "unprognostic (2.60e-1)" "unprognostic (2.44e-3)" "unprognostic (1.26e-2)" "prognostic unfavourable (4.33e-4)" "unprognostic (1.44e-1)" "unprognostic (4.09e-1)" "unprognostic (2.12e-1)" "unprognostic (1.27e-2)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 14.5 0.1 0.0 0.0 0.0 0.1 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 9.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 240.2 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 1.0 0.5 1.6 0.5 1.1 0.5 0.3 0.4 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.1 9.7 0.0 0.0 0.0 86.1 0.0 0.0 0.0 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 23.7 8.4 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.4 0.7 0.5 0.2 0.5 0.3 0.3 0.3 0.1 1.0 0.4 0.4 1.6 1.1 0.5 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ALPPL2 ENSG00000163286 "Alkaline phosphatase, placental like 2" P10696 2 232406843-232410714 "Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "fallopian tube: 4.2;lung: 9.4" "Group enriched" "Detected in some" 4 "CAPAN-2: 24.5;HaCaT: 18.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 49.1;testis cancer: 64.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "CAB020698, HPA038764, HPA038765, HPA051699" Supported Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB020698: , HPA038764: , HPA038765: , HPA051699: " "unprognostic (1.39e-1)" "unprognostic (6.63e-3)" "unprognostic (1.27e-2)" "unprognostic (2.89e-1)" "unprognostic (1.46e-1)" "unprognostic (1.26e-1)" "unprognostic (1.69e-3)" "unprognostic (1.65e-1)" "unprognostic (2.67e-1)" "unprognostic (6.72e-3)" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.0 1.0 0.0 0.0 0.2 1.5 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 9.4 0.0 0.0 0.0 1.5 0.0 0.0 0.0 1.9 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.6 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 0.0 0.0 0.5 24.5 0.0 0.0 0.0 18.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 ANK2 LQT4 ENSG00000145362 "Ankyrin 2" Q01484 4 112818109-113383740 "Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Transporters" "Endocytosis, Protein transport, Transport" "Disease mutation, Long QT syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 58.5;heart muscle: 56.7;kidney: 59.8;skeletal muscle: 66.9" "Cell line enhanced" "Detected in many" "ASC diff: 16.1;ASC TERT1: 22.5;RH-30: 30.8;SH-SY5Y: 15.5" "Cancer enhanced" "Detected in many" "glioma: 10.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008007, CAB015178, HPA035970" Enhanced Approved Supported "Plasma membrane" "Plasma membrane" "CAB015178: AB_2242828, HPA008007: , HPA035970: " "unprognostic (8.33e-2)" "unprognostic (9.47e-2)" "unprognostic (1.33e-2)" "unprognostic (7.63e-2)" "unprognostic (2.73e-1)" "unprognostic (1.71e-1)" "unprognostic (1.54e-1)" "unprognostic (2.15e-2)" "unprognostic (1.23e-1)" "unprognostic (1.63e-1)" "unprognostic (1.79e-3)" "unprognostic (2.94e-2)" "prognostic unfavourable (2.41e-6)" "unprognostic (1.18e-2)" "unprognostic (3.16e-1)" "unprognostic (1.51e-3)" "unprognostic (2.04e-3)" 17.3 8.7 34.0 6.3 42.1 0.8 10.7 43.7 58.5 20.9 9.5 24.5 0.6 4.3 10.5 4.3 8.3 5.8 13.0 56.7 29.4 30.3 59.8 2.0 4.6 5.1 28.7 38.7 19.0 2.4 1.6 8.6 2.0 42.1 5.4 7.2 7.8 2.6 8.7 66.9 3.5 4.7 15.2 19.0 15.1 3.8 5.8 24.2 0.0 5.6 4.4 4.5 4.5 4.8 0.6 0.0 0.0 0.0 0.0 0.1 0.0 0.0 1.9 10.2 4.2 16.1 22.5 0.0 1.0 1.8 0.7 2.0 4.0 0.0 4.2 1.4 3.6 0.0 7.5 0.4 0.6 1.9 6.2 2.4 0.0 1.7 1.0 1.0 0.7 9.6 1.6 0.9 3.9 0.0 0.0 6.9 3.4 0.1 0.2 0.0 5.3 1.7 0.5 30.8 0.0 0.1 0.0 8.3 15.5 0.1 0.3 5.3 0.1 0.6 0.0 3.2 1.7 0.2 1.9 4.1 1.1 0.6 12.7 0.4 4.7 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.0 42.1 43.7 54.3 29.4 30.3 28.7 38.7 42.1 24.2 ANK3 ENSG00000151150 "Ankyrin 3" Q12955 10 60026298-60733490 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autism spectrum disorder, Cancer-related genes, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 95.4;parathyroid gland: 74.4" "Cell line enhanced" "Detected in many" "RT4: 24.3;SK-BR-3: 24.4" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "CAB013249, CAB015179, HPA038455" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB013249: AB_2533145, CAB015179: AB_633909, HPA038455: " "unprognostic (1.91e-1)" "unprognostic (5.33e-3)" "unprognostic (6.76e-3)" "unprognostic (1.94e-1)" "unprognostic (1.13e-1)" "unprognostic (3.70e-3)" "unprognostic (3.47e-1)" "unprognostic (1.62e-1)" "unprognostic (1.89e-1)" "unprognostic (1.21e-2)" "unprognostic (3.83e-1)" "unprognostic (2.28e-2)" "prognostic favourable (8.88e-16)" "unprognostic (5.75e-2)" "unprognostic (2.59e-1)" "unprognostic (1.00e-1)" "unprognostic (2.83e-2)" 2.7 3.1 21.1 3.1 24.8 1.1 9.1 95.4 29.1 5.5 10.5 21.5 19.4 15.7 9.7 52.9 7.1 8.2 8.9 31.2 24.4 16.4 38.9 6.6 10.1 2.5 26.8 19.8 5.2 5.0 74.4 10.5 31.9 31.9 8.6 8.8 6.5 16.1 19.4 29.2 16.0 10.6 5.9 16.5 5.9 6.3 3.4 30.0 0.6 17.2 4.6 3.4 5.6 6.6 6.2 3.5 1.7 0.4 2.1 7.7 1.3 4.1 2.4 15.0 0.2 0.0 0.9 11.6 0.3 0.2 0.0 0.3 10.7 8.1 0.2 4.9 0.3 5.9 8.0 7.2 0.2 0.2 5.4 0.1 4.6 0.0 3.1 0.0 0.2 7.4 4.6 3.8 0.2 1.7 2.0 10.1 3.4 13.8 0.0 0.4 6.8 13.0 0.0 10.8 2.0 2.7 24.3 7.8 1.4 0.3 24.4 0.0 14.2 0.0 4.9 0.4 1.5 6.6 0.7 0.4 0.0 0.0 2.7 0.1 9.3 1.7 0.4 0.6 4.1 0.3 3.7 6.2 7.0 2.2 0.2 1.9 7.7 1.9 1.1 2.1 0.4 3.5 1.0 1.3 21.1 24.8 95.4 29.1 24.4 16.4 26.8 19.8 31.9 30.0 ANKRD13A "ANKRD13, NY-REN-25" ENSG00000076513 "Ankyrin repeat domain 13A" Q8IZ07 12 109999186-110039763 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "fHDF/TERT166: 48.8;HBF TERT88: 49.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039488, HPA043218" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA039488: AB_10673612, HPA043218: AB_2678367" "unprognostic (1.54e-1)" "unprognostic (3.94e-3)" "unprognostic (5.81e-1)" "unprognostic (1.62e-2)" "unprognostic (1.05e-1)" "prognostic favourable (7.70e-6)" "unprognostic (5.68e-2)" "unprognostic (1.31e-2)" "unprognostic (2.19e-1)" "prognostic unfavourable (6.77e-4)" "unprognostic (9.71e-3)" "unprognostic (1.67e-1)" "unprognostic (2.67e-2)" "unprognostic (2.57e-1)" "unprognostic (2.13e-2)" "unprognostic (1.08e-1)" "unprognostic (5.29e-2)" 11.1 12.3 7.0 19.8 12.6 18.3 10.2 6.8 12.8 10.6 13.8 23.3 8.6 7.9 12.0 6.9 19.9 9.8 13.1 9.1 9.2 6.4 12.8 14.0 15.1 28.7 13.1 8.3 11.1 10.6 6.5 5.3 39.4 9.5 12.6 13.0 17.1 21.7 15.1 6.2 21.1 16.8 31.0 12.3 24.2 12.7 45.8 13.8 13.3 19.1 8.0 36.5 21.5 13.0 3.9 2.5 8.9 4.2 1.4 2.9 1.3 37.4 1.7 4.1 3.8 6.4 6.3 5.1 37.7 36.2 36.5 19.5 5.0 2.5 25.0 2.9 48.8 4.5 5.2 5.7 49.4 27.9 4.3 9.2 3.9 4.1 5.6 10.7 11.1 5.5 6.1 15.6 9.0 5.5 7.1 4.1 16.2 1.3 9.4 4.7 2.2 7.8 8.2 11.5 9.9 5.3 4.9 8.5 4.0 7.0 13.9 4.8 6.3 9.1 6.9 27.4 4.8 15.1 20.3 8.8 5.2 33.4 13.4 7.5 3.9 2.6 1.9 8.9 0.9 4.2 2.9 3.9 2.4 1.1 2.5 1.9 1.4 1.8 6.0 1.4 2.0 1.9 1.0 1.3 7.0 12.6 6.8 12.8 9.2 6.4 13.1 8.3 9.5 13.8 ANPEP "CD13, gp150, LAP1, p150, PEPN" ENSG00000166825 "Alanyl aminopeptidase, membrane" P15144 15 89784889-89815401 "CD markers, Enzymes, Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Aminopeptidase, Developmental protein, Host cell receptor for virus entry, Hydrolase, Metalloprotease, Protease, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 195.3;kidney: 78.7;pancreas: 93.9" "Cell line enhanced" "Detected in many" "ASC TERT1: 77.0;BJ: 76.7;BJ hTERT+: 109.7;HMC-1: 69.8;HSkMC: 67.4;HUVEC TERT2: 85.8;TIME: 85.8;U-2197: 93.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enriched" "Detected in many" 5 "neutrophil: 59.4" "Lineage enriched" "Detected in many" 5 "granulocytes: 59.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in single" "CAB002417, HPA004625" Enhanced Supported "Plasma membrane" 1500000000 "Plasma membrane" "CAB002417: AB_563491, HPA004625: " "unprognostic (6.31e-2)" "unprognostic (7.94e-3)" "unprognostic (6.91e-2)" "unprognostic (2.16e-1)" "unprognostic (2.50e-1)" "unprognostic (1.13e-1)" "unprognostic (2.23e-2)" "unprognostic (1.89e-1)" "unprognostic (2.50e-1)" "unprognostic (7.73e-2)" "unprognostic (5.28e-3)" "unprognostic (3.96e-1)" "unprognostic (4.04e-3)" "unprognostic (3.20e-2)" "unprognostic (2.01e-2)" "unprognostic (4.61e-3)" "unprognostic (1.99e-2)" 21.3 1.1 0.6 2.9 0.8 9.5 17.0 1.0 1.3 8.2 21.2 0.8 0.5 195.3 1.4 8.4 3.6 1.4 27.7 3.7 0.4 0.3 78.7 37.7 9.7 9.3 0.9 0.9 1.8 93.9 0.0 0.7 14.7 1.3 8.6 4.7 4.0 6.6 1.8 1.6 4.9 155.8 4.3 1.2 7.2 0.8 4.7 0.2 5.6 1.5 4.2 3.8 4.7 3.0 0.0 6.9 59.4 12.8 0.0 0.0 5.5 0.0 4.9 0.0 0.0 60.1 77.0 0.5 76.7 109.7 9.4 8.3 0.5 0.0 0.0 0.9 65.8 0.0 0.5 0.0 3.7 0.0 0.0 14.5 0.4 11.4 35.4 1.0 69.8 67.4 0.1 29.7 0.0 85.8 0.4 0.1 3.6 0.0 0.0 34.1 0.2 5.2 0.0 0.0 0.8 42.9 0.0 0.1 0.7 0.0 0.1 0.0 0.0 6.7 85.8 41.4 0.0 93.5 0.0 0.0 0.0 0.0 0.1 0.0 2.2 5.7 12.8 10.4 0.0 7.0 0.0 0.0 0.0 0.0 6.9 0.0 0.0 0.0 59.4 0.0 12.0 0.1 0.0 5.5 0.6 0.8 1.0 1.3 0.4 0.3 0.9 0.9 1.3 0.2 AP2M1 "AP50, CLAPM1, mu2" ENSG00000161203 "Adaptor related protein complex 2 mu 1 subunit" Q96CW1 3 184174689-184184091 "Plasma proteins, Predicted intracellular proteins" "Endocytosis, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA036849, HPA069870" Uncertain Supported "Plasma membrane" 340000 "Plasma membrane" "HPA036849: AB_10672101, HPA069870: " "unprognostic (1.16e-1)" "unprognostic (1.35e-2)" "unprognostic (5.28e-3)" "unprognostic (4.96e-3)" "unprognostic (1.79e-1)" "unprognostic (2.88e-2)" "prognostic unfavourable (9.12e-4)" "unprognostic (3.80e-3)" "unprognostic (2.09e-1)" "unprognostic (5.53e-2)" "unprognostic (4.11e-2)" "unprognostic (9.18e-2)" "prognostic unfavourable (7.45e-6)" "unprognostic (2.61e-2)" "unprognostic (4.09e-2)" "unprognostic (1.60e-2)" "unprognostic (1.28e-1)" 37.6 78.2 58.6 38.3 78.2 47.7 32.5 64.2 111.9 52.4 42.7 33.5 35.4 40.7 46.7 27.0 54.9 39.1 41.2 86.8 62.5 64.6 39.7 36.8 35.8 35.2 57.5 83.0 49.8 26.0 53.6 48.2 59.0 79.8 40.0 35.6 44.4 40.2 61.3 33.9 38.1 36.1 60.3 41.5 34.1 32.9 27.8 32.1 30.5 35.3 34.5 37.1 49.5 38.8 26.4 59.3 51.4 62.6 34.9 39.5 77.6 47.9 36.9 31.8 35.7 51.1 53.8 32.9 80.9 47.1 91.5 64.4 39.7 35.2 22.0 99.0 121.0 54.6 42.9 54.7 75.8 45.2 53.6 56.9 42.4 35.1 60.4 27.9 36.2 68.2 31.1 57.9 37.2 67.9 27.2 43.3 85.6 109.9 35.9 16.6 77.4 55.4 33.5 40.6 43.6 56.7 43.8 33.9 24.7 63.5 80.0 37.5 107.1 34.1 72.8 58.1 47.2 56.7 106.6 39.1 34.2 49.2 109.5 41.3 37.8 37.5 62.6 51.4 32.5 52.7 32.0 26.4 30.3 31.1 59.3 25.5 26.1 26.7 28.5 34.9 42.2 29.7 39.5 77.6 58.6 78.2 64.2 111.9 62.5 64.6 57.5 83.0 79.8 32.1 APBB1 "Fe65, RIR" ENSG00000166313 "Amyloid beta precursor protein binding family B member 1" O00213 11 6395124-6419414 "Plasma proteins, Predicted intracellular proteins" "Apoptosis, DNA damage, Transcription, Transcription regulation" "Activator, Chromatin regulator, Repressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 84.6" "Cell line enhanced" "Detected in many" "SCLC-21H: 28.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "naive CD4 T-cell: 34.4" "Lineage enriched" "Detected in many" 5 "T-cells: 34.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038521, HPA038522" Approved Supported "Plasma membrane" "Plasma membrane" "HPA038521: , HPA038522: " "unprognostic (4.76e-2)" "unprognostic (1.98e-1)" "unprognostic (4.46e-3)" "unprognostic (1.97e-2)" "unprognostic (6.84e-2)" "unprognostic (1.75e-1)" "prognostic unfavourable (2.44e-4)" "unprognostic (7.30e-2)" "unprognostic (3.22e-3)" "unprognostic (2.36e-1)" "prognostic favourable (1.86e-5)" "unprognostic (2.21e-1)" "prognostic favourable (7.44e-13)" "unprognostic (1.32e-2)" "unprognostic (2.71e-2)" "unprognostic (1.91e-1)" "unprognostic (1.09e-2)" 7.9 14.0 26.0 6.9 26.0 1.9 5.5 54.3 84.6 11.5 9.6 31.1 3.7 4.5 15.7 3.2 9.2 19.7 7.0 21.8 29.5 23.9 9.2 2.3 9.4 7.5 27.0 30.7 21.3 9.5 14.8 15.7 5.4 25.8 10.9 3.3 5.5 8.0 16.5 21.5 4.6 5.2 19.5 36.4 5.9 5.7 7.2 24.7 6.0 7.7 2.5 6.6 7.7 5.8 6.3 0.6 3.0 0.6 5.5 34.4 11.3 0.0 5.9 20.6 9.2 11.2 11.5 0.0 9.6 16.8 16.8 21.2 10.7 4.1 0.0 1.5 17.6 0.2 17.9 3.0 8.0 10.7 13.5 0.1 3.8 0.3 8.0 0.0 4.0 10.3 0.7 7.8 1.2 20.8 0.4 0.3 6.1 0.2 0.2 0.0 7.4 6.3 0.1 0.8 0.0 0.7 0.0 28.3 16.0 1.4 1.2 6.4 0.8 1.3 9.1 1.7 10.4 11.1 1.9 5.6 2.6 0.7 8.7 0.0 5.7 3.0 0.6 0.1 9.1 0.5 9.8 2.6 12.7 11.7 0.6 6.3 34.4 20.0 0.5 5.5 0.2 0.1 17.0 11.3 26.0 26.0 54.3 49.3 29.5 23.9 27.0 30.7 25.8 24.7 APMAP "BSCv, C20orf3" ENSG00000101474 "Adipocyte plasma membrane associated protein" Q9HDC9 20 24962925-24992979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 93.8;liver: 100.5" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Group enriched" "Detected in all" 5 "granulocytes: 93.8;NK-cells: 43.2;T-cells: 53.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012863, HPA064700" Uncertain Approved "Plasma membrane" 80000000 "Plasma membrane" "HPA012863: AB_1845683, HPA064700: " "unprognostic (4.07e-3)" "unprognostic (2.50e-2)" "unprognostic (1.20e-1)" "unprognostic (8.16e-2)" "unprognostic (6.79e-2)" "unprognostic (2.14e-2)" "unprognostic (1.10e-2)" "unprognostic (4.09e-2)" "unprognostic (3.10e-2)" "unprognostic (1.19e-2)" "unprognostic (6.46e-2)" "unprognostic (1.54e-1)" "unprognostic (7.99e-3)" "unprognostic (8.26e-2)" "unprognostic (1.67e-1)" "unprognostic (1.23e-1)" "unprognostic (3.51e-2)" 43.5 13.0 14.8 12.4 16.1 44.5 23.1 47.3 22.7 11.7 12.3 15.7 17.9 8.9 14.8 31.8 7.5 13.0 13.4 10.2 18.2 20.9 12.9 100.5 14.4 15.9 15.4 17.2 12.3 12.2 18.9 20.2 28.3 17.0 12.5 12.4 11.6 10.6 18.7 9.8 14.0 9.3 13.8 13.7 16.9 10.2 19.9 15.4 10.6 57.9 5.7 9.2 13.0 10.6 5.2 13.9 93.8 13.9 43.2 53.4 40.1 23.0 40.0 20.6 30.8 40.0 21.9 20.9 30.1 33.0 29.1 30.2 23.6 40.9 9.5 35.2 36.2 42.5 18.8 35.0 34.2 12.7 14.7 10.5 14.4 47.9 31.5 20.6 25.4 29.6 49.6 34.1 24.5 41.4 12.4 43.0 28.2 34.6 14.1 23.2 12.9 36.4 11.8 68.3 19.9 31.0 21.1 33.7 13.0 31.0 53.7 33.3 19.0 17.3 36.2 35.0 31.4 29.6 44.8 24.5 27.1 10.6 18.4 31.3 33.2 7.4 13.9 26.1 53.4 13.4 33.0 5.1 15.1 38.8 13.9 5.2 11.9 30.9 93.8 43.2 9.0 6.8 9.9 40.1 14.8 16.1 47.3 22.7 18.2 20.9 15.4 17.2 17.0 15.4 APOD ENSG00000189058 "Apolipoprotein D" P05090 3 195568702-195584205 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" Transport "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 6 "breast: 840.7" "Group enriched" "Detected in some" 7 "ASC diff: 233.9;ASC TERT1: 126.0" "Cancer enhanced" "Detected in all" "melanoma: 925.2" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "memory B-cell: 6.7" "Lineage enriched" "Detected in single" 10 "B-cells: 6.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA040520 Enhanced Approved "Plasma membrane" "Secreted to blood" 27730000 220000000000 "Plasma membrane" "HPA040520: " "prognostic favourable (5.51e-4)" "unprognostic (7.62e-3)" "unprognostic (7.85e-3)" "unprognostic (3.34e-3)" "unprognostic (2.20e-1)" "unprognostic (1.02e-2)" "unprognostic (3.09e-2)" "unprognostic (2.06e-3)" "unprognostic (1.26e-1)" "unprognostic (3.45e-1)" "unprognostic (3.38e-1)" "unprognostic (3.19e-1)" "unprognostic (6.90e-3)" "prognostic unfavourable (6.02e-4)" "unprognostic (1.38e-1)" "prognostic unfavourable (4.12e-4)" "unprognostic (1.71e-3)" 134.4 15.2 39.7 5.7 39.9 3.4 840.7 14.7 66.1 75.0 16.4 79.7 10.9 12.9 36.6 30.0 46.1 42.9 36.4 124.7 45.5 29.2 8.5 3.5 11.8 6.5 96.9 28.2 19.4 28.3 9.0 14.3 59.6 50.9 39.7 13.1 99.1 152.5 35.1 110.4 66.0 7.2 30.4 81.6 3.6 28.7 32.0 56.5 0.0 87.7 42.2 6.6 62.1 95.7 6.7 0.1 0.4 0.6 0.0 0.1 0.1 0.0 0.1 0.0 0.0 233.9 126.0 0.3 2.0 0.5 0.0 0.0 12.9 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.9 0.0 0.0 6.4 1.4 0.0 1.1 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.3 2.0 4.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 25.3 0.4 0.1 0.0 0.1 0.1 0.0 6.7 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 0.6 0.1 0.0 0.1 39.7 39.9 14.7 39.5 45.5 29.2 96.9 28.2 50.9 56.5 AQP1 "CHIP28, CO" ENSG00000240583 "Aquaporin 1 (Colton blood group)" P29972 7 30911694-30925516 "Blood group antigen proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "kidney: 156.5" "Cell line enhanced" "Detected in some" "EFO-21: 20.5;HeLa: 6.9;SH-SY5Y: 7.7;U-2 OS: 9.5;WM-115: 37.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "CAB001707, HPA019206" Enhanced Supported "Plasma membrane" 250000 "Plasma membrane" "CAB001707: , HPA019206: AB_1844965" "unprognostic (4.18e-2)" "unprognostic (7.82e-3)" "unprognostic (1.10e-2)" "unprognostic (1.08e-1)" "unprognostic (1.02e-1)" "prognostic favourable (6.52e-4)" "unprognostic (1.95e-3)" "unprognostic (1.66e-1)" "unprognostic (3.00e-2)" "unprognostic (3.80e-2)" "unprognostic (4.16e-1)" "unprognostic (2.05e-2)" "prognostic favourable (1.32e-8)" "unprognostic (3.43e-2)" "unprognostic (1.61e-1)" "unprognostic (2.09e-1)" "unprognostic (7.21e-2)" 68.2 8.0 9.9 8.7 17.1 9.4 51.9 10.7 13.0 46.5 18.1 62.1 7.7 10.8 28.0 20.8 58.8 29.0 36.3 46.7 18.1 15.4 156.5 4.2 103.2 9.1 36.9 17.8 16.4 49.9 12.9 4.0 9.1 63.2 32.4 10.6 8.3 19.8 22.7 35.2 24.8 18.2 41.2 56.4 2.9 18.2 15.0 17.8 1.9 21.3 33.5 12.5 36.0 76.7 0.0 0.1 0.0 0.0 0.0 0.0 1.1 0.0 0.2 0.1 0.6 0.4 1.8 0.4 1.2 0.4 0.0 0.0 0.2 0.3 0.0 20.5 1.1 0.2 0.0 0.0 0.0 0.1 0.2 0.2 6.9 0.0 0.4 0.1 0.0 3.2 0.0 0.1 0.0 2.8 1.1 0.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 5.0 0.1 0.7 0.0 0.1 7.7 1.2 0.6 0.0 0.1 0.1 0.0 0.0 9.5 0.7 0.3 0.5 0.3 0.0 0.1 0.0 37.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.9 17.1 10.7 13.0 18.1 15.4 36.9 17.8 63.2 17.8 AQP5 ENSG00000161798 "Aquaporin 5" P55064 12 49961870-49965681 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" Transport "Disease mutation, Palmoplantar keratoderma" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "salivary gland: 217.9;testis: 76.2" "Group enriched" "Detected in some" 9 "CAPAN-2: 11.2;REH: 12.8" "Cancer enhanced" "Detected in many" "endometrial cancer: 87.5" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" HPA065008 Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA065008: " "unprognostic (4.67e-3)" "unprognostic (5.00e-2)" "unprognostic (3.30e-1)" "unprognostic (6.00e-3)" "unprognostic (1.92e-3)" "prognostic favourable (1.75e-5)" "unprognostic (4.13e-3)" "unprognostic (1.02e-2)" "unprognostic (9.39e-2)" "unprognostic (3.70e-3)" "unprognostic (2.88e-3)" "unprognostic (2.46e-3)" "unprognostic (1.69e-4)" "unprognostic (2.53e-1)" "unprognostic (5.28e-2)" "unprognostic (2.51e-3)" "unprognostic (9.11e-3)" 0.2 0.1 0.4 0.2 1.1 0.0 3.8 0.4 0.3 3.0 0.3 0.4 0.3 3.2 0.6 0.8 3.8 0.1 15.6 1.0 0.3 0.3 0.2 0.2 2.3 0.2 0.7 0.2 0.2 0.8 0.1 0.4 0.2 0.3 0.5 0.0 0.4 217.9 0.6 0.9 23.5 0.3 0.6 0.2 0.2 12.0 76.2 0.3 0.2 0.3 2.8 11.5 0.5 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 11.2 0.0 1.3 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.5 0.9 0.0 12.8 0.0 0.0 0.4 0.0 0.3 0.1 1.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 1.1 0.4 0.3 0.3 0.3 0.7 0.2 0.3 0.3 ARHGAP19 "FLJ00194, MGC14258" ENSG00000213390 "Rho GTPase activating protein 19" Q14CB8 10 97222173-97292673 "Predicted intracellular proteins" "GTPase activation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 30.4" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA035777, HPA043231" Uncertain Enhanced "Plasma membrane" "Plasma membrane" "HPA035777: , HPA043231: AB_10796791" "unprognostic (5.88e-2)" "unprognostic (2.39e-2)" "unprognostic (2.47e-2)" "unprognostic (1.91e-2)" "unprognostic (1.68e-1)" "unprognostic (8.79e-3)" "unprognostic (1.60e-3)" "unprognostic (2.00e-2)" "unprognostic (9.89e-2)" "unprognostic (1.97e-2)" "unprognostic (6.76e-2)" "unprognostic (1.15e-1)" "prognostic unfavourable (7.47e-5)" "unprognostic (1.12e-2)" "unprognostic (1.56e-1)" "unprognostic (2.23e-2)" "unprognostic (4.29e-2)" 5.6 3.7 5.6 8.8 7.6 18.3 8.6 7.2 5.3 7.4 5.1 11.7 3.2 4.1 6.9 3.4 6.1 6.0 4.0 4.9 5.7 4.6 4.6 3.2 5.5 14.1 10.9 3.6 11.4 3.4 8.0 7.3 6.0 7.4 5.8 5.3 7.3 6.4 3.7 4.0 6.0 6.6 5.3 14.2 12.0 4.3 20.1 7.0 30.4 4.4 5.5 14.3 6.7 5.9 5.5 5.3 15.5 7.3 4.1 6.0 5.1 8.2 2.7 14.9 26.0 1.0 3.9 4.6 4.1 4.2 6.6 4.6 5.3 7.5 18.5 3.5 2.8 5.6 12.5 5.1 8.4 9.2 6.8 12.1 3.4 3.5 0.9 18.7 13.0 2.0 1.8 4.6 10.6 8.9 12.0 9.8 5.7 4.1 16.9 4.0 8.0 2.5 20.4 12.7 5.2 2.0 3.7 1.1 6.9 3.0 1.5 6.8 9.2 9.8 4.1 2.7 3.2 4.1 10.6 8.8 9.0 25.0 3.4 22.1 2.9 15.3 7.3 10.2 5.2 6.6 4.9 5.5 5.1 4.8 5.3 5.5 6.0 5.3 15.5 4.1 5.7 3.0 5.9 5.1 5.6 7.6 7.2 5.3 5.7 4.6 10.9 3.6 7.4 7.0 ARHGEF15 "ARGEF15, FLJ13791, KIAA0915, MGC44868, Vsm-RhoGEF" ENSG00000198844 "Rho guanine nucleotide exchange factor 15" O94989 17 8310241-8322516 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 47.3" "Group enriched" "Detected in some" 46 "HUVEC TERT2: 22.9;TIME: 30.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA044443, HPA063495" Supported "Plasma membrane" "Plasma membrane" "HPA044443: AB_10960424, HPA063495: " "unprognostic (3.02e-1)" "unprognostic (2.97e-1)" "unprognostic (1.18e-2)" "unprognostic (7.09e-3)" "unprognostic (3.82e-1)" "unprognostic (7.29e-4)" "unprognostic (1.43e-2)" "unprognostic (1.84e-1)" "unprognostic (1.42e-1)" "unprognostic (3.40e-1)" "unprognostic (1.06e-2)" "unprognostic (1.45e-1)" "unprognostic (2.23e-3)" "unprognostic (4.88e-2)" "unprognostic (1.33e-1)" "unprognostic (1.89e-1)" "unprognostic (9.56e-3)" 47.3 3.6 1.5 4.6 2.6 0.3 24.7 0.9 2.8 9.6 5.7 2.0 3.3 3.1 19.9 4.9 5.0 5.9 7.5 18.5 3.8 1.4 9.7 4.2 19.4 3.0 2.2 1.5 6.8 2.8 4.2 3.0 14.1 3.1 8.7 2.1 10.7 3.4 5.1 15.0 4.9 4.1 7.0 1.7 6.9 4.4 2.7 1.1 0.6 8.7 8.4 2.9 9.4 32.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 22.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 30.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.5 2.6 0.9 2.8 3.8 1.4 2.2 1.5 3.1 1.1 ASB5 ENSG00000164122 "Ankyrin repeat and SOCS box containing 5" Q8WWX0 4 176213673-176277571 "Predicted intracellular proteins, Predicted membrane proteins" "Ubl conjugation pathway" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in many" 4 "skeletal muscle: 133.4" "Cell line enriched" "Detected in some" 16 "LHCN-M2: 161.1" "Cancer enhanced" "Detected in some" "prostate cancer: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA028870 Approved "Plasma membrane" "Plasma membrane" "HPA028870: AB_10611679" "unprognostic (1.76e-1)" "prognostic unfavourable (5.67e-4)" "unprognostic (1.90e-1)" "unprognostic (7.38e-2)" "unprognostic (1.32e-1)" "unprognostic (1.06e-2)" "unprognostic (4.28e-2)" "unprognostic (1.65e-1)" "unprognostic (6.80e-3)" 2.3 0.0 0.3 0.3 0.2 0.0 0.0 0.2 0.2 0.3 3.5 0.0 0.0 0.1 0.2 6.3 7.9 0.0 0.4 1.3 0.2 0.2 0.3 0.0 0.1 0.0 0.5 0.0 0.0 0.0 0.1 0.2 0.0 0.0 9.6 1.3 0.0 8.0 0.1 133.4 0.0 0.5 23.5 1.0 0.0 2.0 2.2 0.0 0.0 2.3 31.4 2.2 15.0 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 3.9 0.0 3.5 7.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 161.1 0.0 0.0 0.0 0.0 0.0 0.0 10.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.2 0.2 0.2 0.2 0.5 0.0 0.0 0.0 ATP1B3 "CD298, FLJ29027" ENSG00000069849 "ATPase Na+/K+ transporting subunit beta 3" P54709 3 141876124-141926514 "CD markers, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Potassium transport, Sodium transport, Sodium/potassium transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB020697, HPA048963" Enhanced Supported "Plasma membrane" 100000 "Plasma membrane" "CAB020697: , HPA048963: " "unprognostic (2.31e-1)" "unprognostic (1.11e-3)" "unprognostic (2.75e-1)" "prognostic favourable (5.19e-5)" "unprognostic (2.60e-2)" "unprognostic (3.31e-2)" "prognostic unfavourable (6.32e-6)" "unprognostic (8.11e-3)" "unprognostic (6.99e-2)" "unprognostic (5.37e-3)" "unprognostic (1.48e-2)" "unprognostic (1.43e-1)" "prognostic unfavourable (1.29e-5)" "unprognostic (5.14e-2)" "unprognostic (2.04e-1)" "unprognostic (7.19e-3)" "unprognostic (6.15e-2)" 50.5 79.9 12.7 26.3 23.3 17.5 105.9 25.7 35.1 17.7 48.2 9.1 16.8 37.3 17.9 14.6 36.9 20.0 47.8 44.0 16.0 18.9 24.9 7.7 44.9 43.4 21.3 12.8 34.7 11.5 6.3 33.8 32.6 43.3 20.5 58.1 23.9 18.4 24.8 7.4 85.4 57.3 24.3 28.4 16.5 13.5 21.1 13.6 14.5 15.6 41.4 18.4 21.9 31.5 10.4 26.8 13.6 60.9 7.8 20.0 22.5 46.3 28.8 27.1 25.4 72.9 21.2 62.2 54.4 49.5 39.6 44.9 44.8 23.3 37.9 49.2 41.3 101.8 26.9 26.0 45.1 20.6 34.1 33.0 32.5 29.0 28.8 27.2 26.0 22.5 62.1 31.0 30.0 42.2 22.7 33.6 40.5 21.1 27.6 45.5 37.7 13.8 37.9 20.3 38.5 33.2 35.8 22.4 15.2 71.0 33.1 73.0 25.2 33.1 29.3 34.8 13.4 52.0 31.6 25.1 32.2 61.0 45.4 29.6 28.6 13.6 27.1 8.9 19.2 44.5 14.1 10.4 15.6 20.0 26.8 7.5 9.2 16.7 1.9 7.8 60.9 16.4 16.9 22.5 12.7 23.3 25.7 35.1 16.0 18.9 21.3 12.8 43.3 13.6 ATP2B1 PMCA1 ENSG00000070961 "ATPase plasma membrane Ca2+ transporting 1" P20020 12 89588049-89709300 "Enzymes, Plasma proteins, Predicted membrane proteins" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 53.8" "Cell line enhanced" "Detected in many" "hTERT-HME1: 58.4;LHCN-M2: 90.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB005605, HPA011166, HPA012945" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB005605: AB_2061563, HPA011166: AB_1855484, HPA012945: AB_1855483" "unprognostic (6.78e-2)" "unprognostic (5.27e-2)" "unprognostic (1.57e-2)" "unprognostic (8.23e-2)" "unprognostic (1.72e-1)" "unprognostic (6.44e-2)" "prognostic unfavourable (7.74e-4)" "unprognostic (2.77e-2)" "unprognostic (2.46e-2)" "unprognostic (7.82e-2)" "unprognostic (5.98e-2)" "unprognostic (2.68e-1)" "unprognostic (4.60e-2)" "unprognostic (1.92e-2)" "unprognostic (2.31e-1)" "unprognostic (1.01e-1)" "unprognostic (1.13e-2)" 8.7 5.1 23.4 12.5 53.8 40.5 8.8 30.9 44.1 9.0 14.0 4.1 4.0 17.8 8.2 5.8 6.5 8.4 11.3 5.2 29.0 11.8 7.4 10.0 9.2 11.8 7.8 31.5 7.6 7.4 13.7 8.7 11.7 9.2 6.4 14.8 2.9 5.6 6.9 10.9 11.3 12.8 8.7 6.1 12.7 12.4 9.8 16.4 5.7 6.3 6.0 12.3 9.9 7.4 27.1 16.2 41.5 25.6 8.4 16.3 6.2 4.1 21.1 8.3 4.0 12.1 19.3 3.8 12.8 41.9 12.4 19.8 8.4 3.9 8.2 0.9 17.7 3.7 7.3 3.5 34.7 2.8 8.5 2.9 7.4 7.4 39.5 12.2 4.9 15.9 6.7 38.6 58.4 3.1 4.8 3.0 90.7 6.6 3.8 5.2 6.5 10.1 5.4 26.8 3.4 11.8 19.3 7.9 4.3 14.8 4.2 3.5 6.1 1.4 2.2 33.7 5.5 12.3 13.9 2.3 3.5 8.8 15.3 3.5 7.4 2.7 13.0 6.7 7.1 13.6 9.0 27.1 12.4 9.0 16.2 27.0 4.6 5.7 41.5 8.4 25.6 2.9 16.3 6.2 23.4 53.8 30.9 44.1 29.0 11.8 7.8 31.5 9.2 16.4 ATP2B4 "ATP2B2, MXRA1, PMCA4" ENSG00000058668 "ATPase plasma membrane Ca2+ transporting 4" P23634 1 203626561-203744081 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ: 42.6;BJ hTERT+: 60.6;fHDF/TERT166: 45.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB016118, HPA040431" Enhanced Supported "Plasma membrane" 21000 "Plasma membrane" "CAB016118: AB_2061729, HPA040431: " "unprognostic (7.43e-2)" "unprognostic (1.58e-1)" "unprognostic (1.60e-2)" "unprognostic (8.17e-2)" "unprognostic (2.53e-2)" "unprognostic (9.23e-3)" "unprognostic (8.68e-2)" "unprognostic (3.81e-2)" "unprognostic (9.74e-2)" "unprognostic (1.70e-1)" "unprognostic (1.64e-2)" "unprognostic (1.12e-1)" "prognostic unfavourable (1.21e-4)" "unprognostic (3.52e-3)" "unprognostic (2.61e-2)" "unprognostic (1.30e-1)" "unprognostic (2.56e-3)" 23.0 14.0 24.8 10.8 14.2 5.9 11.6 9.4 23.6 32.6 44.2 7.5 12.9 5.3 69.6 13.1 20.4 27.0 13.9 24.0 13.1 8.7 5.0 14.2 16.1 5.3 6.4 19.2 21.9 6.4 8.0 4.8 16.2 9.3 17.0 13.4 11.6 7.5 31.5 5.4 22.0 13.2 74.2 5.7 4.8 16.4 13.1 7.5 9.0 8.3 8.4 7.7 32.8 14.2 1.0 4.2 4.5 2.2 4.2 10.4 2.6 9.3 1.7 3.4 3.2 26.5 39.5 18.3 42.6 60.6 7.3 6.2 0.8 4.8 2.1 6.2 45.9 9.2 5.0 5.9 7.6 27.0 1.8 6.3 8.5 0.5 9.5 9.0 11.2 28.7 5.8 23.2 3.6 13.8 2.7 4.3 5.3 0.5 9.1 3.0 2.1 5.3 4.7 2.6 3.4 2.4 0.8 1.0 1.5 15.0 2.2 6.8 2.0 4.4 12.1 17.6 2.6 29.5 10.2 2.9 4.2 1.2 17.6 6.5 5.2 3.0 2.2 0.0 10.4 1.5 7.9 1.0 6.6 8.3 2.4 0.3 1.6 4.2 4.5 4.2 2.2 4.2 6.3 2.6 24.8 14.2 9.4 23.6 13.1 8.7 6.4 19.2 9.3 7.5 BACE1 BACE ENSG00000186318 "Beta-secretase 1" P56817 11 117285207-117316259 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Aspartyl protease, Hydrolase, Protease" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 8 "brain: 53.0;pancreas: 161.1" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB016358 Approved Supported "Plasma membrane" "Plasma membrane" "CAB016358: AB_626716" "unprognostic (7.96e-3)" "unprognostic (8.05e-2)" "unprognostic (3.55e-2)" "unprognostic (3.05e-3)" "unprognostic (8.94e-2)" "unprognostic (3.39e-1)" "unprognostic (1.03e-1)" "unprognostic (2.60e-1)" "unprognostic (4.54e-2)" "unprognostic (8.04e-2)" "unprognostic (8.09e-2)" "unprognostic (1.09e-1)" "unprognostic (1.12e-1)" "unprognostic (1.35e-2)" "unprognostic (1.16e-1)" "unprognostic (1.27e-1)" "prognostic unfavourable (6.76e-4)" 6.5 7.1 12.1 3.8 18.8 2.2 5.5 9.6 22.4 9.8 4.6 42.5 2.7 3.4 9.3 5.6 7.6 8.6 9.1 5.9 16.9 12.4 6.8 12.1 7.3 2.8 28.8 15.0 11.4 161.1 12.8 4.2 6.3 26.4 6.5 4.7 6.9 5.3 9.9 6.2 7.2 3.6 11.7 53.0 5.7 4.9 4.1 21.4 0.0 6.3 2.3 2.8 6.7 5.5 4.0 2.2 0.7 3.2 2.2 6.7 1.1 3.9 4.6 9.6 14.7 32.0 34.5 0.4 21.2 18.5 10.3 8.4 3.6 6.2 0.7 5.2 38.3 6.9 10.3 6.1 8.5 2.3 5.5 2.3 7.9 4.3 15.8 0.8 0.5 29.9 9.5 13.2 12.8 8.9 0.8 0.4 18.9 14.2 0.6 1.9 6.2 10.4 1.8 4.3 0.8 4.4 2.2 12.5 14.0 7.9 1.0 2.3 10.2 2.7 12.1 18.6 2.0 19.4 6.8 0.3 0.3 0.4 8.7 1.2 13.0 0.6 2.0 0.7 2.0 3.2 5.2 4.0 6.7 5.3 2.2 1.8 3.1 2.7 0.0 2.2 1.3 1.3 6.3 1.1 12.1 18.8 9.6 21.7 16.9 12.4 28.8 15.0 26.4 21.4 BASP1 "CAP-23, CAP23, NAP-22, NAP22" ENSG00000176788 "Brain abundant membrane attached signal protein 1" P80723 5 17065598-17276843 "Plasma proteins, Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 107.3;epididymis: 126.9" "Cell line enhanced" "Detected in many" "HeLa: 113.7;SiHa: 109.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "neutrophil: 42.4" "Lineage enriched" "Detected in many" 17 "granulocytes: 42.4" "Low region specificity" "Detected in many" "HPA045218, HPA050333" Enhanced Enhanced "Plasma membrane" 85000000 "Plasma membrane" "HPA045218: AB_2679263, HPA050333: " "unprognostic (3.35e-2)" "unprognostic (3.13e-2)" "unprognostic (1.04e-1)" "unprognostic (1.32e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (5.63e-4)" "unprognostic (2.40e-1)" "unprognostic (1.02e-2)" "unprognostic (2.39e-1)" "unprognostic (1.89e-1)" "unprognostic (2.52e-1)" "unprognostic (2.31e-1)" "prognostic unfavourable (5.25e-11)" "unprognostic (1.95e-3)" "unprognostic (1.04e-1)" "unprognostic (3.61e-2)" "unprognostic (1.70e-1)" 9.2 6.7 64.3 28.4 37.4 31.1 4.8 37.2 107.3 16.2 5.2 4.0 15.1 3.8 15.5 126.9 4.0 3.6 12.7 4.4 65.0 55.8 4.2 7.7 9.1 30.2 30.1 56.6 11.7 2.5 3.6 6.4 36.4 21.9 32.2 5.5 7.9 3.8 11.5 1.6 6.0 5.7 14.2 11.0 21.9 9.2 2.2 4.3 3.7 3.6 1.3 35.4 17.6 13.0 2.5 1.6 42.4 1.1 0.6 0.1 0.2 0.0 17.0 21.2 0.0 10.2 10.9 30.4 21.2 7.0 17.9 19.0 0.8 0.0 6.6 3.0 15.2 1.4 13.5 14.8 23.3 2.7 7.6 0.0 113.7 0.0 22.7 13.1 0.1 18.7 18.5 20.2 17.0 19.3 0.0 0.0 19.0 24.4 0.0 12.0 15.6 5.2 0.0 0.0 3.6 6.4 4.2 13.6 2.8 109.2 10.0 0.0 0.0 13.6 24.6 23.7 0.0 1.9 3.4 0.2 0.0 3.5 23.9 16.3 3.1 6.2 1.1 7.8 0.0 0.4 0.0 1.8 0.0 0.0 1.6 2.5 0.0 0.0 42.4 0.6 0.6 0.1 0.1 0.2 64.3 37.4 37.2 107.3 65.0 55.8 30.1 56.6 21.9 4.3 BDKRB2 BK-2 ENSG00000168398 "Bradykinin receptor B2" P30411 14 96204679-96244166 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 22.3;BJ hTERT+: 41.1;U-87 MG: 17.7" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 6 "cerebellum: 13.5;pons and medulla: 5.7" "Cell type enhanced" "Detected in single" "memory CD8 T-cell: 1.2" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA003551, HPA050841" Approved Supported "Plasma membrane" "Plasma membrane" "HPA003551: , HPA050841: " "unprognostic (1.03e-1)" "unprognostic (7.90e-2)" "unprognostic (1.12e-1)" "unprognostic (1.83e-1)" "unprognostic (8.79e-3)" "unprognostic (2.68e-2)" "unprognostic (1.93e-1)" "unprognostic (4.66e-2)" "unprognostic (1.94e-1)" "unprognostic (2.84e-2)" "unprognostic (3.19e-1)" "unprognostic (1.72e-1)" "unprognostic (3.32e-3)" "unprognostic (3.11e-2)" "unprognostic (9.40e-2)" "unprognostic (9.90e-2)" "unprognostic (1.49e-2)" 9.0 1.2 1.5 3.7 1.0 0.0 4.7 13.5 1.1 12.2 9.0 1.3 4.4 5.6 8.5 12.7 14.9 5.1 21.1 4.3 0.8 0.7 12.1 0.7 2.2 0.4 0.9 0.3 4.7 6.8 0.9 1.1 2.9 5.7 6.9 9.2 0.9 3.1 11.3 2.7 4.0 10.3 11.3 1.3 0.4 4.2 3.2 0.0 0.6 3.6 13.9 4.4 16.7 13.5 0.0 0.9 0.0 0.0 0.0 1.2 0.0 0.7 2.6 0.0 4.8 7.3 22.3 0.0 2.4 41.1 1.4 1.6 0.1 4.5 0.0 0.1 3.7 6.4 0.0 1.0 1.2 0.5 0.0 0.0 0.5 0.0 3.5 0.0 0.0 6.8 3.3 4.1 2.1 0.0 0.0 0.0 0.0 3.3 0.0 0.0 0.0 0.0 0.0 1.0 0.0 1.4 0.0 1.5 0.5 0.7 6.8 0.0 0.4 0.0 0.0 0.1 0.1 1.4 0.0 0.1 0.0 0.0 17.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 1.5 1.0 13.5 1.1 0.8 0.7 0.9 0.3 5.7 0.0 BIN2 BRAP-1 ENSG00000110934 "Bridging integrator 2" 12 51281038-51324668 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 85.3;bone marrow: 38.0;lymphoid tissue: 24.8" "Cell line enhanced" "Detected in some" "HEL: 23.3;HMC-1: 39.7;Karpas-707: 17.3;NB-4: 39.5;RPMI-8226: 15.5;THP-1: 33.5;U-937: 21.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA038666, HPA038667" Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA038666: AB_2676139, HPA038667: AB_2676140" "unprognostic (8.44e-3)" "prognostic favourable (1.33e-4)" "unprognostic (2.48e-1)" "prognostic favourable (6.34e-4)" "unprognostic (4.63e-1)" "unprognostic (2.00e-3)" "unprognostic (1.21e-1)" "unprognostic (3.59e-2)" "unprognostic (3.72e-2)" "unprognostic (7.47e-2)" "unprognostic (5.71e-2)" "unprognostic (3.29e-1)" "unprognostic (1.65e-3)" "unprognostic (4.03e-1)" "unprognostic (3.96e-2)" "unprognostic (1.24e-1)" "unprognostic (2.22e-1)" 4.6 1.8 3.5 12.3 4.7 38.0 1.7 1.8 2.0 2.3 3.3 3.6 0.7 2.2 1.4 2.8 2.2 1.4 3.6 2.2 3.1 2.1 2.5 3.1 7.7 23.9 4.4 0.9 1.8 2.3 0.0 1.7 8.4 3.2 1.8 3.6 1.5 4.7 0.6 1.9 2.0 3.3 2.3 4.1 18.3 2.6 3.5 3.9 24.8 1.9 0.7 17.5 4.4 1.9 10.5 17.1 85.3 59.9 35.8 47.7 61.4 0.0 0.0 0.0 0.0 0.0 0.0 11.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 10.8 0.0 23.3 0.0 0.0 0.0 9.7 39.7 0.0 0.0 0.0 0.0 0.0 0.0 17.3 0.0 0.1 6.7 39.5 0.0 0.0 0.0 0.0 15.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 33.5 0.0 0.0 0.0 0.0 0.0 9.3 0.0 2.3 0.0 21.9 0.0 85.3 30.9 37.4 47.7 49.0 38.5 8.1 32.4 39.8 17.1 10.5 25.3 33.5 61.0 35.8 59.9 6.3 40.9 61.4 3.5 4.7 1.8 2.0 3.1 2.1 4.4 0.9 3.2 3.9 BTN2A1 "BT2.1, BTF1, BTN2.1" ENSG00000112763 "Butyrophilin subfamily 2 member A1" Q7KYR7 6 26457904-26476621 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA019208 Approved Approved "Plasma membrane" "Plasma membrane" "HPA019208: AB_1845492" "unprognostic (1.86e-1)" "unprognostic (3.48e-1)" "unprognostic (1.20e-1)" "unprognostic (2.87e-1)" "unprognostic (2.29e-1)" "unprognostic (6.17e-2)" "unprognostic (5.74e-3)" "unprognostic (1.22e-2)" "unprognostic (1.03e-1)" "unprognostic (3.26e-2)" "unprognostic (6.90e-3)" "unprognostic (5.14e-2)" "prognostic unfavourable (5.90e-5)" "unprognostic (1.97e-1)" "unprognostic (4.89e-2)" "unprognostic (7.92e-2)" "prognostic favourable (4.52e-5)" 15.3 16.7 10.8 16.3 13.7 18.5 17.2 42.2 16.2 14.8 15.8 13.2 17.4 12.2 18.8 15.0 11.5 14.9 12.7 15.6 11.2 14.6 13.1 8.5 17.2 16.3 14.4 10.2 15.8 8.9 7.7 16.9 23.2 16.1 16.5 14.6 12.0 11.1 19.3 12.1 9.5 13.9 21.1 15.6 23.5 12.4 13.0 15.0 11.3 10.8 7.3 14.4 21.4 13.4 4.8 4.7 28.8 4.8 4.8 8.1 3.4 7.5 6.9 13.7 8.4 6.2 5.0 0.6 16.7 14.1 20.5 18.8 6.1 5.1 6.2 23.0 11.8 3.4 10.8 4.3 19.6 9.0 10.6 3.7 7.4 7.5 9.6 5.3 10.0 6.9 4.1 22.8 7.4 7.4 6.0 9.9 17.5 3.2 9.4 8.9 4.7 5.7 7.8 13.5 6.5 7.6 3.8 14.3 7.8 5.3 6.8 11.9 2.2 4.7 9.7 15.4 8.2 13.3 18.7 8.0 18.6 5.2 6.1 10.6 24.3 16.7 4.8 15.5 6.5 2.7 5.9 4.8 5.4 7.1 4.3 3.9 5.0 6.4 28.8 4.8 4.1 4.7 8.1 3.4 10.8 13.7 42.2 16.2 11.2 14.6 14.4 10.2 16.1 15.0 C14orf37 UT2 ENSG00000139971 "Chromosome 14 open reading frame 37" Q86TY3 14 57999735-58298139 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 21.5" "Cell line enhanced" "Detected in many" "AF22: 11.0;AN3-CA: 6.9;fHDF/TERT166: 12.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001580, HPA001789" Enhanced Approved "Plasma membrane" 270000 "Plasma membrane" "HPA001580: , HPA001789: AB_1078328" "unprognostic (2.56e-2)" "unprognostic (2.04e-2)" "unprognostic (1.20e-3)" "unprognostic (8.56e-2)" "unprognostic (1.15e-1)" "unprognostic (6.97e-3)" "unprognostic (1.94e-1)" "unprognostic (7.84e-3)" "unprognostic (2.66e-1)" "unprognostic (2.32e-1)" "unprognostic (2.42e-1)" "unprognostic (1.01e-1)" "unprognostic (3.87e-8)" "unprognostic (5.22e-6)" "unprognostic (4.93e-2)" "unprognostic (8.74e-4)" "unprognostic (3.01e-4)" 2.8 5.3 11.4 1.5 11.7 1.8 2.4 10.1 14.0 4.1 2.3 3.9 1.1 1.6 6.7 4.0 1.9 4.7 3.9 6.3 8.6 4.6 16.5 2.2 1.8 1.1 5.1 7.8 9.3 2.4 9.2 5.8 1.4 21.5 4.0 2.7 3.9 2.0 3.3 1.2 2.5 1.8 5.0 3.3 1.3 3.0 5.1 5.0 0.0 3.4 0.3 0.9 2.6 3.0 0.3 0.6 0.5 0.3 0.1 0.0 0.0 0.0 0.0 11.0 6.9 5.4 2.3 0.0 2.1 1.7 0.4 0.3 0.5 0.1 0.0 0.7 12.0 0.1 3.4 0.0 0.4 0.1 1.1 0.0 0.0 0.5 0.2 0.0 5.5 2.3 0.2 0.2 0.2 0.5 0.1 0.3 1.4 0.3 0.0 0.0 5.1 2.3 1.6 0.3 2.7 4.4 0.5 1.3 0.1 0.1 0.0 0.3 0.3 0.2 0.1 1.6 4.1 0.6 2.9 0.3 0.3 0.0 3.4 0.3 1.2 0.5 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.3 0.0 0.0 0.4 0.1 0.0 0.6 0.0 0.0 11.4 11.7 10.1 14.0 8.6 4.6 5.1 7.8 21.5 5.0 C19orf48 "BC006151, MGC13170" ENSG00000167747 "Chromosome 19 open reading frame 48" Q6RUI8 19 50797704-50804929 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA042000 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA042000: AB_10797377" "unprognostic (2.25e-1)" "unprognostic (2.82e-2)" "unprognostic (5.39e-2)" "unprognostic (7.92e-2)" "unprognostic (2.86e-1)" "unprognostic (1.69e-1)" "prognostic unfavourable (8.80e-5)" "unprognostic (6.59e-3)" "unprognostic (1.84e-3)" "unprognostic (2.84e-1)" "unprognostic (1.14e-2)" "unprognostic (2.97e-1)" "unprognostic (6.84e-3)" "unprognostic (1.29e-1)" "unprognostic (3.67e-2)" "unprognostic (1.40e-1)" "unprognostic (1.16e-1)" 5.0 9.7 6.5 11.0 6.2 20.7 9.6 7.0 8.9 7.2 9.3 7.0 4.1 6.8 7.8 6.9 13.2 13.5 9.5 4.1 4.0 3.4 7.4 12.0 8.0 22.2 6.8 8.7 13.0 40.7 3.2 4.0 7.5 5.2 32.1 5.8 6.9 8.3 5.6 6.4 15.9 6.4 6.7 5.1 8.8 7.0 19.8 5.0 23.6 17.9 9.1 12.5 5.1 7.3 29.0 20.8 2.8 8.7 12.4 21.6 9.9 21.4 34.2 16.1 10.1 3.1 9.6 14.9 19.4 13.3 28.7 28.7 41.1 20.0 36.8 9.0 7.5 15.3 26.8 27.3 9.9 11.5 64.8 24.5 14.5 23.9 8.7 25.6 12.4 15.7 28.4 29.9 32.6 15.3 26.8 18.4 13.3 18.5 34.3 31.1 12.9 43.7 25.8 26.3 34.9 9.3 35.9 26.6 12.8 19.5 25.3 26.4 14.9 25.2 7.2 13.3 24.6 8.1 26.3 10.8 12.2 30.3 8.1 23.3 17.8 1.0 6.0 2.8 9.9 8.7 14.0 29.0 14.1 11.2 11.8 27.3 21.6 16.1 0.4 12.4 6.3 20.8 14.5 9.9 6.5 6.2 7.0 8.9 4.0 3.4 6.8 8.7 5.2 5.0 C1orf54 FLJ23221 ENSG00000118292 "Chromosome 1 open reading frame 54" Q8WWF1 1 150268200-150280916 "Predicted secreted proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "AF22: 20.5;AN3-CA: 30.9;ASC diff: 22.0;ASC TERT1: 36.7;HSkMC: 29.7;HUVEC TERT2: 28.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 5 "myeloid DC: 36.2" "Lineage enriched" "Detected in many" 5 "dendritic cells: 36.2" "Low region specificity" "Detected in all" "HPA026518, HPA043874" Approved Approved "Plasma membrane" "Secreted to blood" "Plasma membrane" "HPA026518: AB_1845647, HPA043874: " "unprognostic (4.64e-3)" "unprognostic (6.81e-3)" "unprognostic (4.01e-3)" "unprognostic (5.69e-3)" "unprognostic (2.22e-1)" "unprognostic (1.72e-1)" "unprognostic (1.51e-2)" "unprognostic (1.88e-1)" "unprognostic (1.26e-1)" "unprognostic (1.33e-1)" "unprognostic (3.45e-1)" "unprognostic (3.21e-1)" "prognostic unfavourable (2.43e-4)" "unprognostic (3.16e-2)" "unprognostic (8.06e-2)" "unprognostic (1.33e-2)" "unprognostic (4.48e-2)" 16.0 8.8 16.4 19.0 19.3 4.5 13.8 5.8 10.5 11.9 14.0 4.5 19.1 5.8 19.8 21.1 11.0 17.1 21.6 13.8 13.7 13.7 12.7 12.0 11.8 21.5 21.8 8.3 8.3 6.8 2.0 6.7 24.4 14.0 15.3 11.1 10.9 9.8 30.4 13.4 4.5 8.1 24.1 20.4 27.3 8.3 5.7 14.8 4.9 8.3 17.1 11.2 22.0 14.3 0.3 36.2 0.4 7.7 0.2 1.5 2.2 0.5 0.1 20.5 30.9 22.0 36.7 0.6 3.3 4.9 0.9 3.0 0.2 0.6 0.1 1.1 2.9 0.8 0.0 0.1 1.1 0.3 3.6 0.5 0.5 0.3 4.5 1.1 0.8 29.7 1.5 6.1 0.4 28.5 0.4 4.0 3.1 1.1 0.2 7.1 1.7 1.1 5.1 0.5 0.4 0.3 1.6 0.4 0.4 0.4 0.2 2.2 0.4 15.5 0.2 7.3 0.6 0.2 0.3 1.7 1.4 0.3 16.2 0.9 0.2 0.0 7.7 0.3 0.2 6.8 0.9 0.3 1.5 0.6 36.2 0.3 1.5 0.8 0.4 0.2 1.9 0.7 0.6 2.2 16.4 19.3 5.8 10.5 13.7 13.7 21.8 8.3 14.0 14.8 CA14 ENSG00000118298 "Carbonic anhydrase 14" Q9ULX7 1 150257159-150265078 "Enzymes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Lyase "FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 20.9;retina: 29.4;seminal vesicle: 16.5;skeletal muscle: 24.1" "Group enriched" "Detected in some" 18 "AF22: 28.0;AN3-CA: 16.6;NTERA-2: 21.8;SK-MEL-30: 55.8" "Group enriched" "Detected in many" 7 "glioma: 4.9;melanoma: 23.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA008482 Approved Approved "Plasma membrane" "Plasma membrane" "HPA008482: AB_1078395" "unprognostic (3.06e-2)" "unprognostic (1.67e-1)" "unprognostic (2.10e-2)" "unprognostic (3.25e-2)" "prognostic favourable (8.47e-4)" "unprognostic (7.28e-2)" "unprognostic (4.48e-2)" "unprognostic (1.49e-1)" "unprognostic (2.10e-1)" "unprognostic (2.47e-1)" "unprognostic (5.46e-2)" "unprognostic (1.73e-1)" "unprognostic (5.89e-3)" "unprognostic (1.91e-1)" "unprognostic (1.49e-1)" "unprognostic (1.22e-1)" "unprognostic (5.80e-2)" 0.1 0.3 4.6 0.2 5.2 0.9 0.3 1.4 6.8 0.1 1.7 10.8 0.1 0.3 0.1 0.5 1.6 1.3 0.7 4.4 6.4 4.1 0.3 6.3 0.2 0.2 11.3 3.2 1.4 0.3 0.8 0.1 0.3 4.4 3.2 0.7 29.4 0.6 16.5 24.1 3.7 0.6 0.5 20.9 0.3 0.8 0.5 2.7 0.1 0.9 0.1 0.1 0.2 0.1 2.8 2.2 2.1 2.0 0.2 1.6 0.2 0.2 0.0 28.0 16.6 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.1 0.1 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.0 21.8 0.2 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.0 0.1 55.8 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.2 1.2 0.1 0.1 0.1 0.0 0.0 0.9 1.3 1.6 2.0 0.6 2.0 1.0 1.2 0.2 2.8 1.2 1.3 2.1 0.2 0.5 2.2 0.0 0.2 4.6 5.2 1.4 4.7 6.4 4.1 11.3 3.2 4.4 2.7 CALCRL "CGRPR, CRLR" ENSG00000064989 "Calcitonin receptor like receptor" Q16602 2 187343129-187448460 "G-protein coupled receptors, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 91.0" "Cell line enriched" "Detected in some" 4 "HUVEC TERT2: 61.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 5 "classical monocyte: 3.3;myeloid DC: 11.2;plasmacytoid DC: 3.3" "Group enriched" "Detected in many" 6 "dendritic cells: 11.2;monocytes: 3.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008070, HPA046515" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA008070: AB_1845912, HPA046515: " "unprognostic (7.06e-2)" "unprognostic (5.71e-2)" "unprognostic (1.59e-1)" "unprognostic (2.13e-1)" "unprognostic (3.44e-3)" "unprognostic (7.60e-3)" "unprognostic (9.25e-3)" "unprognostic (4.14e-2)" "unprognostic (7.71e-3)" "unprognostic (3.32e-1)" "unprognostic (3.77e-1)" "unprognostic (3.44e-1)" "unprognostic (1.51e-3)" "unprognostic (1.90e-2)" "unprognostic (2.02e-1)" "unprognostic (1.30e-1)" "unprognostic (2.50e-2)" 42.4 5.2 4.9 6.4 3.8 0.2 19.6 7.3 9.4 21.2 12.6 2.6 4.0 3.1 17.9 6.8 16.3 6.5 13.4 15.1 4.5 3.8 16.5 12.5 91.0 16.9 4.7 3.5 15.2 3.7 8.2 5.3 6.4 7.5 10.7 5.3 7.5 8.4 4.4 5.0 4.2 5.6 14.5 18.1 9.1 5.0 7.9 2.8 2.3 16.9 11.8 4.7 10.6 14.0 0.2 11.2 0.1 3.3 1.2 1.1 1.1 0.0 0.0 3.1 0.0 2.3 0.5 0.0 0.2 0.4 0.0 0.3 0.0 0.3 0.0 0.8 0.2 0.0 0.0 0.2 0.0 0.4 0.2 0.5 0.0 0.0 1.7 0.0 0.0 1.6 0.1 0.1 0.7 61.0 0.0 0.8 0.4 0.0 0.2 0.0 0.1 0.0 0.0 1.1 0.1 14.3 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 8.8 0.2 0.0 0.0 0.1 2.2 0.0 0.2 0.1 0.0 0.0 0.0 3.3 0.0 0.0 0.6 0.0 0.2 0.0 0.0 11.2 0.0 1.1 0.2 0.1 1.2 1.2 3.3 0.0 1.1 4.9 3.8 7.3 3.7 4.5 3.8 4.7 3.5 7.5 2.8 CASKIN2 "ANKS5B, FLJ21609, KIAA1139" ENSG00000177303 "CASK interacting protein 2" Q8WXE0 17 75500261-75515583 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA071906, HPA075184" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA071906: , HPA075184: " "unprognostic (1.60e-1)" "unprognostic (4.54e-2)" "unprognostic (9.12e-3)" "unprognostic (5.27e-3)" "unprognostic (9.32e-2)" "unprognostic (5.78e-2)" "unprognostic (2.87e-2)" "unprognostic (4.10e-2)" "unprognostic (7.67e-2)" "unprognostic (1.33e-1)" "prognostic favourable (2.47e-5)" "unprognostic (1.82e-2)" "prognostic favourable (4.83e-8)" "unprognostic (1.43e-1)" "unprognostic (1.52e-1)" "unprognostic (1.39e-1)" "unprognostic (4.95e-2)" 25.4 13.4 10.7 6.2 13.7 0.8 16.4 8.6 15.1 11.6 8.7 18.4 9.3 10.8 15.5 7.3 11.1 13.3 13.7 16.8 10.9 7.6 14.9 10.1 24.6 5.7 11.2 7.9 13.5 10.9 10.6 8.5 14.4 11.5 9.2 3.9 18.1 12.5 11.6 13.3 8.6 8.3 13.0 9.5 27.1 9.2 5.9 12.6 0.6 13.8 7.5 3.0 9.1 11.9 0.1 0.9 0.1 0.3 0.2 0.6 0.0 8.7 11.6 6.9 9.8 4.6 2.9 7.7 4.4 5.9 10.8 7.0 12.5 3.7 0.2 5.1 5.1 8.1 5.6 5.1 2.7 3.0 7.3 6.2 10.7 5.0 5.4 0.2 8.7 2.4 7.1 5.6 4.0 10.9 4.4 1.1 3.3 20.3 15.7 0.5 5.1 11.9 8.4 14.9 1.4 7.0 8.9 7.1 7.1 9.3 12.7 7.6 9.4 2.6 9.2 11.1 10.2 5.4 5.7 1.0 3.7 0.9 3.9 0.2 7.7 0.0 0.3 0.0 0.6 0.1 0.1 0.1 0.3 0.6 0.2 0.1 0.3 0.4 0.1 0.2 0.2 0.9 0.4 0.0 10.7 13.7 8.6 15.1 10.9 7.6 11.2 7.9 11.5 12.6 CAVIN3 "cavin-3, HSRBC, MGC20400, PRKCDBP, SRBC" ENSG00000170955 "Caveolae associated protein 3" Q969G5 11 6318946-6320647 "Predicted intracellular proteins" "Biological rhythms" "Tumor suppressor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 73.7" "Cell line enhanced" "Detected in many" "A-431: 29.6;BJ: 28.5;HaCaT: 22.9;TIME: 33.9;U-87 MG: 32.1;WM-115: 34.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 5 "classical monocyte: 8.1;myeloid DC: 22.4" "Group enriched" "Detected in many" 5 "dendritic cells: 22.4;monocytes: 8.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA055136, HPA073327" Approved Approved "Plasma membrane" "Plasma membrane" "HPA055136: AB_2682711, HPA073327: " "unprognostic (7.92e-2)" "prognostic unfavourable (3.75e-5)" "unprognostic (3.12e-2)" "unprognostic (2.30e-1)" "unprognostic (4.69e-2)" "unprognostic (2.69e-1)" "unprognostic (2.24e-2)" "unprognostic (1.19e-3)" "unprognostic (2.49e-2)" "unprognostic (6.03e-3)" "unprognostic (3.37e-1)" "unprognostic (6.66e-2)" "prognostic unfavourable (5.21e-6)" "unprognostic (3.85e-2)" "unprognostic (1.70e-1)" "unprognostic (1.62e-1)" "unprognostic (1.96e-2)" 30.2 5.1 0.9 14.2 1.6 0.8 12.6 0.8 2.9 38.3 16.1 1.8 14.2 5.8 31.6 32.2 20.3 13.4 15.3 16.8 0.9 1.0 8.6 2.6 9.8 6.8 2.2 3.5 14.0 5.6 1.0 1.7 22.0 2.8 20.9 2.3 11.1 5.0 11.0 12.1 6.8 7.9 34.7 1.3 9.8 11.3 73.7 0.4 0.7 5.5 14.5 4.3 26.5 16.5 0.0 22.4 0.1 8.1 0.1 3.1 2.7 29.6 2.8 0.0 0.1 1.1 5.1 0.0 28.5 8.8 3.9 4.1 0.0 0.0 0.0 9.5 4.0 22.9 0.0 1.7 0.5 7.5 0.0 0.0 2.9 0.0 3.0 0.0 0.1 3.3 2.4 1.4 1.2 6.9 0.0 0.2 2.4 0.0 0.0 0.0 19.0 0.5 0.0 0.0 0.0 3.4 0.0 0.0 0.0 10.2 0.0 6.2 0.0 0.1 33.9 0.0 0.1 11.1 0.1 0.0 0.2 0.0 32.1 0.0 34.0 0.0 8.1 0.0 0.0 0.5 0.0 0.0 0.4 0.0 22.4 0.0 0.0 0.0 0.1 0.1 0.0 0.0 3.1 2.7 0.9 1.6 0.8 2.9 0.9 1.0 2.2 3.5 2.8 0.4 CBWD1 ENSG00000172785 "COBW domain containing 1" Q9BRT8 9 121038-179147 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "NB-4: 53.7" "Low cancer specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" "Plasma membrane" "HPA042759: , HPA042813: " "unprognostic (3.75e-2)" "unprognostic (3.47e-2)" "unprognostic (5.23e-2)" "unprognostic (4.15e-2)" "unprognostic (1.39e-1)" "unprognostic (2.67e-2)" "unprognostic (3.91e-2)" "unprognostic (3.72e-1)" "unprognostic (4.15e-2)" "unprognostic (2.07e-3)" "unprognostic (1.82e-1)" "unprognostic (4.68e-2)" "unprognostic (5.80e-7)" "unprognostic (7.19e-2)" "unprognostic (1.04e-1)" "unprognostic (8.94e-2)" "unprognostic (4.98e-3)" 6.3 14.1 5.5 5.3 6.7 3.8 7.2 5.5 4.5 4.9 5.5 4.6 4.5 8.3 10.4 5.0 3.5 7.0 4.9 6.9 16.3 10.1 5.7 4.1 5.9 5.5 10.5 7.5 7.6 8.3 7.2 5.7 8.6 4.5 7.5 7.1 4.1 4.2 4.8 5.6 6.1 6.3 10.0 7.3 6.9 5.1 8.2 28.0 7.0 28.2 4.5 7.6 15.6 12.5 4.7 6.9 3.6 9.0 8.2 15.3 6.6 4.4 9.2 7.0 6.9 4.8 11.5 8.6 2.4 2.2 3.3 6.3 10.0 19.7 11.6 0.1 11.2 21.1 9.8 33.1 5.2 7.3 3.0 2.2 18.1 9.8 3.8 25.4 7.5 15.1 7.1 53.7 6.9 10.3 13.8 10.5 21.9 11.9 35.7 12.4 7.5 13.6 5.1 5.1 10.7 31.8 10.2 4.9 6.9 6.3 5.7 3.0 4.1 13.2 12.1 17.8 5.7 1.2 25.3 7.0 4.2 28.2 6.8 8.2 7.6 6.7 28.0 5.6 6.7 7.3 3.8 4.5 21.3 7.4 6.6 15.6 CBWD2 ENSG00000136682 "COBW domain containing 2" Q8IUF1 2 113437691-113496189 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 27.4" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" "Plasma membrane" "HPA042759: , HPA042813: " "unprognostic (4.67e-2)" "unprognostic (2.17e-1)" "unprognostic (4.14e-1)" "prognostic unfavourable (3.22e-5)" "unprognostic (7.69e-2)" "unprognostic (2.17e-1)" "unprognostic (2.16e-3)" "unprognostic (1.31e-3)" "unprognostic (3.69e-2)" "unprognostic (1.72e-2)" "unprognostic (5.85e-2)" "unprognostic (1.39e-1)" "unprognostic (8.50e-2)" "unprognostic (1.90e-1)" "unprognostic (4.90e-2)" "unprognostic (3.21e-1)" "unprognostic (7.57e-3)" 2.0 5.7 3.2 2.6 6.0 0.3 4.3 7.0 4.1 5.6 3.6 0.9 4.1 4.9 5.9 2.1 2.5 9.1 3.1 4.5 8.9 6.6 1.8 1.3 3.2 3.0 3.6 7.7 5.3 3.4 4.1 3.6 4.3 5.0 15.0 1.7 2.2 5.0 1.6 2.3 3.3 1.2 6.2 2.5 4.2 2.5 7.8 26.5 13.8 27.4 7.5 10.4 17.5 8.2 5.0 5.5 6.2 14.4 6.7 10.3 6.4 4.1 5.1 6.7 8.4 5.2 10.9 19.8 6.8 6.9 5.8 7.1 6.9 3.7 15.3 9.0 8.9 15.7 4.8 3.8 4.3 6.2 4.4 7.4 4.4 9.2 5.1 11.9 7.4 8.8 12.0 12.8 6.6 11.0 5.7 14.4 28.5 13.5 13.4 15.2 4.5 16.7 2.4 2.7 7.9 11.1 10.9 4.3 6.1 2.6 6.2 4.6 19.2 5.8 7.1 23.6 10.2 4.2 27.4 13.8 5.2 27.1 5.6 7.3 7.9 6.1 26.5 7.8 6.8 6.2 7.5 7.5 21.2 6.5 10.4 17.5 CBWD3 bA561O23.1 ENSG00000196873 "COBW domain containing 3" Q5JTY5 9 68232003-68300015 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in all" "blood: 34.4" "Low cell line specificity" "Detected in all" "Not detected" "Not detected" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042759, HPA042813" Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA042759: , HPA042813: " "unprognostic (1.72e-2)" "unprognostic (2.15e-1)" "unprognostic (1.95e-1)" "unprognostic (9.71e-3)" "unprognostic (9.99e-2)" "unprognostic (6.38e-2)" "unprognostic (3.44e-2)" "unprognostic (1.79e-2)" "unprognostic (3.54e-2)" "unprognostic (1.81e-1)" "unprognostic (1.05e-2)" "unprognostic (2.05e-2)" "unprognostic (1.05e-3)" "unprognostic (3.77e-2)" "unprognostic (1.67e-1)" "unprognostic (4.43e-3)" "unprognostic (5.16e-4)" 3.8 6.0 4.4 6.6 4.9 4.0 6.5 5.7 5.1 2.7 4.7 4.2 2.9 2.1 5.4 3.0 1.8 2.9 4.8 4.4 7.7 11.1 2.9 5.7 4.5 3.6 10.7 4.2 5.0 5.5 4.1 3.2 3.7 3.6 5.2 4.9 7.6 2.8 3.9 5.0 6.3 3.2 5.1 4.3 4.5 3.5 20.3 24.4 34.4 33.9 5.7 14.0 19.9 21.1 15.7 7.7 12.0 5.8 1.9 10.2 10.6 4.2 4.5 5.3 4.4 20.8 24.6 10.3 7.7 26.0 14.1 20.9 12.3 37.7 9.1 9.4 35.9 20.9 7.3 17.7 11.8 4.8 6.5 8.2 10.7 10.4 17.2 20.0 6.6 13.6 20.7 23.7 11.4 26.5 9.5 24.1 26.6 5.1 9.2 12.0 7.7 17.4 10.5 13.0 7.6 20.7 4.9 7.0 17.7 11.4 20.4 11.9 47.0 30.0 20.8 26.3 12.5 9.1 33.9 24.8 11.6 27.2 10.0 20.3 10.8 11.9 24.4 18.4 11.7 10.9 34.4 5.7 19.0 18.3 14.0 19.9 CBWD5 ENSG00000147996 "COBW domain containing 5" Q5RIA9 9 65668805-65734041 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA042759, HPA042813" Approved Approved "Plasma membrane" "Plasma membrane" "HPA042759: , HPA042813: " "unprognostic (1.34e-1)" "unprognostic (3.62e-2)" "unprognostic (8.18e-2)" "unprognostic (4.23e-3)" "unprognostic (5.25e-3)" "unprognostic (1.02e-3)" "unprognostic (5.32e-3)" "unprognostic (9.24e-2)" "unprognostic (2.07e-1)" "unprognostic (1.54e-2)" "unprognostic (1.11e-2)" "unprognostic (6.46e-3)" "unprognostic (1.03e-1)" "unprognostic (4.61e-3)" "unprognostic (1.17e-1)" "unprognostic (5.68e-2)" "unprognostic (3.87e-1)" 4.1 6.0 5.2 3.7 6.8 2.5 9.2 8.2 3.7 2.8 3.3 5.4 1.7 4.8 3.3 1.7 2.2 2.4 6.2 6.0 7.6 17.9 1.9 2.6 4.8 2.1 6.6 2.9 4.0 2.9 4.3 5.5 2.2 3.8 2.1 2.8 4.4 2.5 2.6 5.7 2.2 2.1 5.1 4.4 5.4 1.5 5.5 11.7 7.7 14.0 2.5 5.5 9.3 14.9 16.2 5.7 7.3 8.9 4.1 7.0 10.6 7.2 8.4 8.7 2.1 13.9 20.4 6.8 6.1 11.1 26.2 8.5 16.0 3.3 6.3 5.7 26.1 36.3 6.7 12.8 3.7 7.2 9.9 7.7 6.3 15.2 8.0 15.3 8.6 18.1 6.4 13.6 7.1 17.4 11.2 8.0 20.4 13.4 9.8 7.7 7.8 8.6 6.8 3.1 31.7 8.6 4.3 3.8 14.1 11.7 12.2 5.0 13.4 4.8 16.0 14.8 14.4 1.6 11.6 7.7 3.4 14.0 3.7 5.5 5.5 4.7 11.7 2.9 5.1 4.1 7.1 2.5 8.5 4.9 4.1 9.3 CBWD6 CBWD7 ENSG00000215126 "COBW domain containing 6" Q4V339 9 41131306-41199261 "Predicted intracellular proteins" "Evidence at transcript level" "Evidence at transcript level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in many" "blood: 9.3;liver: 6.1" "Cell line enhanced" "Detected in many" "PC-3: 19.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "HPA042759, HPA042813" Approved Approved "Plasma membrane" "Plasma membrane" "HPA042759: , HPA042813: " "unprognostic (9.48e-2)" "unprognostic (6.02e-2)" "unprognostic (1.62e-2)" "unprognostic (1.91e-2)" "unprognostic (1.30e-2)" "unprognostic (6.28e-2)" "unprognostic (5.92e-2)" "unprognostic (3.71e-2)" "unprognostic (2.07e-2)" "unprognostic (1.12e-1)" "unprognostic (4.24e-2)" "unprognostic (1.09e-1)" "unprognostic (2.28e-4)" "unprognostic (5.65e-2)" "unprognostic (1.65e-1)" "unprognostic (1.01e-2)" "unprognostic (9.94e-4)" 0.1 5.2 2.2 0.4 2.4 2.0 2.8 1.0 2.0 0.2 0.3 1.2 0.1 0.0 0.2 0.0 1.6 1.3 2.8 1.5 2.1 6.1 0.1 0.0 1.2 0.2 1.3 0.0 0.5 0.0 0.6 0.0 2.8 2.5 4.3 0.4 0.9 0.0 1.2 0.3 0.2 0.1 0.3 0.2 0.2 0.1 4.8 4.0 2.5 9.3 0.6 4.3 2.8 1.4 0.3 0.6 0.3 0.7 1.8 1.2 7.8 8.7 9.0 0.0 2.9 0.9 1.8 0.4 6.3 1.2 11.4 0.2 0.3 1.8 7.3 0.5 4.1 2.1 0.0 2.2 0.7 0.2 1.1 6.0 7.5 6.9 1.0 1.1 12.3 1.2 3.4 0.6 1.9 19.1 0.8 7.6 2.6 8.0 0.5 0.9 1.0 1.9 0.7 0.9 0.6 1.2 11.5 0.1 0.8 0.3 0.8 3.4 0.6 10.1 1.2 0.8 0.9 1.6 5.9 2.5 0.8 6.8 1.4 4.8 4.3 3.5 3.3 1.8 3.0 3.4 0.9 0.6 9.3 4.0 1.8 2.8 CCNYL1 FLJ40432 ENSG00000163249 "Cyclin Y like 1" Q8N7R7 2 207711540-207761839 "Predicted intracellular proteins" Cyclin "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 41.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" HPA046825 Approved Approved "Plasma membrane" "Plasma membrane" "HPA046825: AB_10963934" "unprognostic (2.59e-2)" "unprognostic (1.23e-1)" "unprognostic (1.03e-2)" "unprognostic (1.20e-3)" "unprognostic (1.78e-1)" "unprognostic (1.59e-1)" "unprognostic (1.31e-3)" "unprognostic (5.48e-2)" "unprognostic (1.65e-1)" "unprognostic (1.41e-2)" "unprognostic (7.12e-3)" "unprognostic (7.99e-2)" "unprognostic (3.92e-2)" "unprognostic (8.08e-2)" "unprognostic (7.91e-2)" "unprognostic (2.37e-2)" "unprognostic (1.96e-3)" 17.5 8.0 9.8 12.2 10.7 10.6 14.5 4.8 12.8 12.6 18.1 11.2 11.5 13.3 8.8 8.2 24.6 8.0 10.0 11.7 8.0 7.2 15.9 18.4 14.5 11.9 9.1 10.1 6.3 21.6 6.9 8.3 16.8 9.3 7.9 16.4 7.9 12.1 10.0 10.1 5.8 16.3 10.8 11.7 12.1 14.8 18.3 8.1 10.9 14.4 6.6 13.9 10.8 13.9 4.1 1.8 4.6 3.8 1.9 2.7 0.9 11.7 5.1 6.9 9.8 9.3 10.6 41.7 7.2 12.3 7.6 8.3 22.9 11.2 4.5 7.0 13.2 8.3 8.2 13.5 7.4 1.6 6.2 6.0 5.9 19.2 8.8 5.6 7.2 5.0 5.5 9.2 10.6 24.4 2.9 4.7 9.9 6.0 4.9 4.9 13.7 5.6 4.2 6.8 3.6 8.1 8.9 1.6 5.4 9.0 3.8 11.0 3.5 14.2 13.0 8.5 8.7 10.7 4.9 2.7 3.7 6.9 9.6 6.4 7.3 1.7 3.8 1.5 1.1 1.9 1.4 1.2 1.9 1.9 1.8 4.1 1.5 2.7 4.6 1.9 1.7 1.7 1.3 0.9 9.8 10.7 4.8 12.8 8.0 7.2 9.1 10.1 9.3 8.1 CCR4 "CC-CKR-4, CD194, ChemR13, CKR4, CMKBR4, k5-5" ENSG00000183813 "C-C motif chemokine receptor 4" P51679 3 32951574-32956349 "CD markers, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 28.9;lymphoid tissue: 57.1" "Cell line enriched" "Detected in some" 17 "HDLM-2: 65.5" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Cell type enriched" "Detected in some" 5 "T-reg: 28.9" "Lineage enriched" "Detected in single" 48 "T-cells: 28.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA031613 Approved Supported "Plasma membrane" "Plasma membrane" "HPA031613: AB_10601096" "unprognostic (4.63e-3)" "unprognostic (8.70e-3)" "unprognostic (2.82e-3)" "unprognostic (2.64e-3)" "unprognostic (1.18e-1)" "unprognostic (4.59e-7)" "unprognostic (3.02e-1)" "unprognostic (5.05e-3)" "unprognostic (1.53e-2)" "unprognostic (1.69e-2)" "unprognostic (1.75e-1)" "unprognostic (2.17e-1)" "unprognostic (9.88e-3)" "unprognostic (2.04e-1)" "unprognostic (5.53e-4)" "unprognostic (1.54e-1)" "unprognostic (1.40e-1)" 1.5 0.6 0.3 12.6 0.4 1.5 1.1 0.3 0.3 1.1 1.1 0.1 0.7 0.4 1.0 0.6 1.6 0.8 3.8 0.8 0.3 0.3 1.8 0.9 6.0 24.1 0.3 0.0 0.5 0.5 0.5 0.5 0.1 0.1 1.5 1.2 0.8 4.3 0.2 1.8 2.2 5.0 0.4 0.4 10.2 1.3 2.7 0.0 57.1 1.3 2.8 29.7 8.6 1.1 0.2 0.2 0.5 0.1 0.1 28.9 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 65.5 0.0 3.9 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 1.0 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.5 0.1 0.1 0.2 0.1 0.2 0.1 6.0 1.8 0.0 0.2 0.1 0.1 0.5 0.1 0.1 0.2 28.9 0.8 0.3 0.4 0.3 0.3 0.3 0.3 0.3 0.0 0.1 0.0 CD109 "CPAMD7, DKFZp762L1111, FLJ38569" ENSG00000156535 "CD109 molecule" Q6YHK3 6 73695785-73828316 "CD markers, Plasma proteins, Predicted membrane proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "parathyroid gland: 203.4" "Cell line enhanced" "Detected in many" "ASC TERT1: 61.6;BJ hTERT+: 37.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA008992, HPA015723" Enhanced Supported "Plasma membrane" 120000000 "Plasma membrane" "HPA008992: , HPA015723: " "unprognostic (2.28e-1)" "unprognostic (1.03e-1)" "unprognostic (7.76e-2)" "unprognostic (1.52e-2)" "unprognostic (9.17e-3)" "unprognostic (1.36e-1)" "unprognostic (1.03e-3)" "unprognostic (1.23e-3)" "unprognostic (7.49e-2)" "unprognostic (2.47e-1)" "unprognostic (1.15e-3)" "unprognostic (8.81e-2)" "prognostic unfavourable (2.65e-4)" "prognostic unfavourable (7.96e-5)" "unprognostic (9.50e-2)" "unprognostic (2.02e-1)" "prognostic unfavourable (4.68e-4)" 27.4 1.5 1.6 1.9 2.2 1.9 6.5 0.4 1.9 15.0 7.1 3.4 2.0 1.5 22.5 8.5 22.4 3.4 2.4 8.2 1.8 1.4 3.5 1.4 14.5 1.4 1.7 1.4 2.8 1.2 203.4 0.6 5.0 3.0 7.1 2.1 0.6 4.2 2.2 4.1 12.4 2.4 12.6 4.5 1.7 1.5 3.3 2.8 6.3 1.7 16.8 4.7 8.7 8.0 0.3 2.6 1.4 0.4 0.6 0.4 0.3 9.2 8.3 0.5 0.0 12.7 61.6 0.0 8.4 37.8 2.8 6.1 0.0 5.4 0.0 5.2 17.3 26.1 0.9 16.9 3.7 2.5 1.4 3.3 6.8 1.4 2.7 0.0 0.0 16.9 13.4 5.2 21.1 20.0 0.0 0.0 12.6 0.2 0.2 0.0 0.6 5.4 0.7 2.4 11.4 1.2 1.0 0.0 0.0 19.1 0.1 8.3 0.2 1.5 18.5 26.4 3.7 4.7 7.2 0.1 5.2 0.0 10.6 0.0 23.4 0.6 0.4 0.3 0.2 0.2 0.1 0.2 0.3 0.2 2.6 0.3 0.4 0.2 1.4 0.6 0.2 1.4 0.1 0.3 1.6 2.2 0.4 1.9 1.8 1.4 1.7 1.4 3.0 2.8 CD163 "M130, MM130, SCARI1" ENSG00000177575 "CD163 molecule" Q86VB7 12 7470813-7503893 "CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Acute phase, Inflammatory response" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 113.6" "Cell line enhanced" "Detected in some" "ASC diff: 2.1;CACO-2: 1.9;HSkMC: 5.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 10 "classical monocyte: 28.2;myeloid DC: 25.3" "Group enriched" "Detected in many" 40 "dendritic cells: 25.3;monocytes: 28.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB002432, HPA046404, HPA051974" Enhanced Approved "Plasma membrane" "Secreted to blood" 903333333 1600000000 "Plasma membrane" "CAB002432: AB_563510, HPA046404: AB_2679655, HPA051974: AB_2681678" "unprognostic (1.13e-1)" "unprognostic (2.13e-1)" "unprognostic (5.02e-3)" "unprognostic (2.72e-1)" "unprognostic (6.17e-3)" "unprognostic (2.09e-1)" "unprognostic (1.02e-1)" "unprognostic (1.21e-1)" "unprognostic (2.78e-1)" "prognostic unfavourable (7.27e-4)" "unprognostic (1.04e-1)" "unprognostic (6.50e-2)" "unprognostic (1.84e-2)" "unprognostic (8.77e-2)" "unprognostic (4.95e-2)" "unprognostic (1.61e-1)" "unprognostic (1.20e-2)" 66.7 23.8 2.1 44.6 7.2 4.1 23.2 2.8 4.9 11.3 25.3 1.6 1.4 3.5 7.2 16.8 11.3 20.1 13.2 15.7 2.8 1.8 43.9 38.9 81.0 99.8 6.9 0.5 10.3 6.7 3.1 11.7 31.9 9.9 6.8 6.5 9.8 8.6 2.2 15.2 4.0 12.5 37.2 5.7 113.6 10.2 19.6 4.3 3.4 15.5 2.9 3.5 20.1 8.3 0.0 25.3 0.6 28.2 0.0 0.0 6.3 0.0 0.0 0.0 0.0 2.1 1.1 0.4 0.0 0.1 0.0 0.0 1.9 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.6 0.3 5.9 0.0 0.4 0.6 0.0 0.0 0.0 0.2 0.0 0.1 0.6 0.6 0.0 0.1 1.0 0.1 0.0 0.0 0.3 0.6 0.1 0.2 0.0 0.0 0.3 0.0 1.1 0.3 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.5 28.2 0.1 0.0 2.5 0.0 0.0 0.0 0.0 25.3 0.0 0.0 0.0 0.6 0.0 0.0 0.3 0.0 6.3 2.1 7.2 2.8 2.4 2.8 1.8 6.9 0.5 9.9 4.3 CD200R1 "CD200R, HCRTR2, MOX2R, OX2R" ENSG00000163606 "CD200 receptor 1" Q8TD46 3 112921209-112975122 "Predicted intracellular proteins, Predicted membrane proteins" "Host-virus interaction" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "blood: 46.7;lymphoid tissue: 21.2" "Cell line enriched" "Detected in some" 8 "HEL: 25.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 5 "basophil: 46.7;eosinophil: 12.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 46.7" HPA068512 Supported "Plasma membrane" "Intracellular and membrane" 1500000 "Plasma membrane" "HPA068512: " "unprognostic (1.49e-2)" "unprognostic (1.06e-2)" "unprognostic (2.55e-1)" "unprognostic (1.97e-2)" "unprognostic (1.53e-1)" "unprognostic (1.24e-2)" "unprognostic (1.13e-1)" "unprognostic (2.06e-3)" "unprognostic (8.30e-2)" "unprognostic (1.85e-1)" "unprognostic (7.98e-2)" "unprognostic (2.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.77e-1)" "unprognostic (7.84e-3)" "unprognostic (1.25e-1)" "unprognostic (5.12e-3)" 3.6 1.6 1.0 9.5 1.4 1.8 3.8 0.8 1.4 5.0 3.5 0.3 1.5 2.0 3.9 5.4 7.5 1.3 2.7 5.8 1.0 1.2 1.4 3.4 4.3 9.0 1.0 0.0 1.0 1.1 0.5 1.0 7.8 0.4 4.2 3.5 2.4 2.5 1.6 0.9 3.4 3.3 1.7 0.9 21.2 1.7 2.5 0.5 15.8 2.0 3.9 17.0 3.8 2.0 2.3 5.8 46.7 0.8 0.6 3.7 1.3 0.6 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.5 0.4 0.8 0.2 0.0 0.0 0.0 0.0 0.0 3.1 0.2 25.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.4 0.0 0.0 1.1 0.0 46.7 0.8 12.7 1.0 0.4 1.8 2.3 3.7 2.1 5.8 1.2 3.6 1.7 0.2 0.6 0.1 0.1 1.0 1.3 1.0 1.4 0.8 1.4 1.0 1.2 1.0 0.0 0.4 0.5 CD38 ENSG00000004468 "CD38 molecule" P28907 4 15778275-15853230 "Cancer-related genes, CD markers, Enzymes, Predicted intracellular proteins" "Hydrolase, Receptor, Transferase" "Cancer-related genes, Diabetes mellitus" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "lymphoid tissue: 94.9;seminal vesicle: 104.1" "Cell line enhanced" "Detected in some" "Daudi: 49.8;Karpas-707: 13.9;MOLT-4: 12.6;REH: 10.0;U-266/70: 10.8;U-698: 9.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 15.3" "Group enriched" "Detected in all" 4 "B-cells: 9.0;dendritic cells: 5.1;NK-cells: 15.3" "Low region specificity" "Detected in all" "CAB002493, HPA022132, CAB025255, HPA052381" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB002493: AB_563556, CAB025255: , HPA022132: AB_1846300, HPA052381: AB_2681807" "unprognostic (1.27e-2)" "unprognostic (8.06e-3)" "unprognostic (1.06e-2)" "prognostic favourable (9.68e-4)" "unprognostic (1.13e-1)" "unprognostic (1.82e-3)" "unprognostic (2.74e-1)" "unprognostic (8.51e-2)" "unprognostic (5.87e-2)" "unprognostic (6.15e-6)" "unprognostic (5.23e-1)" "unprognostic (4.34e-1)" "unprognostic (6.63e-6)" "unprognostic (1.79e-1)" "unprognostic (5.74e-2)" "unprognostic (2.12e-2)" "unprognostic (2.13e-1)" 4.1 3.3 3.8 17.6 8.5 9.3 2.6 0.7 12.0 1.0 3.2 10.4 14.6 4.3 0.7 0.9 2.3 2.4 1.5 5.0 4.0 4.2 1.2 5.4 4.7 16.1 4.9 3.1 0.6 0.7 0.0 2.5 0.6 3.1 10.8 2.7 4.4 2.8 104.1 14.2 0.5 6.2 0.9 1.8 20.6 2.0 0.7 2.5 94.9 2.8 2.0 13.2 7.6 0.9 9.0 5.1 1.3 2.2 15.3 2.3 3.7 0.0 4.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 49.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 13.9 0.0 0.0 12.6 3.0 0.0 0.0 10.0 0.0 7.8 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.0 2.2 0.2 0.0 0.0 0.0 0.0 10.8 0.1 9.4 0.1 2.4 0.1 0.0 1.7 0.0 1.1 2.2 0.3 9.0 1.4 1.2 4.1 6.6 2.3 1.8 1.3 15.3 1.4 5.1 2.1 3.7 3.8 8.5 0.7 6.2 4.0 4.2 4.9 3.1 3.1 2.5 CD4 ENSG00000010610 "CD4 molecule" P01730 12 6786858-6820808 "CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "lymphoid tissue: 111.5;parathyroid gland: 78.4" "Group enriched" "Detected in some" 6 "HEL: 33.5;HL-60: 13.5;NB-4: 19.3;THP-1: 38.1;U-937: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 17 "classical monocyte: 42.2;intermediate monocyte: 42.5;memory CD4 T-cell: 29.1;myeloid DC: 29.3;naive CD4 T-cell: 24.8;non-classical monocyte: 33.3;plasmacytoid DC: 46.7;T-reg: 26.4" "Group enriched" "Detected in many" 20 "dendritic cells: 46.7;monocytes: 42.5;T-cells: 29.1" "Region enriched" "Detected in single" 15 "basal ganglia: 41.4" "Low region specificity" "Detected in many" "CAB000011, HPA004252, HPA004472, CAB068180" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB000011: AB_442062, CAB068180: , HPA004252: AB_1078466, HPA004472: AB_1078465" "unprognostic (1.39e-2)" "unprognostic (1.12e-2)" "unprognostic (2.75e-2)" "prognostic favourable (2.16e-4)" "unprognostic (7.76e-2)" "unprognostic (4.82e-3)" "unprognostic (3.70e-2)" "unprognostic (2.74e-2)" "unprognostic (7.04e-2)" "unprognostic (2.40e-1)" "unprognostic (1.13e-1)" "unprognostic (1.92e-1)" "prognostic unfavourable (7.45e-4)" "unprognostic (1.06e-1)" "unprognostic (4.65e-3)" "unprognostic (9.08e-3)" "unprognostic (2.95e-1)" 13.8 5.4 6.1 16.0 5.8 4.4 5.6 1.2 4.3 4.5 5.1 8.6 1.8 3.6 3.5 8.3 3.0 5.5 7.3 5.4 4.9 4.4 6.1 32.2 24.0 30.8 6.3 3.1 3.0 3.1 78.4 3.4 10.9 6.2 4.1 6.5 5.7 5.4 3.9 1.9 3.5 9.5 5.2 10.2 49.1 3.9 2.8 5.7 111.5 3.9 4.1 18.6 8.6 3.2 0.1 46.7 1.9 42.5 0.3 29.1 33.6 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 33.5 0.0 0.2 3.7 13.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.8 19.3 0.3 0.0 0.0 0.0 4.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 38.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.1 42.2 0.3 0.3 42.5 1.1 0.0 29.1 0.1 29.3 0.1 24.8 0.1 1.9 0.3 33.3 46.7 26.4 33.6 6.1 5.8 1.2 4.3 4.9 4.4 6.3 3.1 6.2 5.7 CD46 "MCP, MGC26544, MIC10, TLX, TRA2.10" ENSG00000117335 "CD46 molecule" P15529 1 207752057-207795513 "Cancer-related genes, CD markers, Disease related genes, Plasma proteins, Predicted membrane proteins" "Complement pathway, Fertilization, Host-virus interaction, Immunity, Innate immunity" "Host cell receptor for virus entry, Receptor" "Cancer-related genes, Disease mutation, Hemolytic uremic syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in all" 4 "basophil: 41.7;eosinophil: 63.7;neutrophil: 69.8" "Lineage enriched" "Detected in all" 5 "granulocytes: 69.8" "CAB010401, HPA016903" Enhanced Uncertain "Plasma membrane" 1000000 "Plasma membrane" "CAB010401: AB_2291289, HPA016903: AB_1846309" "unprognostic (1.42e-2)" "prognostic unfavourable (8.54e-5)" "unprognostic (3.94e-2)" "unprognostic (2.14e-2)" "unprognostic (3.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.91e-2)" "unprognostic (1.82e-1)" "unprognostic (1.25e-1)" "unprognostic (2.74e-1)" "unprognostic (8.79e-2)" "unprognostic (2.50e-1)" "unprognostic (6.78e-3)" "prognostic favourable (2.38e-4)" "unprognostic (1.76e-1)" "unprognostic (8.23e-2)" "unprognostic (1.49e-2)" 38.0 78.0 13.0 22.9 20.5 18.5 57.0 12.9 17.8 27.5 35.4 25.3 64.3 32.9 39.7 32.6 43.2 30.4 25.2 20.6 16.1 15.5 50.8 57.8 43.6 25.0 21.4 13.2 27.6 47.9 86.6 32.7 119.6 29.1 47.0 28.5 26.7 68.4 60.5 18.8 18.4 39.8 25.0 21.8 26.9 33.9 16.5 20.7 20.3 25.3 21.8 30.3 37.2 27.0 7.7 8.1 69.8 14.1 7.5 13.5 14.9 26.2 14.8 13.9 6.4 44.0 43.5 21.2 19.7 28.7 13.0 17.7 14.6 69.9 4.0 20.1 19.6 35.6 10.4 27.0 19.9 20.2 14.8 8.7 16.3 26.1 28.0 19.0 30.4 37.4 40.3 19.6 15.5 36.4 18.3 17.5 20.0 12.3 9.0 16.7 15.9 14.8 6.1 22.1 24.7 53.3 52.0 14.1 9.6 24.9 56.1 32.3 44.1 16.3 31.2 14.0 12.5 29.4 22.4 23.6 28.5 12.1 20.5 12.5 13.1 41.7 13.5 63.7 9.2 14.0 12.5 7.7 11.7 10.1 8.1 6.0 13.5 11.2 69.8 7.5 14.1 4.2 10.1 14.9 13.0 20.5 12.9 17.8 16.1 15.5 21.4 13.2 29.1 20.7 CD81 "TAPA-1, TAPA1, TSPAN28" ENSG00000110651 "CD81 molecule" P60033 11 2376177-2397419 "CD markers, Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Adaptive immunity, Host-virus interaction, Immunity" "Host cell receptor for virus entry, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 231.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory B-cell: 41.4;naive B-cell: 37.6" "Lineage enriched" "Detected in all" 4 "B-cells: 41.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002507, HPA007234" Supported Supported "Plasma membrane" 1900000 "Plasma membrane" "CAB002507: AB_563639, HPA007234: AB_1846333" "unprognostic (2.96e-1)" "unprognostic (3.40e-1)" "prognostic unfavourable (7.56e-4)" "unprognostic (1.84e-2)" "prognostic unfavourable (8.21e-5)" "unprognostic (6.03e-2)" "unprognostic (1.75e-1)" "unprognostic (1.31e-1)" "unprognostic (2.09e-1)" "unprognostic (1.24e-1)" "prognostic favourable (3.86e-4)" "unprognostic (3.07e-3)" "unprognostic (2.08e-1)" "unprognostic (3.55e-2)" "unprognostic (1.67e-1)" "unprognostic (2.06e-1)" "unprognostic (2.06e-1)" 102.5 43.7 52.8 40.1 57.0 9.6 79.3 31.7 63.2 124.7 88.9 75.8 261.4 21.1 143.5 141.5 56.8 123.1 86.8 101.2 46.6 52.8 65.5 123.9 107.4 82.4 70.4 51.3 77.9 62.4 41.4 42.9 61.2 63.0 89.3 34.0 46.6 59.7 263.3 22.6 59.6 39.7 138.9 59.3 64.5 52.1 57.6 53.3 25.3 66.3 38.5 37.9 93.5 80.2 41.4 2.1 5.7 1.8 3.5 9.9 2.7 24.5 25.5 20.5 31.3 231.4 131.6 17.2 46.5 103.0 37.6 38.0 23.9 0.1 21.0 16.8 130.3 32.3 12.6 33.1 15.5 9.9 38.9 3.2 9.7 0.0 76.6 13.6 27.6 95.6 47.3 15.3 23.3 35.9 14.3 36.9 52.5 18.8 11.5 17.4 24.6 20.7 23.7 10.3 13.4 40.4 16.6 22.1 24.5 14.8 39.0 28.0 12.9 24.9 47.8 19.2 14.2 35.9 15.9 27.3 6.2 38.3 27.9 8.1 32.8 0.2 0.9 5.7 6.0 1.4 9.9 41.4 4.3 9.4 0.6 37.6 2.6 5.0 0.3 3.5 1.8 2.1 3.0 2.7 52.8 57.0 31.7 63.2 46.6 52.8 70.4 51.3 63.0 53.3 CD8A CD8 ENSG00000153563 "CD8a molecule" P01732 2 86784610-86808396 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 14 "blood: 82.2;lymphoid tissue: 262.3" "Cell line enriched" "Detected in some" 4 "MOLT-4: 17.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 13 "MAIT T-cell: 36.7;memory CD8 T-cell: 82.2;naive CD8 T-cell: 77.8" "Lineage enriched" "Detected in many" 20 "T-cells: 82.2" "Low region specificity" "Detected in all" "CAB000012, HPA037756, CAB075722" Enhanced Supported "Plasma membrane" "Intracellular and membrane" 500000 "Plasma membrane" "CAB000012: AB_2075537, CAB075722: , HPA037756: " "unprognostic (1.29e-3)" "prognostic favourable (4.54e-4)" "unprognostic (9.26e-3)" "prognostic favourable (6.15e-6)" "unprognostic (7.28e-2)" "unprognostic (2.79e-3)" "unprognostic (1.03e-2)" "unprognostic (2.00e-2)" "unprognostic (1.35e-2)" "unprognostic (4.50e-3)" "unprognostic (1.09e-1)" "unprognostic (1.14e-1)" "prognostic unfavourable (1.91e-5)" "unprognostic (1.36e-1)" "unprognostic (1.48e-1)" "unprognostic (6.74e-2)" "unprognostic (1.56e-2)" 2.4 1.4 1.4 7.4 2.8 6.8 1.5 1.4 1.2 2.1 5.3 0.8 0.8 4.2 1.5 2.1 2.0 2.1 4.5 1.6 1.2 1.6 1.3 2.1 6.0 23.8 1.0 0.5 1.7 1.2 0.0 0.9 0.6 0.7 2.3 1.9 1.8 3.0 1.1 0.8 0.7 12.2 0.7 1.7 46.4 5.4 1.0 0.5 262.3 2.2 1.6 8.1 3.8 1.9 0.0 0.1 0.6 0.1 4.0 82.2 17.4 0.3 0.2 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.3 0.0 0.8 17.4 1.1 0.6 0.3 0.1 0.9 3.9 0.0 0.4 0.9 2.4 0.2 0.1 0.0 0.4 0.5 0.0 0.0 0.6 0.1 0.0 0.1 0.3 0.9 0.0 0.0 0.1 0.1 0.1 0.0 4.8 0.0 36.7 0.0 0.3 82.2 0.0 0.0 0.3 77.8 0.6 4.0 0.1 0.1 0.1 17.4 1.4 2.8 1.4 1.2 1.2 1.6 1.0 0.5 0.7 0.5 CD8B CD8B1 ENSG00000172116 "CD8b molecule" P10966 2 86815339-86861924 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "blood: 132.1;lymphoid tissue: 61.5" "Cell line enriched" "Detected in some" 55 "RPMI-8226: 154.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 10 "memory CD8 T-cell: 73.5;naive CD8 T-cell: 132.1" "Lineage enriched" "Detected in many" 40 "T-cells: 132.1" "CAB004353, HPA029164" Enhanced Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB004353: AB_627211, HPA029164: " "unprognostic (1.83e-3)" "unprognostic (1.98e-3)" "unprognostic (2.22e-2)" "prognostic favourable (7.88e-7)" "unprognostic (6.23e-2)" "unprognostic (7.05e-3)" "unprognostic (1.11e-2)" "unprognostic (2.59e-2)" "unprognostic (5.50e-3)" "unprognostic (5.91e-2)" "unprognostic (9.25e-2)" "unprognostic (4.60e-1)" "prognostic unfavourable (7.11e-6)" "unprognostic (7.84e-2)" "unprognostic (3.00e-1)" "unprognostic (1.86e-2)" "unprognostic (4.33e-2)" 1.2 0.7 1.0 5.3 1.0 3.9 1.0 1.3 1.3 21.2 1.1 1.0 1.0 2.5 1.2 1.0 1.0 1.1 1.8 1.0 1.0 1.8 1.0 1.0 2.7 14.4 1.7 1.0 1.3 1.0 6.4 7.4 1.0 2.2 1.3 1.3 1.0 1.0 1.0 1.0 0.9 11.4 1.0 1.5 12.7 2.3 1.0 1.0 61.5 1.5 1.0 8.1 1.8 1.3 0.1 0.1 3.2 0.1 0.1 132.1 36.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 154.8 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 3.2 0.1 0.0 2.0 0.1 10.0 0.0 0.2 73.5 0.0 0.1 0.5 132.1 0.7 0.1 0.1 0.1 0.2 36.3 1.0 1.0 1.3 1.3 1.0 1.8 1.7 1.0 2.2 1.0 CD9 "BA2, MIC3, MRP-1, P24, TSPAN29" ENSG00000010278 "CD9 molecule" P21926 12 6199715-6238271 "Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Transporters" "Cell adhesion, Fertilization" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CAPAN-2: 127.8;HUVEC TERT2: 82.6;RT4: 94.7;TIME: 188.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 21 "basophil: 137.8;eosinophil: 98.3" "Lineage enriched" "Detected in many" 24 "granulocytes: 137.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB002490 Supported Supported "Plasma membrane" 68000000 "Plasma membrane" "CAB002490: AB_563643" "unprognostic (1.38e-1)" "unprognostic (6.36e-3)" "unprognostic (8.27e-3)" "unprognostic (6.98e-3)" "unprognostic (3.89e-1)" "unprognostic (2.81e-1)" "unprognostic (1.32e-1)" "unprognostic (2.08e-2)" "unprognostic (2.90e-1)" "unprognostic (2.60e-2)" "prognostic unfavourable (1.59e-4)" "unprognostic (2.30e-1)" "prognostic favourable (6.49e-5)" "unprognostic (6.10e-2)" "unprognostic (1.77e-1)" "prognostic favourable (8.93e-5)" "unprognostic (9.26e-2)" 38.1 44.5 20.0 24.1 36.2 3.1 48.2 6.8 29.6 55.0 68.3 63.1 151.6 19.5 36.2 43.4 139.8 38.4 23.2 39.2 30.3 15.6 39.9 12.2 61.1 8.2 43.3 23.3 14.1 23.3 89.5 15.2 13.0 28.7 77.9 73.5 25.5 91.6 180.4 11.3 60.1 29.6 62.2 48.9 12.2 27.7 10.4 47.7 6.0 63.6 112.3 85.8 54.5 76.0 1.9 0.9 137.8 5.6 0.2 1.1 5.6 33.9 14.9 0.3 9.2 14.7 15.1 12.9 20.1 40.2 6.9 10.6 10.9 127.8 0.1 5.0 4.3 74.5 7.8 40.2 5.3 1.7 5.5 0.1 11.3 2.3 6.3 0.1 42.8 0.0 29.9 12.6 10.9 82.6 1.5 0.1 4.3 48.6 0.1 3.7 11.6 15.0 0.3 24.6 43.2 67.6 94.7 0.0 2.9 20.0 16.6 17.2 7.7 3.5 188.9 0.7 18.9 0.7 2.4 0.1 0.1 5.1 11.8 0.0 18.6 137.8 5.6 98.3 0.1 1.8 0.2 0.5 0.1 0.1 0.9 1.9 0.4 1.1 2.6 0.2 0.0 0.3 0.0 5.6 20.0 36.2 6.8 29.6 30.3 15.6 43.3 23.3 28.7 47.7 CD99L2 "CD99B, MIC2L1" ENSG00000102181 "CD99 molecule like 2" Q8TCZ2 X 150766337-150898816 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 72.2" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038782, HPA038783, HPA061400" Enhanced Supported "Plasma membrane" 790000 "Plasma membrane" "HPA038782: AB_10795139, HPA038783: AB_10794734, HPA061400: " "unprognostic (2.10e-2)" "unprognostic (2.62e-3)" "unprognostic (3.12e-3)" "unprognostic (6.03e-3)" "unprognostic (1.22e-1)" "unprognostic (2.66e-1)" "unprognostic (5.56e-2)" "prognostic favourable (4.96e-4)" "unprognostic (1.10e-1)" "unprognostic (1.28e-1)" "prognostic favourable (2.74e-5)" "unprognostic (5.50e-2)" "unprognostic (5.13e-2)" "unprognostic (1.35e-1)" "unprognostic (6.74e-2)" "unprognostic (9.23e-2)" "prognostic unfavourable (8.74e-4)" 27.1 16.5 23.3 9.2 30.1 4.5 17.8 27.5 56.7 19.2 12.6 21.0 5.5 6.7 17.6 16.5 9.7 17.6 12.4 32.1 26.3 32.0 14.0 17.0 14.9 9.6 30.5 26.6 26.0 8.4 9.7 8.7 21.5 43.1 13.9 7.4 11.9 8.3 22.0 72.2 6.7 8.0 20.8 31.9 12.5 8.0 7.6 13.3 3.0 7.3 6.9 7.0 10.7 7.7 7.2 10.7 9.4 15.1 8.8 8.9 8.4 2.2 22.6 8.6 10.7 45.6 28.5 2.5 18.6 21.9 9.4 13.6 1.6 2.9 8.2 45.3 32.4 3.7 11.7 12.6 7.8 19.1 9.1 3.5 5.4 2.2 12.3 5.9 6.8 26.9 4.2 6.9 13.3 11.1 2.4 21.6 11.8 4.8 5.2 8.6 3.6 12.3 5.2 7.0 11.2 9.2 1.5 11.4 5.8 7.3 6.3 8.3 1.8 10.2 13.0 14.0 4.3 18.1 13.4 18.4 30.4 8.0 17.6 11.9 10.5 9.4 11.2 7.6 8.8 9.9 7.8 6.4 8.2 8.9 10.7 7.2 8.3 8.5 2.8 8.8 15.1 7.8 5.9 8.4 23.3 30.1 27.5 55.2 26.3 32.0 30.5 26.6 43.1 13.3 CDH13 CDHH ENSG00000140945 "Cadherin 13" P55290 16 82626803-83800640 "Plasma proteins, Predicted intracellular proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "LHCN-M2: 47.5;U-138 MG: 61.3;U-87 MG: 53.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.9;monocytes: 7.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA001380, CAB025863" Enhanced Supported "Plasma membrane" "Intracellular and membrane" 230000000 "Plasma membrane" "CAB025863: , HPA001380: AB_1078371" "unprognostic (2.50e-2)" "unprognostic (2.75e-2)" "unprognostic (5.61e-2)" "unprognostic (4.06e-1)" "unprognostic (4.88e-2)" "unprognostic (3.30e-3)" "unprognostic (3.01e-1)" "unprognostic (5.76e-2)" "unprognostic (3.49e-2)" "unprognostic (3.34e-1)" "unprognostic (2.21e-1)" "unprognostic (3.26e-1)" "prognostic unfavourable (1.73e-6)" "unprognostic (5.16e-3)" "unprognostic (2.01e-1)" "unprognostic (1.25e-1)" "unprognostic (1.21e-1)" 14.0 2.3 13.9 2.7 14.8 0.7 7.6 0.6 32.5 32.7 3.6 2.0 2.8 1.3 36.1 8.9 6.4 6.1 3.6 34.6 5.2 9.9 3.7 1.4 10.8 1.2 4.2 13.3 3.2 0.8 1.1 0.7 4.0 3.8 2.8 4.2 0.9 4.0 5.0 37.2 14.3 1.8 19.5 3.4 1.6 1.7 3.6 1.6 0.0 4.1 21.3 2.7 4.6 14.6 1.0 0.9 2.9 7.2 0.1 0.1 0.3 2.2 0.0 0.8 0.1 14.0 13.5 0.0 10.0 11.0 11.6 5.0 0.0 0.0 0.0 1.9 29.1 18.9 0.2 14.9 17.5 0.0 0.1 0.0 7.4 0.0 8.1 0.1 0.1 1.7 13.0 23.3 28.5 5.7 0.0 0.1 47.5 0.1 0.0 0.1 2.3 4.1 0.0 12.5 0.0 10.0 0.1 0.0 0.0 17.9 0.1 0.0 0.2 0.0 9.1 61.3 5.0 0.4 9.0 0.0 0.0 0.0 53.4 0.1 15.0 2.9 1.0 2.4 0.1 3.8 0.1 0.9 0.1 0.0 0.9 1.0 0.1 0.1 2.0 0.1 7.2 0.6 0.1 0.3 13.9 14.8 0.6 32.5 5.2 9.9 4.2 13.3 3.8 1.6 CDH4 ENSG00000179242 "Cadherin 4" P55283 20 61252426-61940617 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.4;lymphoid tissue: 10.2;skeletal muscle: 9.8" "Cell line enhanced" "Detected in some" "AF22: 7.9;hTERT-HME1: 10.4;U-2 OS: 14.2;U-251 MG: 24.7" "Group enriched" "Detected in many" 6 "glioma: 6.9;renal cancer: 3.4;thyroid cancer: 2.8" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "T-reg: 2.4" "Lineage enriched" "Detected in single" 25 "T-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA015613 Supported "Plasma membrane" "Plasma membrane" "HPA015613: AB_1845905" "unprognostic (1.64e-1)" "unprognostic (1.19e-2)" "unprognostic (3.39e-4)" "unprognostic (2.16e-1)" "unprognostic (2.59e-2)" "unprognostic (1.08e-1)" "unprognostic (5.64e-2)" "unprognostic (1.34e-1)" "unprognostic (1.01e-1)" "unprognostic (1.27e-1)" "unprognostic (1.85e-1)" "unprognostic (6.72e-2)" "unprognostic (6.08e-3)" "unprognostic (1.75e-1)" "unprognostic (1.27e-1)" "unprognostic (2.64e-2)" "unprognostic (6.78e-2)" 1.0 1.2 17.4 0.7 15.8 0.9 0.9 1.3 13.6 0.9 0.7 4.0 0.0 0.8 0.9 0.7 1.4 2.6 0.9 1.0 10.2 6.9 0.8 0.9 1.0 0.9 2.8 11.8 6.2 2.0 0.7 0.5 0.9 3.3 0.8 0.7 0.6 1.5 3.6 9.8 2.7 0.8 0.7 1.6 10.2 0.8 1.9 3.1 0.0 1.7 0.0 0.7 0.8 0.3 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.1 0.9 7.9 0.0 0.1 0.5 0.1 2.2 0.0 4.0 0.4 0.2 0.0 0.0 0.2 2.6 2.9 0.0 4.3 1.6 0.2 0.0 0.0 0.1 0.1 5.5 0.0 0.1 0.8 1.0 0.8 10.4 0.8 0.0 0.0 1.6 0.3 0.1 0.0 0.9 0.0 0.0 0.0 1.1 2.5 0.0 0.7 1.9 0.0 0.1 0.1 0.0 0.0 0.0 0.0 14.2 0.1 24.7 4.6 0.1 0.0 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 2.4 0.0 17.4 15.8 1.3 13.6 10.2 6.9 2.8 11.8 3.3 3.1 CDH8 ENSG00000150394 "Cadherin 8" P55286 16 61647242-62037035 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 5 "brain: 29.6;seminal vesicle: 9.5" "Group enriched" "Detected in some" 4 "AF22: 6.8;fHDF/TERT166: 6.0;HaCaT: 13.6;LHCN-M2: 16.4" "Cancer enhanced" "Detected in single" "testis cancer: 0.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "basophil: 1.0" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014908, HPA076441" Approved Approved "Plasma membrane" "Plasma membrane" "HPA014908: AB_1845908, HPA076441: " "unprognostic (1.91e-1)" "unprognostic (2.41e-1)" "unprognostic (4.02e-2)" "unprognostic (7.70e-2)" "unprognostic (1.96e-1)" "unprognostic (3.26e-2)" "unprognostic (1.83e-1)" "unprognostic (8.71e-2)" "unprognostic (3.66e-2)" "unprognostic (5.41e-2)" "unprognostic (2.85e-1)" "unprognostic (6.59e-2)" "unprognostic (2.91e-4)" "unprognostic (6.02e-2)" "unprognostic (4.06e-1)" "unprognostic (2.26e-1)" "unprognostic (1.06e-1)" 0.9 0.9 13.0 0.7 20.4 0.7 1.2 0.5 29.6 1.4 0.8 5.5 0.0 1.2 0.9 1.1 1.0 0.7 1.1 1.1 10.4 7.7 0.8 0.7 0.9 0.7 9.3 12.2 3.7 0.7 0.8 0.9 1.3 12.8 1.4 0.9 0.0 1.4 9.5 1.4 0.9 1.0 1.4 7.7 0.8 0.8 1.2 5.6 0.0 1.0 0.0 0.8 1.7 0.3 0.0 0.0 1.0 0.2 0.1 0.1 0.0 0.0 0.0 6.8 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 6.0 13.6 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.3 0.0 16.4 0.0 0.0 0.0 1.2 1.2 0.0 0.0 1.0 0.0 1.8 0.1 0.1 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.1 0.1 0.0 0.1 0.0 13.0 20.4 0.5 17.8 10.4 7.7 9.3 12.2 12.8 5.6 CDRT15 ENSG00000223510 "CMT1A duplicated region transcript 15" Q96T59 17 14235673-14236862 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "skin 1: 5.1;testis: 19.0" "Cell line enhanced" "Detected in many" "HEK 293: 6.9" "Not detected" "Not detected" "Cell type enhanced" "Detected in single" "T-reg: 2.0" "Low lineage specificity" "Detected in single" HPA055952 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA055952: " "unprognostic (3.27e-2)" "unprognostic (1.77e-2)" "unprognostic (8.61e-2)" "unprognostic (9.33e-2)" "unprognostic (5.15e-3)" "unprognostic (2.90e-1)" "unprognostic (6.16e-3)" "unprognostic (1.98e-1)" "unprognostic (1.15e-3)" "unprognostic (2.66e-1)" "unprognostic (2.55e-1)" "unprognostic (1.99e-1)" "unprognostic (5.30e-7)" "unprognostic (1.55e-1)" "unprognostic (1.52e-1)" "unprognostic (6.81e-2)" "unprognostic (2.38e-2)" 0.1 0.3 0.0 1.5 0.0 0.5 0.1 0.3 0.1 0.2 0.2 0.9 0.1 0.0 0.4 0.2 0.4 0.2 0.1 0.1 0.1 0.5 0.2 3.8 0.1 0.4 0.2 0.0 0.1 0.0 0.2 0.0 0.9 0.0 0.1 5.1 1.0 0.0 0.3 1.1 0.4 19.0 0.5 0.0 0.2 0.2 0.2 0.3 0.5 0.1 0.0 2.0 0.0 1.3 2.3 1.6 3.7 0.0 0.0 0.9 1.4 0.0 0.0 0.1 4.4 0.6 3.7 0.9 0.0 1.7 0.0 0.0 0.0 3.7 6.9 2.1 3.8 3.1 0.0 1.7 2.7 0.0 0.0 0.0 0.0 0.0 1.7 0.8 0.0 0.9 1.8 2.7 1.5 2.3 1.4 0.7 1.5 0.0 1.9 1.8 3.3 0.4 1.0 0.6 0.8 0.9 2.0 6.0 0.9 1.4 1.6 1.2 1.4 1.7 0.9 2.8 4.3 0.0 0.1 0.5 0.4 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.0 0.0 CEACAM5 "CD66e, CEA" ENSG00000105388 "Carcinoembryonic antigen related cell adhesion molecule 5" P06731 19 41708585-41729798 "Cancer-related genes, CD markers, Plasma proteins, Predicted intracellular proteins" "Apoptosis, Cell adhesion" "Cancer-related genes, Oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 103.5;intestine: 118.2;lymphoid tissue: 100.6" "Cell line enriched" "Detected in some" 6 "HaCaT: 17.0" "Cancer enhanced" "Detected in many" "colorectal cancer: 1007.1" "Not detected" "Not detected" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in single" "CAB000021, CAB000022, HPA011041, HPA019758" Enhanced Supported "Plasma membrane" "Intracellular and membrane" 19000000 "Plasma membrane" "CAB000021: , CAB000022: AB_2335697, HPA011041: AB_1078481, HPA019758: AB_1846326" "unprognostic (1.54e-2)" "unprognostic (7.59e-2)" "unprognostic (5.49e-3)" "unprognostic (1.80e-1)" "unprognostic (1.38e-2)" "unprognostic (2.22e-1)" "unprognostic (3.49e-1)" "unprognostic (2.11e-1)" "unprognostic (2.19e-2)" "unprognostic (2.89e-1)" "unprognostic (8.67e-9)" "unprognostic (2.92e-1)" "unprognostic (2.71e-2)" "unprognostic (6.31e-2)" "unprognostic (1.85e-1)" 0.1 0.1 0.1 78.8 0.1 0.0 0.1 0.1 0.2 12.5 117.1 0.2 0.1 2.5 0.9 0.1 103.5 0.3 1.2 0.1 0.1 0.1 0.1 0.1 3.3 0.1 0.1 0.1 0.2 0.2 0.0 0.2 0.5 0.1 0.3 118.2 0.2 6.8 0.1 0.1 0.6 12.8 3.3 0.1 0.1 20.1 0.2 0.1 0.6 0.2 29.4 100.6 2.0 14.1 0.6 0.6 1.8 0.7 0.6 0.5 0.3 0.0 0.2 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.7 2.6 0.0 0.1 0.0 17.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 1.2 0.2 0.0 0.4 1.4 0.3 0.0 0.1 0.0 0.5 0.9 0.2 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.4 0.0 0.4 0.4 0.0 0.0 0.1 0.1 0.2 1.2 0.3 0.8 0.3 0.2 0.1 0.5 0.2 0.3 0.6 0.6 0.4 0.5 1.8 0.6 0.7 0.5 0.3 0.3 0.1 0.1 0.1 0.2 0.1 0.1 0.1 0.1 0.1 0.1 CELSR1 "ADGRC1, CDHF9, FMI2, HFMI2, ME2" ENSG00000075275 "Cadherin EGF LAG seven-pass G-type receptor 1" Q9NYQ6 22 46360834-46537170 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 23.8;HaCaT: 15.0;T-47d: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "memory B-cell: 3.0;naive B-cell: 3.0" "Lineage enriched" "Detected in single" 4 "B-cells: 3.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA052976, HPA060521" Supported "Plasma membrane" "Plasma membrane" "HPA052976: , HPA060521: " "unprognostic (5.62e-2)" "unprognostic (4.93e-2)" "unprognostic (4.22e-2)" "unprognostic (1.54e-3)" "unprognostic (2.71e-1)" "unprognostic (1.83e-1)" "unprognostic (3.66e-1)" "unprognostic (3.36e-1)" "unprognostic (5.31e-2)" "unprognostic (1.05e-2)" "unprognostic (1.18e-2)" "unprognostic (8.59e-2)" "unprognostic (2.44e-2)" "unprognostic (1.17e-1)" "unprognostic (2.67e-2)" "unprognostic (1.13e-1)" "unprognostic (1.07e-1)" 3.4 0.5 0.6 5.0 1.4 0.3 4.1 0.4 0.3 8.7 1.3 0.9 3.6 0.3 5.7 7.5 14.2 11.1 5.3 4.6 0.7 0.7 16.2 0.8 19.3 4.2 0.4 0.0 6.0 2.6 7.5 3.8 3.4 2.2 7.2 0.4 3.8 22.6 3.0 0.3 13.9 2.3 3.1 0.4 1.8 3.6 2.8 0.0 1.8 5.7 12.7 12.8 3.1 5.0 3.0 0.2 0.0 0.0 0.7 0.1 0.0 8.5 23.8 4.5 3.9 0.0 0.0 2.1 0.7 1.5 1.4 0.3 5.7 6.7 0.0 11.8 0.1 15.0 3.7 11.4 0.5 0.0 4.6 0.0 9.5 0.2 0.2 1.5 0.6 0.0 10.6 0.0 9.5 0.0 0.0 0.0 0.0 10.8 0.0 1.7 1.7 3.8 0.0 0.0 2.8 6.3 5.3 0.2 0.3 7.4 6.0 1.2 17.0 5.0 0.3 0.0 0.1 0.0 0.1 4.5 0.2 2.4 5.9 0.0 5.1 0.0 0.0 0.0 0.1 0.0 0.0 3.0 0.0 0.0 0.0 3.0 0.0 0.0 0.0 0.7 0.0 0.2 0.0 0.0 0.6 1.4 0.4 0.3 0.7 0.7 0.4 0.0 2.2 0.0 CHRM3 ENSG00000133019 "Cholinergic receptor muscarinic 3" P20309 1 239386565-239915452 "Disease related genes, FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "retina: 39.8" "Cell line enhanced" "Detected in some" "RPMI-8226: 9.9;SH-SY5Y: 31.8;U-266/70: 13.2;U-266/84: 9.4" "Low cancer specificity" "Detected in many" "Region enhanced" "Detected in many" "cerebral cortex: 8.7" "Cell type enhanced" "Detected in some" "naive CD4 T-cell: 2.3" "Group enriched" "Detected in many" 18 "monocytes: 1.2;T-cells: 2.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA024106, HPA048036" Approved Supported "Plasma membrane" "Plasma membrane" "HPA024106: AB_1854211, HPA048036: " "unprognostic (1.63e-1)" "unprognostic (4.82e-2)" "unprognostic (1.05e-1)" "unprognostic (4.11e-3)" "unprognostic (3.48e-3)" "unprognostic (5.81e-2)" "unprognostic (2.30e-3)" "unprognostic (5.18e-2)" "unprognostic (1.71e-1)" "unprognostic (1.27e-1)" "unprognostic (6.29e-2)" "unprognostic (6.44e-2)" "unprognostic (5.34e-4)" "unprognostic (3.04e-2)" "unprognostic (2.67e-1)" "unprognostic (1.02e-1)" "unprognostic (4.88e-2)" 0.8 0.0 2.1 1.4 1.8 0.0 0.8 0.8 8.7 0.8 5.9 0.8 0.8 0.8 1.4 0.8 6.6 0.3 0.8 0.8 2.5 1.8 0.8 0.8 1.5 0.8 0.8 1.1 4.3 8.7 0.2 0.8 0.8 0.8 3.8 2.2 39.8 13.7 2.5 0.8 0.7 1.2 3.3 0.8 1.0 4.8 1.7 0.8 1.3 1.3 0.8 1.6 7.1 0.8 0.0 0.0 0.0 1.2 0.0 2.3 0.2 0.0 0.0 0.2 0.2 0.0 0.0 0.5 0.3 0.0 0.2 0.0 0.0 0.0 0.0 1.3 0.0 3.4 0.3 2.3 1.6 0.0 2.2 0.3 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.6 5.5 0.5 0.8 0.0 0.0 2.8 5.0 0.0 0.7 9.9 0.4 0.5 0.0 31.8 0.0 0.1 0.1 1.1 0.0 0.0 1.3 0.5 0.1 0.3 13.2 9.4 0.0 0.2 0.0 0.2 0.0 0.0 0.0 0.3 1.2 0.7 0.0 0.5 0.4 0.0 0.0 2.3 0.7 0.0 0.0 0.7 0.0 0.5 0.2 2.1 1.8 0.8 8.7 2.5 1.8 0.8 1.1 0.8 0.8 CHRNA1 CHRNA ENSG00000138435 "Cholinergic receptor nicotinic alpha 1 subunit" P02708 2 174747592-174787935 "Disease related genes, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel, Ligand-gated ion channel, Receptor" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 8 "skeletal muscle: 96.7" "Group enriched" "Detected in some" 18 "LHCN-M2: 87.3;RH-30: 71.4" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Region enhanced" "Detected in single" "hippocampal formation: 2.0" "Cell type enriched" "Detected in single" 27 "plasmacytoid DC: 2.6" "Lineage enriched" "Detected in single" 27 "dendritic cells: 2.6" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA071554 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA071554: " "unprognostic (1.49e-1)" "unprognostic (1.97e-1)" "unprognostic (1.22e-3)" "unprognostic (2.28e-2)" "unprognostic (2.96e-1)" "unprognostic (8.55e-3)" "unprognostic (5.34e-2)" "unprognostic (5.29e-3)" "unprognostic (9.59e-2)" "unprognostic (9.64e-2)" "unprognostic (9.66e-2)" "unprognostic (6.37e-2)" "unprognostic (4.18e-4)" "unprognostic (2.04e-1)" "unprognostic (1.31e-1)" "unprognostic (1.86e-1)" "unprognostic (7.18e-2)" 4.5 0.0 0.5 0.5 0.1 0.0 0.6 0.0 0.4 0.7 1.7 0.0 0.1 0.2 0.0 4.6 1.2 0.0 0.0 0.3 2.0 0.1 0.0 0.2 0.7 0.9 0.1 0.0 0.0 0.0 0.0 12.1 0.2 0.0 2.4 1.0 0.0 1.5 0.0 96.7 0.0 0.0 0.0 0.8 0.1 0.0 0.3 0.0 0.5 0.0 4.5 1.3 0.1 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.3 0.0 0.0 0.0 0.2 0.0 0.0 87.3 0.0 0.0 0.0 0.0 0.0 0.0 71.4 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.5 0.1 0.0 0.4 2.0 0.1 0.1 0.0 0.0 0.0 CLDN4 "CPE-R, CPETR, CPETR1, hCPE-R, WBSCR8" ENSG00000189143 "Claudin 4" O14493 7 73799542-73832693 "Cancer-related genes, Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Chloride channel, Ion channel" "Cancer-related genes, Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 141.0" "Cell line enhanced" "Detected in some" "A-431: 43.1;BEWO: 50.7;CAPAN-2: 94.7;MCF7: 48.3;PC-3: 61.7;RT4: 41.7;SK-BR-3: 80.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" CAB002610 Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB002610: " "unprognostic (1.14e-1)" "unprognostic (2.79e-2)" "unprognostic (2.25e-1)" "unprognostic (1.23e-2)" "unprognostic (1.56e-2)" "unprognostic (1.84e-1)" "unprognostic (1.60e-2)" "unprognostic (7.09e-2)" "unprognostic (3.07e-1)" "prognostic unfavourable (3.28e-4)" "unprognostic (2.16e-3)" "unprognostic (5.11e-1)" "prognostic favourable (3.46e-10)" "unprognostic (5.77e-2)" "unprognostic (1.37e-1)" "unprognostic (9.38e-2)" "unprognostic (4.63e-2)" 0.7 0.2 0.4 17.1 0.4 0.0 17.1 0.4 0.5 17.5 53.7 0.7 23.2 25.0 5.1 15.9 62.3 15.4 15.4 0.5 0.4 0.3 30.2 2.0 28.8 0.4 0.4 0.4 5.5 32.4 2.7 3.5 78.1 1.3 31.8 24.7 0.7 52.0 25.7 0.6 35.3 93.3 2.7 0.4 0.4 2.7 2.5 0.4 3.8 141.0 60.9 55.7 38.5 21.0 0.1 0.1 0.2 0.1 0.1 0.6 0.0 43.1 0.5 0.0 0.2 0.0 0.0 50.7 0.4 0.0 0.0 0.0 22.5 94.7 0.0 3.5 0.0 23.8 0.0 0.0 0.0 0.0 0.0 0.0 2.6 15.2 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 48.3 0.0 0.2 0.0 61.7 0.0 0.8 1.0 11.6 41.7 10.1 0.2 0.0 80.3 0.1 31.4 0.1 0.0 0.1 1.8 0.4 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.1 0.0 0.1 0.0 0.0 0.4 0.4 0.4 0.5 0.4 0.3 0.4 0.4 1.3 0.4 CLEC2A "INPE5792, KACL, PILAR, UNQ5792" ENSG00000188393 "C-type lectin domain family 2 member A" Q6UVW9 12 9898673-9932381 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 9 "skin 1: 37.0" "Group enriched" "Detected in some" 6 "fHDF/TERT166: 13.2;U-937: 32.9" "Cancer enhanced" "Detected in some" "cervical cancer: 1.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA048530, HPA072407" Approved Uncertain "Plasma membrane" "Plasma membrane" "HPA048530: , HPA072407: " "unprognostic (3.10e-1)" "unprognostic (5.29e-2)" "unprognostic (2.23e-1)" 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 1.7 0.0 0.0 0.0 0.0 1.3 3.9 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 37.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 13.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 32.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 CMTM7 "CKLFSF7, FLJ30992" ENSG00000153551 "CKLF like MARVEL transmembrane domain containing 7" Q96FZ5 3 32391671-32483067 "Predicted membrane proteins, Transporters" Chemotaxis Cytokine "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "CAPAN-2: 41.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077409 Approved "Plasma membrane" "Plasma membrane" "HPA077409: " "unprognostic (2.27e-3)" "unprognostic (3.16e-2)" "unprognostic (3.98e-2)" "unprognostic (1.15e-1)" "unprognostic (5.42e-2)" "unprognostic (3.16e-2)" "prognostic unfavourable (3.21e-4)" "unprognostic (3.03e-2)" "unprognostic (3.92e-2)" "unprognostic (2.60e-1)" "unprognostic (6.55e-3)" "unprognostic (1.64e-1)" "prognostic unfavourable (1.00e-6)" "unprognostic (5.86e-2)" "unprognostic (2.51e-1)" "unprognostic (3.79e-1)" "unprognostic (3.12e-2)" 14.5 6.5 3.3 18.9 5.7 23.8 43.1 4.5 2.2 10.0 6.2 4.3 11.0 3.1 7.7 12.3 4.8 24.5 14.6 8.3 2.8 2.8 14.8 5.9 25.1 47.5 5.9 1.0 9.3 27.6 0.9 2.8 11.4 4.7 12.8 5.9 6.1 8.7 17.6 4.0 6.4 10.9 7.0 10.3 32.4 8.2 5.8 4.6 45.9 24.5 3.3 23.1 16.5 12.4 10.0 24.8 24.4 47.0 4.9 36.2 22.1 0.1 4.7 10.1 12.3 9.5 9.4 28.9 4.6 5.5 8.3 7.7 5.2 41.1 0.0 14.2 5.5 5.2 12.5 21.2 7.3 0.0 9.9 5.4 0.0 12.0 38.8 1.4 8.8 9.9 2.8 8.5 13.5 18.5 4.5 12.3 6.1 0.1 0.0 12.7 12.2 21.6 26.4 3.8 25.1 11.6 9.1 0.5 10.5 0.6 0.7 23.5 6.4 14.3 10.7 7.8 7.9 8.6 15.9 3.5 1.3 0.0 2.8 17.2 16.4 5.5 47.0 24.4 5.3 44.1 3.2 10.0 17.9 10.9 24.8 7.0 19.5 13.5 18.0 4.9 37.2 10.5 36.2 22.1 3.3 5.7 4.5 2.2 2.8 2.8 5.9 1.0 4.7 4.6 CPZ ENSG00000109625 "Carboxypeptidase Z" Q66K79 4 8592660-8619759 "Enzymes, Predicted intracellular proteins, Predicted secreted proteins" "Wnt signaling pathway" "Carboxypeptidase, Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ovary: 63.2" "Cell line enhanced" "Detected in some" "BEWO: 29.2;BJ: 16.8;BJ hTERT+: 22.6;RH-30: 24.8;U-2197: 18.1" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA078608 Approved "Plasma membrane" "Secreted to extracellular matrix" "Plasma membrane" "HPA078608: " "unprognostic (2.58e-1)" "unprognostic (7.16e-2)" "unprognostic (4.83e-2)" "unprognostic (1.42e-1)" "unprognostic (7.77e-2)" "unprognostic (2.20e-2)" "unprognostic (2.98e-1)" "unprognostic (7.77e-2)" "unprognostic (2.30e-1)" "unprognostic (1.95e-2)" "unprognostic (1.41e-1)" "unprognostic (1.59e-1)" "unprognostic (7.23e-8)" "unprognostic (4.30e-3)" "unprognostic (3.58e-2)" "unprognostic (6.13e-4)" "unprognostic (5.51e-2)" 4.3 0.9 0.3 2.8 1.1 0.0 5.4 1.1 1.6 15.7 1.8 1.5 27.1 0.1 7.9 24.1 3.0 7.4 12.9 2.4 0.4 0.3 1.5 0.8 2.9 0.7 1.5 0.4 63.2 1.1 0.3 2.3 18.9 2.3 4.1 0.5 4.4 0.8 20.6 0.3 5.5 1.2 10.3 1.3 0.7 1.7 4.4 0.1 1.6 3.5 0.1 2.2 9.8 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.3 0.1 0.0 0.7 2.2 0.2 29.2 16.8 22.6 6.3 2.5 0.7 0.3 0.0 1.6 9.2 0.0 0.0 0.0 2.4 0.0 1.2 0.0 0.1 0.3 2.0 0.0 0.0 4.1 0.0 0.0 0.0 0.0 0.4 0.0 0.4 2.5 0.0 0.0 3.9 9.2 0.0 24.8 0.0 0.0 0.5 0.0 0.0 0.6 0.2 0.0 0.1 0.0 0.0 0.9 1.2 18.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 1.1 1.1 1.6 0.4 0.3 1.5 0.4 2.3 0.1 CRK ENSG00000167193 "CRK proto-oncogene, adaptor protein" P46108 17 1420689-1463162 "Predicted intracellular proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010485, HPA068087" Approved Approved "Plasma membrane" 390000 "Plasma membrane" "CAB010485: AB_2085043, HPA068087: " "unprognostic (6.82e-3)" "unprognostic (1.94e-1)" "unprognostic (8.70e-3)" "unprognostic (5.34e-2)" "unprognostic (2.43e-1)" "unprognostic (3.32e-2)" "unprognostic (2.48e-1)" "unprognostic (1.67e-2)" "unprognostic (6.65e-2)" "unprognostic (1.88e-1)" "unprognostic (2.65e-1)" "unprognostic (5.35e-2)" "unprognostic (1.96e-1)" "unprognostic (1.67e-1)" "unprognostic (3.77e-1)" "unprognostic (1.56e-1)" "unprognostic (3.93e-2)" 37.1 22.1 23.3 15.9 23.7 4.2 40.0 25.1 23.4 23.3 27.2 21.2 31.5 21.4 26.0 27.5 25.9 19.0 27.5 22.0 23.0 21.6 26.0 40.5 25.6 14.6 25.3 18.4 21.4 22.1 22.6 11.8 33.6 24.2 22.4 28.6 18.0 21.2 27.3 27.8 18.1 26.9 29.3 24.0 17.6 21.6 17.9 26.4 13.6 32.5 20.2 15.8 28.8 40.7 5.5 4.7 16.3 4.6 3.0 4.2 1.7 14.8 23.2 17.3 18.4 29.4 24.8 16.2 25.8 21.8 20.4 19.1 29.9 8.8 7.2 12.9 29.6 23.1 23.0 18.6 30.1 3.6 15.7 8.0 15.2 16.4 27.3 3.4 7.1 23.9 22.1 21.1 26.7 25.0 13.5 6.9 28.4 15.1 3.7 4.0 15.7 11.6 7.9 8.7 6.5 26.8 16.1 6.4 16.9 24.6 15.3 17.6 15.0 5.8 26.6 20.6 11.8 21.7 25.3 3.3 5.0 4.5 17.4 6.8 22.4 5.4 4.4 5.4 3.6 4.6 3.6 4.1 3.8 3.1 4.7 5.5 2.9 4.2 16.3 3.0 4.6 4.4 2.6 1.7 23.3 23.7 25.1 22.3 23.0 21.6 25.3 18.4 24.2 26.4 CTNNB1 "armadillo, beta-catenin, CTNNB" ENSG00000168036 "Catenin beta 1" P35222 3 41194741-41260096 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Host-virus interaction, Neurogenesis, Transcription, Transcription regulation, Wnt signaling pathway" Activator "Cancer-related genes, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB000108, CAB001950, HPA029159, HPA029160" Supported Enhanced "Plasma membrane" 1000000 "Plasma membrane" "CAB000108: , CAB001950: , HPA029159: AB_10599619, HPA029160: AB_10600996" "unprognostic (2.47e-1)" "unprognostic (3.48e-2)" "prognostic favourable (7.54e-4)" "unprognostic (1.61e-1)" "unprognostic (9.55e-2)" "unprognostic (1.05e-2)" "unprognostic (3.20e-3)" "unprognostic (2.79e-1)" "unprognostic (1.57e-1)" "unprognostic (1.80e-2)" "unprognostic (1.88e-2)" "unprognostic (9.05e-2)" "unprognostic (1.97e-3)" "unprognostic (1.82e-2)" "unprognostic (1.17e-1)" "unprognostic (2.61e-1)" "unprognostic (9.79e-2)" 52.9 54.5 38.8 33.5 45.9 46.3 70.5 78.8 59.3 71.7 49.6 57.3 34.2 48.7 79.2 42.5 46.3 49.8 45.0 42.1 38.6 41.5 46.9 53.2 53.6 31.6 37.0 47.0 84.2 38.6 59.2 44.0 82.6 41.5 50.8 50.1 75.9 53.9 49.7 31.2 44.7 70.4 66.5 39.4 41.0 37.3 29.0 39.3 40.1 62.3 44.5 36.6 46.9 54.2 10.1 13.5 7.5 14.5 11.1 13.5 4.8 22.6 30.2 63.7 35.6 34.4 28.2 48.9 25.6 36.4 42.8 42.5 20.8 32.4 18.6 23.4 45.2 17.0 46.1 73.9 45.9 17.2 31.4 30.0 40.1 74.3 25.7 17.0 14.4 41.0 33.5 51.1 31.1 37.6 21.2 11.6 47.4 23.0 11.9 9.2 58.0 23.5 9.0 41.5 12.4 26.5 70.9 15.2 25.8 42.4 21.6 113.7 35.4 35.4 48.4 32.2 24.7 20.6 37.5 7.2 11.2 19.8 33.0 21.5 53.7 4.3 8.1 6.9 11.2 14.5 13.5 9.6 10.5 12.1 13.5 10.1 10.7 10.8 7.5 11.1 13.7 11.7 12.6 4.8 38.8 45.9 78.8 59.3 38.6 41.5 37.0 47.0 41.5 39.3 CTNND1 "CTNND, KIAA0384, p120, p120cas, p120ctn" ENSG00000198561 "Catenin delta 1" O60716 11 57753243-57819546 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cell adhesion, Transcription, Transcription regulation, Wnt signaling pathway" "Cancer-related genes, Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "intermediate monocyte: 12.5;non-classical monocyte: 11.9" "Group enriched" "Detected in many" 8 "dendritic cells: 10.2;monocytes: 12.5" "Low region specificity" "Detected in all" "CAB003837, HPA015954, HPA015955" Enhanced Enhanced "Plasma membrane" 15000 "Plasma membrane" "CAB003837: AB_562066, HPA015954: AB_2669326, HPA015955: AB_1846068" "unprognostic (1.06e-2)" "unprognostic (1.60e-2)" "unprognostic (5.17e-3)" "unprognostic (4.87e-2)" "unprognostic (7.81e-2)" "unprognostic (2.30e-1)" "unprognostic (2.98e-2)" "unprognostic (3.52e-3)" "unprognostic (4.17e-1)" "unprognostic (2.89e-2)" "prognostic unfavourable (3.02e-4)" "unprognostic (2.75e-1)" "prognostic favourable (3.54e-4)" "unprognostic (7.17e-2)" "unprognostic (4.09e-2)" "unprognostic (3.34e-1)" "unprognostic (7.33e-2)" 39.7 19.9 15.1 20.4 17.0 3.2 31.4 15.0 20.5 28.8 41.9 25.7 49.2 37.5 32.7 32.7 76.3 22.9 28.8 18.2 15.6 10.3 30.6 31.2 34.0 11.6 14.4 12.8 23.3 50.4 41.9 34.5 49.8 16.4 29.7 39.8 34.4 46.4 39.1 11.8 48.7 82.0 22.8 17.2 25.9 39.4 27.8 14.7 7.1 38.4 34.9 45.6 32.3 38.9 1.4 10.2 0.4 12.5 0.4 0.5 2.3 37.4 28.1 25.1 16.8 13.6 18.6 35.6 17.2 19.4 15.6 14.9 21.8 41.6 0.7 30.4 21.3 49.2 20.2 26.1 20.0 0.4 6.6 9.3 11.0 24.6 14.1 2.0 14.7 20.5 31.6 19.7 20.2 47.4 14.0 0.4 17.2 12.1 0.7 3.5 17.9 15.1 0.7 21.2 0.8 23.3 40.0 2.3 11.2 24.3 33.3 25.4 35.0 2.5 40.1 15.0 12.9 14.7 9.7 1.3 0.8 1.1 14.0 1.2 26.4 0.0 6.9 0.2 0.2 12.5 0.5 1.0 0.1 0.4 10.2 1.4 0.2 0.3 0.4 0.4 11.9 3.1 0.2 2.3 15.1 17.0 15.0 20.5 15.6 10.3 14.4 12.8 16.4 14.7 CX3CL1 "ABCD-3, C3Xkine, CXC3, CXC3C, fractalkine, neurotactin, NTN, SCYD1" ENSG00000006210 "C-X3-C motif chemokine ligand 1" P78423 16 57372458-57385048 "Plasma proteins, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Chemotaxis" Cytokine "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 6 "EFO-21: 13.4;HDLM-2: 36.5;Hep G2: 27.2;RPTEC TERT1: 16.2;SK-BR-3: 9.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB026192, HPA040361" Approved Supported "Plasma membrane" "Secreted to blood" 1867500 "Plasma membrane" "CAB026192: , HPA040361: AB_10796453" "unprognostic (6.89e-3)" "prognostic favourable (9.46e-4)" "unprognostic (1.52e-2)" "unprognostic (3.20e-2)" "unprognostic (1.73e-1)" "unprognostic (1.82e-1)" "unprognostic (7.12e-2)" "unprognostic (2.08e-3)" "unprognostic (4.49e-2)" "unprognostic (3.70e-1)" "unprognostic (2.59e-2)" "unprognostic (2.06e-2)" "prognostic favourable (8.52e-7)" "unprognostic (5.19e-2)" "unprognostic (2.72e-1)" "unprognostic (1.11e-2)" "unprognostic (9.33e-2)" 24.3 3.6 13.4 4.7 26.6 0.7 42.5 3.8 45.1 12.4 5.9 6.9 8.7 4.2 12.1 7.0 10.7 11.7 14.9 12.0 16.4 13.8 14.5 11.2 35.3 6.0 9.2 18.0 5.2 9.6 3.8 4.5 3.4 11.7 22.3 4.5 12.2 39.9 34.4 9.2 9.9 5.0 21.7 6.6 1.5 5.0 3.8 3.9 0.8 12.0 5.7 4.9 19.7 6.7 1.0 0.8 2.1 0.7 0.8 0.6 0.2 0.0 0.3 3.5 3.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 1.3 0.0 0.0 13.4 0.0 0.1 0.0 0.0 0.0 36.5 0.2 0.0 0.0 27.2 0.4 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 1.2 0.0 0.0 0.5 0.0 16.2 0.0 0.1 3.1 0.0 9.5 0.8 0.0 0.1 0.0 0.1 2.2 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.6 1.4 0.7 0.5 0.6 0.4 0.3 0.6 0.4 0.3 0.2 1.0 0.4 0.6 2.1 0.8 0.4 0.8 0.2 0.2 13.4 26.6 3.8 37.3 16.4 13.8 9.2 18.0 11.7 3.9 DCHS1 "CDH25, CDHR6, FIB1, FLJ11790, KIAA1773, PCDH16" ENSG00000166341 "Dachsous cadherin-related 1" Q96JQ0 11 6621323-6655854 "Disease related genes, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Deafness, Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AF22: 18.8;HUVEC TERT2: 26.1;REH: 12.6;SH-SY5Y: 18.2;TIME: 11.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA017970, HPA050246" Approved Approved "Plasma membrane" 75000 "Plasma membrane" "HPA017970: , HPA050246: " "unprognostic (2.42e-1)" "unprognostic (1.13e-1)" "unprognostic (8.93e-2)" "unprognostic (3.52e-2)" "unprognostic (1.83e-1)" "unprognostic (1.38e-3)" "unprognostic (2.52e-2)" "unprognostic (4.55e-3)" "unprognostic (2.63e-2)" "unprognostic (2.93e-2)" "unprognostic (5.96e-2)" "unprognostic (6.87e-2)" "prognostic unfavourable (9.32e-4)" "unprognostic (5.62e-2)" "unprognostic (2.28e-1)" "unprognostic (1.60e-2)" "unprognostic (1.24e-3)" 9.0 2.0 4.1 7.7 4.7 0.5 6.8 5.2 4.4 26.1 12.9 4.4 9.0 3.8 23.9 4.7 5.0 10.4 9.1 8.0 4.0 4.5 3.4 5.6 7.7 3.9 2.5 3.4 13.7 3.3 1.6 2.7 9.7 3.3 12.0 3.4 9.7 3.3 12.0 3.5 3.4 6.0 16.0 1.6 10.2 6.8 2.6 2.5 5.8 3.3 2.6 2.6 10.9 11.9 0.0 1.4 0.1 0.0 0.0 0.9 0.4 0.0 0.0 18.8 0.1 0.0 0.0 0.1 0.6 4.8 3.0 3.4 0.1 0.0 0.1 2.9 5.4 0.0 1.5 0.0 2.1 0.0 0.5 0.3 0.0 0.0 0.2 0.1 0.0 0.6 0.1 1.4 0.0 26.1 0.1 0.0 1.1 0.0 0.6 0.3 2.8 0.0 12.6 0.0 0.0 0.0 0.0 1.4 18.2 0.0 0.1 0.1 0.0 0.7 11.1 0.0 5.8 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.2 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.6 0.6 0.0 0.0 0.8 0.9 0.1 0.0 0.0 1.4 0.0 0.4 4.1 4.7 5.2 4.4 4.0 4.5 2.5 3.4 3.3 2.5 DENND6B "AFI1B, FAM116B, MGC33692" ENSG00000205593 "DENN domain containing 6B" Q8NEG7 22 50309030-50327060 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "fallopian tube: 24.7" "Cell line enhanced" "Detected in many" "Daudi: 8.2;RPMI-8226: 11.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018934, HPA021653, HPA029570" Uncertain Uncertain "Plasma membrane" "Plasma membrane" "HPA018934: AB_1848365, HPA021653: AB_1848366, HPA029570: AB_10602131" "unprognostic (2.50e-2)" "unprognostic (2.55e-2)" "prognostic unfavourable (1.41e-4)" "prognostic favourable (5.93e-5)" "unprognostic (9.39e-2)" "unprognostic (3.17e-1)" "unprognostic (1.89e-3)" "unprognostic (1.16e-1)" "unprognostic (5.10e-2)" "unprognostic (4.50e-2)" "unprognostic (1.19e-2)" "unprognostic (1.18e-1)" "unprognostic (8.92e-2)" "unprognostic (1.10e-1)" "unprognostic (4.15e-1)" "unprognostic (1.56e-1)" "unprognostic (1.31e-2)" 2.7 5.5 11.6 4.3 17.0 2.0 3.2 21.1 22.8 5.7 2.8 7.5 5.5 2.5 5.2 5.3 3.4 24.7 6.2 2.3 8.4 10.2 5.7 1.3 7.3 5.2 4.9 14.4 4.3 6.4 6.8 15.1 2.3 10.4 4.7 2.3 4.1 5.9 7.4 1.1 5.0 3.0 3.6 3.2 4.4 4.2 9.0 4.5 0.0 6.0 1.0 3.5 4.4 2.7 0.7 1.8 0.5 3.9 1.0 0.7 0.9 0.6 2.3 4.9 5.4 1.2 4.8 0.0 1.0 2.4 0.6 0.4 0.1 3.5 8.2 2.1 2.3 4.2 0.1 0.1 0.2 2.0 1.2 1.4 3.9 0.2 1.1 0.2 3.7 4.1 5.2 0.1 0.7 1.0 1.7 1.5 1.2 3.6 0.0 0.8 0.3 0.2 1.1 0.0 11.9 6.2 2.0 2.1 4.0 2.6 3.4 0.4 5.4 1.2 1.1 0.9 0.8 0.8 0.1 1.3 0.3 1.1 2.2 0.9 1.0 0.5 2.6 0.1 0.4 3.2 0.6 0.6 0.6 0.7 1.8 0.7 0.6 0.7 0.5 1.0 3.9 1.4 0.6 0.9 11.6 17.0 21.1 22.8 8.4 10.2 4.9 14.4 10.4 4.5 DHDDS "DS, FLJ13102, HDS, RP59" ENSG00000117682 "Dehydrodolichyl diphosphate synthase subunit" Q86SQ9 1 26432282-26471294 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism" Transferase "Disease mutation, Epilepsy, Mental retardation, Retinitis pigmentosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA026721, HPA026727" Uncertain Uncertain "Plasma membrane" "Plasma membrane" "HPA026721: AB_1847643, HPA026727: AB_1847644" "unprognostic (1.11e-2)" "unprognostic (5.43e-2)" "unprognostic (5.12e-2)" "unprognostic (9.81e-2)" "unprognostic (6.71e-2)" "unprognostic (7.23e-2)" "unprognostic (1.32e-3)" "unprognostic (3.81e-3)" "unprognostic (2.40e-1)" "unprognostic (5.42e-2)" "unprognostic (4.51e-2)" "unprognostic (3.40e-2)" "prognostic favourable (4.08e-7)" "unprognostic (9.42e-2)" "unprognostic (2.85e-1)" "unprognostic (2.22e-1)" "unprognostic (2.95e-1)" 31.8 14.4 11.2 10.8 15.9 6.4 15.0 45.9 18.8 10.4 23.1 12.5 8.3 12.2 15.4 21.9 18.9 9.2 10.9 14.8 9.7 10.7 16.2 15.3 9.5 10.3 12.1 15.8 9.8 14.7 23.2 15.5 13.1 20.6 9.6 23.9 22.0 56.9 9.1 10.3 13.1 12.2 11.3 7.6 10.5 14.2 12.9 8.9 9.7 12.1 11.1 16.9 10.6 9.8 11.1 11.2 11.8 19.5 8.1 11.6 8.2 14.7 12.0 8.0 11.0 16.5 13.9 13.8 25.2 15.7 19.5 19.5 18.5 16.2 16.7 15.4 23.5 10.8 10.8 19.7 18.7 10.2 5.7 16.5 29.9 13.6 15.6 18.0 24.4 19.0 11.8 26.9 15.1 24.6 11.8 18.4 17.9 10.1 9.2 7.6 12.6 16.1 11.0 14.2 14.2 10.6 13.9 11.3 9.0 17.0 18.7 11.1 14.1 10.2 31.2 13.6 13.2 25.5 14.3 22.3 29.9 18.0 21.4 22.7 13.2 6.5 13.4 7.1 11.6 19.5 8.4 11.1 7.7 7.5 11.2 9.3 6.5 9.0 11.8 8.1 18.0 9.1 7.3 8.2 11.2 15.9 45.9 18.8 9.7 10.7 12.1 15.8 20.6 8.9 DIAPH1 "DFNA1, hDIA1, LFHL1" ENSG00000131504 "Diaphanous related formin 1" O60610 5 141515016-141619055 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Hearing Actin-binding "Cancer-related genes, Deafness, Disease mutation, Epilepsy, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 79.8" "Cell line enhanced" "Detected in all" "HMC-1: 105.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004916, HPA076913" Approved Approved "Plasma membrane" 10000000 "Plasma membrane" "HPA004916: AB_1847668, HPA076913: " "unprognostic (6.79e-2)" "unprognostic (2.99e-1)" "unprognostic (2.12e-3)" "unprognostic (3.73e-2)" "unprognostic (4.18e-2)" "unprognostic (1.54e-1)" "unprognostic (2.08e-1)" "unprognostic (4.54e-3)" "unprognostic (2.03e-1)" "unprognostic (1.27e-2)" "prognostic unfavourable (7.81e-5)" "unprognostic (2.88e-3)" "prognostic favourable (1.29e-5)" "unprognostic (1.64e-2)" "unprognostic (1.84e-2)" "unprognostic (7.00e-2)" "unprognostic (1.65e-1)" 14.5 10.0 5.2 22.3 10.4 27.9 10.6 8.8 7.8 11.6 17.1 3.9 11.4 14.2 9.9 16.8 26.5 9.1 15.7 21.3 5.1 6.3 30.1 48.7 22.4 21.7 3.8 4.3 9.7 20.2 17.6 22.1 28.2 7.2 7.8 11.0 8.8 18.0 13.8 79.8 19.1 24.1 9.6 3.4 20.2 15.5 12.1 2.9 44.2 14.9 23.8 34.1 12.3 13.3 5.9 8.6 19.2 9.3 8.2 22.7 9.3 25.5 16.6 9.6 12.6 7.7 10.4 13.3 10.5 11.2 12.3 12.9 56.6 24.5 28.6 16.1 15.4 28.5 21.4 35.8 15.6 15.4 11.9 49.3 21.9 18.4 7.3 34.3 105.8 6.6 19.0 17.7 17.9 16.1 17.3 20.2 12.1 24.9 38.1 44.8 9.5 11.0 42.8 15.8 15.8 23.6 28.2 12.8 6.8 26.0 34.7 10.4 14.5 16.6 9.3 17.3 9.2 9.5 21.4 10.1 16.0 19.8 9.4 27.5 10.7 12.7 8.6 19.2 22.7 9.2 15.2 5.9 14.4 17.6 8.6 5.0 10.5 17.3 9.4 8.2 9.3 6.6 11.9 9.3 5.2 10.4 8.8 7.8 5.1 6.3 3.8 4.3 7.2 2.9 DNAJB13 "RSPH16A, TSARG6" ENSG00000187726 "DnaJ heat shock protein family (Hsp40) member B13" P59910 11 73950319-73970366 "Disease related genes, Predicted intracellular proteins" "Cilium biogenesis/degradation" Chaperone "Ciliopathy, Disease mutation, Primary ciliary dyskinesia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "fallopian tube: 30.4;testis: 10.8" "Cell line enhanced" "Detected in many" "RPTEC TERT1: 8.1" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.9" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA052465, HPA061330" Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA052465: AB_2681842, HPA061330: " "unprognostic (1.07e-1)" "unprognostic (3.23e-2)" "unprognostic (3.27e-3)" "unprognostic (1.56e-2)" "unprognostic (1.03e-1)" "unprognostic (1.20e-4)" "unprognostic (1.30e-2)" "unprognostic (1.72e-4)" "unprognostic (5.00e-2)" "unprognostic (4.73e-2)" "unprognostic (6.30e-2)" "unprognostic (1.22e-1)" "prognostic unfavourable (2.10e-6)" "unprognostic (3.32e-2)" "unprognostic (1.41e-1)" "unprognostic (9.44e-2)" "unprognostic (2.40e-2)" 0.0 0.0 1.2 0.4 1.4 2.1 0.0 0.0 0.1 4.7 0.0 0.1 1.0 3.2 0.0 30.4 1.1 0.0 1.6 1.5 0.6 0.0 1.9 1.0 0.0 0.0 0.3 0.0 0.5 0.1 0.3 0.0 0.4 1.6 0.0 0.2 1.4 0.0 0.2 0.5 0.0 10.8 0.1 0.0 0.0 0.0 1.6 3.4 3.1 0.8 0.6 1.7 0.4 0.4 0.9 1.3 1.7 0.1 0.4 0.8 0.3 0.0 0.4 0.1 1.7 0.7 1.8 3.9 0.7 1.3 0.3 0.0 0.1 5.0 0.8 2.0 1.9 0.7 0.0 1.1 1.5 0.0 0.8 0.4 0.0 0.0 0.7 5.1 1.0 0.8 1.2 1.8 0.6 2.9 0.8 2.7 1.8 8.1 1.6 0.7 2.0 1.0 4.2 0.4 0.7 1.4 0.3 0.6 1.3 1.8 0.7 4.3 3.4 3.4 0.6 0.5 0.5 3.1 0.8 1.1 1.2 0.2 0.4 1.6 1.2 0.7 0.7 1.5 1.0 1.7 1.4 0.6 0.3 3.4 1.1 0.4 DUS1L "DUS1, PP3111" ENSG00000169718 "Dihydrouridine synthase 1 like" Q6P1R4 17 82057506-82065887 "Predicted intracellular proteins" "tRNA processing" Oxidoreductase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023384 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA023384: AB_1847879" "unprognostic (4.42e-2)" "unprognostic (2.19e-2)" "unprognostic (4.30e-2)" "unprognostic (3.03e-2)" "unprognostic (1.73e-3)" "unprognostic (1.84e-1)" "unprognostic (4.01e-2)" "unprognostic (5.17e-2)" "unprognostic (1.10e-1)" "unprognostic (4.16e-3)" "unprognostic (5.23e-3)" "unprognostic (3.13e-1)" "prognostic unfavourable (5.89e-5)" "unprognostic (4.17e-2)" "unprognostic (8.57e-2)" "unprognostic (3.47e-1)" "unprognostic (1.70e-3)" 21.4 17.5 12.4 29.1 16.5 37.1 20.2 21.4 20.3 17.7 29.5 14.1 26.8 30.8 18.1 23.4 26.0 18.5 27.9 23.8 13.0 10.9 19.8 54.6 21.5 31.2 18.9 16.0 20.1 59.6 15.2 23.5 16.5 12.9 26.9 14.8 16.0 45.4 18.9 44.1 40.8 28.0 19.6 10.5 30.9 28.9 23.7 12.4 28.0 22.8 26.2 30.4 17.0 18.5 5.0 10.6 6.3 6.0 7.9 9.8 2.9 35.8 23.1 8.0 9.5 6.4 6.4 25.8 12.7 5.7 12.3 8.8 21.0 16.1 29.4 14.8 7.1 24.1 9.9 13.0 5.0 11.6 60.4 18.6 32.2 36.6 14.3 28.8 23.2 9.6 16.4 8.1 10.3 13.8 32.1 14.9 6.2 56.1 39.8 24.8 9.7 33.8 30.6 9.5 31.6 9.1 23.6 43.0 27.0 9.7 40.7 26.0 23.8 27.7 10.5 20.1 20.4 17.2 31.9 37.3 10.3 23.8 12.7 21.5 13.8 4.2 5.0 6.3 6.0 5.1 8.7 5.0 6.1 7.0 4.8 5.0 9.8 8.1 1.7 7.9 6.0 10.6 9.8 2.9 12.4 16.5 21.4 20.3 13.0 10.9 18.9 16.0 12.9 12.4 EFNB1 "CFNS, Elk-L, EPLG2, LERK2" ENSG00000090776 "Ephrin B1" P98172 X 68828997-68842147 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted membrane proteins" "Differentiation, Neurogenesis" "Developmental protein" "Cancer-related genes, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HBEC3-KT: 35.4;hTCEpi: 27.6;PC-3: 26.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "myeloid DC: 7.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB031489, HPA067188" Uncertain Supported "Plasma membrane" 790000 "Plasma membrane" "CAB031489: AB_631414, HPA067188: " "unprognostic (2.00e-1)" "unprognostic (1.33e-2)" "unprognostic (1.77e-2)" "prognostic unfavourable (3.32e-5)" "unprognostic (1.04e-1)" "unprognostic (2.48e-2)" "unprognostic (8.05e-3)" "unprognostic (2.15e-1)" "prognostic unfavourable (8.68e-4)" "unprognostic (3.94e-2)" "prognostic unfavourable (4.29e-4)" "unprognostic (1.29e-1)" "unprognostic (2.17e-3)" "unprognostic (2.76e-2)" "unprognostic (8.03e-2)" "unprognostic (1.72e-3)" "unprognostic (1.86e-2)" 36.5 13.2 5.0 11.5 4.5 1.3 26.5 2.3 4.7 19.5 21.1 4.7 13.1 14.0 15.2 14.9 17.4 15.2 33.7 16.0 3.6 2.7 25.5 15.3 23.0 5.2 4.7 3.5 21.6 4.5 15.0 6.4 34.3 3.9 15.9 10.1 14.9 7.0 13.2 9.1 26.4 24.0 12.3 2.6 15.3 13.3 7.4 4.2 4.8 11.9 22.0 11.2 16.7 14.8 0.5 7.1 0.6 3.4 1.3 1.0 1.0 3.7 1.9 15.6 5.7 8.3 5.1 8.2 3.2 3.5 1.4 1.0 1.7 6.9 0.9 21.2 1.2 19.8 14.7 35.4 0.8 1.5 3.7 0.9 0.8 3.0 7.6 0.7 8.0 9.5 27.6 3.5 16.0 10.8 1.0 0.0 1.2 3.0 1.5 0.7 10.8 26.2 6.6 1.6 5.9 5.9 13.1 5.8 2.8 2.4 0.7 0.9 0.6 1.3 18.1 2.7 3.3 7.2 1.2 0.0 0.8 0.9 1.3 4.0 1.7 0.0 1.3 0.6 1.0 3.4 0.6 0.5 0.9 0.9 7.1 0.4 0.8 0.4 0.3 1.3 2.1 1.0 0.4 1.0 5.0 4.5 2.3 4.7 3.6 2.7 4.7 3.5 3.9 4.2 EHD1 "FLJ42622, FLJ44618, H-PAST, HPAST1, PAST1" ENSG00000110047 "EH domain containing 1" Q9H4M9 11 64851642-64888296 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751, HPA067747" Approved Supported "Plasma membrane" 19000000 "Plasma membrane" "HPA049890: , HPA049986: , HPA066751: , HPA067747: " "unprognostic (1.51e-1)" "unprognostic (3.21e-1)" "unprognostic (6.35e-3)" "unprognostic (2.43e-1)" "unprognostic (1.62e-1)" "unprognostic (1.44e-1)" "prognostic unfavourable (2.81e-5)" "unprognostic (1.46e-3)" "unprognostic (9.10e-3)" "unprognostic (9.44e-2)" "unprognostic (2.11e-2)" "unprognostic (1.79e-1)" "unprognostic (1.27e-1)" "unprognostic (6.37e-2)" "unprognostic (9.88e-2)" "unprognostic (2.74e-1)" "unprognostic (2.59e-2)" 17.5 10.4 7.3 33.3 7.4 57.5 12.3 27.2 11.3 11.1 13.5 18.2 8.0 14.7 13.1 10.8 15.5 12.5 15.2 11.3 8.2 9.4 14.5 9.3 18.7 41.1 13.8 5.9 10.0 5.2 5.1 3.4 34.8 16.7 9.0 6.6 8.0 11.9 10.0 13.2 14.1 22.9 12.4 13.1 43.1 12.7 65.8 10.4 21.3 12.3 13.6 33.6 13.5 10.3 10.6 3.5 38.0 13.1 10.2 17.2 10.2 26.4 18.4 6.6 7.3 8.1 13.2 3.9 27.0 24.5 22.9 13.4 23.8 16.6 34.9 9.7 32.2 21.6 6.9 27.2 8.9 21.8 3.8 23.2 9.6 12.0 9.6 7.5 6.3 5.9 5.8 35.4 11.1 22.6 9.5 62.0 17.3 14.1 15.0 12.5 4.4 24.1 6.0 21.3 12.1 21.7 8.8 4.7 4.2 15.1 27.8 12.3 37.8 5.4 31.8 10.2 9.1 27.0 12.9 25.5 11.2 26.8 26.6 9.8 5.5 6.7 5.0 38.0 16.9 6.7 17.2 10.6 11.9 14.6 2.9 8.2 7.2 9.8 23.6 10.2 13.1 3.5 12.9 10.2 7.3 7.4 27.2 11.3 8.2 9.4 13.8 5.9 16.7 10.4 EHD2 PAST2 ENSG00000024422 "EH domain containing 2" Q9NZN4 19 47713343-47743134 "Predicted intracellular proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 58.6;fHDF/TERT166: 46.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.4" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA047394, HPA049890, HPA049986, HPA066751" Approved Supported "Plasma membrane" 580000 "Plasma membrane" "HPA047394: , HPA049890: , HPA049986: , HPA066751: " "unprognostic (1.50e-1)" "unprognostic (2.11e-2)" "unprognostic (3.16e-3)" "unprognostic (1.54e-1)" "unprognostic (3.33e-2)" "unprognostic (5.42e-3)" "unprognostic (3.36e-2)" "unprognostic (1.33e-2)" "unprognostic (2.70e-3)" "prognostic unfavourable (8.75e-4)" "unprognostic (5.49e-3)" "unprognostic (9.50e-2)" "prognostic unfavourable (3.98e-4)" "unprognostic (6.59e-3)" "unprognostic (6.48e-2)" "unprognostic (1.82e-2)" "unprognostic (3.06e-3)" 82.2 17.8 6.7 14.5 6.1 0.6 62.0 4.3 7.5 35.2 29.1 5.0 10.0 6.7 40.2 21.2 33.0 20.7 34.3 19.3 5.4 2.9 8.3 4.5 28.1 13.5 5.4 3.4 34.0 11.1 3.1 3.8 22.8 6.4 28.2 7.3 11.6 9.7 25.1 17.3 15.3 14.3 40.7 4.5 19.0 17.5 12.9 5.7 1.8 15.0 24.6 8.3 35.0 52.6 0.6 0.4 2.4 0.6 0.2 0.5 0.9 11.1 26.1 0.0 0.3 58.6 44.7 0.0 43.7 20.7 15.8 12.9 1.7 5.6 0.0 0.0 46.1 14.1 0.2 22.7 9.6 0.0 0.1 1.4 15.2 0.1 37.1 0.0 3.1 43.2 20.1 13.3 13.1 30.5 4.6 0.0 16.6 2.0 2.2 0.1 0.3 4.7 0.2 1.8 0.0 12.6 0.5 0.0 0.1 38.3 1.4 1.1 3.6 0.7 34.7 23.8 5.3 20.9 9.3 0.0 0.0 0.0 22.1 0.5 5.0 1.0 0.4 0.6 0.3 0.3 0.3 0.5 0.3 0.4 0.1 0.6 0.5 0.5 2.4 0.2 0.6 0.4 0.3 0.9 6.7 6.1 4.3 7.5 5.4 2.9 5.4 3.4 6.4 5.7 EHD3 PAST3 ENSG00000013016 "EH domain containing 3" Q9NZN3 2 31234337-31269447 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 37.4;esophagus: 29.1" "Cell line enhanced" "Detected in many" "BJ: 25.1;BJ hTERT+: 62.1;HEL: 24.1;U-266/70: 15.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "memory B-cell: 17.8;naive B-cell: 4.4" "Lineage enriched" "Detected in many" 9 "B-cells: 17.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA066751" Approved Approved "Plasma membrane" 41000000 "Plasma membrane" "HPA049890: , HPA049986: , HPA066751: " "unprognostic (3.44e-1)" "unprognostic (8.88e-2)" "unprognostic (2.21e-1)" "unprognostic (3.79e-2)" "unprognostic (3.70e-2)" "unprognostic (1.89e-1)" "unprognostic (5.49e-2)" "unprognostic (1.21e-1)" "unprognostic (3.74e-2)" "unprognostic (9.72e-2)" "unprognostic (9.92e-3)" "unprognostic (1.06e-1)" "prognostic unfavourable (1.02e-4)" "unprognostic (4.88e-3)" "unprognostic (9.41e-2)" "unprognostic (4.79e-3)" "unprognostic (4.92e-3)" 2.7 7.1 15.0 5.6 16.3 2.0 3.3 10.6 37.4 5.6 2.2 7.3 0.0 1.9 3.9 3.4 29.1 4.9 3.6 14.8 16.7 8.9 15.0 10.8 4.8 6.3 9.6 21.6 2.9 1.4 8.7 6.0 11.3 13.3 5.7 2.1 2.8 4.8 4.9 2.3 3.0 2.9 4.8 9.4 5.8 1.9 1.6 6.6 1.2 2.5 1.5 10.4 7.8 4.2 17.8 0.4 1.0 1.9 0.6 1.7 7.8 0.5 2.6 1.4 1.2 2.5 3.8 0.2 25.1 62.1 2.4 2.2 0.0 0.3 0.1 0.9 8.2 0.2 0.0 1.6 1.7 1.0 2.2 24.1 0.1 0.0 8.6 0.0 0.0 6.0 0.7 2.4 1.0 0.0 0.0 0.1 1.8 3.9 0.3 0.0 5.6 1.3 0.8 0.1 0.5 1.9 2.8 0.7 3.9 0.2 0.4 0.0 0.3 0.0 0.0 1.8 1.7 0.1 2.0 15.6 1.9 0.0 4.8 0.0 3.9 0.4 0.4 0.3 1.7 0.8 0.9 17.8 0.9 1.1 0.4 4.4 0.8 0.4 1.0 0.6 1.9 0.0 0.4 7.8 15.0 16.3 10.6 32.7 16.7 8.9 9.6 21.6 13.3 6.6 EHD4 PAST4 ENSG00000103966 "EH domain containing 4" Q9H223 15 41895939-41972578 "Plasma proteins, Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 33.6;TIME: 55.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA049890, HPA049986, HPA052729, HPA066751" Approved Approved "Plasma membrane" 410000 "Plasma membrane" "HPA049890: , HPA049986: , HPA052729: , HPA066751: " "unprognostic (1.45e-1)" "unprognostic (1.37e-1)" "unprognostic (4.34e-3)" "unprognostic (3.36e-2)" "unprognostic (3.46e-2)" "unprognostic (4.48e-3)" "unprognostic (1.52e-1)" "unprognostic (3.36e-3)" "unprognostic (2.25e-1)" "unprognostic (3.74e-1)" "unprognostic (6.93e-2)" "unprognostic (2.35e-1)" "unprognostic (5.05e-2)" "unprognostic (3.49e-2)" "unprognostic (3.19e-2)" "unprognostic (8.27e-2)" "unprognostic (2.72e-1)" 26.1 5.0 3.3 12.9 5.0 8.0 17.9 1.9 5.6 11.4 11.4 4.7 11.3 4.7 20.8 16.4 18.1 10.5 17.4 35.4 4.3 2.6 14.5 22.8 19.9 24.3 7.2 2.0 14.1 14.1 13.9 6.5 14.4 7.5 14.1 9.3 17.4 11.1 12.0 10.5 16.1 16.0 11.6 7.1 11.1 10.0 7.5 4.3 5.3 19.1 9.0 13.7 14.4 10.1 2.6 13.3 7.7 12.7 3.6 6.8 6.2 8.9 3.1 3.0 3.1 1.5 2.2 2.6 4.8 10.1 8.5 12.0 13.1 5.2 1.8 12.9 6.0 9.1 4.5 10.4 6.3 11.1 3.8 2.7 4.6 2.2 3.8 1.2 8.0 1.8 4.1 8.6 9.5 33.6 2.8 2.1 6.8 3.8 1.2 1.4 2.3 10.8 0.0 8.0 2.9 7.6 18.2 5.0 2.1 3.5 7.5 5.4 7.4 1.7 55.3 2.7 5.2 9.9 23.1 5.9 9.4 3.9 3.4 3.0 23.1 0.9 12.7 7.7 3.8 11.2 5.8 2.0 6.0 4.8 13.3 2.6 2.6 3.7 2.1 3.6 4.4 2.2 6.8 6.2 3.3 5.0 1.9 5.6 4.3 2.6 7.2 2.0 7.5 4.3 ELN "SVAS, WBS, WS" ENSG00000049540 Elastin P15502 7 74027789-74069907 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 16.5;BJ: 22.9;fHDF/TERT166: 32.8;U-2197: 130.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "CAB010750, HPA018111, HPA056941" Supported Approved "Plasma membrane" "Secreted to extracellular matrix" 2900000 "Plasma membrane" "CAB010750: AB_476930, HPA018111: AB_1848109, HPA056941: " "unprognostic (1.51e-2)" "unprognostic (4.86e-2)" "unprognostic (2.50e-2)" "unprognostic (1.11e-1)" "unprognostic (1.57e-2)" "unprognostic (2.72e-2)" "unprognostic (3.70e-3)" "unprognostic (1.23e-1)" "unprognostic (3.33e-2)" "unprognostic (2.00e-3)" "unprognostic (2.88e-1)" "unprognostic (1.09e-1)" "unprognostic (2.18e-3)" "unprognostic (1.79e-2)" "unprognostic (3.90e-2)" "prognostic unfavourable (6.29e-4)" "unprognostic (1.62e-3)" 35.0 8.8 4.3 14.9 3.6 0.0 24.8 27.8 5.8 23.3 12.1 12.9 9.1 3.2 22.3 26.0 30.1 17.1 30.8 41.5 5.4 3.0 8.3 3.7 49.7 7.5 4.4 9.2 10.6 35.3 0.7 6.1 22.5 13.7 25.1 4.6 34.3 16.8 14.5 6.0 23.6 9.2 34.7 9.9 10.7 16.0 8.1 6.4 0.9 11.9 10.3 4.4 34.0 21.7 0.4 0.0 0.0 0.0 0.0 0.3 1.1 0.0 0.3 0.1 0.0 16.5 0.1 0.1 22.9 0.0 0.0 0.0 0.1 0.0 0.0 0.0 32.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 1.3 0.1 0.0 8.8 0.1 0.0 0.0 4.5 10.7 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 130.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 4.3 3.6 27.8 5.8 5.4 3.0 4.4 9.2 13.7 6.4 ENC1 "ENC-1, KLHL37, NRPB, PIG10, TP53I10" ENSG00000171617 "Ectodermal-neural cortex 1" O14682 5 74627406-74641424 "Cancer-related genes, Predicted intracellular proteins" "Actin-binding, Developmental protein" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 106.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in all" 7 "amygdala: 39.7;basal ganglia: 42.7;cerebral cortex: 86.4;hippocampal formation: 44.1;olfactory region: 43.9" "Group enriched" "Detected in many" 6 "classical monocyte: 5.4;eosinophil: 3.4;gdT-cell: 2.3;intermediate monocyte: 4.8;memory CD8 T-cell: 3.0;myeloid DC: 2.4;naive CD8 T-cell: 2.5;neutrophil: 1.4;NK-cell: 2.8;non-classical monocyte: 1.3" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA078061 Uncertain "Plasma membrane" "Plasma membrane" "HPA078061: " "prognostic unfavourable (3.88e-4)" "unprognostic (4.90e-2)" "unprognostic (1.13e-1)" "unprognostic (3.00e-3)" "unprognostic (1.05e-1)" "unprognostic (2.22e-3)" "unprognostic (1.36e-1)" "unprognostic (9.74e-2)" "unprognostic (1.24e-1)" "unprognostic (2.59e-1)" "unprognostic (4.98e-2)" "unprognostic (8.08e-2)" "prognostic unfavourable (2.95e-5)" "unprognostic (9.69e-2)" "unprognostic (3.08e-1)" "unprognostic (2.88e-1)" "unprognostic (5.65e-2)" 2.2 1.1 39.7 4.7 42.7 5.4 1.8 1.3 106.8 4.2 5.2 2.4 2.1 6.4 2.9 1.6 2.5 1.3 7.5 3.2 44.1 7.7 2.2 6.4 4.8 2.2 4.6 43.9 6.0 12.3 1.0 2.4 4.2 4.9 4.3 8.1 0.8 5.4 7.4 1.7 1.7 8.1 3.0 2.3 4.0 9.8 4.5 1.5 0.5 1.3 0.3 2.0 6.5 1.3 0.4 2.4 3.4 5.4 2.8 3.0 1.4 11.9 14.8 14.8 7.0 6.4 1.6 31.9 8.0 9.1 9.2 6.8 23.9 20.2 0.0 10.0 6.8 9.7 0.2 15.5 20.1 0.2 1.1 13.2 2.8 10.4 0.6 1.3 0.1 2.5 1.0 24.4 2.4 7.5 2.9 7.7 24.0 2.9 1.2 1.7 15.4 13.3 1.5 9.7 1.2 5.0 9.1 19.9 8.1 1.4 6.6 0.7 3.1 1.6 17.8 15.6 26.1 9.2 25.8 0.1 0.0 0.2 18.0 1.1 23.7 0.0 5.4 3.4 2.3 4.8 0.0 0.1 0.5 3.0 2.4 0.4 0.2 2.5 1.4 2.8 1.3 0.0 0.0 1.4 39.7 42.7 1.3 86.4 44.1 7.7 4.6 43.9 4.9 1.5 ENOX1 "cCNOX, CNOX, FLJ10094, PIG38" ENSG00000120658 "Ecto-NOX disulfide-thiol exchanger 1" Q8TC92 13 43213518-43786908 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 12.6;RH-30: 17.5;TIME: 12.6;U-2197: 13.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 2.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA038355 Approved Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA038355: AB_10673171" "unprognostic (9.64e-2)" "unprognostic (3.38e-3)" "unprognostic (1.64e-1)" "unprognostic (1.20e-3)" "unprognostic (1.06e-1)" "unprognostic (2.69e-1)" "unprognostic (2.88e-1)" "unprognostic (6.72e-3)" "unprognostic (2.60e-1)" "unprognostic (2.29e-3)" "unprognostic (1.32e-1)" "unprognostic (9.93e-2)" "unprognostic (1.32e-3)" "unprognostic (1.07e-2)" "unprognostic (1.48e-1)" "unprognostic (2.08e-3)" "unprognostic (1.42e-2)" 5.7 2.2 10.7 4.5 14.8 0.8 2.8 2.1 17.0 5.2 8.5 15.0 0.2 1.3 7.2 2.0 2.1 4.7 3.1 8.3 10.3 6.0 6.1 1.0 1.9 3.5 9.4 10.6 11.2 2.5 0.7 2.3 7.8 15.6 5.6 3.1 3.2 1.3 6.9 11.0 1.4 2.2 8.8 7.7 1.5 3.5 14.5 15.0 0.1 1.4 0.3 2.6 4.8 3.7 0.2 2.3 0.9 0.3 0.3 0.2 0.1 0.1 0.2 2.5 0.0 2.5 9.8 0.5 1.1 2.7 4.1 4.0 1.7 0.3 0.0 0.1 3.6 0.1 0.5 0.3 1.8 2.9 4.0 0.5 2.9 0.0 1.6 0.1 0.6 9.4 0.8 12.6 6.3 0.3 0.0 0.6 2.5 0.2 4.0 0.1 2.7 1.1 0.0 17.5 0.0 2.2 0.5 8.6 3.3 1.5 2.5 0.6 0.5 0.0 12.6 1.4 0.4 13.0 1.3 0.0 0.0 0.0 6.0 0.0 9.1 0.9 0.1 0.3 0.1 0.1 0.2 0.2 0.1 0.1 2.3 0.1 0.2 0.1 0.3 0.3 0.3 0.3 0.2 0.1 10.7 14.8 2.1 17.0 10.3 6.0 9.4 10.6 15.6 15.0 ENOX2 "APK1, COVA1, tNOX" ENSG00000165675 "Ecto-NOX disulfide-thiol exchanger 2" Q16206 X 130623369-130903317 "Predicted intracellular proteins" "Biological rhythms, Electron transport, Growth regulation, Transport" Oxidoreductase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000514, HPA003027" Uncertain Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA000514: AB_1078558, HPA003027: " "unprognostic (1.34e-2)" "unprognostic (7.02e-2)" "unprognostic (9.75e-2)" "unprognostic (1.08e-1)" "unprognostic (1.94e-1)" "unprognostic (2.60e-1)" "unprognostic (4.07e-2)" "unprognostic (6.07e-2)" "unprognostic (6.27e-3)" "unprognostic (5.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.44e-1)" "prognostic favourable (1.09e-5)" "unprognostic (6.42e-2)" "unprognostic (4.60e-2)" "unprognostic (3.02e-1)" "unprognostic (1.38e-1)" 13.1 14.6 13.5 14.8 17.6 4.7 11.4 7.6 11.0 13.2 11.6 13.9 10.7 8.0 15.6 12.9 13.3 13.2 11.2 18.9 14.6 13.1 10.4 23.6 8.8 16.0 14.7 8.8 14.6 7.4 12.5 12.3 11.7 12.2 12.9 9.3 8.5 10.3 15.1 11.2 8.6 11.1 14.5 13.4 17.7 9.2 9.7 17.7 17.4 11.0 11.7 15.9 14.2 9.7 12.8 11.9 15.0 16.7 11.3 13.3 9.7 12.3 9.1 14.0 5.8 12.0 11.4 5.6 10.5 12.1 7.1 4.4 4.3 10.7 8.7 25.4 8.8 8.7 9.1 9.7 8.8 11.5 10.0 20.2 6.2 5.7 9.3 14.7 14.2 9.0 16.6 7.7 9.6 10.6 12.4 7.1 5.5 17.2 9.2 3.2 7.3 12.7 6.6 8.7 9.6 8.2 8.7 4.2 8.5 9.1 6.0 14.7 3.9 8.1 8.6 6.8 4.1 10.9 21.3 7.4 3.6 5.7 19.8 15.4 11.5 8.0 12.0 15.0 10.4 16.7 11.1 12.8 12.2 10.8 11.9 11.6 13.3 11.7 2.1 11.3 7.8 5.7 13.2 9.7 13.5 17.6 7.6 11.0 14.6 13.1 14.7 8.8 12.2 17.7 EPB41L1 "4.1N, KIAA0338" ENSG00000088367 "Erythrocyte membrane protein band 4.1 like 1" Q9H4G0 20 36091504-36232799 "Disease related genes, Predicted intracellular proteins" Actin-binding "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "A549: 40.3;HaCaT: 59.3;SK-BR-3: 46.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 15 "plasmacytoid DC: 3.9" "Lineage enriched" "Detected in single" 15 "dendritic cells: 3.9" "Low region specificity" "Detected in all" "HPA054104, HPA056817" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA054104: AB_2682380, HPA056817: AB_2683244" "unprognostic (2.01e-2)" "unprognostic (7.77e-2)" "unprognostic (1.76e-2)" "prognostic unfavourable (6.46e-5)" "unprognostic (1.19e-1)" "unprognostic (2.31e-1)" "unprognostic (1.23e-1)" "unprognostic (1.56e-2)" "unprognostic (3.87e-1)" "unprognostic (5.83e-3)" "prognostic unfavourable (9.30e-4)" "unprognostic (1.78e-1)" "prognostic favourable (4.39e-10)" "unprognostic (1.25e-1)" "unprognostic (1.71e-1)" "unprognostic (2.47e-1)" "unprognostic (2.26e-2)" 23.1 57.8 36.0 3.5 39.5 0.3 10.9 21.5 56.8 18.4 14.0 28.8 7.3 6.2 13.1 14.7 21.5 21.4 18.3 9.4 31.2 34.6 30.5 3.9 13.5 1.9 35.2 39.4 20.2 13.2 16.8 8.7 9.8 45.2 12.9 9.8 9.4 23.9 20.8 4.8 6.5 7.4 12.7 22.3 3.6 27.9 8.2 23.7 0.0 11.4 4.6 6.1 14.9 11.1 0.2 3.9 0.0 0.0 0.0 0.2 0.0 12.8 40.3 14.4 5.3 9.4 5.9 13.6 4.2 9.3 8.8 7.0 26.6 23.3 0.7 6.9 12.8 59.3 6.6 4.8 6.6 0.1 3.8 0.1 13.5 25.9 2.8 0.0 4.9 5.1 2.3 8.2 0.6 2.1 0.6 10.3 7.5 8.3 0.4 0.2 5.5 12.6 0.6 4.0 15.9 7.5 20.8 5.1 6.3 18.5 46.5 1.6 11.4 0.5 1.8 10.5 11.4 5.3 0.9 13.6 4.6 0.1 18.2 0.0 1.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.9 0.0 0.0 36.0 39.5 21.5 56.8 31.2 34.6 35.2 39.4 45.2 23.7 EPB41L5 "BE37, FLJ12957, KIAA1548, YMO1, YRT" ENSG00000115109 "Erythrocyte membrane protein band 4.1 like 5" Q9HCM4 2 120013005-120179119 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "CACO-2: 24.8;MCF7: 37.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA037563, HPA037564" Uncertain Enhanced "Plasma membrane" "Plasma membrane" "HPA037563: AB_2675546, HPA037564: AB_2675547" "unprognostic (1.27e-2)" "unprognostic (2.15e-1)" "unprognostic (2.56e-2)" "unprognostic (2.31e-1)" "unprognostic (3.33e-2)" "unprognostic (1.47e-2)" "unprognostic (1.53e-1)" "unprognostic (9.06e-3)" "unprognostic (5.93e-2)" "unprognostic (8.76e-2)" "unprognostic (2.20e-2)" "unprognostic (9.51e-2)" "prognostic favourable (2.28e-6)" "unprognostic (1.99e-1)" "unprognostic (3.88e-1)" "unprognostic (9.59e-2)" "unprognostic (2.61e-1)" 4.6 5.0 7.4 6.0 11.6 1.1 13.3 19.4 12.6 7.4 8.6 6.9 4.3 10.6 7.2 4.9 7.0 10.2 6.2 4.9 8.5 7.4 25.6 42.3 36.3 3.8 7.6 6.5 9.4 20.3 13.0 15.8 7.5 12.2 9.9 7.0 7.1 10.8 6.6 8.6 6.6 9.5 7.5 14.8 2.2 7.0 22.0 6.1 2.9 25.2 6.4 5.0 5.3 8.4 4.7 0.4 1.8 1.4 1.5 3.2 1.4 7.9 2.7 11.0 8.5 7.7 5.6 9.6 1.7 1.7 3.6 3.2 24.8 5.3 0.1 6.0 2.1 5.5 14.8 6.8 5.4 1.6 4.6 2.3 1.3 13.8 9.0 1.0 2.5 5.0 12.8 6.7 4.8 10.1 5.4 0.6 7.1 37.1 1.8 3.5 9.9 2.5 0.0 3.3 2.2 11.3 7.7 5.7 10.9 7.5 13.4 3.7 6.4 1.9 8.3 0.3 5.3 5.7 1.7 0.8 1.5 4.1 0.9 0.0 2.0 0.3 1.4 1.5 1.1 0.3 0.3 4.7 1.2 1.1 0.4 3.6 3.2 2.4 1.8 1.5 0.9 0.0 0.5 1.4 7.4 11.6 19.4 12.6 8.5 7.4 7.6 6.5 12.2 6.1 EPCAM "17-1A, 323/A3, CD326, CO-17A, EGP-2, EGP34, EGP40, Ep-CAM, ESA, GA733-2, HEA125, KS1/4, KSA, Ly74, M4S1, MH99, MIC18, MK-1, MOC31, TACST-1, TACSTD1, TROP1" ENSG00000119888 "Epithelial cell adhesion molecule" P16422 2 47345158-47387601 "Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Tumor antigen" "Cancer-related genes, Disease mutation, FDA approved drug targets, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 303.2" "Cell line enhanced" "Detected in many" "A-431: 58.3;CACO-2: 75.6;CAPAN-2: 106.4;RPTEC TERT1: 45.4;SCLC-21H: 41.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in single" "plasmacytoid DC: 1.9" "Lineage enriched" "Detected in single" 5 "dendritic cells: 1.9" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB003809, HPA026761, CAB030012, CAB055098, HPA067463" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB003809: AB_562285, CAB030012: AB_756075, CAB055098: AB_2335685, HPA026761: AB_1848198, HPA067463: " "unprognostic (6.79e-2)" "unprognostic (2.28e-1)" "unprognostic (1.59e-2)" "unprognostic (1.16e-2)" "unprognostic (1.61e-1)" "unprognostic (3.49e-2)" "unprognostic (2.01e-1)" "unprognostic (3.61e-2)" "unprognostic (3.40e-1)" "prognostic favourable (3.30e-4)" "unprognostic (5.27e-2)" "unprognostic (3.28e-2)" "prognostic favourable (1.04e-6)" "unprognostic (6.38e-3)" "unprognostic (1.28e-1)" "unprognostic (6.45e-3)" "unprognostic (6.08e-2)" 0.4 2.1 1.8 49.8 3.0 0.2 8.9 0.6 1.0 10.8 155.8 0.7 31.5 66.8 4.4 35.2 2.8 10.2 41.6 0.4 1.7 2.7 60.2 1.2 22.6 0.4 1.2 0.4 3.8 54.1 19.8 38.7 2.2 0.9 9.0 70.5 0.7 47.2 25.0 0.5 2.0 303.2 1.7 1.4 0.5 15.3 5.5 0.9 1.7 83.6 4.2 4.1 4.1 2.1 0.2 1.9 0.4 0.2 0.0 0.0 0.6 58.3 0.6 0.0 0.1 0.0 0.0 37.0 0.0 0.0 0.0 0.0 75.6 106.4 0.0 16.4 0.1 27.5 0.5 6.9 0.2 0.0 6.7 0.0 0.3 29.7 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.1 17.4 0.0 0.0 29.8 0.0 2.8 19.1 3.8 0.0 0.0 14.8 45.4 25.8 41.1 0.3 0.4 21.7 0.0 18.3 0.1 0.0 0.0 0.7 0.2 0.1 4.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.2 1.9 0.0 0.6 1.8 3.0 0.6 1.0 1.7 2.7 1.2 0.4 0.9 0.9 EZR VIL2 ENSG00000092820 Ezrin P15311 6 158765741-158819412 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cell shape" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004035, HPA021616, CAB047324, CAB075739" Enhanced Enhanced "Plasma membrane" 75000000 "Plasma membrane" "CAB004035: AB_2100309, CAB047324: , CAB075739: , HPA021616: AB_1848342" "unprognostic (4.79e-3)" "unprognostic (1.48e-1)" "unprognostic (1.97e-2)" "unprognostic (2.50e-1)" "unprognostic (1.07e-1)" "unprognostic (1.31e-3)" "unprognostic (1.76e-2)" "unprognostic (2.41e-1)" "unprognostic (1.32e-1)" "unprognostic (7.53e-2)" "prognostic unfavourable (1.70e-4)" "unprognostic (5.59e-2)" "prognostic favourable (9.56e-8)" "unprognostic (1.16e-1)" "unprognostic (1.32e-1)" "unprognostic (1.34e-2)" "unprognostic (9.00e-2)" 22.8 56.4 30.9 31.2 31.4 24.7 13.3 4.0 21.5 18.0 45.5 28.2 35.2 33.8 9.8 25.8 71.8 25.1 30.2 34.3 37.6 13.9 53.5 16.2 44.3 36.7 14.8 19.0 20.7 33.0 77.1 14.6 125.1 23.5 21.7 22.8 37.0 27.4 32.0 13.6 47.5 87.9 22.8 12.8 26.0 55.4 21.4 22.2 41.6 37.1 34.4 75.6 38.2 25.3 81.7 30.0 24.3 31.2 20.7 61.7 41.1 87.0 47.6 11.8 16.9 1.3 1.4 68.9 27.4 9.0 30.9 26.1 55.7 48.3 87.7 27.2 31.3 66.8 23.2 30.5 35.9 30.6 15.0 1.8 28.9 24.6 31.4 21.7 13.5 2.3 23.7 29.1 28.3 20.2 17.3 43.0 17.9 22.9 30.7 26.2 19.6 15.9 23.1 5.5 19.9 63.5 26.5 21.4 17.5 47.9 69.1 5.2 16.8 28.7 26.1 10.0 32.1 13.7 42.1 29.7 27.0 75.2 6.2 11.2 11.9 24.3 14.0 16.4 34.8 31.2 41.0 81.7 36.7 42.9 30.0 67.5 19.9 26.5 6.1 20.7 30.6 14.0 61.7 41.1 30.9 31.4 4.0 21.5 37.6 13.9 14.8 19.0 23.5 22.2 F2RL1 "GPR11, PAR2" ENSG00000164251 "F2R like trypsin receptor 1" P55085 5 76818933-76835315 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "Immunity, Inflammatory response, Innate immunity" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 64.1" "Cell line enhanced" "Detected in many" "HUVEC TERT2: 23.6;PC-3: 34.4;RPTEC TERT1: 57.0" "Low cancer specificity" "Detected in all" "Region enriched" "Detected in many" 5 "pons and medulla: 7.8" "Cell type enriched" "Detected in many" 4 "neutrophil: 24.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 24.9" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB012989, HPA014091" Approved Approved "Plasma membrane" "Plasma membrane" "CAB012989: AB_2533199, HPA014091: " "unprognostic (1.29e-2)" "unprognostic (4.05e-2)" "prognostic favourable (3.88e-4)" "unprognostic (1.98e-2)" "unprognostic (8.22e-2)" "prognostic unfavourable (5.88e-4)" "unprognostic (1.36e-1)" "prognostic unfavourable (8.92e-4)" "unprognostic (6.13e-2)" "unprognostic (4.07e-1)" "unprognostic (2.16e-3)" "unprognostic (1.52e-2)" "prognostic favourable (5.86e-7)" "unprognostic (1.11e-1)" "unprognostic (1.74e-1)" "unprognostic (3.76e-2)" "unprognostic (9.73e-2)" 0.6 1.1 1.0 7.2 1.4 0.1 2.9 0.4 0.8 2.4 34.0 1.1 25.3 17.4 1.0 2.2 6.4 2.9 13.6 3.6 1.1 0.9 28.9 7.4 2.8 3.7 0.8 0.4 1.2 16.6 1.3 3.2 2.8 7.8 6.0 21.4 1.1 7.1 23.7 0.3 24.8 64.1 0.7 1.5 3.5 16.8 0.8 0.5 0.6 9.6 5.8 3.1 5.3 3.9 0.3 2.7 24.9 5.7 0.3 2.3 2.0 8.6 14.3 1.2 0.0 0.4 1.1 9.2 0.4 4.7 0.2 0.7 12.3 22.4 0.0 19.3 1.0 14.9 7.5 6.6 0.4 0.0 7.0 0.2 0.3 8.7 3.1 0.0 0.0 1.6 19.0 2.2 14.2 23.6 0.1 0.0 0.0 4.7 1.0 0.0 1.5 34.4 0.0 0.0 0.2 57.0 16.1 0.6 0.1 3.4 3.4 0.0 1.4 0.0 15.6 0.0 9.0 0.0 0.0 1.3 0.2 0.0 5.1 0.0 0.4 4.6 5.7 1.0 0.3 1.9 1.2 0.3 2.3 1.2 2.7 0.1 2.2 1.3 24.9 0.3 0.3 0.3 0.6 2.0 1.0 1.4 0.4 0.8 1.1 0.9 0.8 0.4 7.8 0.5 FARS2 "dJ236A3.1, FARS1" ENSG00000145982 "Phenylalanyl-tRNA synthetase 2, mitochondrial" O95363 6 5261044-5771580 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins" "Protein biosynthesis" "Aminoacyl-tRNA synthetase, Ligase" "Disease mutation, Hereditary spastic paraplegia, Neurodegeneration, Primary mitochondrial disease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA018148, HPA028836" Approved Uncertain "Plasma membrane" "Plasma membrane" "HPA018148: AB_1848426, HPA028836: AB_10601377" "unprognostic (2.73e-1)" "unprognostic (4.08e-3)" "prognostic favourable (5.14e-4)" "unprognostic (2.68e-1)" "unprognostic (1.94e-2)" "unprognostic (5.34e-3)" "unprognostic (1.82e-1)" "unprognostic (4.31e-3)" "unprognostic (7.18e-2)" "unprognostic (1.02e-2)" "unprognostic (8.91e-2)" "unprognostic (2.50e-1)" "prognostic favourable (1.24e-6)" "unprognostic (2.81e-2)" "unprognostic (2.83e-1)" "unprognostic (2.02e-2)" "unprognostic (1.57e-1)" 14.2 19.0 10.6 16.5 14.5 13.2 14.8 16.5 18.8 14.7 13.5 16.4 13.4 9.6 15.3 12.7 13.7 19.8 11.6 19.0 10.5 9.0 18.4 18.5 13.0 21.8 8.9 15.0 11.7 14.0 18.9 29.2 11.4 10.6 12.2 15.2 19.3 15.3 13.5 22.8 15.4 13.0 13.2 8.5 15.0 13.9 15.4 11.0 20.6 19.7 16.0 22.0 13.1 12.9 13.9 16.8 3.2 10.3 14.9 17.5 10.9 8.2 7.9 8.5 9.1 10.6 12.8 7.0 9.1 10.7 11.8 11.6 10.7 6.3 11.6 14.2 8.7 8.2 10.9 14.6 12.4 34.6 7.2 4.6 7.0 9.2 5.5 11.1 6.9 10.1 14.5 13.5 9.6 14.2 13.6 2.7 8.6 8.4 11.8 12.2 5.2 7.7 11.8 10.6 22.7 11.3 9.8 14.6 7.3 8.3 6.7 10.2 13.4 12.0 8.0 12.9 5.9 7.5 11.6 5.6 19.3 6.3 7.1 6.5 15.9 0.1 9.4 3.2 15.6 10.3 13.9 13.9 14.1 14.5 16.8 11.3 15.6 15.5 0.7 14.9 7.3 9.9 17.5 10.9 10.6 14.5 16.5 18.8 10.5 9.0 8.9 15.0 10.6 11.0 FBLN2 ENSG00000163520 "Fibulin 2" P98095 3 13549131-13638422 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 80.5" "Cell line enhanced" "Detected in some" "ASC diff: 73.8;fHDF/TERT166: 48.4;HMC-1: 58.9;HSkMC: 42.8;U-2197: 26.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 9.2;naive CD8 T-cell: 5.4" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 7 "olfactory region: 15.4" "Low region specificity" "Detected in all" "HPA001934, CAB018622" Enhanced Supported "Plasma membrane" "Secreted to extracellular matrix" 28000000 "Plasma membrane" "CAB018622: AB_2294196, HPA001934: AB_1078827" "unprognostic (1.19e-1)" "unprognostic (7.76e-2)" "unprognostic (3.21e-1)" "prognostic unfavourable (9.48e-4)" "unprognostic (2.82e-2)" "unprognostic (1.05e-1)" "prognostic favourable (3.17e-4)" "unprognostic (8.02e-2)" "unprognostic (1.72e-1)" "unprognostic (1.70e-2)" "unprognostic (2.57e-1)" "unprognostic (4.66e-2)" "unprognostic (2.13e-2)" "unprognostic (1.89e-2)" "unprognostic (2.82e-2)" "unprognostic (2.61e-2)" "unprognostic (1.41e-1)" 58.5 2.7 1.8 8.0 2.2 0.1 34.3 0.8 3.2 21.4 11.5 1.3 9.5 2.1 11.6 23.6 32.7 7.2 21.9 80.5 1.6 1.7 2.1 1.2 7.8 5.1 2.4 1.4 6.3 3.2 1.1 0.9 31.8 2.3 22.1 4.2 7.9 10.8 3.3 20.1 20.8 6.1 42.9 1.5 2.3 6.9 41.8 0.5 4.8 20.7 23.8 8.5 34.2 36.3 2.2 9.2 0.0 0.0 0.4 5.4 1.1 0.0 0.2 9.5 0.0 73.8 10.0 4.5 23.0 18.4 23.1 15.3 1.4 0.0 0.0 1.1 48.4 0.0 0.0 0.1 4.3 0.0 0.0 18.2 0.4 0.0 5.0 0.0 58.9 42.8 0.3 3.6 0.0 0.0 0.1 0.1 0.1 0.0 0.9 0.1 2.2 0.1 0.0 0.0 0.0 0.1 0.0 0.5 0.4 0.0 16.9 0.0 0.0 0.0 0.0 0.0 0.0 26.1 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.2 1.7 0.0 0.3 9.2 2.2 0.0 5.4 0.0 0.4 0.0 0.7 0.0 1.1 1.8 2.2 0.8 3.2 1.6 1.7 2.4 1.4 2.3 0.5 FBLN5 "ARMD3, DANCE, EVEC, UP50" ENSG00000140092 "Fibulin 5" Q9UBX5 14 91869412-91947987 "Disease related genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion" "Age-related macular degeneration, Charcot-Marie-Tooth disease, Disease mutation, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "ASC diff: 85.9;ASC TERT1: 44.9;BJ: 40.2;BJ hTERT+: 37.7;fHDF/TERT166: 71.8;HSkMC: 41.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 8.5" "Group enriched" "Detected in many" 19 "granulocytes: 8.5;T-cells: 2.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000848, HPA000868, CAB025843" Supported Supported "Plasma membrane" "Secreted to extracellular matrix" 4500000 "Plasma membrane" "CAB025843: , HPA000848: AB_1078620, HPA000868: AB_1078619" "unprognostic (5.53e-3)" "unprognostic (1.14e-1)" "unprognostic (7.78e-2)" "unprognostic (9.29e-2)" "unprognostic (5.55e-3)" "unprognostic (4.73e-2)" "prognostic favourable (6.75e-4)" "unprognostic (5.21e-3)" "unprognostic (4.76e-2)" "unprognostic (1.25e-2)" "unprognostic (3.74e-2)" "unprognostic (1.90e-1)" "unprognostic (7.26e-2)" "unprognostic (1.56e-3)" "unprognostic (1.73e-1)" "unprognostic (5.18e-2)" "unprognostic (3.17e-3)" 48.3 23.5 3.4 11.5 9.5 1.8 49.5 2.2 5.6 52.4 26.6 5.3 20.3 6.0 51.7 36.0 22.6 32.2 97.4 54.5 2.5 2.6 38.9 12.1 50.5 8.6 7.0 4.1 36.5 14.6 7.6 3.9 21.0 9.4 41.2 6.4 40.6 18.3 23.8 24.7 17.5 12.8 51.8 6.8 48.2 18.8 43.9 2.1 1.2 30.3 15.1 9.4 56.4 51.1 0.2 0.1 8.5 0.3 0.0 2.8 0.6 0.0 0.2 0.0 0.0 85.9 44.9 4.5 40.2 37.7 1.1 0.8 0.7 0.0 0.0 0.8 71.8 0.0 1.8 0.1 0.2 0.0 0.4 0.0 0.8 0.0 14.3 0.0 0.0 41.2 0.0 0.7 2.6 1.8 0.0 0.0 4.6 0.1 0.0 0.0 0.0 0.1 0.0 5.7 0.0 0.2 0.0 0.0 0.0 2.2 0.1 0.5 0.5 0.0 0.3 0.5 1.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.5 0.2 3.5 1.2 0.2 0.7 0.1 0.5 0.1 0.0 0.2 1.7 2.8 4.1 0.0 0.3 0.1 0.1 0.6 3.4 9.5 2.2 5.6 2.5 2.6 7.0 4.1 9.4 2.1 FCAR CD89 ENSG00000186431 "Fc fragment of IgA receptor" P24071 19 54874248-54890472 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "IgA-binding protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "bone marrow: 28.1;lung: 19.5;lymphoid tissue: 15.9" "Cell line enhanced" "Detected in single" "THP-1: 1.7" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 6 "classical monocyte: 2.6;neutrophil: 6.1" "Group enriched" "Detected in many" 44 "granulocytes: 6.1;monocytes: 2.6" "Low region specificity" "Detected in many" HPA014050 Approved Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA014050: AB_1846338" "unprognostic (1.46e-1)" "unprognostic (5.74e-2)" "unprognostic (1.30e-1)" "unprognostic (4.71e-3)" "unprognostic (3.46e-1)" "unprognostic (2.02e-1)" "unprognostic (7.99e-2)" "unprognostic (1.54e-2)" "unprognostic (1.59e-2)" "unprognostic (4.70e-2)" "unprognostic (1.41e-2)" "unprognostic (7.05e-2)" "unprognostic (4.19e-6)" "unprognostic (9.23e-2)" "unprognostic (8.10e-3)" "unprognostic (8.04e-3)" "unprognostic (9.81e-2)" 4.0 0.6 0.4 1.5 4.4 28.1 0.8 0.1 1.0 0.6 0.6 0.7 0.0 0.6 0.6 0.6 0.6 3.8 0.6 8.2 2.0 0.4 0.6 1.8 19.5 15.9 1.2 0.0 2.2 0.6 0.6 0.3 1.5 4.3 0.6 0.6 0.9 0.6 0.6 0.6 0.6 0.6 0.7 2.7 14.9 0.9 2.1 0.0 1.0 0.6 0.3 0.6 4.4 4.8 0.0 0.0 6.1 2.6 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 1.7 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 0.1 0.0 0.0 0.7 0.4 4.4 0.1 1.0 2.0 0.4 1.2 0.0 4.3 0.0 FFAR4 "GPR120, GPR129, O3FAR1, PGR4" ENSG00000186188 "Free fatty acid receptor 4" Q5NUL3 10 93566665-93604480 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "intestine: 15.8;lung: 11.7;pituitary gland: 39.2" "Cell line enhanced" "Detected in some" "A549: 3.3;CACO-2: 2.7;HaCaT: 5.5;NB-4: 6.1" "Cancer enhanced" "Detected in some" "colorectal cancer: 4.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 3.4" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in many" HPA042563 Uncertain "Plasma membrane" "Plasma membrane" "HPA042563: AB_10794762" "unprognostic (1.96e-1)" "unprognostic (1.06e-2)" "unprognostic (1.14e-2)" "unprognostic (4.21e-2)" "unprognostic (2.12e-1)" "unprognostic (4.98e-4)" "unprognostic (1.41e-3)" "unprognostic (1.20e-2)" "unprognostic (2.34e-2)" "unprognostic (7.87e-2)" "unprognostic (9.51e-2)" "unprognostic (1.49e-1)" "unprognostic (3.85e-2)" "unprognostic (5.32e-2)" "unprognostic (2.71e-1)" "unprognostic (1.02e-1)" "unprognostic (1.49e-1)" 5.2 0.6 1.8 2.8 1.7 0.2 1.9 0.1 2.6 0.2 11.3 1.1 0.0 0.7 0.1 0.1 0.4 1.4 2.6 1.2 0.9 1.6 0.3 0.6 11.7 1.3 0.6 1.0 0.3 1.1 0.1 39.2 0.4 0.8 0.2 15.8 0.3 0.9 0.1 0.5 1.3 1.0 0.3 2.6 0.2 0.7 2.0 0.9 0.7 0.2 0.0 0.6 0.3 0.2 0.5 3.4 1.3 3.0 0.7 0.3 0.8 0.1 3.3 0.1 0.1 0.0 0.0 0.4 0.3 0.0 0.0 0.0 2.7 0.8 0.2 0.5 0.0 5.5 0.0 0.0 0.0 0.4 0.1 0.0 0.5 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.2 0.0 0.0 0.0 6.1 0.3 0.0 0.1 0.1 0.0 0.0 0.4 0.4 0.1 0.1 0.1 0.0 1.1 0.2 0.3 0.1 0.2 0.3 0.1 0.2 0.1 0.0 0.1 0.1 0.1 0.9 3.0 0.2 0.3 0.6 0.2 0.4 0.2 0.2 3.4 0.5 0.2 0.3 1.3 0.7 0.4 0.4 0.1 0.8 1.8 1.7 0.1 2.6 0.9 1.6 0.6 1.0 0.8 0.9 FGD5 "FLJ00274, FLJ39957, ZFYVE23" ENSG00000154783 "FYVE, RhoGEF and PH domain containing 5" Q6ZNL6 3 14810853-14934565 "Predicted intracellular proteins" "Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 4 "HUVEC TERT2: 40.4;TIME: 33.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA014436, HPA014536, HPA019191" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA014436: , HPA014536: AB_1848518, HPA019191: AB_1848519" "unprognostic (2.57e-1)" "unprognostic (7.33e-2)" "unprognostic (1.03e-1)" "unprognostic (3.28e-2)" "unprognostic (2.02e-2)" "unprognostic (1.03e-3)" "unprognostic (1.08e-1)" "unprognostic (4.10e-2)" "unprognostic (6.34e-2)" "unprognostic (5.53e-2)" "unprognostic (1.46e-1)" "unprognostic (9.39e-2)" "unprognostic (6.84e-3)" "unprognostic (1.71e-2)" "unprognostic (3.46e-1)" "unprognostic (1.32e-2)" "prognostic favourable (7.50e-4)" 18.9 3.7 2.2 10.7 2.7 0.0 18.9 1.2 4.0 11.0 9.2 1.9 8.3 7.3 17.7 9.5 5.7 8.1 14.3 12.3 2.3 2.2 10.3 2.5 27.3 8.1 2.7 1.9 7.2 6.5 2.8 3.9 14.3 3.1 8.3 3.8 8.4 4.5 4.0 7.9 6.0 8.6 9.6 2.4 29.3 5.2 7.1 1.6 1.0 8.6 8.4 3.6 7.2 20.5 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 40.4 0.0 0.0 0.0 0.0 0.1 0.0 2.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 33.0 0.0 2.8 9.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 2.7 1.2 4.0 2.3 2.2 2.7 1.9 3.1 1.6 FILIP1L "DOC-1, GIP130" ENSG00000168386 "Filamin A interacting protein 1 like" Q4L180 3 99830141-100114513 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 26.8;HDLM-2: 25.0;TIME: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "non-classical monocyte: 5.9" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in some" 7 "olfactory region: 22.1" "Low region specificity" "Detected in all" HPA043133 Approved Approved "Plasma membrane" "Plasma membrane" "HPA043133: AB_10793991" "unprognostic (9.14e-2)" "unprognostic (2.16e-1)" "unprognostic (7.73e-2)" "unprognostic (5.25e-2)" "unprognostic (6.68e-2)" "unprognostic (1.06e-2)" "unprognostic (4.40e-2)" "unprognostic (1.29e-1)" "unprognostic (2.08e-2)" "unprognostic (2.18e-1)" "unprognostic (1.02e-1)" "unprognostic (3.32e-1)" "prognostic unfavourable (9.40e-4)" "unprognostic (2.46e-2)" "unprognostic (9.44e-2)" "unprognostic (5.30e-2)" "unprognostic (1.82e-3)" 29.0 7.5 11.7 22.1 2.4 0.0 15.2 1.3 7.4 36.2 28.3 0.9 27.2 6.9 52.5 50.0 25.3 17.8 24.3 23.8 4.0 2.1 12.5 6.7 15.9 10.9 2.9 6.5 65.6 10.3 7.7 3.1 14.6 9.4 36.7 7.7 5.5 6.1 36.8 44.8 9.5 19.2 86.3 2.2 27.1 25.1 19.9 1.3 2.5 11.7 53.4 5.8 49.8 16.2 1.5 4.4 0.5 5.9 1.0 0.4 0.5 18.4 0.0 7.2 0.0 12.0 10.2 0.6 9.4 18.9 16.5 18.7 5.6 0.0 0.0 1.6 26.8 2.2 0.0 4.6 19.6 25.0 0.2 1.5 0.0 7.3 6.0 0.4 0.0 8.1 1.7 1.8 0.0 7.3 1.1 0.1 2.4 0.1 1.6 0.3 0.4 0.0 0.0 8.5 0.2 11.0 0.3 0.6 1.2 0.1 0.1 0.0 0.0 3.3 46.6 2.9 0.0 0.6 4.9 1.3 0.0 0.1 2.1 0.1 0.0 0.3 1.0 0.2 0.3 2.2 0.1 1.4 0.4 0.3 4.4 1.5 0.2 0.2 0.5 1.0 5.9 0.8 0.3 0.5 11.7 2.4 1.3 7.4 4.0 2.1 2.9 6.5 9.4 1.3 FKBP2 "FKBP-13, PPIase" ENSG00000173486 "FK506 binding protein 2" P26885 11 64241003-64244132 "Enzymes, Predicted intracellular proteins" "Isomerase, Rotamase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "plasmacytoid DC: 119.6" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025561, HPA049405" Enhanced Approved "Plasma membrane" "Intracellular and membrane" 400000 "Plasma membrane" "CAB025561: , HPA049405: " "unprognostic (4.94e-2)" "unprognostic (1.12e-1)" "unprognostic (5.77e-2)" "unprognostic (2.66e-3)" "unprognostic (7.40e-2)" "unprognostic (1.92e-2)" "unprognostic (8.64e-2)" "unprognostic (1.62e-1)" "unprognostic (3.23e-1)" "unprognostic (5.91e-3)" "unprognostic (5.86e-2)" "unprognostic (7.18e-2)" "unprognostic (1.70e-2)" "unprognostic (1.58e-1)" "unprognostic (5.23e-1)" "unprognostic (2.30e-1)" "unprognostic (3.57e-2)" 18.2 35.8 28.9 20.2 35.5 12.1 20.2 18.8 27.1 31.3 28.0 20.3 87.8 39.0 24.4 102.7 20.8 25.5 30.3 28.0 29.7 35.7 40.3 89.6 18.8 17.0 39.3 24.8 22.1 107.2 34.0 57.2 59.2 29.0 26.1 21.9 19.4 59.3 116.6 11.8 18.5 30.2 19.7 28.5 20.9 31.1 19.8 20.6 12.4 63.2 18.6 18.8 21.3 23.9 21.3 119.6 29.0 25.4 20.0 30.7 15.5 24.0 31.7 17.2 34.7 37.2 21.3 24.4 29.2 29.6 22.1 20.6 31.2 54.2 17.8 46.5 35.8 31.5 13.6 24.2 10.5 22.1 11.8 19.8 42.2 31.9 48.9 16.4 27.8 24.7 36.1 29.2 32.4 17.5 14.8 53.4 26.2 39.8 17.9 25.9 20.0 28.6 16.0 17.0 64.9 39.9 24.1 24.0 20.9 20.0 56.7 32.1 21.8 14.2 16.6 26.6 23.7 42.2 15.6 32.5 10.1 14.5 35.6 17.3 30.0 29.0 24.5 3.4 24.1 25.4 30.7 21.3 19.2 23.3 23.2 20.5 13.0 18.1 9.1 20.0 20.8 119.6 7.1 15.5 28.9 35.5 18.8 27.1 29.7 35.7 39.3 24.8 29.0 20.6 FZD1 DKFZp564G072 ENSG00000157240 "Frizzled class receptor 1" Q9UP38 7 91264364-91271326 "Cancer-related genes, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins, Transporters" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 61.2" "Cell line enhanced" "Detected in many" "AF22: 16.3;HSkMC: 21.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2;non-classical monocyte: 5.4" "Lineage enriched" "Detected in many" 4 "monocytes: 5.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB013008 Approved Supported "Plasma membrane" "Plasma membrane" "CAB013008: " "unprognostic (1.46e-1)" "unprognostic (1.70e-1)" "unprognostic (1.15e-1)" "unprognostic (3.16e-2)" "unprognostic (4.51e-3)" "unprognostic (2.09e-1)" "unprognostic (5.29e-3)" "unprognostic (3.70e-2)" "unprognostic (2.36e-2)" "unprognostic (5.48e-3)" "unprognostic (2.14e-1)" "unprognostic (7.39e-3)" "prognostic favourable (8.87e-7)" "unprognostic (1.05e-2)" "unprognostic (4.16e-2)" "unprognostic (5.53e-2)" "unprognostic (4.13e-2)" 5.8 4.6 2.6 4.9 3.5 0.9 10.7 8.2 2.8 17.6 8.5 4.1 9.3 4.9 10.1 9.9 7.8 6.1 11.0 12.3 6.1 1.8 15.3 3.9 10.5 1.4 2.0 3.2 15.0 7.9 2.5 4.6 10.0 5.7 12.3 3.7 11.1 9.2 17.5 3.1 10.7 8.3 7.2 4.6 3.4 4.5 4.4 3.5 1.4 61.2 6.5 2.9 10.4 13.9 0.1 1.3 0.2 5.4 0.0 0.0 0.4 0.5 1.6 16.3 1.7 13.3 11.5 3.0 5.9 3.8 2.2 1.5 0.7 2.8 0.0 1.4 3.8 3.0 2.5 1.3 1.4 0.0 3.2 0.1 3.1 0.8 0.9 2.6 0.7 21.8 2.3 5.0 1.6 0.5 0.9 2.3 6.3 3.9 0.4 0.7 4.2 2.7 3.2 10.0 0.2 3.5 7.6 2.2 4.3 4.5 3.7 0.9 1.9 2.4 2.4 9.3 7.0 9.8 2.4 2.2 1.5 0.2 10.0 2.2 10.7 0.0 1.4 0.0 0.0 4.2 0.0 0.1 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 5.4 0.1 0.0 0.4 2.6 3.5 8.2 2.8 6.1 1.8 2.0 3.2 5.7 3.5 FZD6 Hfz6 ENSG00000164930 "Frizzled class receptor 6" O60353 8 103298433-103332866 "Disease related genes, G-protein coupled receptors, Potential drug targets, Predicted membrane proteins" "Wnt signaling pathway" "Developmental protein, G-protein coupled receptor, Receptor, Transducer" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "hTCEpi: 41.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 7.9" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA017991 Approved Approved "Plasma membrane" "Plasma membrane" "HPA017991: AB_1849138" "unprognostic (8.22e-3)" "unprognostic (2.64e-1)" "unprognostic (4.75e-2)" "unprognostic (2.57e-1)" "unprognostic (1.22e-2)" "unprognostic (6.99e-2)" "unprognostic (4.01e-2)" "unprognostic (2.74e-1)" "unprognostic (2.43e-1)" "unprognostic (2.66e-1)" "prognostic unfavourable (1.20e-6)" "unprognostic (3.62e-2)" "unprognostic (1.83e-1)" "unprognostic (2.86e-1)" "unprognostic (1.32e-1)" "unprognostic (4.92e-2)" "unprognostic (7.54e-2)" 13.1 9.2 3.4 5.2 3.8 0.5 13.3 4.3 5.9 12.1 10.7 3.5 8.6 4.0 12.0 16.4 17.9 17.8 12.3 9.6 3.7 3.8 17.4 5.8 17.1 4.7 4.2 2.9 11.6 14.4 21.3 27.2 14.1 10.0 12.4 4.9 11.6 15.3 8.8 4.3 16.9 7.7 12.7 4.2 6.1 8.0 7.2 1.5 10.9 21.2 18.7 14.7 15.9 11.3 1.7 1.0 0.2 0.0 7.9 2.2 0.5 19.4 4.0 9.4 0.0 2.2 7.0 5.8 10.4 11.4 9.3 6.1 2.1 15.0 0.0 17.8 9.2 28.9 5.3 21.5 16.5 4.4 6.4 10.3 4.5 2.6 31.1 0.0 0.0 7.9 41.5 9.8 30.4 19.0 1.0 8.5 9.9 8.0 9.1 0.8 2.2 6.9 0.7 4.5 0.0 18.8 12.3 3.3 2.6 14.5 7.6 18.8 0.0 3.5 1.5 2.2 10.9 8.3 10.6 2.2 1.1 4.2 6.1 0.0 13.4 0.0 0.0 0.2 0.6 0.0 0.0 0.9 2.1 0.9 1.0 1.7 2.2 1.0 0.0 7.9 0.0 0.2 0.6 0.5 3.4 3.8 4.3 5.9 3.7 3.8 4.2 2.9 10.0 1.5 GAB2 KIAA0571 ENSG00000033327 "GRB2 associated binding protein 2" Q9UQC2 11 78215297-78418348 "Predicted intracellular proteins, RAS pathway related proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 49.1" "Cell line enhanced" "Detected in many" "SH-SY5Y: 31.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 9.4;neutrophil: 16.3" "Lineage enriched" "Detected in many" 5 "granulocytes: 16.3" "HPA000271, HPA001368, CAB022159" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB022159: , HPA000271: AB_1078925, HPA001368: " "unprognostic (2.51e-2)" "unprognostic (1.90e-1)" "unprognostic (3.56e-3)" "unprognostic (1.99e-3)" "unprognostic (1.04e-2)" "unprognostic (4.69e-2)" "unprognostic (4.47e-2)" "unprognostic (1.08e-1)" "unprognostic (6.54e-2)" "unprognostic (1.37e-1)" "unprognostic (2.25e-1)" "unprognostic (1.74e-1)" "prognostic favourable (9.32e-5)" "unprognostic (6.95e-2)" "unprognostic (4.35e-1)" "unprognostic (3.99e-2)" "unprognostic (1.67e-2)" 15.5 8.4 31.1 12.0 26.9 32.9 11.6 5.7 21.5 10.2 8.9 49.1 1.6 13.7 16.8 4.6 8.2 13.5 9.1 13.6 30.4 21.3 5.2 4.5 16.1 6.8 31.5 14.8 20.0 5.9 10.4 7.0 14.6 24.7 6.5 10.9 6.6 5.4 7.3 5.2 8.8 10.1 17.1 35.4 11.8 7.4 5.5 26.0 9.4 6.5 3.0 5.6 9.3 12.3 0.5 1.7 16.3 3.4 0.0 0.1 0.7 1.7 1.5 4.4 0.5 6.4 2.8 19.4 2.7 3.3 2.0 1.6 11.4 0.9 0.5 12.4 3.8 2.8 10.3 0.2 2.6 17.2 1.1 6.9 2.7 2.0 3.2 2.6 1.4 3.0 0.9 7.7 1.2 11.5 18.1 0.6 3.3 0.7 1.3 6.5 1.4 2.1 13.0 4.2 0.2 3.6 6.5 3.8 31.0 0.7 1.4 7.1 6.5 7.5 9.4 0.9 2.2 7.5 0.6 4.8 0.7 0.3 0.7 4.1 8.2 9.4 2.4 0.7 0.0 1.4 0.0 0.5 0.0 0.0 0.8 0.3 0.0 0.0 16.3 0.0 3.4 1.7 0.1 0.7 31.1 26.9 5.7 19.3 30.4 21.3 31.5 14.8 24.7 26.0 GABRA5 ENSG00000186297 "Gamma-aminobutyric acid type A receptor alpha5 subunit" P31644 15 26866363-26949207 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Transport" "Chloride channel, Ion channel, Ligand-gated ion channel, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "brain: 52.6" "Group enriched" "Detected in some" 12 "A549: 25.8;HAP1: 8.9;NTERA-2: 10.7;U-2 OS: 9.3" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA077031, CAB079022" Supported Supported "Plasma membrane" "Plasma membrane" "CAB079022: , HPA077031: " "unprognostic (6.33e-2)" "unprognostic (8.94e-3)" "unprognostic (1.04e-1)" "unprognostic (2.50e-1)" "unprognostic (1.81e-1)" "unprognostic (3.75e-1)" "unprognostic (9.50e-3)" "unprognostic (2.57e-1)" "unprognostic (7.63e-2)" "unprognostic (8.50e-2)" "unprognostic (1.44e-2)" 0.8 0.8 12.0 0.8 48.2 0.8 0.8 0.1 52.6 0.8 0.8 0.8 0.0 0.8 0.8 0.7 2.5 0.8 1.5 0.9 20.9 6.0 0.9 0.8 0.8 0.8 2.3 15.2 0.7 0.7 0.7 0.1 0.8 1.0 1.0 0.7 0.0 0.7 0.9 0.7 0.8 0.7 1.4 0.3 0.8 1.1 1.4 2.0 1.3 0.9 0.0 1.1 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 25.8 0.3 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.5 0.0 8.9 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 10.7 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.4 0.0 0.0 0.1 0.0 0.0 0.0 0.0 9.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 12.0 48.2 0.1 26.0 20.9 6.0 2.3 15.2 1.0 2.0 GAP43 "B-50, PP46" ENSG00000172020 "Growth associated protein 43" P17677 3 115623324-115721490 "Plasma proteins, Predicted intracellular proteins, Transporters" "Differentiation, Growth regulation, Neurogenesis" "Calmodulin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 25 "brain: 132.7" "Cell line enhanced" "Detected in some" "AF22: 16.4;NTERA-2: 34.8;SCLC-21H: 22.4;SH-SY5Y: 16.8;U-87 MG: 7.8" "Cancer enriched" "Detected in many" 43 "glioma: 245.6" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "naive CD8 T-cell: 1.7" "Lineage enriched" "Detected in single" 17 "T-cells: 1.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004417, HPA013392, HPA015600, CAB078783" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB004417: AB_627660, CAB078783: AB_2620096, HPA013392: AB_1849468, HPA015600: AB_1849466" "unprognostic (1.24e-1)" "unprognostic (1.31e-1)" "unprognostic (1.15e-2)" "unprognostic (5.72e-5)" "unprognostic (7.44e-3)" "unprognostic (2.19e-2)" "unprognostic (3.97e-3)" "unprognostic (3.15e-3)" "unprognostic (6.08e-4)" "unprognostic (3.33e-1)" "unprognostic (2.17e-2)" "unprognostic (1.62e-1)" "unprognostic (5.35e-8)" "unprognostic (1.15e-1)" "unprognostic (1.09e-1)" "unprognostic (2.78e-2)" "unprognostic (1.29e-3)" 1.8 5.0 48.8 5.2 38.3 1.4 1.9 31.2 132.7 1.6 4.1 4.3 0.0 2.7 1.5 1.5 1.9 1.5 3.8 3.6 29.0 56.6 1.4 1.4 1.5 1.5 30.6 42.2 1.4 1.8 1.4 1.5 2.2 25.7 1.7 4.0 0.8 2.2 1.5 1.4 1.4 4.3 3.6 6.1 1.4 1.5 1.6 5.7 0.0 1.5 0.0 1.6 1.7 0.2 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 3.5 0.0 0.0 0.0 3.7 0.0 0.0 0.0 0.0 34.8 0.0 0.0 0.0 0.0 0.0 0.0 22.4 16.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 7.8 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 48.8 38.3 31.2 75.7 29.0 56.6 30.6 42.2 25.7 5.7 GCSAML-AS1 ENSG00000284824 "GCSAML antisense RNA 1" Q8N628 1 247524679-247532613 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enriched" "Detected in single" 6 "testis: 4.5" "Cell line enhanced" "Detected in some" "HMC-1: 2.0;SK-MEL-30: 1.2" "Not detected" "Not detected" "Not detected" "Not detected" HPA058578 Uncertain "Plasma membrane" "Plasma membrane" "HPA058578: " 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.5 0.0 0.0 0.0 0.0 0.8 0.6 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.4 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.4 0.0 0.8 0.0 0.0 GLP2R ENSG00000065325 "Glucagon like peptide 2 receptor" O95838 17 9822206-9892102 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "gallbladder: 32.7" "Cell line enriched" "Detected in some" 5 "HeLa: 41.8" "Cancer enhanced" "Detected in single" "pancreatic cancer: 1.1" "Group enriched" "Detected in some" 4 "basal ganglia: 2.9;cerebral cortex: 4.1;olfactory region: 1.6" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 6 "cerebral cortex: 2.1;hippocampal formation: 2.6" "Low region specificity" "Detected in many" "CAB022690, HPA049244" Supported Supported "Plasma membrane" "Plasma membrane" "CAB022690: , HPA049244: " "unprognostic (2.14e-1)" "unprognostic (2.45e-3)" "unprognostic (2.66e-3)" "unprognostic (2.21e-2)" "unprognostic (3.81e-3)" "unprognostic (2.09e-1)" "unprognostic (1.39e-2)" "unprognostic (5.15e-2)" "unprognostic (7.63e-2)" "unprognostic (7.14e-2)" "unprognostic (2.19e-1)" "unprognostic (6.16e-3)" "unprognostic (3.40e-8)" "unprognostic (9.53e-5)" "unprognostic (5.51e-2)" "unprognostic (3.92e-1)" "unprognostic (6.48e-3)" 7.9 0.7 0.6 2.0 2.9 0.0 2.6 0.3 4.3 6.6 14.5 0.0 1.7 12.4 1.9 0.4 5.3 1.4 32.7 0.9 0.6 0.5 0.4 3.2 1.4 0.7 0.6 1.6 0.8 2.1 0.0 0.3 1.5 0.5 8.4 7.5 0.8 0.4 0.2 0.3 0.3 15.4 15.6 0.6 0.3 4.9 1.1 0.2 0.0 0.5 0.1 0.4 13.5 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 0.4 0.0 0.4 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 41.8 0.3 0.5 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 0.0 0.0 0.0 0.0 0.0 0.0 3.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 2.9 0.3 4.1 0.6 0.5 0.6 1.6 0.5 0.2 GNB2 ENSG00000172354 "G protein subunit beta 2" P62879 7 100673531-100679174 "Predicted intracellular proteins, RAS pathway related proteins" Transducer "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "neutrophil: 42.7" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB010032, HPA040736" Approved Supported "Plasma membrane" 36000000 "Plasma membrane" "CAB010032: AB_2263466, HPA040736: " "unprognostic (1.55e-1)" "unprognostic (5.76e-2)" "unprognostic (1.01e-3)" "unprognostic (2.76e-1)" "unprognostic (1.11e-2)" "unprognostic (1.94e-1)" "unprognostic (3.68e-3)" "unprognostic (3.52e-1)" "unprognostic (6.58e-2)" "unprognostic (2.54e-1)" "unprognostic (9.79e-3)" "unprognostic (1.70e-1)" "unprognostic (3.75e-2)" "unprognostic (1.24e-1)" "unprognostic (3.19e-1)" "unprognostic (5.29e-2)" "unprognostic (2.98e-1)" 49.9 45.9 43.8 41.6 58.4 60.9 88.8 31.7 40.9 40.5 43.1 22.3 39.4 34.8 41.1 39.7 74.6 49.6 44.0 54.0 38.9 36.1 39.1 72.9 49.1 94.9 32.5 42.3 47.5 45.6 33.5 45.9 38.0 35.6 47.7 29.0 28.8 77.8 42.5 39.2 59.9 38.3 39.1 23.6 50.7 42.2 31.9 33.9 43.7 40.9 45.8 35.1 37.8 50.1 6.3 9.9 42.7 14.8 5.2 7.9 4.0 51.1 39.5 33.3 40.4 26.0 31.0 28.8 30.8 43.0 44.3 36.8 30.0 49.5 22.9 33.8 45.6 35.8 26.3 45.9 15.7 32.0 22.5 17.3 30.3 24.5 43.5 22.5 37.6 39.8 43.8 45.7 37.2 50.8 32.1 45.3 40.1 138.2 35.6 64.0 25.8 42.9 33.7 20.4 36.6 35.3 42.6 35.3 57.3 40.8 67.1 28.4 28.7 28.0 47.9 47.6 52.7 92.4 38.4 13.1 15.7 33.9 36.0 50.3 65.6 7.8 10.6 23.6 6.5 14.8 6.1 4.8 6.8 5.7 9.9 6.3 4.5 4.7 42.7 5.2 12.2 8.5 7.9 4.0 43.8 58.4 31.7 40.9 38.9 36.1 32.5 42.3 35.6 33.9 GNB4 ENSG00000114450 "G protein subunit beta 4" Q9HAV0 3 179396089-179451590 "Disease related genes, Predicted intracellular proteins, RAS pathway related proteins" Transducer "Charcot-Marie-Tooth disease, Disease mutation, Neurodegeneration, Neuropathy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018383, CAB018737, HPA040736" Supported Supported "Plasma membrane" 18000000 "Plasma membrane" "CAB018383: AB_631542, CAB018737: AB_640712, HPA040736: " "unprognostic (2.56e-2)" "unprognostic (1.95e-1)" "unprognostic (1.62e-1)" "unprognostic (1.01e-1)" "unprognostic (5.97e-3)" "unprognostic (2.12e-1)" "unprognostic (1.44e-2)" "unprognostic (8.28e-2)" "unprognostic (1.16e-1)" "unprognostic (3.44e-1)" "unprognostic (1.56e-1)" "unprognostic (2.32e-2)" "prognostic unfavourable (1.39e-6)" "unprognostic (1.90e-3)" "unprognostic (3.13e-2)" "unprognostic (8.90e-2)" "unprognostic (2.80e-3)" 16.6 5.3 11.9 16.7 9.9 20.7 12.4 3.2 16.6 10.4 11.1 13.9 2.2 4.4 11.3 10.7 16.1 10.2 11.9 11.0 9.8 6.2 5.0 6.3 14.3 12.6 10.1 8.0 6.3 3.7 2.1 4.3 16.6 9.9 5.1 7.2 6.6 8.8 3.6 4.3 27.0 7.7 16.9 19.4 14.9 10.6 3.7 9.4 5.6 8.8 9.6 8.6 9.5 11.9 8.2 13.6 7.0 15.3 1.8 0.3 4.2 10.3 4.5 12.5 0.2 8.3 14.3 14.5 14.7 10.0 16.3 19.4 0.1 1.1 19.2 3.4 16.0 0.2 11.0 13.3 17.4 41.0 8.2 21.7 17.4 0.1 8.1 19.0 5.1 11.6 2.0 12.9 6.5 17.9 5.7 0.2 14.6 0.4 9.3 7.7 6.3 5.5 18.7 16.0 8.1 12.1 0.5 2.0 6.6 11.8 11.2 19.5 22.0 8.6 14.6 16.0 8.9 4.0 19.5 0.0 0.2 0.2 8.7 17.0 11.1 2.2 11.5 5.4 0.1 15.3 0.1 3.6 0.2 0.1 13.6 8.2 0.2 0.1 7.0 1.8 12.6 6.9 0.3 4.2 11.9 9.9 3.2 14.7 9.8 6.2 10.1 8.0 9.9 9.4 GPC3 "DGSX, OCI-5, SDYS, SGB, SGBS, SGBS1" ENSG00000147257 "Glypican 3" P51654 X 133535745-133985895 "Cancer-related genes, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Protease inhibitor" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "placenta: 262.7" "Group enriched" "Detected in some" 8 "HAP1: 53.1;Hep G2: 209.8" "Cancer enhanced" "Detected in all" "liver cancer: 269.0" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 4 "naive CD4 T-cell: 5.0;naive CD8 T-cell: 3.5;NK-cell: 1.7" "Group enriched" "Detected in many" 12 "NK-cells: 1.7;T-cells: 5.0" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006316 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA006316: AB_1078994" "unprognostic (2.06e-1)" "unprognostic (2.36e-1)" "unprognostic (9.51e-2)" "unprognostic (4.17e-2)" "unprognostic (1.78e-1)" "unprognostic (1.46e-1)" "unprognostic (6.10e-2)" "unprognostic (1.17e-2)" "unprognostic (2.07e-2)" "unprognostic (3.92e-3)" "unprognostic (6.06e-2)" "unprognostic (1.71e-1)" "unprognostic (3.81e-3)" "prognostic unfavourable (4.83e-4)" "unprognostic (1.43e-1)" "unprognostic (2.21e-1)" "unprognostic (1.60e-1)" 30.1 5.9 0.4 3.6 0.7 0.0 50.2 0.6 0.4 3.3 4.5 0.5 2.2 0.5 2.5 11.7 2.0 3.4 9.2 8.0 0.4 1.1 21.2 1.1 37.0 1.9 1.6 0.4 6.0 4.6 0.3 16.9 262.7 1.6 3.6 1.0 6.3 3.8 2.3 4.1 5.5 1.8 3.3 2.1 0.9 4.0 2.1 0.3 2.3 7.2 11.2 3.0 7.6 8.0 0.0 0.2 0.0 0.0 1.7 5.0 0.6 0.0 0.0 2.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.4 0.0 0.0 0.0 0.0 0.0 53.1 0.0 0.0 0.0 2.4 0.0 0.1 209.8 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 16.1 0.0 0.0 0.0 0.0 14.5 0.6 1.7 4.3 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.8 0.5 0.2 0.0 5.0 3.5 0.0 1.7 0.0 0.0 0.0 0.6 0.4 0.7 0.6 0.4 0.4 1.1 1.6 0.4 1.6 0.3 GPR156 "GABABL, PGR28" ENSG00000175697 "G protein-coupled receptor 156" Q8NFN8 3 120164645-120285094 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "testis: 7.7" "Cell line enhanced" "Detected in some" "fHDF/TERT166: 3.0;PC-3: 3.0;SiHa: 7.9;U-2 OS: 4.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA028642, HPA028644" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA028642: AB_10599711, HPA028644: AB_10600441" "unprognostic (2.85e-3)" "unprognostic (1.02e-1)" "unprognostic (3.53e-3)" "unprognostic (2.02e-3)" "unprognostic (1.07e-1)" "unprognostic (3.79e-1)" "unprognostic (2.62e-4)" "unprognostic (2.03e-1)" "unprognostic (4.54e-4)" "unprognostic (5.03e-2)" "unprognostic (1.57e-1)" "unprognostic (1.10e-1)" "unprognostic (4.03e-5)" "unprognostic (2.43e-2)" "unprognostic (3.43e-2)" "unprognostic (4.91e-3)" "unprognostic (6.71e-2)" 0.9 0.5 0.8 1.6 2.2 0.0 1.0 0.1 1.0 1.4 0.7 0.0 0.0 0.0 1.2 0.0 1.9 3.4 1.3 0.2 0.4 0.3 0.3 0.0 0.2 0.0 0.3 0.0 1.4 0.0 0.0 1.4 1.2 0.7 1.9 0.2 0.4 2.4 1.5 0.1 0.3 0.2 1.6 1.5 0.1 0.3 7.7 1.2 0.0 0.1 0.0 0.4 2.5 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.2 0.0 0.2 0.8 0.1 0.9 1.3 0.1 0.6 0.0 0.8 3.0 0.1 0.1 0.1 0.5 0.0 0.0 0.0 2.0 0.0 0.8 0.2 0.0 1.9 0.2 0.4 0.0 0.0 0.0 0.3 1.0 0.0 0.0 0.0 0.9 3.0 0.0 0.0 0.0 0.0 0.0 1.0 1.5 7.9 0.0 0.9 1.0 0.1 0.2 0.2 4.4 0.0 0.3 1.0 0.4 0.1 1.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.8 2.2 0.1 1.0 0.4 0.3 0.3 0.0 0.7 1.2 GPR160 "GPCR1, GPCR150" ENSG00000173890 "G protein-coupled receptor 160" Q9UJ42 3 170037929-170085403 "G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "parathyroid gland: 71.0" "Cell line enhanced" "Detected in many" "RPMI-8226: 30.4;SK-BR-3: 24.2;THP-1: 47.8;U-266/70: 52.8;U-266/84: 30.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" HPA006970 Approved Supported "Plasma membrane" "Plasma membrane" "HPA006970: AB_1849275" "unprognostic (1.70e-1)" "unprognostic (5.08e-3)" "unprognostic (2.96e-2)" "unprognostic (2.39e-3)" "unprognostic (2.20e-1)" "unprognostic (3.01e-1)" "unprognostic (5.21e-2)" "prognostic favourable (1.21e-4)" "unprognostic (5.71e-3)" "unprognostic (1.35e-1)" "unprognostic (4.35e-2)" "unprognostic (1.77e-1)" "prognostic favourable (4.93e-7)" "unprognostic (1.40e-1)" "unprognostic (2.25e-1)" "unprognostic (1.43e-1)" "prognostic favourable (3.61e-4)" 7.0 1.4 3.1 21.7 2.5 23.6 8.2 0.9 1.8 2.6 31.2 1.5 7.9 18.0 1.9 21.5 2.6 1.8 16.2 3.0 1.9 1.7 27.4 2.1 23.2 25.6 2.7 0.4 1.6 14.7 71.0 3.5 2.9 1.8 10.7 18.1 11.8 14.2 4.7 2.0 1.8 43.2 0.9 4.7 17.9 18.0 2.9 2.4 6.6 3.8 1.0 10.7 9.1 6.9 11.2 2.9 10.1 1.1 0.3 3.0 1.2 15.6 0.3 0.0 0.1 0.0 0.1 3.9 0.1 0.1 0.1 0.5 2.8 2.0 7.2 3.3 0.1 0.1 2.1 0.1 0.2 11.0 4.3 4.7 0.2 5.8 0.0 9.2 6.4 0.0 0.2 0.5 0.5 0.3 1.5 18.8 0.1 10.0 0.6 1.9 2.5 0.6 1.3 0.3 30.4 8.2 21.6 1.5 0.4 0.1 24.2 1.1 14.2 47.8 0.4 0.0 0.1 1.8 1.1 52.8 30.3 12.7 0.2 10.0 0.7 1.5 1.1 8.1 0.5 0.4 0.9 6.8 0.9 0.4 2.2 11.2 3.0 1.1 10.1 0.3 0.1 2.9 0.3 1.2 3.1 2.5 0.9 1.8 1.9 1.7 2.7 0.4 1.8 2.4 GRID2IP ENSG00000215045 "Grid2 interacting protein" A4D2P6 7 6497462-6551436 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "No human protein/transcript evidence" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 6 "brain: 23.6" "Cell line enriched" "Detected in some" 4 "REH: 8.7" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 23.6" "Cell type enhanced" "Detected in single" "NK-cell: 1.1" "Low lineage specificity" "Detected in single" "Group enriched" "Detected in some" 5 "cerebellum: 25.2;thalamus: 7.9" "Group enriched" "Detected in many" 5 "cerebellum: 14.3;midbrain: 10.0;pons and medulla: 9.7;thalamus: 14.7" HPA045381 Approved "Plasma membrane" "Plasma membrane" "HPA045381: AB_10962495" "unprognostic (1.77e-1)" "unprognostic (2.64e-1)" "unprognostic (3.39e-4)" "unprognostic (1.19e-3)" "unprognostic (5.52e-2)" "unprognostic (2.50e-2)" "unprognostic (2.82e-1)" "unprognostic (2.37e-2)" "unprognostic (1.92e-3)" "unprognostic (2.06e-3)" "unprognostic (1.64e-1)" "unprognostic (3.40e-2)" "unprognostic (3.38e-2)" "unprognostic (5.54e-2)" "unprognostic (8.08e-2)" "unprognostic (1.87e-1)" "unprognostic (3.17e-1)" 0.2 1.7 0.8 0.6 3.6 1.1 1.1 23.6 6.6 0.6 1.4 6.5 0.0 1.8 0.4 0.1 1.2 1.1 0.6 0.3 1.6 1.6 0.7 0.3 1.2 0.5 0.7 1.2 0.9 1.8 3.9 3.0 0.2 5.5 2.3 0.7 0.3 2.1 1.6 0.2 3.4 1.6 0.0 1.5 1.4 2.2 1.2 6.8 2.5 1.6 0.0 0.6 0.9 0.8 0.7 0.2 0.0 0.2 1.1 0.4 0.1 0.3 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.5 0.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.6 0.7 0.0 0.2 0.0 8.7 0.3 0.2 0.1 0.3 0.1 1.1 0.0 0.8 0.0 2.0 0.2 0.1 0.0 0.9 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.2 0.0 0.0 0.6 0.4 0.0 0.0 1.1 0.2 0.2 0.0 0.1 0.8 3.6 23.6 6.6 1.6 1.6 0.7 1.2 5.5 6.8 GRPR "BB2, BB2R" ENSG00000126010 "Gastrin releasing peptide receptor" P30550 X 16123556-16153021 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 24.5" "Group enriched" "Detected in some" 10 "PC-3: 17.6;T-47d: 22.0;U-138 MG: 30.1" "Cancer enhanced" "Detected in some" "breast cancer: 6.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "intermediate monocyte: 1.9;non-classical monocyte: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in single" "Low region specificity" "Detected in all" HPA069604 Supported "Plasma membrane" "Plasma membrane" "HPA069604: " "unprognostic (3.32e-2)" "unprognostic (1.97e-1)" "unprognostic (1.72e-1)" "unprognostic (9.24e-2)" "unprognostic (2.87e-1)" "unprognostic (9.17e-2)" "unprognostic (5.06e-2)" "unprognostic (2.82e-1)" "unprognostic (1.01e-1)" "unprognostic (3.68e-3)" "unprognostic (2.62e-1)" "unprognostic (1.57e-1)" "unprognostic (5.59e-2)" "unprognostic (2.15e-2)" "unprognostic (2.56e-1)" "unprognostic (2.92e-1)" "unprognostic (2.86e-2)" 0.5 0.4 3.4 4.7 2.3 0.2 3.5 0.3 3.5 3.7 1.4 0.0 2.5 0.2 1.0 2.8 7.5 0.3 0.2 0.5 3.5 0.4 0.3 0.3 0.4 0.2 0.3 1.9 0.3 24.5 0.4 0.3 0.2 1.1 0.7 0.6 2.0 0.4 0.4 0.4 0.3 0.5 1.2 0.4 0.3 2.1 0.4 0.0 0.0 0.4 0.0 0.2 0.4 0.4 0.6 0.2 0.4 1.9 0.0 0.1 0.4 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.0 0.5 0.2 0.0 0.5 0.0 2.3 0.9 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.3 0.0 0.0 0.0 0.2 17.6 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 22.0 0.0 0.1 30.1 0.3 0.0 0.9 0.1 0.1 0.1 0.0 0.0 0.4 0.0 1.1 0.0 0.1 1.9 0.0 0.0 0.0 0.0 0.2 0.6 0.0 0.0 0.4 0.0 1.6 0.1 0.0 0.4 3.4 2.3 0.3 3.5 3.5 0.4 0.3 1.9 1.1 0.0 GUCA1A "C6orf131, COD3, CORD14, dJ139D8.6, GCAP, GCAP1, GUCA, GUCA1" ENSG00000048545 "Guanylate cyclase activator 1A" P43080 6 42155406-42180056 "Disease related genes, Predicted intracellular proteins" "Sensory transduction, Vision" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "retina: 91.2;testis: 62.2" "Group enriched" "Detected in some" 8 "NTERA-2: 7.0;SH-SY5Y: 8.8" "Cancer enriched" "Detected in single" 9 "testis cancer: 3.5" "Region enhanced" "Detected in many" "basal ganglia: 10.0" "Cell type enriched" "Detected in single" 84 "plasmacytoid DC: 8.4" "Lineage enriched" "Detected in single" 84 "dendritic cells: 8.4" "Not detected" "Not detected" "Not detected" "Not detected" HPA005561 Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA005561: " "unprognostic (1.91e-2)" "unprognostic (3.92e-3)" "unprognostic (2.49e-2)" "unprognostic (9.16e-2)" "unprognostic (1.04e-4)" "unprognostic (9.70e-2)" "unprognostic (6.71e-3)" "unprognostic (1.89e-1)" "unprognostic (1.59e-2)" "unprognostic (3.08e-3)" "unprognostic (2.79e-1)" "unprognostic (1.51e-1)" "unprognostic (1.54e-1)" "unprognostic (1.16e-1)" 0.2 0.2 2.7 0.3 10.0 0.2 0.2 0.1 1.6 0.2 0.2 0.1 0.1 0.1 0.1 0.4 0.2 0.1 0.2 0.1 1.5 5.4 0.1 0.1 0.2 0.3 1.1 0.1 0.1 0.1 0.1 0.1 0.2 0.3 0.2 0.2 91.2 0.2 0.1 0.1 0.2 0.2 0.3 0.2 0.1 0.1 62.2 0.1 0.1 0.1 0.1 0.5 0.3 0.1 0.0 8.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.1 0.1 0.0 0.6 0.6 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.0 2.7 10.0 0.1 0.8 1.5 5.4 1.1 0.1 0.3 0.1 GYPC "CD236, CD236R, Ge, GPC, GYPD" ENSG00000136732 "Glycophorin C (Gerbich blood group)" P04921 2 126655933-126696670 "Blood group antigen proteins, CD markers, Predicted membrane proteins" "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HHSteC: 61.5;K-562: 45.7;SK-MEL-30: 90.3;U-266/70: 51.0" "Cancer enhanced" "Detected in all" "melanoma: 66.9" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008965, CAB009445" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB009445: AB_2116251, HPA008965: AB_1078455" "unprognostic (1.63e-2)" "unprognostic (7.14e-3)" "unprognostic (8.39e-2)" "unprognostic (3.31e-3)" "unprognostic (4.19e-2)" "unprognostic (1.69e-2)" "unprognostic (8.82e-2)" "unprognostic (3.52e-1)" "unprognostic (1.19e-1)" "unprognostic (2.21e-1)" "unprognostic (1.25e-1)" "unprognostic (1.11e-1)" "unprognostic (2.05e-2)" "unprognostic (2.73e-2)" "unprognostic (1.51e-1)" "unprognostic (2.29e-1)" "unprognostic (8.00e-3)" 44.5 21.7 3.9 34.5 5.3 95.0 99.8 1.3 4.3 20.7 24.8 5.9 9.8 5.0 20.3 26.0 22.9 18.5 21.4 61.2 4.4 3.4 15.2 6.3 29.5 75.8 8.0 3.7 37.4 18.7 1.7 5.5 17.5 5.6 24.5 5.5 13.8 13.0 15.5 48.9 11.3 15.2 34.8 8.3 41.1 13.5 13.4 4.6 28.5 11.6 29.9 22.5 37.1 38.8 21.2 9.9 4.2 7.7 14.7 41.4 21.8 0.1 0.0 22.1 0.0 16.4 14.4 0.0 3.3 25.6 4.0 11.9 0.0 0.0 0.0 0.0 9.2 0.0 12.0 0.0 1.3 10.5 0.0 37.1 0.0 0.0 61.5 12.9 0.1 32.3 0.0 3.2 0.0 0.1 45.7 30.7 9.6 0.0 0.0 20.5 6.6 0.0 2.4 1.6 0.0 1.6 0.0 0.0 0.0 0.0 0.0 90.3 0.0 35.3 8.9 15.2 0.1 1.0 0.1 51.0 33.0 0.0 7.3 18.8 13.7 0.1 5.9 0.4 32.3 7.7 36.4 18.9 29.3 39.1 9.9 21.2 41.4 40.4 4.2 14.7 4.7 5.5 35.1 21.8 3.9 5.3 1.3 4.3 4.4 3.4 8.0 3.7 5.6 4.6 HRASLS5 HRLP5 ENSG00000168004 "HRAS like suppressor family member 5" Q96KN8 11 63461404-63491194 "Predicted intracellular proteins" "Acyltransferase, Hydrolase, Transferase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 14.5;testis: 49.4" "Group enriched" "Detected in some" 4 "HAP1: 15.4;NB-4: 5.0" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 65 "basophil: 5.1;eosinophil: 14.5" "Lineage enriched" "Detected in single" 104 "granulocytes: 14.5" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA042493 Uncertain "Plasma membrane" "Plasma membrane" "HPA042493: AB_10797499" "unprognostic (3.16e-1)" "unprognostic (3.45e-2)" "unprognostic (2.83e-3)" "unprognostic (4.24e-2)" "prognostic unfavourable (1.12e-4)" "unprognostic (7.11e-3)" "unprognostic (2.14e-1)" "unprognostic (6.66e-2)" "unprognostic (9.46e-2)" "unprognostic (8.89e-3)" "unprognostic (3.15e-2)" "unprognostic (7.33e-2)" "unprognostic (1.04e-5)" "unprognostic (1.52e-1)" "unprognostic (1.21e-2)" "unprognostic (2.57e-3)" "unprognostic (4.50e-4)" 12.4 0.5 2.2 0.4 2.2 0.3 7.6 0.3 2.3 0.4 0.8 2.5 1.7 0.4 0.7 1.0 1.0 1.1 0.9 1.3 1.3 0.9 0.4 0.3 0.8 0.3 1.2 2.1 1.0 11.0 0.2 0.4 0.2 1.7 0.9 0.4 0.6 0.7 2.5 0.3 0.4 0.5 1.3 3.3 0.3 0.6 49.4 0.9 0.0 0.4 0.3 0.3 0.8 0.4 0.0 0.0 14.5 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 5.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.5 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 5.1 0.0 14.5 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 2.2 0.3 2.3 1.3 0.9 1.2 2.1 1.7 0.9 HTR1B "5-HT1B, 5-HT1DB, HTR1D2, S12" ENSG00000135312 "5-hydroxytryptamine receptor 1B" P28222 6 77461753-77463773 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins, Transporters" Behavior "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 11.8;placenta: 14.2;stomach 1: 10.2" "Group enriched" "Detected in some" 15 "HUVEC TERT2: 40.8;TIME: 18.0" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "basal ganglia: 11.8" "Cell type enriched" "Detected in single" 17 "basophil: 1.6" "Lineage enriched" "Detected in single" 17 "granulocytes: 1.6" "Region enriched" "Detected in many" 4 "basal ganglia: 34.5" HPA028808 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA028808: " "unprognostic (3.86e-2)" "unprognostic (3.56e-1)" "unprognostic (7.68e-2)" "unprognostic (2.58e-1)" "unprognostic (1.88e-1)" "unprognostic (1.18e-2)" "unprognostic (2.67e-1)" "unprognostic (2.11e-1)" "unprognostic (8.96e-2)" "unprognostic (4.03e-1)" "unprognostic (1.77e-2)" "unprognostic (1.24e-1)" "unprognostic (1.10e-3)" "unprognostic (3.08e-2)" "unprognostic (2.81e-2)" "unprognostic (1.34e-1)" "unprognostic (1.02e-1)" 2.2 1.5 1.3 1.1 11.8 0.3 2.4 0.4 3.7 2.9 0.6 0.1 0.0 0.6 1.1 1.0 1.4 0.8 2.8 0.4 1.0 2.1 0.9 0.3 1.1 0.3 1.2 0.9 1.1 0.5 0.3 0.5 14.2 3.0 1.6 0.4 0.3 1.3 1.2 0.9 0.5 0.4 4.1 0.6 0.4 10.2 1.5 0.6 0.0 0.5 0.0 0.3 2.6 1.4 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 1.9 0.9 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.2 0.1 0.4 1.0 40.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 11.8 0.4 3.7 1.0 2.1 1.2 0.9 3.0 0.6 HTRA1 "ARMD7, HtrA, IGFBP5-protease, PRSS11" ENSG00000166033 "HtrA serine peptidase 1" Q92743 10 122461525-122514908 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted secreted proteins" "Growth factor binding, Hydrolase, Protease, Serine protease" "Age-related macular degeneration, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 198.9;ASC TERT1: 73.9;fHDF/TERT166: 67.4;HSkMC: 129.7;LHCN-M2: 98.6;U-87 MG: 81.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "classical monocyte: 2.4;memory CD4 T-cell: 1.6" "Group enriched" "Detected in many" 20 "monocytes: 2.4;T-cells: 1.6" "Low region specificity" "Detected in all" HPA036655 Approved Supported "Plasma membrane" "Secreted to blood" 24800000 2600000 "Plasma membrane" "HPA036655: AB_10671966" "unprognostic (3.84e-1)" "unprognostic (3.42e-2)" "unprognostic (1.57e-2)" "unprognostic (1.86e-2)" "unprognostic (1.22e-3)" "unprognostic (8.71e-3)" "unprognostic (2.33e-2)" "unprognostic (3.83e-1)" "unprognostic (7.22e-2)" "unprognostic (3.36e-2)" "unprognostic (1.32e-1)" "unprognostic (1.54e-1)" "prognostic unfavourable (7.90e-7)" "unprognostic (7.12e-3)" "unprognostic (9.13e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (5.62e-6)" 40.8 21.8 64.5 9.1 79.0 0.5 48.2 16.2 62.8 50.4 19.3 60.8 7.2 5.6 47.6 67.0 15.6 19.5 78.7 28.7 50.8 35.4 34.7 60.4 14.6 9.1 62.7 32.5 111.3 14.5 37.6 26.9 114.1 41.9 19.5 14.0 20.7 19.3 31.5 7.5 29.6 9.3 40.5 46.5 10.5 12.9 9.8 49.5 1.7 13.3 8.5 7.1 41.5 27.3 0.0 0.0 0.0 2.4 0.0 1.6 0.7 0.0 3.4 1.5 0.4 198.9 73.9 0.0 8.5 15.6 3.5 1.9 0.0 0.0 0.0 2.3 67.4 1.0 0.6 9.7 0.5 0.0 0.3 0.0 5.7 0.0 10.1 0.0 0.0 129.7 35.7 2.0 16.6 16.3 0.0 0.1 98.6 1.7 0.0 0.0 1.6 5.4 0.0 0.1 0.0 22.5 0.1 0.1 0.3 21.4 0.0 9.2 0.6 0.0 10.7 25.1 0.3 11.3 7.2 0.0 0.0 0.0 81.4 0.0 11.7 0.0 2.4 0.0 0.6 0.0 0.4 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 64.5 79.0 16.2 54.6 50.8 35.4 62.7 32.5 41.9 49.5 IFIT5 RI58 ENSG00000152778 "Interferon induced protein with tetratricopeptide repeats 5" Q13325 10 89414586-89421001 "Predicted intracellular proteins" "Antiviral defense, Immunity, Innate immunity" "RNA-binding, tRNA-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+ SV40 Large T+: 30.1;BJ hTERT+ SV40 Large T+ RasG12V: 36.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037957, HPA062180" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA037957: AB_10672499, HPA062180: " "unprognostic (2.17e-1)" "unprognostic (1.85e-1)" "unprognostic (1.38e-1)" "unprognostic (1.26e-1)" "unprognostic (1.67e-3)" "unprognostic (4.19e-2)" "unprognostic (2.88e-2)" "unprognostic (2.80e-1)" "unprognostic (1.45e-1)" "unprognostic (8.89e-2)" "unprognostic (1.63e-1)" "unprognostic (1.86e-1)" "unprognostic (3.24e-2)" "unprognostic (1.48e-1)" "unprognostic (3.42e-1)" "unprognostic (2.43e-2)" "unprognostic (1.73e-1)" 26.6 14.5 15.6 9.7 14.8 11.5 13.1 16.1 15.2 11.9 10.0 11.4 5.5 8.9 11.7 10.9 12.4 10.9 11.9 13.4 15.6 18.1 13.0 14.2 16.8 11.9 17.6 12.3 16.1 8.8 30.2 12.1 13.1 20.6 12.5 8.9 8.4 11.0 10.3 6.6 5.8 11.7 12.8 16.7 20.1 8.8 7.0 15.4 11.1 15.3 5.5 10.1 13.7 14.0 9.1 5.5 21.2 10.4 3.6 8.0 5.0 9.8 2.7 4.0 14.5 13.2 13.1 0.5 7.1 17.1 30.1 36.0 0.1 4.8 0.4 3.0 10.2 8.2 5.5 5.4 7.8 4.5 3.1 1.1 2.1 1.6 14.9 0.1 0.9 11.3 2.4 6.9 6.0 1.6 0.0 7.7 9.6 1.9 2.7 1.4 0.5 4.7 2.6 5.1 0.9 8.3 1.2 0.5 3.2 3.7 1.7 16.1 1.5 1.0 4.0 3.8 2.8 6.5 5.1 1.0 0.1 0.0 6.5 0.9 3.2 8.1 6.3 8.2 6.2 10.0 7.6 9.1 6.9 6.0 5.5 7.4 8.0 6.6 21.2 3.6 10.4 0.4 6.3 5.0 15.6 14.8 16.1 14.0 15.6 18.1 17.6 12.3 20.6 15.4 IFNGR1 "CD119, IFNGR" ENSG00000027697 "Interferon gamma receptor 1" P15260 6 137197484-137219449 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "hTCEpi: 57.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025889, HPA029213, HPA063871" Approved Approved "Plasma membrane" "Plasma membrane" "CAB025889: , HPA029213: AB_10601023, HPA063871: " "unprognostic (1.73e-1)" "unprognostic (8.86e-2)" "unprognostic (9.85e-3)" "unprognostic (1.71e-1)" "unprognostic (6.55e-2)" "unprognostic (1.25e-1)" "unprognostic (4.05e-1)" "unprognostic (6.97e-2)" "unprognostic (9.86e-2)" "unprognostic (1.57e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "prognostic unfavourable (5.48e-4)" "unprognostic (1.58e-1)" "unprognostic (2.87e-2)" "unprognostic (1.81e-2)" "unprognostic (5.38e-3)" 69.5 22.2 17.4 36.9 23.5 37.7 65.3 8.4 18.5 23.6 27.1 27.8 13.8 28.0 19.2 21.2 23.0 20.3 25.9 53.7 20.6 17.4 19.3 66.4 58.7 86.9 33.8 13.2 19.2 17.5 9.2 12.8 47.0 29.9 20.1 22.8 11.6 24.5 18.0 25.3 24.0 46.7 22.5 45.7 69.1 20.3 14.1 26.3 14.5 22.8 19.7 38.2 25.0 22.3 12.2 39.4 92.3 65.4 5.4 29.7 52.3 4.9 4.7 6.2 8.0 41.1 21.7 5.2 14.1 20.8 9.1 12.4 30.7 9.6 4.9 22.4 8.1 30.5 5.5 14.2 12.8 10.5 7.6 7.7 5.8 45.4 23.2 23.9 11.4 47.8 57.5 7.6 12.4 11.4 6.4 8.3 6.9 5.5 3.8 11.0 5.1 3.8 11.8 6.5 7.3 15.9 23.2 6.3 9.7 17.3 10.2 12.7 3.6 15.8 15.9 8.9 6.5 11.6 7.4 6.2 5.8 5.5 4.6 15.9 8.6 16.5 65.4 43.3 14.1 63.0 29.7 10.9 8.0 11.8 39.4 12.2 5.2 5.8 92.3 5.4 44.1 10.1 5.6 52.3 17.4 23.5 8.4 18.5 20.6 17.4 33.8 13.2 29.9 26.3 IL12RB1 "CD212, IL12RB" ENSG00000096996 "Interleukin 12 receptor subunit beta 1" P42701 19 18058995-18098944 "CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.6;lymphoid tissue: 21.4" "Cell line enhanced" "Detected in some" "Daudi: 10.4;HDLM-2: 17.6;Karpas-707: 30.1;U-698: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074414 Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA074414: " "unprognostic (7.70e-3)" "prognostic favourable (3.41e-4)" "unprognostic (9.08e-3)" "unprognostic (1.18e-4)" "unprognostic (2.91e-1)" "unprognostic (1.33e-3)" "unprognostic (2.27e-1)" "unprognostic (8.99e-2)" "unprognostic (1.65e-2)" "unprognostic (1.35e-1)" "unprognostic (1.51e-1)" "unprognostic (2.94e-1)" "prognostic unfavourable (5.90e-5)" "unprognostic (1.49e-1)" "unprognostic (2.21e-2)" "unprognostic (4.34e-2)" "unprognostic (2.93e-2)" 1.9 1.5 1.3 17.5 2.1 5.6 1.2 0.5 1.0 0.9 3.4 2.4 1.1 2.9 1.0 2.4 1.3 1.5 2.5 1.4 1.3 1.2 1.8 1.8 5.0 16.0 2.0 0.2 1.1 1.3 1.2 1.1 2.4 1.4 1.7 2.0 1.1 6.6 0.2 0.9 1.0 8.0 1.0 2.4 21.4 2.3 0.7 2.2 10.1 1.3 0.7 16.9 3.8 1.0 4.9 5.9 6.2 14.0 16.2 28.6 9.0 0.2 0.1 0.1 0.2 0.0 0.1 0.5 0.1 0.1 0.2 0.6 0.2 1.0 10.4 0.1 0.1 0.2 0.1 0.0 0.0 17.6 0.2 1.2 0.3 0.2 0.4 0.7 1.7 0.0 0.0 0.3 0.1 0.0 0.2 30.1 0.0 0.1 4.9 0.2 0.1 0.1 3.5 0.1 0.4 0.0 0.0 0.2 0.1 0.2 0.2 0.2 0.2 5.7 0.2 0.3 0.3 0.1 0.1 3.6 5.4 8.8 0.4 6.0 0.7 3.3 5.1 3.6 22.8 14.0 28.6 4.9 15.5 18.3 5.9 3.7 8.7 15.2 6.2 16.2 13.2 3.5 20.5 9.0 1.3 2.1 0.5 1.0 1.3 1.2 2.0 0.2 1.4 2.2 IL12RB2 ENSG00000081985 "Interleukin 12 receptor subunit beta 2" Q99665 1 67307364-67396900 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 18.2;pancreas: 15.0" "Cell line enhanced" "Detected in some" "HMC-1: 4.4;SCLC-21H: 8.7;SK-MEL-30: 21.9;THP-1: 12.7" "Cancer enhanced" "Detected in many" "melanoma: 5.6" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "NK-cell: 18.2" "Group enriched" "Detected in many" 42 "NK-cells: 18.2;T-cells: 6.1" "Region enhanced" "Detected in single" "olfactory region: 1.8" "Low region specificity" "Detected in all" HPA024168 Uncertain Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA024168: AB_1851629" "unprognostic (1.32e-1)" "unprognostic (1.54e-3)" "unprognostic (2.09e-1)" "unprognostic (2.68e-2)" "unprognostic (2.82e-2)" "unprognostic (1.09e-3)" "unprognostic (2.37e-2)" "unprognostic (3.90e-2)" "unprognostic (1.10e-1)" "unprognostic (2.38e-2)" "unprognostic (1.39e-1)" "unprognostic (3.60e-2)" "unprognostic (1.08e-3)" "unprognostic (1.82e-1)" "unprognostic (4.69e-2)" "unprognostic (7.11e-3)" "unprognostic (1.90e-1)" 3.8 1.0 1.8 3.1 3.6 1.5 3.7 0.6 7.7 2.4 1.0 0.0 0.0 0.7 0.8 1.1 3.2 0.9 1.1 5.2 9.6 1.1 1.5 1.4 1.8 4.3 1.0 6.0 0.8 15.0 0.9 0.8 14.1 1.6 1.2 0.9 1.3 7.2 1.7 11.4 2.1 1.4 1.0 1.0 2.5 1.0 2.3 0.0 1.1 1.1 3.2 1.6 1.4 1.2 0.0 0.0 0.2 0.0 18.2 6.1 1.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.2 0.0 0.0 0.1 0.0 0.1 2.0 1.2 0.0 0.0 0.0 0.1 0.4 0.0 0.0 0.1 4.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 8.7 0.4 0.0 0.0 21.9 0.0 12.7 0.0 0.0 0.0 0.4 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.1 0.0 2.7 0.0 1.5 1.0 0.0 0.0 0.0 0.0 0.2 18.2 0.0 0.0 3.9 1.0 1.8 3.6 0.6 7.7 9.6 1.1 1.0 6.0 1.6 0.0 ILDR2 C1orf32 ENSG00000143195 "Immunoglobulin like domain containing receptor 2" Q71H61 1 166895711-166975482 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 14.6;testis: 18.0" "Cell line enhanced" "Detected in some" "AF22: 9.8;MOLT-4: 5.1;U-2 OS: 12.6;U-251 MG: 6.6" "Cancer enhanced" "Detected in some" "glioma: 4.3" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA012545, HPA012815" Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA012545: AB_2126894, HPA012815: " "unprognostic (9.14e-2)" "unprognostic (5.05e-2)" "unprognostic (8.27e-2)" "unprognostic (2.16e-1)" "unprognostic (5.89e-2)" "unprognostic (5.33e-2)" "unprognostic (2.89e-5)" "unprognostic (2.09e-1)" "unprognostic (8.55e-2)" "unprognostic (4.51e-2)" "unprognostic (1.52e-1)" "unprognostic (2.58e-1)" "unprognostic (9.17e-2)" "unprognostic (5.87e-3)" "unprognostic (4.92e-2)" "unprognostic (1.64e-1)" "unprognostic (1.36e-1)" 0.8 1.1 9.8 0.9 6.4 1.4 0.5 2.1 14.6 0.7 2.9 3.6 0.1 0.7 0.9 1.4 0.9 0.8 1.3 3.1 7.2 7.7 6.3 1.3 1.4 1.0 2.7 8.0 0.8 0.7 0.5 3.3 0.8 3.1 2.3 1.2 2.8 0.8 2.8 0.8 0.7 0.8 2.0 2.3 0.7 0.7 18.0 3.1 1.9 0.9 0.0 1.1 0.9 0.3 0.0 0.4 0.3 0.0 0.0 0.3 0.5 0.0 0.0 9.8 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 1.2 1.0 1.8 0.3 0.0 0.0 0.0 0.0 0.0 2.3 1.9 0.0 0.0 0.2 0.0 3.2 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 5.1 0.0 3.4 0.0 0.0 0.3 0.7 0.7 0.2 1.3 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.6 0.0 6.6 2.3 0.0 0.5 1.4 1.3 0.4 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.4 0.0 0.3 0.0 0.3 0.0 0.0 0.1 0.0 0.5 9.8 6.4 2.1 11.4 7.2 7.7 2.7 8.0 3.1 3.1 ITGA2B "CD41, CD41B, GP2B, PPP1R93" ENSG00000005961 "Integrin subunit alpha 2b" P08514 17 44372180-44389505 "Cancer-related genes, Candidate cardiovascular disease genes, CD markers, Disease related genes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 28.5;epididymis: 25.2;lymphoid tissue: 22.8" "Group enriched" "Detected in some" 13 "HEL: 69.4;HMC-1: 118.6" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in some" 10 "basophil: 28.5" "Lineage enriched" "Detected in single" 54 "granulocytes: 28.5" "Low region specificity" "Detected in single" "CAB018611, HPA031168, HPA031169, HPA031170, HPA031171" Enhanced Approved "Plasma membrane" 1100000000 "Plasma membrane" "CAB018611: AB_2265153, HPA031168: AB_10670151, HPA031169: AB_10669671, HPA031170: AB_10696214, HPA031171: AB_10669773" "unprognostic (6.11e-2)" "unprognostic (3.23e-2)" "unprognostic (1.23e-1)" "unprognostic (4.85e-2)" "unprognostic (1.59e-2)" "unprognostic (3.98e-3)" "unprognostic (4.23e-5)" "unprognostic (1.25e-1)" "unprognostic (1.33e-2)" "unprognostic (7.22e-2)" "unprognostic (2.97e-3)" "unprognostic (1.30e-1)" "unprognostic (8.83e-9)" "unprognostic (7.82e-2)" "unprognostic (1.85e-1)" "unprognostic (1.95e-1)" "unprognostic (2.25e-1)" 0.7 0.2 1.4 0.4 1.0 15.2 0.6 3.8 2.4 1.2 0.9 0.4 0.4 0.1 1.1 25.2 0.7 1.9 1.4 10.6 0.9 1.6 1.0 0.4 6.5 0.5 0.7 0.8 2.1 2.5 0.1 2.5 1.9 1.1 0.6 0.3 0.6 0.4 1.6 0.8 0.1 0.6 0.4 0.8 22.8 0.2 3.0 0.4 0.4 5.2 1.0 0.6 0.7 1.9 0.0 0.5 28.5 0.2 0.0 0.2 11.1 0.0 0.1 0.7 0.0 0.0 0.0 2.8 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.4 69.4 0.0 0.6 0.0 0.0 118.6 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 7.2 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.6 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 28.5 0.2 2.1 0.1 0.0 0.2 0.0 0.0 0.0 0.3 0.0 0.0 0.0 2.8 0.0 0.0 0.5 0.0 11.1 1.4 1.0 3.8 2.4 0.9 1.6 0.7 0.8 1.1 0.4 ITGA3 "CD49c, GAP-B3, MSK18, VCA-2, VLA3a" ENSG00000005884 "Integrin subunit alpha 3" P26006 17 50055968-50090481 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, Disease mutation, Epidermolysis bullosa" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HBEC3-KT: 74.7;hTERT-HME1: 64.9;RPTEC TERT1: 65.8;U-138 MG: 65.1;U-87 MG: 112.1;WM-115: 67.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "T-reg: 1.1" "Lineage enriched" "Detected in single" 4 "T-cells: 1.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA008572, CAB018594" Enhanced Supported "Plasma membrane" 180000 "Plasma membrane" "CAB018594: AB_668044, HPA008572: AB_2668094" "unprognostic (3.24e-3)" "prognostic unfavourable (6.75e-4)" "unprognostic (9.51e-2)" "unprognostic (3.46e-3)" "unprognostic (3.45e-3)" "prognostic unfavourable (1.36e-4)" "unprognostic (8.28e-3)" "unprognostic (2.76e-3)" "unprognostic (1.26e-3)" "unprognostic (1.82e-2)" "prognostic unfavourable (5.95e-5)" "unprognostic (7.05e-2)" "unprognostic (1.14e-1)" "unprognostic (1.93e-1)" "unprognostic (1.30e-1)" "unprognostic (1.28e-2)" "unprognostic (2.35e-2)" 15.7 15.8 4.1 8.6 5.1 0.1 8.7 7.7 6.5 10.9 20.9 2.3 8.9 17.1 11.6 11.6 12.8 14.5 32.6 8.4 4.2 5.4 36.0 1.7 37.6 3.2 3.2 6.7 10.7 8.0 13.0 11.2 26.4 4.3 12.0 8.9 11.6 10.0 9.7 6.6 17.3 37.3 11.6 3.3 6.5 13.7 3.9 1.5 3.3 36.1 13.3 8.3 19.0 8.1 0.2 0.0 0.0 0.0 0.0 1.1 0.2 20.5 27.2 0.1 0.8 0.5 2.1 4.4 9.6 20.8 14.6 11.1 0.6 32.1 0.0 60.9 7.0 14.6 0.2 74.7 8.9 2.5 0.4 0.0 6.9 0.1 12.9 0.0 0.6 2.6 36.9 14.6 64.9 10.7 0.0 0.3 27.4 5.9 0.0 0.0 0.6 16.5 0.0 1.4 1.5 65.8 35.8 1.1 0.4 10.5 1.4 24.1 2.4 0.2 23.1 65.1 20.5 0.6 37.5 0.9 1.5 0.6 112.1 0.2 67.6 0.0 0.0 0.0 0.8 0.0 1.0 0.2 0.1 0.1 0.0 0.2 0.2 0.6 0.0 0.0 0.0 0.0 1.1 0.2 4.1 5.1 7.7 6.5 4.2 5.4 3.2 6.7 4.3 1.5 ITGA4 CD49d ENSG00000115232 "Integrin subunit alpha 4" P13612 2 181457202-181536187 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Integrin, Receptor" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 38.4;lymphoid tissue: 101.6" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 38.7;HEL: 61.5;MOLT-4: 71.7" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Region enriched" "Detected in many" 7 "cerebellum: 26.0" HPA074961 Approved "Plasma membrane" "Intracellular and membrane" 100000 "Plasma membrane" "HPA074961: " "unprognostic (5.31e-2)" "unprognostic (1.54e-1)" "unprognostic (1.99e-2)" "unprognostic (3.94e-2)" "unprognostic (3.76e-1)" "prognostic favourable (8.29e-4)" "unprognostic (1.27e-1)" "unprognostic (1.11e-2)" "unprognostic (1.76e-1)" "unprognostic (2.67e-2)" "unprognostic (1.85e-1)" "unprognostic (1.94e-1)" "prognostic unfavourable (3.08e-5)" "unprognostic (2.26e-2)" "unprognostic (8.64e-3)" "unprognostic (2.49e-1)" "unprognostic (2.57e-2)" 3.8 1.7 1.3 39.7 1.1 19.2 3.2 2.4 1.9 6.7 4.8 0.5 1.1 3.8 3.0 3.1 2.9 2.1 6.9 1.7 2.9 1.3 3.0 2.5 13.6 33.7 1.2 0.5 1.8 1.6 0.0 1.3 7.1 0.9 3.8 4.9 2.9 7.5 2.0 1.0 1.5 11.6 2.4 1.6 36.0 4.4 1.2 0.2 101.6 2.6 1.5 14.3 6.0 4.1 11.0 19.1 38.4 38.3 8.8 15.9 16.2 0.0 0.2 1.0 0.0 9.1 13.8 0.0 8.9 11.2 4.8 10.1 0.0 0.0 7.1 0.0 38.7 5.3 3.1 0.1 5.8 0.0 0.7 61.5 0.2 0.0 0.9 27.2 1.5 9.8 0.0 0.3 0.0 0.4 0.0 10.4 3.0 0.0 71.7 19.1 0.8 0.0 15.7 4.5 1.0 0.0 0.0 1.6 0.6 0.0 0.0 0.3 0.0 18.0 4.8 1.5 0.9 0.1 1.8 20.4 15.1 4.0 0.8 13.5 20.6 6.7 16.2 38.4 12.9 38.3 9.7 11.0 14.6 15.9 19.1 10.0 8.5 10.4 2.1 8.8 37.5 5.0 3.7 16.2 1.3 1.1 2.4 1.9 2.9 1.3 1.2 0.5 0.9 0.2 ITSN1 "ITSN, MGC134948, MGC134949, SH3D1A, SH3P17" ENSG00000205726 "Intersectin 1" Q15811 21 33642400-33899861 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Endocytosis, Exocytosis, Host-virus interaction, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in all" "BEWO: 42.4;NTERA-2: 38.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "classical monocyte: 5.9;eosinophil: 7.2;intermediate monocyte: 4.1;myeloid DC: 1.8;non-classical monocyte: 6.3" "Group enriched" "Detected in many" 7 "dendritic cells: 1.8;granulocytes: 7.2;monocytes: 6.3" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA018007 Approved Supported "Plasma membrane" "Plasma membrane" "HPA018007: AB_1851836" "unprognostic (2.12e-1)" "unprognostic (1.51e-1)" "unprognostic (1.62e-1)" "unprognostic (1.21e-1)" "unprognostic (3.91e-1)" "unprognostic (1.81e-1)" "unprognostic (1.10e-1)" "unprognostic (3.94e-2)" "unprognostic (7.33e-3)" "unprognostic (1.31e-2)" "unprognostic (3.23e-1)" "unprognostic (3.25e-2)" "unprognostic (1.16e-2)" "unprognostic (6.78e-3)" "unprognostic (2.37e-1)" "unprognostic (6.02e-2)" "unprognostic (5.64e-2)" 47.4 14.9 24.9 8.9 24.5 5.7 21.7 24.2 24.8 15.5 11.2 10.2 12.3 8.3 17.9 11.8 11.0 13.6 18.5 18.3 24.6 12.1 10.7 23.1 9.5 5.9 12.1 20.4 19.2 4.9 8.4 7.7 22.0 21.1 14.2 10.6 11.4 6.9 21.9 18.0 11.0 9.0 17.4 11.1 13.4 10.3 11.2 15.0 2.4 9.3 4.0 3.9 13.1 12.5 0.0 1.8 7.2 6.3 0.1 0.7 1.1 12.7 5.3 25.8 8.5 12.1 11.7 42.4 12.9 12.5 7.6 7.3 20.2 9.7 3.0 10.5 15.4 4.9 15.3 8.9 8.2 1.2 6.7 3.6 11.0 9.4 9.2 2.5 3.6 11.5 8.1 14.2 7.9 20.0 4.7 2.1 12.1 2.9 3.5 3.4 38.2 4.1 4.6 12.4 6.2 11.3 5.2 4.9 5.3 18.5 3.8 4.6 4.7 2.5 18.0 8.5 11.6 6.6 4.4 2.6 7.1 2.8 7.7 8.1 9.4 0.0 5.9 7.2 0.4 4.1 0.5 0.0 0.7 0.2 1.8 0.0 0.3 0.1 0.3 0.1 6.3 0.4 0.0 1.1 24.9 24.5 24.2 24.8 24.6 12.1 12.1 20.4 21.1 15.0 IYD "C6orf71, DEHAL1, dJ422F24.1" ENSG00000009765 "Iodotyrosine deiodinase" Q6PHW0 6 150368892-150405969 "Disease related genes, Enzymes, Potential drug targets, Predicted membrane proteins" Oxidoreductase "Congenital hypothyroidism, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 16 "thyroid gland: 212.3" "Group enriched" "Detected in some" 6 "CACO-2: 3.3;SK-BR-3: 8.2" "Cancer enriched" "Detected in many" 20 "thyroid cancer: 80.7" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 5.9" "Low lineage specificity" "Detected in many" "Group enriched" "Detected in some" 13 "hippocampal formation: 8.1;thalamus: 2.6" "Low region specificity" "Detected in all" HPA059627 Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA059627: " "unprognostic (3.73e-4)" "unprognostic (2.93e-2)" "unprognostic (5.97e-2)" "unprognostic (1.95e-2)" "unprognostic (1.55e-1)" "unprognostic (2.98e-2)" "prognostic favourable (6.22e-4)" "unprognostic (1.11e-1)" "unprognostic (3.80e-2)" "unprognostic (1.17e-1)" "unprognostic (7.41e-2)" "unprognostic (1.02e-1)" "unprognostic (3.07e-9)" "unprognostic (9.79e-3)" "unprognostic (2.04e-1)" "unprognostic (2.03e-2)" "unprognostic (2.18e-2)" 0.1 0.1 0.1 0.6 0.1 0.0 0.1 0.1 0.1 0.1 8.2 0.1 0.1 3.6 0.1 0.3 0.1 0.1 6.7 0.1 0.1 0.1 5.4 6.8 0.2 0.0 0.1 0.0 0.1 0.2 0.0 0.1 0.0 0.5 0.1 1.2 0.0 0.3 0.0 0.1 0.2 13.5 0.0 0.1 0.1 0.3 0.1 0.0 0.0 212.3 0.0 0.1 0.1 0.1 1.4 1.0 5.9 1.3 2.3 0.7 2.3 0.2 0.0 0.2 0.3 0.1 0.9 0.5 0.0 0.0 0.1 0.0 3.3 0.6 0.2 0.1 0.0 0.3 0.0 0.0 0.0 0.4 0.3 0.5 0.8 0.3 0.0 0.1 0.8 0.0 0.0 0.1 0.0 0.0 0.3 0.6 0.0 0.5 0.0 0.4 0.3 0.2 0.3 0.2 0.2 0.0 0.8 0.4 0.2 0.0 8.2 0.0 0.8 0.1 0.2 0.2 0.2 0.3 0.0 0.3 0.1 0.1 0.5 0.3 0.2 3.3 1.3 0.7 0.7 1.1 0.5 0.6 0.6 0.5 0.1 1.4 0.6 0.7 5.9 2.3 0.5 1.0 0.5 2.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.5 0.0 KANK1 "ANKRD15, KANK, KIAA0172" ENSG00000107104 "KN motif and ankyrin repeat domains 1" Q14678 9 470291-746106 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Transcription, Transcription regulation" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Hep G2: 34.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 7.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA005539, HPA056090" Approved Supported "Plasma membrane" "Plasma membrane" "HPA005539: AB_1078164, HPA056090: " "unprognostic (6.59e-2)" "unprognostic (3.33e-2)" "unprognostic (1.06e-3)" "unprognostic (1.30e-1)" "unprognostic (2.69e-1)" "unprognostic (7.53e-2)" "unprognostic (3.33e-1)" "unprognostic (1.23e-2)" "unprognostic (4.91e-2)" "unprognostic (3.05e-2)" "unprognostic (2.84e-2)" "unprognostic (1.24e-1)" "unprognostic (3.07e-2)" "unprognostic (2.72e-1)" "unprognostic (3.06e-2)" "unprognostic (1.82e-1)" "unprognostic (1.61e-1)" 28.9 5.3 23.9 8.7 23.2 1.4 15.5 17.7 18.2 18.2 17.4 28.5 7.6 8.8 26.5 10.3 33.7 12.7 13.2 46.5 21.9 10.4 19.8 39.4 10.0 6.9 21.4 14.8 16.9 17.0 9.5 14.7 18.2 16.5 23.4 11.2 14.8 17.9 24.4 24.2 20.0 9.2 27.6 21.3 3.9 10.7 12.1 23.5 2.8 16.2 8.2 8.8 28.9 26.3 1.5 7.1 0.0 0.2 0.2 4.4 1.0 2.0 4.3 1.4 26.8 22.2 8.5 7.4 13.6 9.6 1.1 1.4 10.9 0.9 16.6 3.3 16.8 4.5 5.8 11.1 2.0 8.0 3.0 0.0 6.3 34.4 3.1 3.9 0.0 4.8 15.6 1.2 13.5 11.5 0.8 21.0 8.6 5.1 1.6 16.8 1.9 3.3 0.6 2.9 3.0 9.1 13.2 0.6 0.0 1.3 4.0 18.1 2.6 3.1 16.9 3.1 1.1 4.0 6.2 3.6 21.5 0.0 2.1 7.6 5.8 0.0 0.2 0.0 0.2 0.2 0.0 1.5 2.3 0.8 0.7 1.2 4.4 1.4 0.0 0.2 0.0 7.1 3.0 1.0 23.9 23.2 17.7 17.6 21.9 10.4 21.4 14.8 16.5 23.5 KANK3 "ANKRD47, FLJ46061" ENSG00000186994 "KN motif and ankyrin repeat domains 3" Q6NY19 19 8322584-8343262 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in some" "HUVEC TERT2: 9.1;TIME: 16.4;U-266/70: 6.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 5 "granulocytes: 1.0;NK-cells: 3.6;T-cells: 3.5" "Low region specificity" "Detected in all" "Region enriched" "Detected in all" 5 "olfactory region: 34.0" HPA051153 Approved Approved "Plasma membrane" "Plasma membrane" "HPA051153: AB_2681365" "unprognostic (1.56e-1)" "unprognostic (1.63e-4)" "unprognostic (1.54e-2)" "unprognostic (8.95e-3)" "unprognostic (1.07e-1)" "unprognostic (2.84e-3)" "unprognostic (1.82e-3)" "unprognostic (3.26e-2)" "unprognostic (1.19e-1)" "unprognostic (1.39e-2)" "unprognostic (1.34e-2)" "unprognostic (4.77e-1)" "prognostic favourable (1.69e-5)" "unprognostic (5.03e-2)" "unprognostic (1.67e-1)" "unprognostic (2.86e-1)" "unprognostic (3.24e-1)" 23.3 3.6 5.2 3.8 4.8 1.2 13.2 2.7 6.5 3.8 5.6 1.6 2.9 4.0 5.4 6.2 4.7 5.2 3.4 9.6 6.2 2.9 7.7 2.3 19.0 6.3 4.4 1.6 3.1 3.1 1.6 3.5 18.3 4.8 3.3 1.2 6.4 3.4 2.8 15.5 3.5 4.0 3.5 2.8 21.0 3.1 2.5 5.0 0.3 7.9 3.0 1.6 2.5 6.7 0.5 0.3 1.0 0.3 3.6 3.5 0.7 0.1 0.7 0.3 0.6 0.0 0.0 0.3 0.1 0.1 0.0 0.1 0.8 0.2 0.0 2.6 0.0 0.1 0.6 2.9 0.0 0.8 1.6 0.4 0.4 0.5 0.1 0.2 1.5 0.0 0.9 0.0 0.0 9.1 0.0 0.4 0.0 0.5 0.0 0.5 0.6 0.3 1.5 0.0 0.7 0.1 0.2 0.0 0.1 0.0 0.8 0.1 0.6 0.0 16.4 0.1 1.5 0.4 0.1 6.8 0.2 0.3 0.2 0.1 0.2 0.8 0.3 0.1 3.5 0.1 1.6 0.3 1.9 0.6 0.1 0.5 0.8 1.3 1.0 3.6 0.1 0.3 1.3 0.7 5.2 4.8 2.7 6.5 6.2 2.9 4.4 1.6 4.8 5.0 KCNH8 "elk3, Kv12.1" ENSG00000183960 "Potassium voltage-gated channel subfamily H member 8" Q96L42 3 19148454-19535646 "Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "brain: 31.3;pituitary gland: 16.1" "Cell line enriched" "Detected in some" 4 "SH-SY5Y: 9.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 2.1;naive B-cell: 4.5" "Lineage enriched" "Detected in single" 5 "B-cells: 4.5" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA016586, HPA077537, HPA077773" Approved Supported "Plasma membrane" "Plasma membrane" "HPA016586: AB_1852127, HPA077537: , HPA077773: " "unprognostic (6.68e-3)" "unprognostic (1.68e-1)" "unprognostic (2.99e-2)" "unprognostic (8.56e-6)" "unprognostic (1.04e-1)" "unprognostic (1.10e-1)" "unprognostic (1.88e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (1.69e-1)" "unprognostic (5.04e-3)" "unprognostic (2.90e-2)" "unprognostic (1.63e-1)" "unprognostic (1.17e-1)" "unprognostic (3.89e-2)" "unprognostic (8.71e-5)" "unprognostic (1.72e-1)" 0.6 7.0 8.4 1.6 22.0 1.4 2.4 1.3 11.4 1.3 1.9 31.3 0.0 2.2 1.2 1.2 0.7 1.4 2.2 1.0 11.8 5.7 0.7 0.7 0.8 3.2 16.4 10.2 0.7 2.7 0.8 16.1 0.6 15.0 2.2 2.5 0.1 3.3 1.4 0.6 1.9 1.8 1.1 9.9 2.6 5.9 4.0 18.1 0.0 1.1 0.0 3.2 0.9 0.5 4.5 0.9 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 2.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 1.1 9.5 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.1 0.0 0.0 0.0 4.5 0.3 0.0 0.0 0.0 0.0 0.9 0.0 0.0 8.4 22.0 1.3 11.4 11.8 5.7 16.4 10.2 15.0 18.1 KCNK7 K2p7.1 ENSG00000173338 "Potassium two pore domain channel subfamily K member 7" Q9Y2U2 11 65592855-65595996 "Predicted intracellular proteins, Predicted membrane proteins, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "skin 1: 35.0;tongue: 20.7" "Cell line enhanced" "Detected in many" "SCLC-21H: 12.1" "Cancer enhanced" "Detected in many" "head and neck cancer: 4.4" "Low region specificity" "Detected in some" "Group enriched" "Detected in some" 12 "basophil: 4.8;naive B-cell: 2.9;neutrophil: 3.6" "Group enriched" "Detected in many" 12 "B-cells: 2.9;granulocytes: 4.8" "Low region specificity" "Detected in single" "Not detected" "Not detected" HPA077577 Approved "Plasma membrane" "Plasma membrane" "HPA077577: " "unprognostic (1.12e-2)" "unprognostic (1.21e-1)" "unprognostic (6.08e-2)" "unprognostic (5.71e-2)" "unprognostic (8.59e-2)" "unprognostic (1.34e-1)" "unprognostic (1.68e-3)" "unprognostic (8.53e-2)" "unprognostic (1.69e-1)" "unprognostic (2.87e-1)" "unprognostic (6.90e-2)" "unprognostic (4.88e-2)" "unprognostic (1.49e-2)" "unprognostic (2.65e-1)" "unprognostic (3.57e-1)" "unprognostic (1.16e-1)" "unprognostic (8.11e-2)" 0.6 0.6 0.8 0.3 0.7 3.9 2.6 1.6 2.1 1.4 0.5 0.8 0.3 0.4 0.4 0.3 10.8 0.6 0.3 0.5 0.8 0.4 0.3 0.3 0.3 0.3 0.6 1.1 0.6 0.3 0.1 0.3 0.5 0.4 0.3 0.1 0.3 0.8 0.4 1.8 35.0 0.5 0.3 0.7 0.5 0.3 0.3 0.5 0.7 0.3 20.7 5.7 0.3 3.4 2.9 0.0 4.8 0.2 0.2 0.3 0.1 0.5 2.3 0.1 0.7 0.0 0.0 0.2 0.2 0.0 0.5 0.1 0.2 1.6 0.7 0.7 0.2 3.7 0.0 0.0 0.0 0.8 2.6 0.8 1.1 1.0 0.0 0.0 0.6 0.1 0.0 0.2 0.0 0.0 1.4 2.2 0.7 1.7 0.9 0.7 1.0 2.1 1.5 0.0 0.3 1.0 0.2 12.1 2.7 0.5 0.7 1.2 0.6 2.1 0.0 0.6 1.8 1.9 0.1 2.0 1.3 0.4 1.3 1.0 1.0 4.8 0.2 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 2.9 0.1 0.0 3.6 0.2 0.2 0.0 0.0 0.1 0.8 0.7 1.6 2.1 0.8 0.4 0.6 1.1 0.4 0.5 KCNK9 "K2p9.1, TASK-3, TASK3" ENSG00000169427 "Potassium two pore domain channel subfamily K member 9" Q9NPC2 8 139600838-139703056 "Disease related genes, FDA approved drug targets, Predicted membrane proteins, Transporters, Voltage-gated ion channels" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel" "Disease mutation, FDA approved drug targets, Mental retardation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "adrenal gland: 9.4;brain: 15.4" "Group enriched" "Detected in some" 7 "PC-3: 6.5;SCLC-21H: 2.8;SH-SY5Y: 2.1" "Low cancer specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 15.4" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA075842 Approved "Plasma membrane" "Plasma membrane" "HPA075842: " "unprognostic (1.84e-2)" "unprognostic (2.57e-1)" "unprognostic (1.58e-1)" "unprognostic (8.96e-8)" "unprognostic (1.91e-1)" "unprognostic (8.17e-3)" "unprognostic (2.19e-3)" "unprognostic (1.65e-1)" "unprognostic (3.87e-1)" "unprognostic (1.69e-1)" "unprognostic (1.00e-2)" "unprognostic (3.21e-1)" "unprognostic (5.12e-6)" "unprognostic (2.94e-2)" "unprognostic (1.64e-1)" "unprognostic (9.99e-3)" "unprognostic (1.76e-1)" 0.2 9.4 0.5 0.5 1.0 0.1 0.1 15.4 7.7 1.3 0.5 0.0 0.0 0.1 0.3 0.1 0.2 0.3 0.1 0.2 1.6 1.4 0.1 0.1 0.1 0.1 0.7 1.7 0.1 0.1 0.1 1.1 0.2 6.6 0.1 0.2 0.2 0.1 0.1 1.4 0.1 0.1 0.6 0.6 0.1 0.3 0.5 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.2 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 6.5 0.0 0.0 0.0 0.0 0.0 2.8 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.5 1.0 15.4 3.7 1.6 1.4 0.7 1.7 6.6 0.0 KCNU1 "KCa5.1, Kcnma3, KCNMC1, Slo3" ENSG00000215262 "Potassium calcium-activated channel subfamily U member 1" A8MYU2 8 36784324-36936128 "Predicted intracellular proteins, Predicted membrane proteins" "Ion transport, Potassium transport, Transport" "Ion channel, Potassium channel, Voltage-gated channel" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in single" 21 "testis: 15.8" "Cell line enriched" "Detected in some" 5 "HDLM-2: 12.8" "Cancer enhanced" "Detected in single" "liver cancer: 0.8" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA063317 Uncertain "Plasma membrane" "Plasma membrane" "HPA063317: " "unprognostic (2.42e-3)" "unprognostic (4.26e-2)" "unprognostic (2.07e-1)" "unprognostic (4.76e-3)" "unprognostic (7.57e-2)" "unprognostic (1.12e-1)" "unprognostic (1.11e-1)" "unprognostic (2.71e-1)" "unprognostic (1.98e-1)" "unprognostic (7.73e-2)" "unprognostic (1.24e-2)" 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 15.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.1 12.8 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.7 0.2 0.0 0.0 2.3 0.0 0.0 0.0 0.0 0.3 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.2 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 KDR "CD309, FLK1, VEGFR, VEGFR2" ENSG00000128052 "Kinase insert domain receptor" P35968 4 55078259-55125595 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Angiogenesis, Differentiation, Host-virus interaction" "Developmental protein, Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 9 "HUVEC TERT2: 31.8;TIME: 35.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" CAB004028 Enhanced Supported "Plasma membrane" "Intracellular and membrane" 7400000 "Plasma membrane" "CAB004028: AB_2212507" "unprognostic (1.61e-1)" "unprognostic (2.03e-1)" "unprognostic (9.65e-2)" "unprognostic (1.97e-1)" "unprognostic (9.63e-2)" "unprognostic (1.22e-2)" "unprognostic (1.78e-3)" "unprognostic (2.59e-2)" "unprognostic (1.19e-2)" "unprognostic (1.10e-1)" "unprognostic (8.79e-3)" "unprognostic (1.34e-1)" "prognostic unfavourable (7.26e-4)" "unprognostic (4.00e-2)" "unprognostic (2.30e-1)" "unprognostic (3.22e-1)" "unprognostic (1.86e-1)" 19.7 6.2 1.8 4.4 3.1 0.4 20.5 1.1 2.2 11.4 6.0 1.8 11.5 2.3 28.8 10.2 5.2 9.5 6.2 12.1 2.3 1.7 7.8 10.4 13.2 14.1 3.1 2.9 6.0 8.1 8.0 6.8 34.5 3.9 9.5 1.4 27.6 7.1 10.3 5.3 3.0 3.8 7.7 2.6 4.4 4.2 5.3 1.2 0.5 20.0 5.3 3.0 4.4 12.0 0.1 0.1 0.7 0.0 0.2 0.2 0.1 0.0 0.0 1.7 0.0 0.2 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 0.0 0.0 3.7 0.0 0.0 0.3 0.0 0.0 0.2 31.8 0.0 0.0 0.2 0.0 0.0 0.0 0.8 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.9 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.4 0.0 0.1 0.1 0.0 0.7 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.1 0.0 0.2 0.0 0.1 0.0 0.1 1.8 3.1 1.1 2.2 2.3 1.7 3.1 2.9 3.9 1.2 KIAA1324 "EIG121, maba1" ENSG00000116299 KIAA1324 Q6UXG2 1 109113679-109206781 "Predicted intracellular proteins, Predicted membrane proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "pancreas: 79.8;salivary gland: 169.4" "Cell line enhanced" "Detected in some" "MCF7: 14.1;SCLC-21H: 9.1;SK-BR-3: 11.0;T-47d: 37.8;U-87 MG: 7.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Cell type enriched" "Detected in many" 7 "neutrophil: 33.8" "Lineage enriched" "Detected in many" 7 "granulocytes: 33.8" "Low region specificity" "Detected in some" "Low region specificity" "Detected in many" "HPA029869, HPA070749" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA029869: AB_10794320, HPA070749: AB_2686304" "unprognostic (2.10e-1)" "unprognostic (1.42e-2)" "unprognostic (1.99e-2)" "prognostic favourable (2.14e-7)" "unprognostic (4.18e-3)" "unprognostic (5.63e-2)" "unprognostic (1.96e-3)" "prognostic favourable (5.69e-5)" "unprognostic (2.79e-2)" "prognostic favourable (2.16e-4)" "unprognostic (3.50e-3)" "unprognostic (1.01e-1)" "unprognostic (2.22e-16)" "unprognostic (2.46e-1)" "unprognostic (1.75e-1)" "unprognostic (5.64e-2)" "unprognostic (8.02e-2)" 0.7 0.9 3.7 3.6 7.9 0.0 16.4 0.7 5.6 23.9 11.8 0.4 0.0 14.6 5.5 5.7 1.3 7.8 19.1 0.6 3.3 2.3 0.6 0.6 2.2 0.7 1.0 2.7 1.2 79.8 6.1 46.6 0.0 1.1 15.8 10.0 0.0 169.4 0.0 0.6 2.5 16.5 0.2 0.9 0.9 27.3 9.4 1.1 0.0 3.9 5.2 11.5 0.9 0.6 0.2 0.0 33.8 0.0 0.2 4.6 1.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.3 0.4 0.1 0.0 0.1 0.0 0.0 0.2 0.5 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.3 14.1 0.1 0.1 0.2 0.0 0.0 0.1 0.5 0.2 0.0 9.1 0.2 0.0 11.0 0.0 37.8 0.0 0.2 0.0 1.4 0.0 0.1 0.8 2.0 0.0 7.2 0.0 0.0 0.0 0.0 0.0 2.2 0.0 3.9 0.2 3.9 1.7 0.0 0.0 1.8 0.7 33.8 0.2 0.0 0.0 4.6 1.0 3.7 7.9 0.7 5.6 3.3 2.3 1.0 2.7 1.1 1.1 KIT "C-Kit, CD117, PBT, SCFR" ENSG00000157404 "KIT proto-oncogene receptor tyrosine kinase" P10721 4 54657918-54740715 "Cancer-related genes, CD markers, Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins, RAS pathway related proteins" "Kinase, Receptor, Transferase, Tyrosine-protein kinase" "Cancer-related genes, Disease mutation, FDA approved drug targets, Proto-oncogene" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "breast: 65.5" "Group enriched" "Detected in some" 13 "HEL: 47.7;HMC-1: 100.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 12.7;eosinophil: 10.0;NK-cell: 9.7" "Group enriched" "Detected in many" 6 "granulocytes: 12.7;NK-cells: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB003288, HPA004471, CAB068253, CAB072867, HPA073252" Enhanced Supported Supported "Plasma membrane" 48000000 "Plasma membrane" "CAB003288: AB_2335702, CAB068253: , CAB072867: , HPA004471: AB_1078431, HPA073252: " "unprognostic (1.55e-2)" "unprognostic (1.91e-1)" "unprognostic (4.04e-2)" "unprognostic (8.19e-2)" "unprognostic (3.96e-2)" "unprognostic (2.18e-2)" "unprognostic (2.33e-2)" "unprognostic (1.97e-2)" "unprognostic (3.60e-2)" "unprognostic (1.64e-1)" "unprognostic (2.20e-1)" "unprognostic (1.92e-2)" "prognostic favourable (5.63e-4)" "unprognostic (1.34e-3)" "unprognostic (1.87e-1)" "unprognostic (1.29e-2)" "unprognostic (2.30e-1)" 8.1 1.6 9.5 6.6 11.8 3.7 65.5 18.3 12.0 12.1 10.3 6.5 10.2 5.8 8.9 4.2 9.9 2.5 15.5 2.4 36.0 4.4 9.4 1.1 13.8 3.8 3.6 6.0 28.5 2.1 1.3 2.3 6.2 5.7 9.6 10.4 20.7 12.9 6.9 1.3 14.6 8.9 10.2 3.9 3.2 12.8 4.0 4.5 0.4 28.9 4.3 4.9 9.8 12.5 0.0 1.8 12.7 0.9 9.7 1.9 0.1 0.0 0.0 0.7 0.0 0.1 0.0 0.0 0.6 0.9 2.5 3.2 0.0 0.0 0.0 0.0 1.4 0.0 0.5 0.0 2.1 0.0 1.1 47.7 0.0 0.0 0.0 0.0 100.2 0.0 0.0 0.0 0.0 5.6 0.6 0.1 0.0 0.0 0.2 0.4 1.3 0.0 0.1 0.0 0.0 0.0 4.7 1.2 0.4 0.0 0.0 0.0 0.0 0.5 0.0 0.1 0.0 1.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 12.7 0.0 10.0 0.1 0.0 1.9 0.0 0.3 0.7 1.8 0.0 0.0 0.0 0.8 9.7 0.9 0.0 0.0 0.1 9.5 11.8 18.3 12.0 36.0 4.4 3.6 6.0 5.7 4.5 KLHDC7B MGC16635 ENSG00000130487 "Kelch domain containing 7B" Q96G42 22 50548033-50551022 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "kidney: 8.4;parathyroid gland: 12.5" "Cell line enriched" "Detected in some" 4 "HMC-1: 46.4" "Cancer enhanced" "Detected in many" "cervical cancer: 42.3;urothelial cancer: 40.7" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Not detected" "Not detected" "HPA000518, HPA076540" Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA000518: AB_1079213, HPA076540: " "prognostic favourable (1.30e-4)" "unprognostic (3.18e-2)" "unprognostic (2.74e-2)" "unprognostic (2.21e-1)" "unprognostic (3.96e-2)" "unprognostic (6.04e-3)" "unprognostic (3.91e-1)" "unprognostic (1.07e-1)" "unprognostic (1.07e-2)" "unprognostic (7.13e-2)" "unprognostic (3.33e-3)" "unprognostic (2.48e-1)" "unprognostic (2.09e-3)" "unprognostic (2.89e-1)" "unprognostic (4.69e-2)" "unprognostic (3.49e-1)" "unprognostic (1.02e-1)" 0.4 0.4 0.3 3.9 1.2 1.2 0.7 0.3 1.5 1.3 0.3 0.3 0.3 0.3 0.3 0.3 0.7 0.2 0.3 0.3 0.3 0.1 8.4 1.1 1.1 4.0 0.3 0.3 0.8 0.3 12.5 2.2 0.3 0.9 0.7 0.0 0.8 3.0 0.3 0.3 0.3 2.0 0.3 0.3 5.4 0.5 0.3 0.3 6.5 2.9 0.3 1.7 3.0 0.3 3.8 2.0 2.4 4.0 1.4 5.7 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 10.6 0.0 46.4 0.0 0.5 0.0 0.1 0.0 0.0 5.4 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.1 0.0 0.0 2.4 2.2 0.2 4.5 4.0 3.3 3.8 4.7 5.7 2.0 3.1 5.2 4.3 0.4 1.4 2.8 0.7 4.1 2.5 0.3 1.2 0.3 1.5 0.3 0.1 0.3 0.3 0.9 0.3 KLRC1 "CD159a, NKG2, NKG2-A, NKG2-B" ENSG00000134545 "Killer cell lectin like receptor C1" P26715 12 10442264-10454685 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 64.3;lymphoid tissue: 22.1" "Cell line enhanced" "Detected in some" "HeLa: 9.3;Karpas-707: 3.8" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 7 "gdT-cell: 45.7;NK-cell: 64.3" "Group enriched" "Detected in many" 42 "NK-cells: 64.3;T-cells: 45.7" HPA058052 Approved "Plasma membrane" "Plasma membrane" "HPA058052: " "unprognostic (8.17e-3)" "unprognostic (2.13e-2)" "unprognostic (1.48e-2)" "unprognostic (4.58e-7)" "unprognostic (3.57e-1)" "unprognostic (1.17e-2)" "unprognostic (1.05e-1)" "unprognostic (3.68e-2)" "unprognostic (3.73e-4)" "unprognostic (4.13e-2)" "unprognostic (6.49e-2)" "unprognostic (2.54e-1)" "unprognostic (1.18e-4)" "unprognostic (1.88e-1)" "unprognostic (3.23e-1)" "unprognostic (2.45e-1)" "unprognostic (1.92e-3)" 2.4 0.5 1.2 5.8 1.4 5.6 2.3 1.0 2.7 1.7 3.3 0.7 1.2 1.5 5.5 3.9 1.7 2.5 2.4 2.6 1.6 1.3 1.9 2.0 5.9 10.3 2.3 0.6 1.2 1.4 0.3 1.3 3.6 1.5 1.9 2.5 2.0 3.1 0.3 0.5 1.0 5.0 2.1 2.6 22.1 5.2 1.4 0.5 3.5 1.9 3.0 2.9 2.9 1.8 0.1 0.0 1.2 0.1 64.3 45.7 5.1 0.4 1.6 0.1 0.1 0.6 0.4 0.8 0.0 0.0 0.8 1.7 0.0 1.3 0.2 0.1 0.4 0.3 0.6 2.8 1.1 0.9 0.4 2.1 9.3 0.0 0.1 0.6 0.4 1.0 0.0 0.3 0.0 0.8 1.3 3.8 0.8 0.0 0.2 2.8 0.0 0.0 0.9 0.2 0.3 0.2 0.0 0.5 0.1 0.8 0.0 0.3 0.3 0.0 2.6 0.4 0.0 0.0 0.3 0.0 0.0 0.7 2.2 0.8 0.0 0.2 0.0 0.0 45.7 0.0 5.8 0.1 0.0 7.9 0.0 0.0 0.0 6.9 1.2 64.3 0.1 0.0 0.0 5.1 1.2 1.4 1.0 0.9 1.6 1.3 2.3 0.6 1.5 0.5 KLRC2 "CD159c, NKG2-C" ENSG00000205809 "Killer cell lectin like receptor C2" P26717 12 10426854-10442300 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 32.8;brain: 16.2" "Cell line enhanced" "Detected in some" "HEL: 6.1;HeLa: 19.0;HSkMC: 4.6;U-87 MG: 3.1" "Cancer enriched" "Detected in single" 8 "glioma: 3.6" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 10.7;NK-cell: 32.8" "Group enriched" "Detected in many" 92 "NK-cells: 32.8;T-cells: 10.7" HPA058052 Approved "Plasma membrane" "Plasma membrane" "HPA058052: " "unprognostic (9.05e-4)" "unprognostic (2.54e-2)" "unprognostic (3.77e-2)" "unprognostic (2.51e-3)" "unprognostic (2.83e-1)" "unprognostic (9.49e-4)" "unprognostic (1.27e-1)" "unprognostic (8.74e-2)" "unprognostic (2.88e-1)" "unprognostic (4.00e-3)" "unprognostic (2.88e-2)" "unprognostic (9.16e-3)" "unprognostic (1.55e-9)" "unprognostic (8.10e-2)" "unprognostic (2.34e-1)" "unprognostic (8.93e-2)" "unprognostic (5.31e-3)" 0.5 0.2 8.2 0.6 4.6 2.8 1.1 1.2 16.2 0.4 1.9 2.3 0.1 1.0 1.4 1.0 0.8 0.6 1.7 0.2 6.1 5.4 0.1 1.1 1.4 1.5 6.2 2.6 1.5 0.1 0.0 0.1 0.6 3.7 0.3 1.3 0.1 0.5 0.3 0.1 0.2 1.8 0.1 4.1 8.1 3.2 0.5 1.7 2.2 0.2 0.1 2.0 1.2 0.1 0.0 0.0 0.2 0.0 32.8 10.7 1.7 0.0 1.0 0.0 0.3 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 2.4 0.0 0.0 0.0 6.1 19.0 0.3 0.0 0.6 0.0 4.6 0.1 0.0 0.4 0.0 0.1 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.1 1.2 0.2 0.4 0.0 0.0 0.0 0.0 0.6 3.1 0.1 0.1 0.0 0.0 0.0 10.7 0.0 0.2 0.0 0.0 4.7 0.0 0.0 0.0 3.7 0.2 32.8 0.0 0.0 0.0 1.7 8.2 4.6 1.2 3.6 6.1 5.4 6.2 2.6 3.7 1.7 KLRK1 "CD314, D12S2489E, KLR, NKG2-D, NKG2D" ENSG00000213809 "Killer cell lectin like receptor K1" P26718 12 10372353-10391874 "Cancer-related genes, CD markers, Predicted membrane proteins, Transporters" "Adaptive immunity, Differentiation, Immunity, Innate immunity" Receptor "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 50.8;lymphoid tissue: 30.7" "Cell line enriched" "Detected in some" 8 "U-698: 36.0" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Group enriched" "Detected in many" 39 "gdT-cell: 49.4;MAIT T-cell: 18.5;memory CD8 T-cell: 44.0;naive CD8 T-cell: 44.3;NK-cell: 50.8" "Group enriched" "Detected in many" 47 "NK-cells: 50.8;T-cells: 49.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB021896, HPA068877" Enhanced Supported "Plasma membrane" 33000 "Plasma membrane" "CAB021896: , HPA068877: " "unprognostic (3.34e-4)" "unprognostic (2.65e-4)" "unprognostic (3.25e-1)" "unprognostic (2.59e-2)" "unprognostic (1.53e-1)" "unprognostic (1.01e-5)" "unprognostic (5.61e-4)" "unprognostic (1.00e-3)" "unprognostic (1.33e-1)" "unprognostic (9.22e-2)" "unprognostic (1.28e-2)" "unprognostic (2.10e-2)" "unprognostic (6.56e-10)" "unprognostic (1.24e-2)" "unprognostic (6.32e-2)" "unprognostic (7.59e-2)" "unprognostic (7.08e-10)" 4.1 0.9 1.3 18.3 1.1 10.6 2.1 0.4 0.8 2.8 4.5 1.2 0.6 2.0 2.4 2.7 3.1 2.0 7.7 1.3 1.3 1.1 2.4 3.6 13.6 22.2 2.1 0.1 1.5 3.3 0.0 1.2 1.6 1.2 2.2 2.1 2.4 7.0 0.6 0.5 1.1 13.1 1.3 2.1 30.7 3.3 1.9 0.6 6.0 2.9 2.8 11.4 11.3 2.5 1.0 0.2 0.8 0.1 50.8 49.4 16.7 0.2 0.0 0.4 1.8 0.1 4.6 0.4 0.0 0.0 0.0 0.0 0.2 0.0 0.3 0.0 0.0 0.3 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.2 1.6 0.0 0.0 0.1 0.0 0.7 0.0 0.2 0.0 0.2 0.1 0.3 0.0 0.3 0.0 0.0 0.0 0.0 0.5 0.2 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.5 0.0 0.0 0.0 0.0 36.0 0.1 0.0 0.2 0.0 0.0 0.0 49.4 0.1 18.5 0.8 0.3 44.0 0.1 1.0 0.4 44.3 0.8 50.8 0.1 0.2 0.1 16.7 1.3 1.1 0.4 0.8 1.3 1.1 2.1 0.1 1.2 0.6 LAIR1 CD305 ENSG00000167613 "Leukocyte associated immunoglobulin like receptor 1" Q6GTX8 19 54351384-54370558 "CD markers, Predicted intracellular proteins, Predicted membrane proteins" "Adaptive immunity, Immunity" Receptor "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lymphoid tissue: 39.0" "Group enriched" "Detected in some" 5 "HMC-1: 6.5;Karpas-707: 16.7;THP-1: 19.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" HPA011155 Enhanced Supported "Plasma membrane" 130000 "Plasma membrane" "HPA011155: AB_1852685" "unprognostic (1.91e-1)" "unprognostic (1.12e-2)" "unprognostic (2.81e-2)" "unprognostic (1.25e-2)" "unprognostic (2.03e-2)" "unprognostic (4.38e-2)" "unprognostic (2.16e-2)" "unprognostic (1.74e-1)" "unprognostic (5.00e-2)" "unprognostic (2.24e-1)" "unprognostic (2.21e-1)" "unprognostic (7.11e-2)" "prognostic unfavourable (5.01e-5)" "unprognostic (1.72e-1)" "unprognostic (2.72e-3)" "unprognostic (3.52e-2)" "unprognostic (5.22e-2)" 12.7 7.0 4.5 10.9 9.9 13.5 6.9 0.5 4.5 2.7 5.1 6.7 0.2 2.7 2.2 6.8 2.5 3.6 4.4 3.9 5.2 4.2 3.8 2.9 16.5 33.1 10.2 1.9 2.0 2.4 1.4 2.8 7.0 7.0 3.0 2.0 3.1 3.9 2.2 2.3 2.3 7.6 7.8 11.9 28.6 2.9 3.1 7.4 39.0 2.0 0.5 6.1 3.7 1.7 6.0 10.3 12.4 8.8 5.8 8.0 5.7 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.2 0.0 0.0 0.0 2.7 6.5 0.0 0.0 0.0 0.0 0.0 0.0 16.7 0.0 0.0 2.1 1.5 0.0 0.0 2.1 0.1 2.5 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 19.0 0.1 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.2 2.6 0.2 12.4 4.2 10.0 8.0 8.3 4.6 2.3 2.4 4.3 0.1 6.0 3.8 4.9 0.6 5.8 8.8 10.3 1.6 5.7 4.5 9.9 0.5 4.5 5.2 4.2 10.2 1.9 7.0 7.4 LAT2 "HSPC046, LAB, NTAL, WBSCR15, WBSCR5, WSCR5" ENSG00000086730 "Linker for activation of T cells family member 2" Q9GZY6 7 74199652-74229834 "Disease related genes, Predicted intracellular proteins" "Adaptive immunity, Immunity, Mast cell degranulation" "Williams-Beuren syndrome" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 98.4;lymphoid tissue: 36.7" "Cell line enhanced" "Detected in some" "NB-4: 45.6;REH: 51.8;RPMI-8226: 18.5;THP-1: 46.9;U-937: 45.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "basophil: 98.4" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003462 Enhanced Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA003462: AB_1079238" "unprognostic (1.24e-2)" "unprognostic (1.14e-2)" "unprognostic (1.32e-2)" "unprognostic (3.55e-3)" "unprognostic (1.09e-1)" "unprognostic (3.30e-3)" "unprognostic (2.79e-2)" "unprognostic (1.33e-1)" "unprognostic (9.27e-2)" "unprognostic (1.19e-1)" "unprognostic (6.34e-3)" "unprognostic (6.91e-2)" "prognostic unfavourable (4.10e-4)" "unprognostic (1.80e-1)" "prognostic unfavourable (6.10e-4)" "unprognostic (7.44e-2)" "unprognostic (2.03e-1)" 4.6 3.7 10.3 21.4 19.3 32.8 2.5 2.7 9.6 2.8 3.9 11.6 0.5 3.3 2.5 2.4 2.5 3.8 5.9 2.4 8.8 6.5 3.0 3.8 11.6 29.3 21.9 2.5 1.4 2.8 1.0 2.8 4.4 15.7 4.5 4.7 2.3 3.6 2.2 2.7 1.8 9.9 5.0 19.3 36.7 3.6 1.6 17.6 3.2 2.4 1.0 32.7 5.8 4.6 26.8 32.5 98.4 39.5 10.0 1.3 24.7 0.4 0.2 0.2 0.8 0.0 0.0 0.2 0.3 0.3 0.2 0.2 0.4 7.9 5.2 0.1 0.1 0.2 0.0 0.3 0.1 8.3 0.3 2.0 0.3 0.3 0.0 15.2 15.2 0.1 0.2 0.5 0.1 0.0 0.3 2.4 0.1 0.3 0.2 45.6 0.2 0.5 51.8 0.2 18.5 0.0 0.4 0.2 0.2 0.1 0.3 0.2 0.2 46.9 0.6 0.6 5.5 0.2 0.4 0.2 1.5 8.1 2.6 45.8 0.3 98.4 39.5 5.9 1.3 22.3 0.1 24.4 0.3 0.1 32.5 26.8 0.1 0.4 69.1 10.0 12.4 1.2 0.6 24.7 10.3 19.3 2.7 9.6 8.8 6.5 21.9 2.5 15.7 17.6 LGALS4 GAL4 ENSG00000171747 "Galectin 4" P56470 19 38801671-38813364 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 9 "gallbladder: 157.1;intestine: 326.8;lymphoid tissue: 83.5" "Cell line enhanced" "Detected in some" "CACO-2: 3.0;NB-4: 2.6;RT4: 6.9;SH-SY5Y: 2.5" "Group enriched" "Detected in many" 21 "colorectal cancer: 450.7;liver cancer: 133.6;pancreatic cancer: 213.7;stomach cancer: 190.0" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 8 "basophil: 1.7" "Lineage enriched" "Detected in single" 8 "granulocytes: 1.7" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB025653, HPA031184, HPA031185, HPA031186" Enhanced Uncertain "Plasma membrane" 92000 "Plasma membrane" "CAB025653: , HPA031184: AB_2673776, HPA031185: AB_2673777, HPA031186: AB_2673778" "unprognostic (1.11e-1)" "unprognostic (1.12e-1)" "unprognostic (2.57e-3)" "unprognostic (7.88e-2)" "unprognostic (1.12e-1)" "unprognostic (1.61e-2)" "unprognostic (5.01e-2)" "unprognostic (5.34e-2)" "unprognostic (1.54e-1)" "unprognostic (7.58e-2)" "unprognostic (3.80e-2)" "unprognostic (1.48e-2)" "prognostic unfavourable (2.28e-4)" "unprognostic (1.69e-1)" "unprognostic (3.38e-1)" "unprognostic (9.71e-2)" "prognostic favourable (3.21e-4)" 0.3 0.2 0.2 83.5 0.2 0.0 0.3 0.3 0.2 0.3 190.6 0.3 0.3 65.5 0.3 0.5 0.6 0.5 157.1 0.2 0.2 0.2 0.4 20.3 1.5 0.2 0.2 0.2 0.3 8.3 0.0 0.2 0.2 0.2 0.8 75.8 0.3 0.3 0.4 0.3 0.3 326.8 4.9 0.2 0.6 10.5 0.2 0.2 0.3 0.4 0.3 0.2 2.7 0.3 0.0 0.0 1.7 0.0 0.0 0.2 0.0 0.1 0.6 0.2 0.0 0.7 0.1 2.1 0.0 0.0 0.1 0.1 3.0 0.5 0.5 0.4 0.2 0.0 0.0 0.0 0.0 0.7 0.1 0.5 0.3 0.0 0.3 0.0 0.3 0.0 2.1 0.0 0.0 0.1 0.1 0.2 0.0 0.6 0.3 2.6 0.0 0.0 0.3 0.2 2.1 0.2 6.9 0.3 2.5 0.2 0.2 0.1 0.4 2.3 0.0 0.0 0.6 1.7 0.1 0.7 0.4 0.2 0.0 0.2 0.3 1.7 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.3 0.2 0.2 0.2 0.2 0.2 0.2 0.2 LGALS8 PCTA-1 ENSG00000116977 "Galectin 8" O00214 1 236518000-236552981 "Predicted intracellular proteins" Autophagy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "basophil: 38.5" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA012734, HPA030491" Approved Approved "Plasma membrane" "Plasma membrane" "HPA012734: , HPA030491: AB_10602345" "unprognostic (2.03e-2)" "unprognostic (1.54e-1)" "unprognostic (2.38e-2)" "unprognostic (3.80e-3)" "unprognostic (2.02e-3)" "unprognostic (4.71e-3)" "unprognostic (3.93e-2)" "prognostic favourable (9.40e-4)" "unprognostic (9.96e-2)" "unprognostic (1.41e-1)" "unprognostic (2.12e-1)" "unprognostic (1.78e-3)" "prognostic unfavourable (4.93e-7)" "unprognostic (1.41e-1)" "unprognostic (1.57e-1)" "unprognostic (3.15e-2)" "unprognostic (8.21e-2)" 27.8 14.0 15.0 17.0 30.5 28.9 18.6 21.7 22.6 14.1 14.8 9.5 10.7 15.5 13.6 19.2 18.5 12.4 17.2 36.0 16.2 14.8 18.5 34.1 21.0 28.2 13.7 17.0 18.3 18.8 22.5 22.7 43.1 25.2 19.8 14.9 10.0 22.4 17.5 7.7 25.3 18.1 15.3 18.1 41.3 13.6 39.9 14.6 19.9 16.8 13.0 16.4 20.7 14.6 4.4 12.7 38.5 14.2 5.3 8.9 9.3 17.6 9.2 1.3 6.9 16.5 14.1 20.5 13.1 15.0 16.4 19.1 12.5 21.5 0.5 12.8 10.8 19.8 3.6 18.8 15.4 10.2 2.8 11.9 8.0 22.3 20.8 15.8 28.3 12.9 15.0 14.7 5.0 18.1 14.1 8.9 11.8 10.9 7.5 3.1 4.8 6.9 9.1 0.3 1.1 11.6 28.7 4.5 9.2 8.5 27.8 4.7 20.6 12.5 13.2 0.3 8.2 9.8 16.4 3.4 2.6 0.4 17.0 22.2 10.4 38.5 14.2 7.2 5.4 12.9 7.4 4.4 7.8 5.8 12.7 2.9 5.2 5.4 6.7 5.3 8.7 5.8 8.9 9.3 15.0 30.5 21.7 22.6 16.2 14.8 13.7 17.0 25.2 14.6 LINGO1 "FLJ14594, LERN1, LRRN6A" ENSG00000169783 "Leucine rich repeat and Ig domain containing 1" Q96FE5 15 77613027-77820900 "Predicted intracellular proteins, Predicted membrane proteins" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "brain: 67.2" "Cell line enhanced" "Detected in some" "AF22: 13.2;AN3-CA: 11.0;HAP1: 16.6;HEK 293: 11.7;MCF7: 7.1;NTERA-2: 31.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA074653 Enhanced Approved "Plasma membrane" 8400 "Plasma membrane" "HPA074653: " "unprognostic (1.06e-1)" "unprognostic (7.07e-2)" "unprognostic (2.16e-2)" "unprognostic (1.48e-2)" "unprognostic (3.09e-1)" "unprognostic (2.20e-1)" "unprognostic (2.84e-2)" "unprognostic (3.77e-2)" "unprognostic (3.40e-1)" "unprognostic (1.10e-1)" "unprognostic (7.36e-2)" "unprognostic (2.74e-2)" "prognostic unfavourable (3.23e-7)" "unprognostic (2.07e-1)" "unprognostic (7.06e-2)" "unprognostic (2.85e-1)" "unprognostic (2.59e-2)" 3.0 1.6 27.4 1.7 21.8 0.8 1.3 9.1 67.2 3.8 2.0 5.9 0.0 2.0 3.3 2.7 1.4 3.1 2.5 9.7 29.8 12.2 2.2 1.1 1.1 1.3 10.3 21.8 1.7 2.7 1.1 0.5 6.1 6.8 1.7 1.5 1.8 3.4 2.5 1.0 3.0 1.5 4.5 6.8 3.3 2.0 3.7 3.9 0.0 1.7 0.0 1.1 3.2 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 13.2 11.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.8 0.0 0.0 16.6 0.0 0.0 0.0 11.7 0.0 0.0 0.2 0.2 0.0 0.0 0.1 0.3 0.0 0.0 0.0 1.7 0.1 0.0 7.1 0.0 0.0 31.3 0.0 0.0 0.0 0.2 0.0 0.0 2.4 0.7 0.0 1.3 2.8 0.2 0.2 1.1 0.0 2.9 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 27.4 21.8 9.1 47.5 29.8 12.2 10.3 21.8 6.8 3.9 LPAR3 "Edg-7, EDG7, HOFNH30, LP-A3, LPA3, RP4-678I3" ENSG00000171517 "Lysophosphatidic acid receptor 3" Q9UBY5 1 84811602-84893213 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "fallopian tube: 32.0" "Cell line enhanced" "Detected in some" "HAP1: 13.0;HBEC3-KT: 16.0;hTCEpi: 17.2;NTERA-2: 14.5;PC-3: 16.2;SK-MEL-30: 15.3" "Cancer enhanced" "Detected in many" "ovarian cancer: 24.7" "Low region specificity" "Detected in many" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Region enhanced" "Detected in some" "olfactory region: 3.5" "Low region specificity" "Detected in many" HPA013421 Supported "Plasma membrane" "Plasma membrane" "HPA013421: AB_1847990" "unprognostic (2.85e-2)" "unprognostic (1.67e-1)" "unprognostic (2.66e-1)" "unprognostic (4.42e-1)" "unprognostic (2.72e-2)" "unprognostic (6.46e-3)" "unprognostic (1.15e-1)" "unprognostic (1.29e-2)" "unprognostic (1.20e-1)" "prognostic favourable (4.31e-5)" "unprognostic (1.11e-2)" "unprognostic (7.52e-2)" "unprognostic (1.13e-4)" "unprognostic (4.11e-2)" "unprognostic (1.19e-1)" "unprognostic (4.27e-2)" "unprognostic (5.43e-2)" 0.0 1.2 2.4 0.5 1.9 0.3 0.7 0.2 3.5 8.8 0.4 2.2 2.9 0.1 2.4 11.8 7.2 32.0 0.5 12.4 3.7 0.9 0.0 0.1 4.2 0.1 0.1 2.6 5.1 8.6 0.3 0.4 1.1 6.8 11.5 0.5 0.7 5.0 4.7 0.3 4.0 0.5 0.5 0.3 0.1 0.2 14.7 0.2 0.7 0.2 3.3 4.3 4.8 6.9 0.6 0.4 1.1 0.1 1.8 0.5 0.1 0.5 0.1 0.0 0.0 0.0 0.0 0.4 0.2 1.2 1.1 0.8 0.0 0.0 0.0 0.2 0.0 0.2 13.0 16.0 1.0 0.1 2.6 0.0 0.0 0.0 0.4 0.0 0.0 0.1 17.2 4.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 14.5 16.2 0.0 0.0 0.0 0.0 3.7 0.9 0.7 0.0 0.3 15.3 0.0 1.2 0.0 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.7 0.1 0.2 0.3 0.0 0.2 0.4 0.5 0.5 0.3 0.6 0.4 0.3 1.1 1.8 0.1 0.4 0.1 0.1 2.4 1.9 0.2 3.5 3.7 0.9 0.1 2.6 6.8 0.2 LRRC69 ENSG00000214954 "Leucine rich repeat containing 69" Q6ZNQ3 8 91101832-91219236 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "testis: 6.6" "Cell line enhanced" "Detected in some" "HEK 293: 6.8;U-266/70: 17.5;U-266/84: 9.7" "Low cancer specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA046337 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA046337: " "unprognostic (1.63e-2)" "unprognostic (1.02e-1)" "unprognostic (4.69e-1)" "unprognostic (3.28e-1)" "unprognostic (2.78e-1)" "unprognostic (3.17e-1)" "unprognostic (3.51e-2)" "unprognostic (3.50e-2)" "unprognostic (2.49e-2)" "unprognostic (1.47e-1)" "unprognostic (9.18e-2)" "unprognostic (1.88e-1)" "unprognostic (3.09e-6)" "unprognostic (6.91e-2)" "unprognostic (1.60e-1)" "unprognostic (1.43e-1)" "unprognostic (8.68e-5)" 0.8 0.9 0.2 1.5 0.2 0.0 1.0 0.0 0.1 0.7 0.5 0.1 0.5 1.9 0.7 0.4 0.5 1.1 0.1 0.1 0.9 0.7 0.7 1.9 0.3 0.4 0.7 0.3 0.6 0.5 1.0 1.5 1.1 0.3 0.6 3.5 0.6 1.4 0.3 1.2 0.6 6.6 1.3 1.1 1.0 0.8 1.9 2.0 1.5 1.1 0.4 2.3 0.1 0.6 0.7 0.2 0.5 0.7 1.5 1.2 0.4 0.1 0.3 0.3 1.1 0.9 1.0 0.5 0.2 0.6 0.7 1.2 0.3 0.3 6.8 1.4 1.7 0.5 0.2 0.5 1.1 0.4 1.1 0.4 0.8 0.1 1.1 0.6 0.4 0.2 0.3 0.5 0.7 0.4 0.8 0.0 0.7 0.2 0.7 0.0 0.2 0.0 0.4 1.0 1.6 1.2 0.2 0.3 0.7 0.2 0.9 17.5 9.7 4.0 0.1 2.2 0.9 1.3 0.6 1.5 1.5 1.1 1.5 1.2 1.6 0.6 0.1 1.9 2.3 1.2 0.1 0.4 0.6 2.0 2.1 0.1 MAP6 "FLJ41346, KIAA1878, MAP6-N, STOP" ENSG00000171533 "Microtubule associated protein 6" Q96JE9 11 75586918-75669120 "Predicted intracellular proteins" Transport Calmodulin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 35.9" "Group enriched" "Detected in some" 6 "AF22: 19.0;CACO-2: 18.6;HDLM-2: 10.3;SCLC-21H: 31.6;SH-SY5Y: 16.1" "Cancer enhanced" "Detected in many" "glioma: 9.6" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "naive B-cell: 2.4" "Lineage enriched" "Detected in single" 24 "B-cells: 2.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB015442, CAB022600, HPA039061, HPA039062" Enhanced Uncertain "Plasma membrane" "Plasma membrane" "CAB015442: AB_2140997, CAB022600: , HPA039061: , HPA039062: " "unprognostic (3.04e-2)" "unprognostic (6.18e-2)" "unprognostic (3.15e-2)" "unprognostic (9.07e-2)" "unprognostic (7.54e-2)" "unprognostic (4.49e-2)" "unprognostic (8.29e-2)" "unprognostic (2.51e-2)" "unprognostic (5.99e-2)" "unprognostic (7.99e-2)" "prognostic favourable (3.41e-4)" "prognostic favourable (9.15e-4)" "unprognostic (2.43e-2)" "unprognostic (3.96e-3)" "unprognostic (8.09e-3)" "unprognostic (1.77e-1)" "unprognostic (2.03e-1)" 3.0 16.6 23.7 2.1 26.4 0.6 2.6 14.9 35.9 6.9 6.4 10.0 6.1 1.9 10.0 18.6 4.2 34.6 5.8 5.4 21.3 26.6 7.3 1.3 6.5 1.1 17.0 19.9 7.1 3.4 28.7 24.9 1.8 33.2 12.9 3.6 7.5 2.9 18.7 1.1 2.4 2.0 11.5 13.7 1.7 3.6 12.4 9.9 0.0 6.2 0.0 1.0 2.6 3.1 2.4 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.3 19.0 0.0 0.0 0.0 0.0 1.8 0.1 0.1 0.0 18.6 0.0 0.3 0.7 3.1 0.0 1.7 0.2 0.0 10.3 0.2 0.0 0.0 0.0 0.5 0.0 0.0 1.0 0.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 1.4 0.0 0.0 0.0 0.0 0.2 31.6 16.1 2.3 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 23.7 26.4 14.9 29.1 21.3 26.6 17.0 19.9 33.2 9.9 MAPK8IP1 "IB1, JIP-1, JIP1, PRKM8IP" ENSG00000121653 "Mitogen-activated protein kinase 8 interacting protein 1" Q9UQF2 11 45885651-45906465 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes, Diabetes mellitus, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 73.5" "Cell line enhanced" "Detected in many" "SCLC-21H: 38.6" "Cancer enhanced" "Detected in all" "glioma: 51.2" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "NK-cell: 2.6" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058921, HPA070332" Enhanced "Plasma membrane" "Plasma membrane" "HPA058921: , HPA070332: " "unprognostic (3.96e-2)" "unprognostic (8.73e-2)" "unprognostic (1.08e-1)" "unprognostic (6.88e-2)" "unprognostic (5.59e-2)" "unprognostic (2.82e-1)" "unprognostic (8.25e-3)" "unprognostic (3.42e-3)" "unprognostic (1.27e-2)" "unprognostic (9.54e-2)" "unprognostic (3.22e-3)" "unprognostic (2.20e-2)" "prognostic favourable (1.23e-11)" "unprognostic (7.19e-2)" "unprognostic (4.01e-2)" "unprognostic (4.46e-2)" "unprognostic (1.80e-3)" 3.0 12.8 33.3 2.1 29.6 1.4 2.7 24.9 73.5 3.1 1.9 4.6 0.1 1.6 4.9 3.1 2.1 6.6 3.0 2.9 38.1 22.3 5.1 2.7 2.6 1.0 28.0 18.9 4.4 26.4 14.7 24.8 1.6 23.5 4.9 1.5 4.5 4.8 5.0 1.7 1.7 2.0 4.4 44.4 1.7 3.8 10.8 4.8 0.0 3.9 0.5 0.9 2.0 0.4 0.4 0.4 2.1 0.9 2.6 0.2 0.0 0.0 3.5 4.7 13.1 1.8 0.9 0.1 2.5 2.2 5.0 3.6 3.0 0.5 0.2 1.2 2.9 2.8 5.0 2.3 2.2 1.9 6.5 0.0 4.4 2.0 1.6 0.2 2.2 1.2 0.5 3.2 0.6 1.1 5.4 0.8 1.4 1.8 0.1 0.3 12.5 5.2 0.3 7.7 0.1 2.3 0.0 38.6 14.4 4.1 3.4 4.7 5.5 0.2 1.0 6.4 9.8 9.5 4.5 0.5 0.6 0.2 4.0 0.1 1.9 2.1 0.9 0.0 0.2 0.2 0.1 0.2 0.0 0.1 0.0 0.4 0.1 0.2 1.8 2.6 0.0 0.4 0.1 0.0 33.3 29.6 24.9 41.7 38.1 22.3 28.0 18.9 23.5 4.8 MAT2B "MATIIbeta, SDR23E1" ENSG00000038274 "Methionine adenosyltransferase 2B" Q9NZL9 5 163503114-163519336 "Predicted intracellular proteins" "One-carbon metabolism" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA037721, HPA037722" Uncertain Approved "Plasma membrane" 1000000 "Plasma membrane" "HPA037721: AB_10672389, HPA037722: AB_10671718" "unprognostic (1.22e-2)" "unprognostic (2.80e-2)" "unprognostic (1.80e-3)" "unprognostic (1.64e-1)" "unprognostic (5.06e-1)" "unprognostic (2.12e-1)" "unprognostic (1.20e-1)" "unprognostic (1.77e-1)" "unprognostic (9.72e-2)" "unprognostic (1.68e-1)" "unprognostic (5.19e-3)" "unprognostic (3.57e-2)" "prognostic favourable (4.51e-7)" "unprognostic (1.06e-1)" "unprognostic (1.09e-2)" "unprognostic (2.16e-2)" "unprognostic (1.37e-3)" 25.1 32.5 25.2 29.1 28.6 12.1 23.9 37.1 39.6 25.3 41.6 20.1 25.1 38.9 28.0 29.0 27.9 31.9 20.4 41.8 24.2 28.6 48.4 37.2 26.6 41.7 24.7 24.9 35.9 16.4 25.7 17.1 23.9 27.6 30.7 31.4 24.3 28.6 26.8 28.7 20.9 57.2 21.3 21.4 45.5 24.9 18.1 17.7 50.8 53.3 20.1 41.0 32.5 32.9 60.4 34.5 82.4 46.0 62.4 86.8 98.8 19.2 16.8 29.5 16.0 21.9 21.8 17.7 17.2 19.7 19.9 29.1 11.7 36.7 20.6 36.3 18.8 15.9 24.4 35.8 26.3 67.9 20.2 18.7 19.6 17.4 28.8 19.7 12.7 18.1 29.6 25.2 19.6 43.0 14.9 26.0 24.3 11.3 27.1 23.6 11.1 11.4 31.2 14.3 33.9 32.5 21.0 11.6 17.0 22.9 15.5 24.9 21.6 26.6 34.5 21.7 14.1 14.4 29.8 22.2 21.5 18.8 15.8 36.0 14.6 82.4 38.3 75.6 58.7 44.6 64.3 60.4 64.8 63.2 34.5 56.6 66.2 63.6 58.8 62.4 46.0 27.8 86.8 98.8 25.2 28.6 37.1 39.6 24.2 28.6 24.7 24.9 27.6 17.7 MBP ENSG00000197971 "Myelin basic protein" P02686 18 76978827-77133683 "Candidate cardiovascular disease genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Autoimmune encephalomyelitis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 43 "brain: 1297.7" "Cell line enhanced" "Detected in many" "HL-60: 28.4;SK-MEL-30: 59.1" "Group enriched" "Detected in all" 9 "glioma: 47.5;melanoma: 20.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002300, HPA049222, HPA064368" Enhanced Supported Approved "Plasma membrane" "Plasma membrane" "CAB002300: AB_563893, HPA049222: , HPA064368: " "unprognostic (9.36e-2)" "unprognostic (7.60e-2)" "unprognostic (1.28e-2)" "unprognostic (1.22e-1)" "unprognostic (6.93e-2)" "unprognostic (2.81e-1)" "unprognostic (1.14e-1)" "unprognostic (3.31e-1)" "unprognostic (9.87e-2)" "unprognostic (2.90e-2)" "unprognostic (5.25e-2)" "unprognostic (1.95e-1)" "prognostic favourable (4.48e-12)" "unprognostic (2.90e-1)" "unprognostic (5.99e-2)" "unprognostic (1.33e-1)" "unprognostic (6.03e-2)" 4.0 3.4 271.6 6.1 244.9 10.1 4.5 28.7 418.9 5.6 5.5 487.7 0.0 5.9 4.4 3.6 6.4 9.0 5.7 6.8 355.0 247.6 6.2 5.9 6.2 7.1 645.5 43.4 3.7 6.8 16.4 0.7 2.7 242.9 4.5 5.6 0.4 5.0 4.9 29.9 7.9 6.2 3.8 1297.7 7.6 5.1 2.9 224.3 0.0 6.8 0.0 7.7 6.0 0.6 3.4 6.8 23.7 4.7 15.4 17.1 5.6 7.4 6.5 0.0 0.2 11.0 16.4 2.6 0.1 0.2 0.2 0.1 0.9 11.5 4.6 1.3 0.5 14.7 1.1 6.5 0.2 17.8 1.6 2.9 1.1 1.5 6.9 28.4 19.8 2.3 5.5 5.9 9.1 1.9 0.0 1.0 0.0 0.9 1.1 14.6 0.6 5.2 0.4 0.1 10.2 10.4 10.1 0.5 0.1 0.9 0.0 59.1 0.2 17.4 0.0 0.0 0.1 0.0 0.8 0.0 0.1 4.9 1.7 18.0 0.7 11.0 4.7 17.8 13.2 4.6 8.0 3.4 9.4 17.1 5.3 3.3 5.7 10.5 23.7 15.4 4.4 6.8 7.9 5.6 271.6 244.9 28.7 127.7 355.0 247.6 645.5 43.4 242.9 224.3 MCAM "CD146, MUC18" ENSG00000076706 "Melanoma cell adhesion molecule" P43121 11 119308529-119321521 "CD markers, Plasma proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in many" 4 "HUVEC TERT2: 125.3;TIME: 122.3;WM-115: 97.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "MAIT T-cell: 2.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002147, HPA008848" Enhanced Approved "Plasma membrane" 2600000000 "Plasma membrane" "CAB002147: AB_563499, HPA008848: AB_1078445" "unprognostic (6.45e-2)" "prognostic unfavourable (7.61e-4)" "unprognostic (7.03e-2)" "unprognostic (1.22e-2)" "unprognostic (6.67e-2)" "unprognostic (2.34e-1)" "unprognostic (2.23e-2)" "unprognostic (8.42e-2)" "unprognostic (2.09e-2)" "unprognostic (1.45e-1)" "unprognostic (1.58e-1)" "unprognostic (9.39e-2)" "prognostic unfavourable (5.14e-4)" "unprognostic (8.75e-3)" "unprognostic (7.84e-2)" "unprognostic (2.31e-1)" "unprognostic (2.79e-3)" 88.2 8.9 6.4 18.5 10.3 0.4 86.1 17.7 13.4 22.3 33.2 13.3 11.7 8.3 40.1 32.5 27.6 29.3 50.9 32.0 7.1 8.2 7.5 3.8 23.8 13.0 7.4 8.1 23.6 6.2 54.5 3.9 47.4 11.1 22.9 9.7 25.0 9.4 44.9 21.1 10.5 15.6 67.1 6.5 9.6 25.0 18.4 5.4 2.2 13.1 15.7 4.8 55.0 24.3 0.8 0.0 0.3 0.0 0.0 2.2 0.0 0.0 0.5 0.5 0.0 2.5 0.0 2.6 0.3 0.0 3.3 1.5 1.9 0.1 0.1 10.7 1.1 0.3 4.3 0.9 1.7 6.0 1.5 0.1 12.0 2.1 5.9 0.0 0.0 1.7 0.0 4.6 2.1 125.3 4.0 0.1 0.6 0.0 0.1 1.0 2.2 0.4 0.1 16.7 3.5 3.0 0.0 1.4 0.4 9.6 0.2 27.5 0.4 0.1 122.3 0.3 17.9 0.0 9.6 0.2 0.2 0.0 4.9 0.0 97.3 0.0 0.0 0.0 0.0 0.0 2.2 0.8 0.6 1.1 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 1.3 0.0 6.4 10.3 17.7 13.4 7.1 8.2 7.4 8.1 11.1 5.4 MR1 HLALS ENSG00000153029 "Major histocompatibility complex, class I-related" Q95460 1 181033425-181061938 "FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Immunity, Innate immunity" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA048304 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA048304: " "unprognostic (6.89e-2)" "unprognostic (1.54e-1)" "unprognostic (1.31e-2)" "unprognostic (1.96e-1)" "unprognostic (8.66e-3)" "unprognostic (4.37e-2)" "unprognostic (1.96e-1)" "unprognostic (1.36e-2)" "unprognostic (2.03e-1)" "unprognostic (1.18e-1)" "unprognostic (3.49e-2)" "unprognostic (6.41e-2)" "unprognostic (1.05e-2)" "unprognostic (7.40e-3)" "unprognostic (4.69e-2)" "unprognostic (2.39e-1)" "unprognostic (1.07e-2)" 10.5 13.8 5.3 10.2 7.1 7.7 8.3 1.7 5.5 8.6 8.2 5.3 6.8 5.3 10.4 10.9 12.6 8.6 13.2 8.9 5.2 3.1 10.5 10.7 16.6 16.2 5.9 5.0 13.9 5.1 12.4 17.6 11.5 5.1 13.2 6.3 12.3 8.1 8.6 3.8 10.1 7.8 9.6 6.1 14.9 6.7 5.5 6.2 23.2 13.6 7.1 18.4 16.4 9.6 12.9 15.6 24.0 22.2 14.9 14.3 11.1 3.6 2.5 0.0 2.2 15.8 19.2 6.7 7.3 20.1 6.1 10.5 1.0 15.0 4.5 15.3 13.1 9.7 0.3 8.6 5.4 13.6 2.4 6.5 2.9 4.5 5.3 5.3 19.6 12.6 23.9 9.1 9.9 0.6 12.1 12.2 11.8 4.0 5.5 3.8 0.0 0.4 6.3 0.1 12.5 6.7 10.8 0.1 0.2 3.9 7.1 5.1 7.5 11.3 3.8 6.0 0.8 10.4 3.6 20.3 6.9 8.4 5.6 7.1 0.5 24.0 17.9 18.1 14.3 22.2 12.7 12.1 13.0 12.7 15.6 12.9 9.7 14.3 13.4 14.9 18.7 8.4 13.6 11.1 5.3 7.1 1.7 5.5 5.2 3.1 5.9 5.0 5.1 6.2 MS4A1 "B1, Bp35, CD20, MS4A2" ENSG00000156738 "Membrane spanning 4-domains A1" P11836 11 60455752-60470760 "CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "B-cell activation" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 6 "blood: 77.7;intestine: 46.1;lymphoid tissue: 134.1" "Group enriched" "Detected in some" 25 "Daudi: 120.0;U-698: 60.4" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 105 "memory B-cell: 77.7;naive B-cell: 77.7" "Lineage enriched" "Detected in single" 105 "B-cells: 77.7" "Not detected" "Not detected" "Low region specificity" "Detected in some" "CAB000015, HPA014341, HPA014391" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB000015: AB_2282030, HPA014341: AB_1846265, HPA014391: AB_1846264" "prognostic favourable (4.34e-5)" "unprognostic (4.45e-4)" "unprognostic (1.19e-4)" "unprognostic (2.04e-3)" "unprognostic (1.06e-1)" "unprognostic (5.53e-7)" "unprognostic (2.46e-3)" "unprognostic (1.85e-3)" "unprognostic (3.06e-2)" "unprognostic (2.89e-4)" "unprognostic (6.96e-2)" "unprognostic (2.84e-2)" "unprognostic (3.96e-5)" "unprognostic (2.23e-1)" "unprognostic (8.04e-2)" "unprognostic (1.44e-1)" "unprognostic (1.30e-1)" 1.6 0.3 0.3 79.0 0.3 3.6 0.6 0.3 0.3 0.5 2.0 0.0 0.0 0.2 0.4 0.5 7.0 0.4 1.3 0.7 0.3 0.3 2.0 0.9 2.7 81.2 0.3 0.1 0.3 0.4 0.0 0.4 0.4 0.1 1.1 1.7 0.6 14.5 0.2 0.3 0.3 46.1 0.1 0.4 90.7 2.6 0.6 0.0 15.7 2.5 2.7 134.1 6.4 0.8 77.7 0.0 0.2 0.0 0.7 0.6 3.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 120.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 60.4 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.4 77.7 0.3 0.6 0.0 77.7 0.0 0.2 0.2 0.7 0.0 0.0 0.0 3.5 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.1 0.0 MSN ENSG00000147065 Moesin P26038 X 65588377-65741931 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" "Host-virus interaction" "Cancer-related genes, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000263, CAB010898, HPA011135, HPA011227, CAB047336, CAB047337, CAB047338" Enhanced Enhanced "Plasma membrane" 340000000 "Plasma membrane" "CAB010898: AB_260635, CAB047336: , CAB047337: , CAB047338: , HPA000263: AB_1856043, HPA011135: AB_1854053, HPA011227: AB_1854054" "unprognostic (1.03e-1)" "unprognostic (7.89e-2)" "unprognostic (7.64e-2)" "unprognostic (5.38e-2)" "unprognostic (4.08e-3)" "unprognostic (3.51e-2)" "unprognostic (1.11e-2)" "unprognostic (1.44e-2)" "unprognostic (3.35e-2)" "unprognostic (1.70e-2)" "unprognostic (9.04e-3)" "unprognostic (1.32e-1)" "prognostic unfavourable (1.60e-5)" "unprognostic (5.68e-3)" "unprognostic (7.75e-2)" "unprognostic (7.21e-2)" "unprognostic (6.81e-2)" 36.3 17.6 10.2 40.7 14.4 38.5 98.2 8.6 18.6 25.1 21.3 19.2 7.6 6.5 33.4 14.2 15.7 21.8 20.2 53.8 11.5 10.4 25.6 29.5 102.8 85.0 17.5 5.4 28.8 19.4 5.7 10.2 24.2 30.0 23.1 13.0 16.6 16.3 21.9 13.6 19.5 18.3 41.4 21.8 31.6 17.3 9.0 12.9 18.7 26.2 17.6 38.1 22.7 28.9 16.0 36.4 54.1 69.0 28.0 37.1 81.8 27.8 21.4 21.0 17.3 25.2 33.3 0.1 70.7 45.8 39.2 30.4 0.0 4.9 23.4 63.2 62.5 19.2 22.1 50.4 51.2 43.3 6.1 64.9 37.1 0.0 23.8 78.8 105.1 24.9 10.9 72.1 63.8 86.5 31.4 73.0 62.0 0.0 46.5 59.1 26.0 40.7 24.4 37.7 17.8 41.9 0.0 0.1 0.0 56.8 0.4 22.5 0.2 42.9 137.0 44.7 28.4 60.1 46.8 26.5 40.1 25.4 32.7 100.1 49.7 30.8 44.4 30.0 37.1 58.9 27.9 16.0 20.4 29.1 36.4 13.9 14.0 21.3 54.1 28.0 69.0 5.2 15.5 81.8 10.2 14.4 8.6 18.6 11.5 10.4 17.5 5.4 30.0 12.9 MTM1 ENSG00000171100 "Myotubularin 1" Q13496 X 150568619-150673322 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid metabolism, Protein transport, Transport" "Hydrolase, Protein phosphatase" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA010008, HPA010665" Approved Supported "Plasma membrane" "Plasma membrane" "HPA010008: AB_1079426, HPA010665: AB_1079425" "unprognostic (3.66e-3)" "unprognostic (8.43e-3)" "unprognostic (3.52e-3)" "unprognostic (2.13e-1)" "unprognostic (1.08e-1)" "unprognostic (6.45e-2)" "unprognostic (4.98e-2)" "unprognostic (1.22e-1)" "unprognostic (4.74e-1)" "unprognostic (2.35e-2)" "unprognostic (1.08e-1)" "unprognostic (4.59e-2)" "prognostic favourable (7.40e-7)" "unprognostic (4.46e-2)" "unprognostic (1.25e-1)" "unprognostic (4.99e-2)" "unprognostic (2.46e-1)" 10.7 17.9 15.0 10.2 16.4 11.1 9.2 10.6 10.8 9.1 21.5 12.5 12.7 12.8 10.9 10.9 11.1 11.1 8.0 9.0 14.3 12.0 17.9 19.9 12.2 12.4 17.3 9.3 13.8 7.5 21.4 11.9 21.5 12.9 9.5 21.6 8.3 10.2 12.9 11.2 10.2 21.0 8.0 17.2 15.3 8.6 12.1 16.4 14.5 12.7 8.3 13.9 8.5 9.1 6.9 7.9 18.4 7.2 10.1 7.7 4.6 8.5 3.9 5.5 2.0 5.0 5.0 3.5 4.1 5.6 4.7 5.2 3.0 4.7 13.8 7.3 5.2 6.1 4.0 7.9 5.8 3.7 3.5 3.7 3.7 9.1 3.8 15.3 12.5 3.0 9.5 3.8 8.1 6.1 2.3 12.8 5.7 2.8 4.2 15.8 2.8 5.1 5.1 3.1 2.7 8.1 4.8 1.4 1.5 3.5 7.4 5.2 2.6 22.3 5.3 3.1 1.9 8.1 4.2 2.6 5.9 13.1 4.0 9.4 5.1 17.6 6.3 18.4 1.5 7.2 4.9 5.5 6.8 5.2 7.9 6.9 6.5 3.9 8.5 10.1 6.2 5.1 7.7 4.6 15.0 16.4 10.6 10.8 14.3 12.0 17.3 9.3 12.9 16.4 MUC1 "ADMCKD, ADMCKD1, CD227, MCD, MCKD, MCKD1, PEM, PUM" ENSG00000185499 "Mucin 1, cell surface associated" P15941 1 155185824-155192916 "Cancer-related genes, CD markers, Disease related genes, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins" "Cancer-related genes, Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 168.1;kidney: 158.5;lung: 143.5" "Group enriched" "Detected in many" 7 "CAPAN-2: 139.8;RPTEC TERT1: 107.3;T-47d: 47.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in some" "Cell type enhanced" "Detected in some" "T-reg: 4.0" "Group enriched" "Detected in many" 10 "granulocytes: 1.3;T-cells: 4.0" "CAB000036, CAB001986, HPA004179, HPA007235, HPA008855" Enhanced Supported "Plasma membrane" "Secreted in other tissues" 4900000 "Plasma membrane" "CAB000036: AB_2148557, CAB001986: , HPA004179: AB_1846282, HPA007235: AB_1846281, HPA008855: AB_1846283" "unprognostic (4.74e-2)" "unprognostic (2.84e-2)" "unprognostic (2.19e-1)" "unprognostic (8.01e-2)" "unprognostic (1.32e-2)" "unprognostic (1.70e-1)" "unprognostic (2.61e-3)" "unprognostic (6.34e-2)" "unprognostic (1.43e-1)" "unprognostic (3.23e-1)" "prognostic unfavourable (4.60e-4)" "unprognostic (4.75e-1)" "unprognostic (2.05e-2)" "unprognostic (1.13e-1)" "unprognostic (8.12e-2)" "unprognostic (1.42e-1)" "unprognostic (1.21e-1)" 1.5 0.7 0.8 12.6 1.2 0.9 12.6 0.4 0.7 31.6 15.9 1.2 2.4 2.9 10.5 9.8 51.8 18.7 168.1 0.8 0.5 0.3 158.5 2.0 143.5 0.3 0.5 0.3 14.9 74.2 0.0 4.7 15.5 2.1 6.1 16.1 0.8 17.0 5.9 0.8 1.8 3.6 2.8 0.7 0.6 105.0 4.3 0.5 0.7 15.7 10.5 47.8 12.3 5.2 0.0 0.2 1.3 0.1 0.0 4.0 0.2 1.8 0.9 0.6 0.5 0.4 0.5 0.2 0.6 1.5 0.7 1.9 0.0 139.8 0.0 10.2 1.1 2.8 0.1 0.0 0.2 1.2 0.1 0.2 11.8 0.0 0.3 0.0 4.4 1.2 0.2 0.3 0.2 0.2 1.0 1.9 0.5 14.2 0.1 0.1 0.4 0.2 0.2 0.0 3.4 107.3 0.1 0.6 0.2 3.4 5.9 0.1 47.1 0.6 0.2 0.4 0.8 1.3 0.1 2.2 1.1 0.0 0.7 0.1 0.1 1.3 0.1 0.0 0.0 0.0 0.8 0.0 2.3 0.4 0.2 0.0 0.3 0.7 0.0 0.0 0.0 0.0 4.0 0.2 0.8 1.2 0.4 0.7 0.5 0.3 0.5 0.3 2.1 0.5 MYL4 "ALC1, AMLC, GT1, PRO1957" ENSG00000198336 "Myosin light chain 4" P12829 17 47200446-47223679 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Motor protein, Muscle protein, Myosin" "Atrial fibrillation, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 68 "heart muscle: 712.3" "Cell line enriched" "Detected in some" 4 "HEL: 107.4" "Group enriched" "Detected in some" 7 "testis cancer: 2.4;thyroid cancer: 11.7" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 11 "plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 11 "dendritic cells: 5.2" "Group enriched" "Detected in many" 6 "amygdala: 25.9;cerebral cortex: 83.3;hippocampal formation: 27.8" "Low region specificity" "Detected in all" "HPA046859, HPA051884, HPA063034" Enhanced Approved "Plasma membrane" 140000 "Plasma membrane" "HPA046859: , HPA051884: , HPA063034: " "unprognostic (2.43e-2)" "unprognostic (9.57e-2)" "unprognostic (2.25e-1)" "unprognostic (5.51e-2)" "unprognostic (2.33e-1)" "unprognostic (4.12e-3)" "unprognostic (5.06e-3)" "unprognostic (1.34e-1)" "unprognostic (1.13e-1)" "unprognostic (6.52e-2)" "unprognostic (2.10e-2)" "unprognostic (7.37e-2)" "unprognostic (1.00e-6)" "unprognostic (1.92e-4)" "unprognostic (2.54e-1)" "unprognostic (6.51e-3)" "unprognostic (1.50e-1)" 0.1 0.0 0.0 0.1 0.0 10.4 0.1 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.1 0.0 0.0 712.3 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.7 0.0 0.0 0.7 0.1 0.0 0.0 0.8 3.3 0.0 0.5 0.0 0.0 0.1 0.0 0.1 0.2 0.7 0.0 0.1 0.6 4.6 0.1 0.1 0.2 0.2 5.2 0.0 0.4 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.1 0.0 0.0 0.0 0.0 0.0 0.5 0.0 107.4 0.0 0.0 0.0 0.0 0.0 4.4 0.0 0.0 0.0 0.2 25.4 0.0 0.0 0.0 1.9 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 2.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.4 0.2 0.0 0.0 0.0 0.0 0.1 5.2 0.0 0.7 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 0.1 0.0 MYO1B myr1 ENSG00000128641 "Myosin IB" O43795 2 191245185-191425389 "Predicted intracellular proteins" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 92.7" "Cell line enhanced" "Detected in many" "hTERT-HME1: 74.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 4 "memory B-cell: 1.7;naive B-cell: 2.7;naive CD4 T-cell: 1.2" "Group enriched" "Detected in many" 4 "B-cells: 2.7;T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" "HPA013607, HPA060144" Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA013607: AB_1854251, HPA060144: " "unprognostic (4.11e-3)" "unprognostic (7.36e-3)" "unprognostic (1.21e-1)" "unprognostic (4.83e-3)" "unprognostic (2.78e-1)" "unprognostic (1.59e-3)" "unprognostic (1.09e-2)" "unprognostic (1.15e-2)" "unprognostic (3.25e-3)" "unprognostic (5.85e-2)" "unprognostic (4.55e-1)" "unprognostic (9.31e-2)" "prognostic unfavourable (2.36e-5)" "unprognostic (2.22e-2)" "unprognostic (1.79e-1)" "unprognostic (1.47e-1)" "unprognostic (6.55e-2)" 18.8 2.5 3.3 5.9 4.3 0.2 21.8 1.4 4.7 8.2 8.0 2.1 21.6 4.2 11.8 8.2 9.0 4.9 8.9 11.6 3.6 3.1 12.2 92.7 34.5 6.6 3.6 2.3 7.8 34.3 15.0 3.1 15.7 4.4 8.5 7.4 5.8 7.5 18.6 9.3 7.5 5.4 6.7 2.7 6.6 5.0 3.6 2.0 3.6 9.3 10.4 4.8 10.3 9.9 2.7 0.4 0.0 0.0 0.0 1.2 0.0 19.9 10.3 16.8 5.0 4.6 20.0 15.2 38.1 18.9 26.4 26.3 12.6 1.8 0.0 6.3 43.7 44.3 5.5 32.8 33.3 0.0 4.8 0.0 4.8 16.1 10.9 0.4 0.1 8.0 22.7 27.5 74.3 4.8 0.0 0.0 24.3 8.4 7.6 2.4 10.9 16.4 9.8 10.7 1.5 10.3 8.5 8.5 22.4 12.9 2.2 11.5 2.0 0.6 5.8 25.3 12.7 15.2 4.4 0.1 0.0 0.2 15.3 0.0 14.0 0.0 0.0 0.0 0.0 0.0 0.0 1.7 0.1 0.0 0.0 2.7 1.2 0.0 0.0 0.0 0.0 0.4 0.0 0.0 3.3 4.3 1.4 4.7 3.6 3.1 3.6 2.3 4.4 2.0 MYO5B KIAA1119 ENSG00000167306 "Myosin VB" Q9ULV0 18 49822813-50195093 "Disease related genes, Plasma proteins, Predicted intracellular proteins" "Protein transport, Transport" "Actin-binding, Calmodulin-binding, Motor protein, Myosin" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 4 "intestine: 92.2" "Cell line enhanced" "Detected in many" "A-431: 20.6;HaCaT: 32.6;RH-30: 50.5" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "NK-cell: 2.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in some" "HPA040593, HPA040902, HPA069773" Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA040593: AB_10795525, HPA040902: AB_10796230, HPA069773: " "unprognostic (2.51e-1)" "unprognostic (2.15e-2)" "unprognostic (2.12e-2)" "unprognostic (6.17e-3)" "unprognostic (2.14e-1)" "unprognostic (8.84e-3)" "unprognostic (1.32e-1)" "unprognostic (2.59e-1)" "unprognostic (4.13e-2)" "unprognostic (3.46e-1)" "prognostic unfavourable (2.26e-5)" "unprognostic (4.48e-2)" "prognostic favourable (1.45e-11)" "unprognostic (2.17e-3)" "unprognostic (1.50e-1)" "unprognostic (6.56e-2)" "unprognostic (3.28e-1)" 2.0 1.2 1.1 12.7 1.3 0.0 5.2 0.4 2.5 7.5 56.9 1.0 13.7 23.5 1.8 10.4 20.3 4.6 20.6 2.0 1.8 1.2 19.1 13.9 9.4 0.6 0.7 1.5 1.7 16.4 9.3 10.5 13.5 2.1 6.0 17.5 8.4 21.6 8.7 0.6 14.5 92.2 0.8 0.7 0.9 13.1 5.5 0.3 2.4 16.3 14.9 17.4 4.0 11.8 1.0 0.1 0.0 0.0 2.4 0.6 0.0 20.6 5.6 0.1 0.1 0.0 0.0 11.3 0.1 0.8 0.4 0.0 14.6 8.8 0.0 5.2 0.0 32.6 7.4 8.8 0.4 0.0 2.2 0.0 2.5 10.3 0.0 0.0 0.0 0.0 7.8 0.2 5.4 0.7 0.1 8.1 0.8 8.0 0.0 0.0 1.5 2.3 0.0 50.5 3.5 18.6 4.2 11.2 0.2 7.9 9.3 0.0 5.5 0.0 0.4 0.0 11.4 0.1 2.1 5.5 3.4 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.6 1.0 0.4 0.1 0.0 0.0 0.2 0.4 0.0 2.4 0.0 0.1 0.1 0.0 1.1 1.3 0.4 2.5 1.8 1.2 0.7 1.5 2.1 0.3 MYO9A "FLJ11061, FLJ13244, MGC71859" ENSG00000066933 "Myosin IXA" B2RTY4 15 71822289-72118577 "Plasma proteins, Predicted intracellular proteins" "Actin-binding, GTPase activation, Motor protein, Myosin" "Congenital myasthenic syndrome, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA039812, HPA040071" Approved Approved "Plasma membrane" "Plasma membrane" "HPA039812: AB_10961421, HPA040071: AB_10961117" "unprognostic (7.53e-2)" "unprognostic (2.40e-1)" "unprognostic (1.96e-1)" "unprognostic (2.42e-3)" "unprognostic (1.63e-1)" "unprognostic (8.69e-3)" "unprognostic (3.77e-2)" "unprognostic (3.56e-2)" "unprognostic (1.26e-1)" "unprognostic (5.50e-2)" "unprognostic (1.32e-1)" "unprognostic (1.34e-1)" "prognostic favourable (2.14e-4)" "unprognostic (3.44e-1)" "unprognostic (4.41e-1)" "unprognostic (1.25e-1)" "unprognostic (4.23e-2)" 10.5 6.0 13.8 9.6 17.9 6.1 14.8 18.3 16.4 13.3 11.1 7.5 10.6 3.4 15.0 11.0 11.2 10.8 7.5 9.3 9.5 9.3 19.6 5.5 12.2 8.4 9.1 12.0 17.5 5.0 15.9 14.7 10.5 14.6 11.9 9.2 9.1 8.3 11.3 12.9 12.0 8.0 14.4 9.0 10.0 9.7 35.6 11.2 9.1 18.4 6.6 8.8 11.9 13.9 6.1 9.3 5.2 3.4 3.7 7.6 1.3 6.3 9.7 6.4 4.6 9.9 11.7 3.8 6.0 6.6 6.1 6.3 4.7 4.4 28.4 3.6 11.9 6.0 12.9 6.9 8.2 6.2 7.5 7.1 5.5 2.0 6.3 7.2 5.8 6.6 7.0 7.2 10.4 7.7 4.6 6.8 8.2 3.9 4.1 2.9 3.4 4.0 2.9 12.4 2.7 7.5 9.5 3.6 4.0 7.7 6.8 6.2 5.3 3.5 10.3 12.3 6.0 19.8 6.8 4.3 10.8 7.6 7.3 6.0 5.4 2.2 2.2 5.2 5.6 2.0 7.6 4.7 5.4 4.6 2.2 6.1 5.7 5.3 0.3 3.7 3.4 9.3 4.5 1.3 13.8 17.9 18.3 16.4 9.5 9.3 9.1 12.0 14.6 11.2 NCKIPSD "AF3P21, DIP1, ORF1, SPIN90, WASLBP, WISH" ENSG00000213672 "NCK interacting protein with SH3 domain" Q9NZQ3 3 48673844-48686364 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" Proto-oncogene "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in all" 5 "brain: 39.6;parathyroid gland: 123.9" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB019267, HPA050005" Enhanced "Plasma membrane" 42000 "Plasma membrane" "CAB019267: , HPA050005: " "unprognostic (1.55e-2)" "unprognostic (2.02e-1)" "unprognostic (2.15e-1)" "unprognostic (1.79e-1)" "unprognostic (9.64e-3)" "unprognostic (5.50e-3)" "prognostic unfavourable (8.57e-4)" "unprognostic (1.76e-1)" "unprognostic (1.38e-1)" "unprognostic (1.04e-1)" "unprognostic (2.40e-2)" "unprognostic (1.23e-1)" "prognostic favourable (1.20e-5)" "unprognostic (1.60e-2)" "unprognostic (1.55e-1)" "unprognostic (3.73e-2)" "unprognostic (2.09e-2)" 11.7 11.9 14.4 4.9 18.5 4.4 7.8 17.9 39.6 7.0 7.9 10.3 3.5 7.3 7.8 8.6 7.8 9.6 9.3 17.8 12.9 16.0 8.7 6.8 7.4 5.9 11.1 17.8 17.7 8.5 123.9 10.0 8.0 16.9 8.1 7.4 9.6 8.9 11.7 6.4 9.8 7.3 8.7 9.2 5.7 6.2 8.4 10.9 2.9 7.7 1.9 5.4 7.7 6.5 4.9 8.5 1.0 5.3 4.8 6.4 4.7 11.6 10.2 10.5 10.7 14.3 8.7 14.6 11.7 13.1 13.0 16.6 15.1 7.1 8.6 6.4 6.9 7.9 13.3 15.5 7.5 9.6 16.3 15.4 38.1 11.9 12.5 10.4 17.4 8.3 13.5 18.0 11.3 7.3 5.2 11.5 10.4 8.6 9.4 8.8 12.1 18.2 4.8 4.8 14.4 7.1 12.0 11.0 8.9 12.2 11.5 9.8 10.2 12.7 4.1 11.3 12.7 13.3 15.4 10.4 7.6 9.6 12.8 13.9 17.2 1.0 4.6 0.2 3.5 5.3 2.6 4.9 4.2 4.1 5.8 2.6 6.4 4.1 0.3 4.8 2.8 8.5 4.6 4.7 14.4 18.5 17.9 39.6 12.9 16.0 11.1 17.8 16.9 10.9 NCS1 "FREQ, NCS-1" ENSG00000107130 "Neuronal calcium sensor 1" P62166 9 130172578-130237304 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 76.8" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "gdT-cell: 1.2;MAIT T-cell: 1.2" "Lineage enriched" "Detected in single" 13 "T-cells: 1.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB018587, HPA019713" Enhanced Supported Enhanced "Plasma membrane" "Plasma membrane" "CAB018587: AB_649907, HPA019713: AB_1854404" "prognostic unfavourable (5.40e-4)" "unprognostic (1.57e-1)" "unprognostic (4.64e-3)" "prognostic unfavourable (8.69e-4)" "unprognostic (1.29e-1)" "unprognostic (9.23e-2)" "prognostic unfavourable (1.11e-4)" "unprognostic (1.61e-3)" "unprognostic (4.27e-1)" "unprognostic (1.21e-2)" "unprognostic (8.45e-2)" "unprognostic (1.58e-1)" "unprognostic (3.71e-3)" "unprognostic (8.59e-2)" "unprognostic (1.69e-1)" "prognostic unfavourable (8.25e-4)" "unprognostic (1.65e-1)" 5.8 12.6 76.8 7.9 56.6 4.6 2.8 18.6 66.2 7.7 20.1 6.4 5.0 3.6 12.6 4.1 24.9 13.5 8.7 4.6 74.3 25.7 8.7 1.6 2.5 1.6 20.6 28.1 4.6 3.5 1.5 2.7 1.6 17.7 14.9 6.8 4.2 5.3 41.6 0.9 10.0 4.3 34.3 6.8 1.1 5.1 2.2 7.1 0.0 20.1 0.7 2.7 16.4 4.6 0.0 0.0 0.0 0.0 0.0 1.2 0.1 7.7 15.8 8.2 16.4 5.1 11.6 3.9 20.0 9.3 15.4 10.3 7.5 4.0 0.0 7.3 25.2 14.0 13.3 17.5 6.9 22.9 4.0 0.0 10.5 8.0 7.9 0.6 9.7 13.4 8.9 17.4 11.0 14.5 5.6 0.1 22.2 22.2 1.4 7.7 12.5 6.7 0.0 25.9 5.3 15.0 4.9 21.7 20.4 12.3 5.9 11.8 11.0 4.9 11.4 29.9 24.3 23.9 25.6 0.0 0.0 0.0 34.9 2.2 32.2 0.0 0.0 0.0 1.2 0.0 1.2 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 76.8 56.6 18.6 59.9 74.3 25.7 20.6 28.1 17.7 7.1 NECTIN4 "LNIR, nectin-4, PRR4, PVRL4" ENSG00000143217 "Nectin cell adhesion molecule 4" Q96NY8 1 161070995-161089599 "Disease related genes, Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion, Host-virus interaction" "Host cell receptor for virus entry, Receptor" "Disease mutation, Ectodermal dysplasia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 40.1;placenta: 46.6;skin 1: 39.3" "Cell line enhanced" "Detected in some" "BEWO: 27.9;HaCaT: 18.0;MCF7: 11.2;SK-BR-3: 23.4;T-47d: 15.2" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Group enriched" "Detected in some" 7 "basophil: 1.5;eosinophil: 1.2;neutrophil: 3.6" "Lineage enriched" "Detected in single" 12 "granulocytes: 3.6" "Low region specificity" "Detected in all" "Not detected" "Not detected" HPA010775 Enhanced Supported "Plasma membrane" "Secreted in other tissues" 11000 "Plasma membrane" "HPA010775: AB_1079720" "unprognostic (1.09e-3)" "unprognostic (1.52e-1)" "unprognostic (3.51e-1)" "unprognostic (1.11e-2)" "unprognostic (5.69e-3)" "unprognostic (2.09e-2)" "unprognostic (6.69e-3)" "unprognostic (1.02e-1)" "unprognostic (1.69e-1)" "unprognostic (1.18e-1)" "unprognostic (6.49e-3)" "unprognostic (1.13e-1)" "unprognostic (2.24e-8)" "unprognostic (2.98e-2)" "unprognostic (2.43e-1)" "unprognostic (3.68e-2)" "unprognostic (4.97e-2)" 0.2 0.1 0.1 0.8 0.1 0.1 7.7 0.1 0.1 9.8 0.6 0.1 5.4 0.2 1.5 3.7 40.1 1.4 5.6 0.1 0.1 0.1 1.3 0.2 3.1 0.0 0.1 0.0 0.5 4.4 0.0 0.3 46.6 0.1 7.8 0.7 0.1 13.5 5.5 0.1 39.3 0.4 2.0 0.1 0.1 4.5 0.2 0.0 0.5 0.1 22.7 23.1 12.6 18.5 0.2 0.3 3.6 0.1 0.1 0.2 0.0 5.1 0.1 0.0 0.0 0.0 0.0 27.9 0.0 0.0 0.0 0.1 0.0 7.1 0.0 0.1 0.0 18.0 0.0 0.6 0.1 0.0 0.2 0.0 0.4 5.2 0.0 0.0 0.3 0.0 7.2 1.5 1.8 0.0 0.0 0.0 0.0 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 8.4 0.0 0.1 0.1 23.4 0.0 15.2 0.0 0.0 0.0 1.1 0.2 0.1 0.1 0.0 0.0 0.0 0.0 0.1 1.5 0.1 1.2 0.2 0.0 0.1 0.2 0.2 0.0 0.3 0.2 0.1 0.1 3.6 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.0 NID2 ENSG00000087303 "Nidogen 2" Q14112 14 52004803-52069228 "Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "ASC diff: 52.1;BJ: 27.2;BJ hTERT+: 23.2;HHSteC: 28.9;HSkMC: 107.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Not detected" "Not detected" "HPA052460, HPA058772" Enhanced Enhanced "Plasma membrane" "Secreted to extracellular matrix" 2500000 "Plasma membrane" "HPA052460: AB_2681840, HPA058772: AB_2683815" "unprognostic (6.51e-2)" "unprognostic (3.55e-3)" "unprognostic (3.73e-2)" "unprognostic (3.25e-2)" "unprognostic (2.04e-1)" "unprognostic (1.94e-1)" "unprognostic (5.37e-2)" "unprognostic (3.05e-3)" "unprognostic (2.52e-3)" "unprognostic (3.07e-2)" "unprognostic (4.85e-2)" "unprognostic (1.43e-1)" "unprognostic (1.48e-3)" "prognostic unfavourable (7.34e-4)" "unprognostic (4.58e-2)" "unprognostic (2.87e-2)" "prognostic unfavourable (2.78e-4)" 15.0 5.1 0.9 5.3 1.8 0.1 7.6 0.9 1.7 12.9 8.5 5.1 9.0 1.0 9.5 7.6 9.8 6.0 10.2 17.5 1.2 0.9 6.4 2.9 5.1 3.0 1.3 1.2 16.8 13.9 10.2 2.4 32.5 2.5 13.4 3.6 17.4 4.3 8.9 3.9 1.8 3.0 11.4 1.5 1.1 6.6 4.4 0.8 0.7 18.8 3.6 2.2 10.7 5.2 0.0 0.0 0.0 0.0 0.0 0.5 0.6 0.0 0.6 13.6 0.0 52.1 20.7 0.0 27.2 23.2 2.6 2.7 0.0 0.0 0.0 4.0 3.0 1.8 1.7 0.0 0.7 0.0 0.3 0.0 0.4 0.0 28.9 0.0 0.0 107.9 0.0 10.6 0.0 1.4 0.0 0.0 1.5 0.0 0.0 0.0 0.6 0.9 4.0 0.0 0.0 3.5 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 9.9 0.1 5.9 0.0 0.0 0.0 0.0 3.2 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.9 1.8 0.9 1.7 1.2 0.9 1.3 1.2 2.5 0.8 NMUR2 NMU2R ENSG00000132911 "Neuromedin U receptor 2" Q9GZQ4 5 152391532-152433368 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 8.9;stomach 1: 5.0;testis: 8.0" "Cell line enriched" "Detected in some" 8 "EFO-21: 14.5" "Group enriched" "Detected in some" 5 "colorectal cancer: 0.5;endometrial cancer: 0.6;pancreatic cancer: 1.8;stomach cancer: 2.3" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in single" "hypothalamus: 2.0" "Low region specificity" "Detected in all" "HPA027800, HPA045836" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA027800: , HPA045836: AB_10968856" "unprognostic (1.82e-1)" "unprognostic (3.83e-1)" "unprognostic (2.66e-1)" "unprognostic (9.29e-2)" "unprognostic (5.87e-2)" "unprognostic (6.44e-3)" "unprognostic (3.13e-1)" "unprognostic (6.47e-2)" "unprognostic (5.63e-2)" "unprognostic (8.20e-3)" "unprognostic (8.90e-5)" "unprognostic (1.48e-2)" "unprognostic (9.24e-2)" "unprognostic (9.56e-2)" "unprognostic (2.29e-1)" 0.1 0.5 0.6 0.7 1.0 0.0 0.1 0.2 1.2 0.4 0.2 0.7 1.1 0.6 0.9 0.2 0.4 0.1 0.6 1.4 0.9 2.8 2.0 0.1 2.9 0.1 4.3 0.4 0.1 0.0 0.0 0.7 0.5 1.6 0.2 0.4 0.0 0.0 0.2 0.8 0.0 0.3 0.2 8.9 0.0 5.0 8.0 1.4 0.9 2.5 0.0 0.3 0.3 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.7 14.5 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.0 1.8 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 1.0 0.2 1.2 0.9 2.8 4.3 0.4 1.6 1.4 NRXN1 "Hs.22998, KIAA0578" ENSG00000179915 "Neurexin 1" "P58400, Q9ULB1" 2 49918505-51225575 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Angiogenesis, Cell adhesion" "Mental retardation, Schizophrenia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "brain: 81.9" "Cell line enriched" "Detected in some" 8 "SCLC-21H: 28.3" "Cancer enriched" "Detected in single" 8 "glioma: 3.0" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 10 "neutrophil: 4.4" "Lineage enriched" "Detected in single" 14 "granulocytes: 4.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA071400 Supported "Plasma membrane" "Intracellular and membrane" 620000 "Plasma membrane" "HPA071400: " "unprognostic (7.01e-2)" "unprognostic (9.96e-2)" "unprognostic (7.68e-2)" "unprognostic (1.74e-4)" "unprognostic (2.46e-1)" "unprognostic (8.95e-2)" "unprognostic (2.02e-2)" "unprognostic (1.85e-1)" "unprognostic (8.19e-2)" "unprognostic (6.37e-4)" "unprognostic (2.85e-2)" "unprognostic (6.68e-7)" "unprognostic (3.40e-2)" "unprognostic (1.75e-1)" "unprognostic (5.57e-2)" "unprognostic (1.99e-3)" 2.1 3.2 22.4 2.1 20.3 1.4 1.7 56.5 81.9 2.8 5.1 3.0 0.5 2.1 2.1 3.7 3.0 1.4 2.2 3.8 16.9 13.8 1.5 1.6 1.5 1.4 8.3 25.9 2.1 2.3 1.3 4.8 1.1 12.6 2.5 3.8 2.0 3.5 9.3 1.3 2.0 3.1 2.1 6.5 1.3 2.3 6.5 4.7 0.0 1.4 0.0 1.4 2.0 1.6 0.0 0.0 4.4 0.1 0.3 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 3.1 0.0 0.0 0.0 0.0 3.6 0.0 0.0 0.0 0.2 0.0 0.0 28.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.2 2.4 0.2 0.4 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 4.4 0.3 0.0 0.0 0.0 0.0 22.4 20.3 56.5 33.2 16.9 13.8 8.3 25.9 12.6 4.7 NTNG1 "KIAA0976, Lmnt1" ENSG00000162631 "Netrin G1" Q9Y2I2 1 107140007-107483458 "Predicted intracellular proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 16.4" "Cell line enhanced" "Detected in some" "ASC TERT1: 28.2;fHDF/TERT166: 13.7;RPTEC TERT1: 15.3;U-138 MG: 12.9;U-251 MG: 9.3;U-87 MG: 14.4" "Low cancer specificity" "Detected in some" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "memory B-cell: 4.4" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065954 Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA065954: " "unprognostic (1.79e-1)" "unprognostic (4.63e-2)" "unprognostic (1.67e-2)" "unprognostic (9.38e-5)" "unprognostic (1.93e-3)" "unprognostic (9.87e-3)" "unprognostic (3.34e-1)" "unprognostic (8.38e-3)" "unprognostic (1.03e-1)" "unprognostic (2.02e-1)" "unprognostic (5.68e-2)" "unprognostic (2.05e-2)" "unprognostic (3.10e-4)" "unprognostic (2.00e-1)" "unprognostic (1.52e-1)" "unprognostic (1.93e-5)" 4.2 11.0 6.8 1.3 6.4 0.9 1.1 7.3 12.8 7.0 2.9 9.6 0.3 0.8 2.2 0.9 1.2 1.3 2.1 0.9 9.8 16.4 13.0 0.8 9.2 1.7 5.0 5.3 1.9 1.1 0.7 7.4 3.2 10.0 9.0 1.7 6.4 2.8 12.1 1.1 1.9 1.7 7.5 7.4 1.3 1.4 1.7 6.1 0.0 0.8 0.0 2.0 5.3 3.0 4.4 0.8 1.4 0.7 0.8 0.6 0.3 0.0 0.0 1.6 0.0 2.8 28.2 0.0 7.7 1.1 0.6 0.6 0.0 0.0 0.0 0.3 13.7 0.0 0.0 0.8 1.5 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.0 8.0 0.2 2.0 1.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.5 3.5 0.0 1.9 0.0 15.3 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.1 12.9 2.5 4.7 9.3 0.0 0.0 0.0 14.4 0.0 1.4 1.4 0.3 0.4 0.3 0.4 0.5 4.4 0.4 0.3 0.4 1.0 0.6 0.5 0.9 0.8 0.7 0.8 0.4 0.3 6.8 6.4 7.3 12.3 9.8 16.4 5.0 5.3 10.0 6.1 NTSR1 NTR ENSG00000101188 "Neurotensin receptor 1" P30989 20 62708837-62762771 "G-protein coupled receptors, Predicted membrane proteins, Transporters" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 7.0;intestine: 15.1" "Cell line enriched" "Detected in some" 5 "PC-3: 35.0" "Cancer enhanced" "Detected in some" "pancreatic cancer: 2.9" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA050299 Supported "Plasma membrane" "Plasma membrane" "HPA050299: " "unprognostic (4.14e-2)" "unprognostic (2.02e-2)" "unprognostic (2.75e-2)" "unprognostic (8.87e-4)" "unprognostic (9.27e-3)" "unprognostic (1.45e-1)" "unprognostic (4.17e-2)" "unprognostic (2.80e-3)" "unprognostic (7.16e-2)" "unprognostic (3.10e-3)" "unprognostic (3.55e-2)" "unprognostic (2.53e-1)" "unprognostic (1.27e-2)" "unprognostic (1.25e-1)" "unprognostic (1.29e-1)" "unprognostic (1.17e-1)" "unprognostic (2.49e-1)" 0.3 0.1 3.7 2.5 3.6 3.8 0.1 0.1 7.0 0.1 15.1 0.0 0.0 0.4 0.2 0.1 0.1 0.1 1.4 0.1 2.0 1.1 0.6 0.2 0.3 0.3 3.3 1.0 0.4 0.1 0.2 0.3 0.2 1.4 0.2 0.5 1.2 0.3 0.1 0.2 0.2 1.5 0.8 0.8 0.6 0.5 0.5 0.0 0.0 0.1 0.3 0.1 0.3 0.1 0.0 0.3 0.0 0.3 0.0 0.1 0.4 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.3 0.0 0.0 1.2 6.5 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.0 0.2 0.0 0.0 1.6 0.1 1.5 0.2 35.0 1.0 0.0 5.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 6.3 4.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 3.7 3.6 0.1 7.0 2.0 1.1 3.3 1.0 1.4 0.0 OR2C3 "OR2C4, OR2C5P, OST742" ENSG00000196242 "Olfactory receptor family 2 subfamily C member 3" Q8N628 1 247524677-247536440 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "blood: 4.2;testis: 4.6" "Cell line enhanced" "Detected in some" "CAPAN-2: 1.8" "Not detected" "Not detected" "Group enriched" "Detected in some" 12 "basophil: 4.2;plasmacytoid DC: 1.3" "Group enriched" "Detected in many" 18 "dendritic cells: 1.3;granulocytes: 4.2" HPA058578 Approved "Plasma membrane" "Plasma membrane" "HPA058578: " "unprognostic (1.96e-1)" "unprognostic (7.29e-2)" "unprognostic (3.45e-2)" "unprognostic (1.03e-1)" 0.2 0.4 0.1 0.0 0.1 0.1 0.2 0.4 0.1 0.9 0.1 0.0 0.2 0.9 0.1 0.1 0.3 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.3 0.2 1.3 0.1 0.4 0.7 0.0 0.1 0.0 0.5 0.1 0.1 0.4 0.1 0.1 0.1 4.6 0.1 0.0 0.2 0.1 0.0 1.3 4.2 0.0 0.1 0.1 0.0 0.5 0.3 0.6 0.2 0.0 0.2 0.3 0.4 0.0 0.0 0.0 0.3 1.8 0.6 0.2 0.0 0.3 0.0 0.1 0.0 0.7 0.5 0.1 0.2 0.1 0.1 0.2 0.5 0.5 0.0 0.1 0.0 0.1 1.2 0.7 0.1 0.0 0.4 0.2 0.2 0.3 0.0 0.3 0.0 0.0 0.4 0.8 0.3 0.0 0.3 0.5 0.6 0.3 0.7 0.4 1.2 0.1 0.1 0.0 0.2 0.3 0.5 0.1 0.5 4.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 1.3 0.1 0.0 OR8S1 ENSG00000284723 "Olfactory receptor family 8 subfamily S member 1" Q8NH09 12 48525632-48528103 "G-protein coupled receptors, Predicted membrane proteins" "Olfaction, Sensory transduction" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "No human protein/transcript evidence" "No human protein/transcript evidence" "Tissue enhanced" "Detected in some" "intestine: 1.2;ovary: 1.0" "Cell line enhanced" "Detected in some" "BEWO: 1.1;CAPAN-2: 1.5" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" HPA045595 Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA045595: AB_10964447" 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.1 0.0 0.0 0.0 0.0 0.0 1.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 OSBPL6 ORP6 ENSG00000079156 "Oxysterol binding protein like 6" Q9BZF3 2 178194481-178402891 "Plasma proteins, Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skeletal muscle: 33.4" "Cell line enhanced" "Detected in many" "HEL: 24.5;hTERT-HME1: 26.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 2.2" "Group enriched" "Detected in many" 8 "granulocytes: 2.2;T-cells: 1.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA032131 Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA032131: AB_10670963" "unprognostic (6.22e-2)" "unprognostic (1.53e-1)" "unprognostic (2.47e-1)" "unprognostic (5.95e-3)" "unprognostic (5.26e-2)" "unprognostic (1.40e-2)" "unprognostic (7.55e-2)" "unprognostic (4.81e-2)" "unprognostic (3.32e-1)" "unprognostic (1.03e-1)" "unprognostic (3.03e-3)" "unprognostic (3.49e-2)" "unprognostic (1.15e-5)" "unprognostic (1.11e-2)" "unprognostic (1.30e-1)" "unprognostic (3.73e-4)" "unprognostic (4.44e-6)" 2.4 2.8 9.2 1.9 10.5 0.8 3.2 10.2 18.4 1.9 1.7 3.2 0.2 1.6 1.8 1.7 4.1 2.1 2.2 5.9 7.5 6.3 4.5 8.7 6.3 2.0 4.9 8.0 2.8 2.3 1.2 15.1 1.4 11.3 5.3 2.1 2.5 2.9 2.9 33.4 11.6 5.6 2.6 4.3 2.0 1.7 2.4 4.3 0.0 4.1 6.3 1.7 1.5 2.3 0.2 0.1 2.2 0.0 0.2 1.4 0.6 0.0 0.5 4.3 8.7 3.6 4.0 3.3 7.1 3.7 6.3 7.7 0.7 0.1 0.0 0.3 6.5 0.1 10.1 5.8 10.7 0.1 5.2 24.5 1.5 0.0 2.3 4.0 0.1 2.7 9.2 13.8 26.8 3.0 0.4 3.0 8.2 3.5 0.0 0.0 5.2 5.2 0.0 8.8 1.5 0.4 0.0 3.3 1.9 3.2 0.9 7.0 1.2 0.0 5.8 7.2 4.5 4.8 8.2 16.7 6.5 0.0 8.6 0.0 3.3 0.5 0.0 0.0 0.0 0.0 1.2 0.0 0.6 0.8 0.0 0.2 1.4 0.1 2.2 0.2 0.0 0.1 0.0 0.6 9.2 10.5 10.2 18.4 7.5 6.3 4.9 8.0 11.3 4.3 OXGR1 "aKGR, GPR80, GPR99, P2RY15, P2Y15" ENSG00000165621 "Oxoglutarate receptor 1" Q96P68 13 96985719-96994730 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in many" "kidney: 7.0" "Cell line enhanced" "Detected in some" "RT4: 7.6;SK-BR-3: 3.5;T-47d: 1.7;U-2 OS: 4.0" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in some" 5 "myeloid DC: 2.9;plasmacytoid DC: 5.2" "Lineage enriched" "Detected in single" 6 "dendritic cells: 5.2" "Low region specificity" "Detected in some" "Not detected" "Not detected" HPA067673 Supported "Plasma membrane" "Plasma membrane" "HPA067673: " "unprognostic (1.83e-1)" "unprognostic (1.01e-2)" "unprognostic (1.33e-1)" "unprognostic (6.97e-4)" "unprognostic (7.23e-2)" "unprognostic (1.52e-1)" "unprognostic (8.38e-2)" "unprognostic (2.16e-1)" "unprognostic (1.16e-1)" "unprognostic (2.22e-2)" "unprognostic (4.14e-2)" "unprognostic (3.88e-2)" "unprognostic (1.89e-1)" "unprognostic (2.75e-1)" "unprognostic (1.54e-1)" "unprognostic (9.68e-2)" 2.1 0.0 0.7 1.7 0.2 0.0 6.7 0.0 2.0 1.6 3.0 0.1 0.6 4.0 3.2 2.5 0.0 0.0 0.8 0.8 7.0 0.0 0.5 0.0 0.7 0.0 0.6 0.0 0.3 1.2 0.5 2.4 4.9 0.3 0.1 4.3 0.5 0.5 1.6 0.3 0.1 0.0 0.8 0.9 1.8 0.9 0.0 5.2 0.1 0.5 0.0 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 7.6 0.0 0.2 0.0 3.5 0.0 1.7 0.0 0.0 0.0 4.0 0.0 0.2 0.2 0.0 0.0 0.2 0.0 0.3 0.0 0.5 0.1 0.0 0.1 0.8 0.0 0.0 0.0 2.9 0.0 0.1 0.0 0.1 0.0 0.0 5.2 0.0 0.1 PALM2 ENSG00000243444 "Paralemmin 2" Q8IXS6 9 109640788-109946703 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 17.9;liver: 19.7" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 5.8;RH-30: 20.4" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "neutrophil: 1.1" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA074153, HPA076866" Approved "Plasma membrane" "Plasma membrane" "HPA074153: , HPA076866: " "unprognostic (7.68e-2)" "unprognostic (1.21e-1)" "unprognostic (1.44e-2)" "unprognostic (1.17e-3)" "unprognostic (3.14e-3)" "unprognostic (1.11e-1)" "unprognostic (2.51e-2)" "unprognostic (2.77e-2)" "unprognostic (2.36e-2)" "unprognostic (3.35e-1)" "unprognostic (7.62e-2)" "unprognostic (1.09e-1)" "unprognostic (5.59e-2)" "unprognostic (2.50e-2)" "unprognostic (2.02e-1)" "unprognostic (1.74e-6)" "unprognostic (8.39e-2)" 14.8 6.1 8.1 2.0 11.1 1.2 6.7 1.7 17.9 4.3 2.4 9.1 0.0 1.8 4.9 1.7 2.4 3.8 3.0 7.6 6.3 1.8 2.7 19.7 4.8 1.5 5.0 9.7 2.3 2.2 1.4 1.6 3.1 8.4 2.4 2.4 0.0 3.2 1.4 2.5 3.1 2.0 2.2 4.9 1.5 2.2 2.7 8.7 0.0 4.3 0.0 1.4 2.8 2.6 0.5 0.1 1.1 0.2 0.3 0.1 0.0 0.1 0.5 0.5 0.0 0.4 0.9 0.2 0.4 1.2 0.7 1.7 0.3 0.7 0.1 0.1 1.8 1.7 0.0 0.6 1.2 0.1 0.9 0.0 2.4 0.2 0.0 0.0 0.1 2.0 0.8 5.8 0.9 0.0 0.0 0.0 2.4 0.5 0.0 0.0 3.4 1.3 0.0 20.4 0.4 2.8 0.4 3.8 0.0 5.0 0.2 1.6 2.0 0.4 0.2 2.0 2.9 0.1 1.6 0.1 0.7 0.1 1.6 0.0 2.4 0.3 0.2 0.1 0.0 0.0 0.0 0.2 0.1 0.0 0.1 0.5 0.1 0.0 1.1 0.3 0.1 0.1 0.0 0.0 8.1 11.1 1.7 12.7 6.3 1.8 5.0 9.7 8.4 8.7 PANX1 "MRS1, PX1, UNQ2529" ENSG00000110218 "Pannexin 1" Q96RD7 11 94128928-94181972 "Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA016930 Uncertain Enhanced "Plasma membrane" "Plasma membrane" "HPA016930: AB_1854954" "unprognostic (1.65e-2)" "unprognostic (2.32e-2)" "unprognostic (2.41e-1)" "prognostic unfavourable (1.13e-4)" "unprognostic (1.16e-1)" "unprognostic (7.02e-2)" "unprognostic (6.04e-2)" "prognostic unfavourable (7.09e-5)" "unprognostic (1.79e-1)" "unprognostic (1.43e-1)" "unprognostic (1.00e-3)" "unprognostic (3.26e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.15e-2)" "unprognostic (9.45e-2)" "unprognostic (1.79e-1)" "unprognostic (1.26e-3)" 13.5 9.4 7.9 13.5 14.3 3.8 18.0 7.8 14.8 10.1 11.8 5.6 4.3 6.1 10.8 6.6 9.4 8.7 13.7 13.4 5.6 10.2 8.7 19.4 14.7 6.7 7.4 9.2 9.0 8.5 10.1 7.8 11.0 8.7 9.4 8.6 3.9 9.7 8.6 29.8 11.5 7.4 14.7 5.0 9.6 10.7 12.3 7.4 12.7 10.2 13.9 8.7 13.6 14.1 2.6 5.0 3.6 7.4 4.2 5.1 6.1 11.6 5.0 13.2 7.9 12.3 16.8 8.6 14.6 31.2 12.6 15.6 12.7 18.5 3.7 13.7 14.9 24.9 10.3 24.2 12.8 16.0 5.4 17.4 5.2 6.5 11.9 8.9 15.6 13.2 17.1 16.4 14.8 10.5 11.2 13.7 14.0 3.7 14.7 2.1 10.4 9.0 17.6 17.5 4.6 8.2 11.7 5.5 16.0 10.2 5.9 7.0 12.5 4.6 7.5 25.1 13.0 8.2 14.5 2.2 8.5 6.2 10.4 9.2 15.9 3.6 7.4 0.5 4.3 4.2 5.0 2.6 3.5 4.4 5.0 2.4 3.2 3.6 0.5 4.2 2.6 0.8 5.1 6.1 7.9 14.3 7.8 14.8 5.6 10.2 7.4 9.2 8.7 7.4 PANX2 "hPANX2, PX2" ENSG00000073150 "Pannexin 2" Q96RD6 22 50170731-50180294 "Predicted membrane proteins, Transporters" "Ion transport, Transport" "Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 31.4" "Cell line enhanced" "Detected in many" "EFO-21: 8.9;HDLM-2: 13.7;Hep G2: 16.0;MCF7: 8.8" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "neutrophil: 5.2" "Group enriched" "Detected in many" 36 "dendritic cells: 1.8;granulocytes: 5.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004624, HPA039117" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA004624: , HPA039117: AB_10805354" "unprognostic (1.00e-1)" "unprognostic (7.25e-2)" "unprognostic (2.72e-2)" "unprognostic (1.05e-1)" "unprognostic (3.01e-3)" "unprognostic (2.11e-2)" "unprognostic (1.03e-1)" "unprognostic (1.48e-1)" "unprognostic (1.56e-1)" "unprognostic (4.43e-2)" "unprognostic (3.08e-1)" "unprognostic (1.23e-1)" "unprognostic (1.65e-9)" "unprognostic (2.23e-1)" "unprognostic (1.78e-1)" "unprognostic (3.00e-1)" "unprognostic (4.08e-1)" 1.6 2.6 10.3 2.6 9.2 5.3 1.4 22.4 31.4 1.8 1.1 1.2 10.5 1.1 2.4 2.7 3.8 4.9 2.3 1.1 14.2 8.8 3.4 7.8 2.4 1.2 15.9 7.9 3.5 3.0 1.0 4.1 1.6 23.9 3.8 1.0 1.5 5.5 6.2 1.5 2.6 1.2 1.2 4.5 2.7 1.4 2.6 2.4 0.0 3.8 0.2 1.5 1.8 0.9 0.0 1.8 5.2 0.0 0.0 0.0 0.0 0.8 1.8 0.3 1.9 0.0 0.2 4.2 2.2 2.2 0.5 0.3 0.4 6.7 0.0 8.9 0.2 0.4 1.1 0.8 0.1 13.7 1.2 0.3 2.8 16.0 0.7 0.1 1.0 0.1 0.9 0.6 0.0 0.5 1.1 0.0 0.2 8.8 0.0 0.8 3.3 3.6 0.8 0.0 3.3 0.0 1.3 8.4 0.8 1.4 0.1 5.1 0.5 0.6 3.8 0.4 3.6 5.8 4.1 1.5 0.1 0.5 0.2 0.0 6.3 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.2 0.0 0.0 1.8 0.0 0.0 10.3 9.2 22.4 31.4 14.2 8.8 15.9 7.9 23.9 2.4 PARD6G "PAR-6G, PAR6gamma" ENSG00000178184 "Par-6 family cell polarity regulator gamma" Q9BYG4 18 80157232-80247546 "Predicted intracellular proteins" "Cell cycle, Cell division" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "skin 1: 37.0" "Cell line enhanced" "Detected in many" "HMC-1: 21.1;hTCEpi: 19.7;RT4: 15.8;U-2 OS: 17.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "basophil: 2.5" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA047017 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA047017: " "unprognostic (1.11e-1)" "unprognostic (4.39e-2)" "unprognostic (9.88e-2)" "unprognostic (4.40e-2)" "unprognostic (2.97e-1)" "unprognostic (5.48e-3)" "prognostic unfavourable (3.19e-4)" "unprognostic (1.80e-1)" "unprognostic (9.96e-2)" "unprognostic (4.27e-2)" "unprognostic (1.17e-1)" "unprognostic (4.09e-2)" "unprognostic (6.86e-3)" "unprognostic (9.65e-2)" "unprognostic (1.01e-1)" "unprognostic (4.85e-1)" "unprognostic (2.72e-1)" 2.9 2.2 3.1 4.0 3.1 0.8 8.8 2.0 4.3 15.1 5.0 3.1 8.2 2.1 9.5 6.1 17.3 6.7 4.5 3.0 4.3 4.1 5.5 3.5 2.6 10.4 2.8 2.4 8.9 3.1 2.1 3.7 5.7 3.7 8.8 2.5 4.0 7.0 6.6 2.0 37.0 2.9 8.2 2.6 2.4 2.5 2.4 1.8 6.9 20.7 14.1 11.2 8.4 10.7 0.5 0.5 2.5 0.4 0.6 1.0 0.1 1.6 2.4 10.2 7.7 0.3 0.4 7.4 1.9 0.4 1.7 0.2 0.7 0.7 0.0 0.8 0.8 7.6 3.6 10.9 1.6 0.3 3.2 0.1 1.9 5.8 0.5 2.1 21.1 3.4 19.7 0.2 1.0 0.8 0.7 0.5 2.4 2.8 1.9 0.2 3.1 2.9 0.0 6.7 0.8 0.3 15.8 4.3 4.4 2.3 1.3 10.8 1.5 1.9 0.6 3.4 17.0 1.2 0.9 0.5 0.6 0.1 1.1 0.5 6.3 2.5 0.2 0.4 0.3 0.2 0.2 0.3 0.3 1.0 0.2 0.5 0.4 0.5 1.2 0.6 0.4 0.5 0.1 0.1 3.1 3.1 2.0 4.3 4.3 4.1 2.8 2.4 3.7 1.8 PARP6 pART17 ENSG00000137817 "Poly(ADP-ribose) polymerase family member 6" Q2NL67 15 72241181-72272999 "Enzymes, Predicted intracellular proteins" "Glycosyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA026991 Approved Approved "Plasma membrane" "Plasma membrane" "HPA026991: AB_1854989" "unprognostic (3.88e-2)" "prognostic favourable (3.17e-5)" "prognostic unfavourable (3.37e-4)" "unprognostic (3.36e-1)" "unprognostic (7.13e-2)" "unprognostic (3.05e-1)" "unprognostic (2.37e-2)" "unprognostic (1.33e-1)" "unprognostic (2.00e-1)" "unprognostic (2.64e-1)" "unprognostic (8.55e-2)" "unprognostic (6.92e-2)" "prognostic unfavourable (8.02e-8)" "unprognostic (6.81e-2)" "unprognostic (1.14e-1)" "unprognostic (1.45e-1)" "unprognostic (4.42e-2)" 13.7 16.6 28.0 12.8 32.4 25.1 26.5 46.6 41.2 15.5 16.2 16.9 18.2 14.1 23.3 23.8 14.0 17.0 20.2 18.4 26.1 22.4 14.3 9.0 15.7 16.8 19.9 21.8 26.3 20.9 20.6 30.8 17.0 19.4 19.3 14.3 14.5 21.3 18.8 23.9 20.3 14.4 19.6 14.2 18.2 18.2 25.1 15.8 9.6 21.7 12.5 15.8 16.3 15.8 4.1 4.0 12.1 5.3 4.3 4.3 2.9 7.2 13.1 13.8 17.9 14.8 12.4 11.2 6.2 9.4 10.3 15.2 8.6 13.2 10.0 3.9 9.4 9.5 15.2 8.4 5.9 11.8 13.7 14.5 22.9 0.1 12.4 7.4 13.9 15.9 20.8 9.6 26.6 6.9 7.3 11.5 8.3 13.2 6.3 13.1 6.4 0.0 11.8 9.8 7.8 9.6 14.4 39.0 20.7 10.4 8.5 17.0 10.8 8.6 6.5 13.0 11.9 16.9 9.4 13.0 11.9 10.8 9.4 14.6 9.0 1.7 5.3 12.1 3.8 4.4 2.7 3.3 2.7 4.0 4.0 4.1 4.3 3.2 5.7 4.3 4.9 3.1 4.2 2.9 28.0 32.4 46.6 41.2 26.1 22.4 19.9 21.8 19.4 15.8 PCBD2 "DCOH2, DCOHM" ENSG00000132570 "Pterin-4 alpha-carbinolamine dehydratase 2" Q9H0N5 5 134904906-135007959 "Enzymes, Predicted intracellular proteins" "Tetrahydrobiopterin biosynthesis" Lyase "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 47.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA036428 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA036428: AB_10670103" "unprognostic (3.70e-2)" "unprognostic (3.53e-2)" "unprognostic (3.54e-3)" "unprognostic (1.36e-2)" "unprognostic (2.92e-1)" "unprognostic (1.98e-1)" "unprognostic (4.22e-1)" "unprognostic (6.43e-2)" "unprognostic (4.49e-1)" "unprognostic (1.01e-1)" "unprognostic (1.22e-1)" "unprognostic (5.18e-2)" "unprognostic (1.87e-3)" "unprognostic (4.57e-2)" "unprognostic (6.34e-2)" "unprognostic (9.32e-3)" "unprognostic (1.50e-1)" 4.9 8.1 5.4 7.0 6.6 6.6 5.3 3.0 4.4 3.9 8.7 6.5 9.4 8.0 6.5 8.4 9.3 4.9 6.9 13.8 5.0 5.3 9.2 9.8 6.5 5.0 5.6 5.2 5.1 12.9 9.6 6.1 4.8 6.8 4.7 6.4 9.6 14.2 7.9 47.0 6.7 12.7 7.6 7.0 5.5 7.1 5.5 5.8 5.3 8.3 13.5 8.1 5.6 5.5 8.2 11.5 7.2 10.1 6.3 6.6 4.3 7.7 7.5 8.0 6.0 5.6 4.7 5.9 6.2 4.8 3.5 3.6 13.9 19.8 9.2 10.4 4.2 5.3 5.4 5.9 3.3 12.9 3.6 5.3 7.9 8.3 5.4 6.0 3.8 2.5 5.8 3.7 8.5 4.1 7.6 13.9 6.2 15.9 6.3 10.2 4.5 7.3 10.0 7.5 8.2 6.5 6.5 6.0 7.9 9.3 4.8 7.7 13.4 7.9 4.5 6.8 5.1 5.9 7.8 10.8 14.8 6.3 6.1 7.3 4.4 2.7 10.1 7.2 5.1 6.3 5.0 8.2 6.3 5.3 8.6 8.2 5.4 5.3 3.3 6.3 6.1 11.5 6.6 4.3 5.4 6.6 3.0 4.1 5.0 5.3 5.6 5.2 6.8 5.8 PCDHA1 ENSG00000204970 "Protocadherin alpha 1" Q9Y5I3 5 140786136-141012347 "Predicted membrane proteins, Predicted secreted proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 7.1;testis: 3.1" "Cell line enriched" "Detected in some" 7 "T-47d: 14.1" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA035969 Enhanced Approved "Plasma membrane" "Secreted - unknown location" "Plasma membrane" "HPA035969: AB_10673492" "unprognostic (2.76e-5)" "unprognostic (1.19e-1)" "unprognostic (3.74e-2)" "unprognostic (1.09e-4)" "unprognostic (7.38e-2)" "unprognostic (2.86e-2)" "unprognostic (2.26e-3)" "unprognostic (1.25e-2)" "unprognostic (1.91e-2)" "unprognostic (1.81e-1)" "unprognostic (9.01e-5)" "unprognostic (2.46e-2)" "unprognostic (1.91e-1)" "unprognostic (7.57e-2)" "unprognostic (1.11e-1)" "unprognostic (1.77e-3)" "unprognostic (1.29e-1)" 0.2 1.5 4.6 0.2 4.4 0.1 0.2 3.3 7.1 0.2 0.3 0.7 0.5 0.1 0.2 0.2 0.4 0.1 5.0 3.7 0.6 0.1 0.2 0.3 3.4 0.2 0.2 1.0 1.4 0.1 0.2 0.2 0.1 0.1 0.1 0.1 0.6 0.2 3.4 0.2 0.3 3.1 0.2 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.4 0.7 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.3 0.6 0.0 0.0 0.1 0.0 0.0 0.0 1.4 1.0 0.0 0.2 1.8 14.1 0.5 0.0 1.5 1.0 0.7 0.1 0.0 0.1 0.0 0.4 0.1 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 PCDHB11 "ME2, PCDH-BETA11" ENSG00000197479 "Protocadherin beta 11" Q9Y5F2 5 141199582-141203779 "Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 8.0;EFO-21: 11.6;U-2 OS: 4.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" HPA045042 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA045042: " "unprognostic (1.32e-1)" "unprognostic (3.47e-2)" "unprognostic (7.21e-2)" "unprognostic (1.76e-1)" "unprognostic (1.18e-1)" "unprognostic (1.56e-1)" "unprognostic (2.82e-2)" "unprognostic (1.42e-1)" "unprognostic (6.78e-2)" "unprognostic (1.29e-2)" "unprognostic (1.07e-1)" "unprognostic (2.89e-1)" "unprognostic (3.87e-3)" "unprognostic (4.96e-2)" "unprognostic (1.37e-2)" "unprognostic (9.79e-2)" "unprognostic (6.47e-3)" 13.6 2.4 2.8 2.0 4.1 1.1 3.4 8.8 5.0 8.6 3.1 1.4 0.0 1.4 4.9 3.4 4.1 3.1 3.1 3.0 1.4 1.8 5.0 1.3 2.9 1.0 1.5 3.7 11.0 12.0 15.8 3.6 2.2 3.0 4.5 1.7 6.8 3.3 3.6 2.0 2.9 1.8 5.1 1.6 2.2 2.9 2.6 1.3 0.0 2.8 2.3 1.1 5.5 4.2 1.2 1.0 2.8 0.9 1.4 0.8 0.1 0.0 0.2 2.5 8.0 0.1 0.3 1.7 0.2 0.8 0.0 0.0 0.0 0.2 0.0 11.6 0.7 0.1 0.4 0.2 0.0 0.0 0.0 0.0 0.6 0.1 0.0 0.2 0.2 0.2 0.3 0.0 0.0 0.1 0.1 2.0 0.4 0.2 0.0 0.2 0.3 0.4 0.0 3.1 0.0 0.1 0.3 3.3 0.5 1.8 0.2 1.0 1.9 0.0 0.4 0.1 4.2 3.3 0.1 0.1 0.1 0.1 2.1 0.2 2.0 2.2 0.9 0.8 0.8 0.5 0.5 0.6 0.6 0.5 0.3 1.2 0.5 0.7 2.8 1.4 0.4 1.0 0.4 0.1 2.8 4.1 8.8 5.0 1.4 1.8 1.5 3.7 3.0 1.3 PCDHB12 PCDH-BETA12 ENSG00000120328 "Protocadherin beta 12" Q9Y5F1 5 141208697-141212571 "Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at transcript level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in some" "AN3-CA: 4.7;ASC diff: 4.6;EFO-21: 5.3;RH-30: 5.7;U-2 OS: 4.4;U-2197: 4.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" HPA045042 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA045042: " "unprognostic (1.43e-2)" "unprognostic (3.22e-3)" "unprognostic (4.18e-3)" "unprognostic (8.43e-2)" "unprognostic (3.95e-3)" "unprognostic (7.87e-3)" "unprognostic (1.46e-1)" "unprognostic (2.95e-2)" "unprognostic (3.63e-1)" "unprognostic (9.13e-3)" "unprognostic (4.86e-2)" "unprognostic (2.94e-2)" "unprognostic (4.37e-3)" "unprognostic (3.22e-3)" "unprognostic (4.97e-3)" "unprognostic (3.83e-2)" "unprognostic (6.41e-3)" 4.2 2.5 4.4 1.9 5.0 0.4 3.4 9.1 7.5 5.8 3.3 2.5 1.5 1.3 8.0 3.5 1.8 4.9 3.9 3.9 3.1 2.2 2.6 1.5 3.6 0.9 3.0 6.4 8.3 4.0 3.6 13.9 2.0 3.7 4.5 1.8 3.2 1.9 3.9 1.8 1.6 1.7 6.8 3.9 2.6 2.1 3.1 2.7 0.0 1.9 1.2 0.9 3.0 3.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.3 4.7 4.6 2.7 0.7 0.1 3.3 0.3 0.4 0.0 0.0 0.0 5.3 0.5 0.1 0.1 0.0 0.2 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.1 0.1 1.2 0.0 0.0 0.4 0.0 1.2 1.2 0.3 0.0 0.0 0.1 1.0 0.8 5.7 0.0 0.0 0.0 2.8 1.6 0.0 0.0 1.0 3.7 0.8 0.3 0.7 4.4 4.3 0.1 0.0 0.0 0.0 2.8 0.0 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 5.0 9.1 7.5 3.1 2.2 3.0 6.4 3.7 2.7 PCDHGC3 "PC-43, PC43, PCDH-GAMMA-C3, PCDH2" ENSG00000240184 "Protocadherin gamma subfamily C, 3" Q9UN70 5 141475947-141512979 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 99.3" "Cell line enhanced" "Detected in many" "ASC diff: 43.0;ASC TERT1: 41.2;HSkMC: 40.4;U-138 MG: 51.8;WM-115: 77.2" "Group enriched" "Detected in all" 6 "glioma: 55.0;melanoma: 20.7" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 22 "plasmacytoid DC: 15.2" "Lineage enriched" "Detected in single" 22 "dendritic cells: 15.2" "HPA008755, HPA010580, HPA077289" Approved Approved "Plasma membrane" 74000 "Plasma membrane" "HPA008755: AB_1079577, HPA010580: , HPA077289: " "unprognostic (2.52e-1)" "unprognostic (4.83e-3)" "unprognostic (1.17e-1)" "unprognostic (6.76e-2)" "unprognostic (3.76e-1)" "unprognostic (3.44e-2)" "unprognostic (4.30e-1)" "unprognostic (1.87e-1)" "unprognostic (1.70e-1)" "prognostic unfavourable (6.19e-4)" "unprognostic (2.03e-1)" "unprognostic (2.22e-1)" "prognostic unfavourable (8.18e-4)" "unprognostic (3.72e-2)" "unprognostic (5.66e-2)" "unprognostic (9.55e-2)" "prognostic unfavourable (6.00e-4)" 14.9 15.0 52.8 7.0 49.0 0.5 11.2 30.1 99.3 28.0 8.7 38.9 2.4 3.8 20.6 27.6 12.8 15.7 14.6 11.0 40.2 25.2 7.1 8.0 20.9 4.2 32.0 24.9 16.6 4.4 18.8 7.9 17.7 25.8 17.1 10.2 17.3 8.4 20.1 5.8 18.3 5.6 19.8 28.1 5.3 6.6 4.8 24.1 0.9 5.4 6.4 7.1 8.6 11.1 0.6 15.2 0.0 0.0 0.0 0.1 0.0 2.7 1.6 10.7 2.8 43.0 41.2 0.1 14.0 37.5 7.0 7.5 0.0 2.7 9.3 9.1 24.4 10.2 1.4 4.4 6.7 0.0 4.2 0.0 0.2 0.2 13.3 0.1 0.3 40.4 6.7 10.4 8.6 4.6 0.0 0.3 17.5 5.1 0.2 1.0 0.4 0.0 6.3 21.7 0.0 3.7 3.0 3.5 15.2 3.7 0.1 23.0 8.7 13.0 5.6 51.8 2.7 10.1 15.1 0.0 0.1 0.1 12.4 0.0 77.2 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.1 0.2 0.1 0.0 0.0 0.0 0.0 15.2 0.0 0.0 52.8 49.0 30.1 38.9 40.2 25.2 32.0 24.9 25.8 24.1 PDE3A CGI-PDE ENSG00000172572 "Phosphodiesterase 3A" Q14432 12 20369245-20684381 "Disease related genes, Enzymes, FDA approved drug targets, Plasma proteins, Predicted membrane proteins" Hydrolase "Disease mutation, FDA approved drug targets" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "heart muscle: 62.2" "Cell line enhanced" "Detected in some" "AF22: 7.7;HEL: 14.2;HeLa: 38.7;HUVEC TERT2: 6.9;SH-SY5Y: 14.5;U-138 MG: 11.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Region enhanced" "Detected in many" "cerebellum: 35.4" "HPA014492, HPA074258" Uncertain Approved "Plasma membrane" 23000 "Plasma membrane" "HPA014492: AB_1855120, HPA074258: " "unprognostic (2.59e-2)" "unprognostic (2.94e-2)" "unprognostic (1.25e-1)" "unprognostic (3.23e-1)" "unprognostic (2.27e-1)" "unprognostic (1.21e-1)" "unprognostic (3.50e-2)" "unprognostic (1.67e-2)" "unprognostic (8.14e-2)" "unprognostic (1.49e-1)" "unprognostic (4.25e-1)" "unprognostic (3.37e-1)" "prognostic unfavourable (1.72e-6)" "unprognostic (5.58e-2)" "unprognostic (5.94e-2)" "unprognostic (4.28e-2)" "unprognostic (2.76e-4)" 7.1 1.0 1.7 4.7 2.0 0.0 3.8 3.5 1.4 7.8 15.9 1.0 2.0 2.1 7.8 3.5 9.1 4.9 5.5 62.2 1.6 1.4 3.7 1.8 3.9 3.3 1.9 1.1 7.1 6.5 1.0 2.8 13.8 2.7 6.3 9.0 12.0 7.8 4.2 2.0 1.4 21.4 6.0 1.8 2.1 5.5 2.3 0.7 0.0 2.8 1.9 0.9 4.0 3.7 0.0 0.0 0.0 0.0 0.0 0.0 0.7 0.0 0.2 7.7 0.0 1.8 1.3 0.0 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 14.2 38.7 0.2 0.6 0.0 0.0 1.8 0.0 0.4 0.0 6.9 0.0 0.0 0.0 0.0 0.0 0.0 1.3 1.1 0.0 0.0 0.0 2.1 0.0 0.1 14.5 0.0 0.0 0.0 0.0 0.0 0.2 11.2 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 1.7 2.0 3.5 1.4 1.6 1.4 1.9 1.1 2.7 0.7 PDE4A DPDE2 ENSG00000065989 "Phosphodiesterase 4A" P27815 19 10416773-10469631 "Enzymes, FDA approved drug targets, Predicted intracellular proteins" Hydrolase "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 38.5;testis: 31.8" "Cell line enhanced" "Detected in many" "HMC-1: 21.6;NB-4: 24.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB017632, HPA043310, HPA076091" Uncertain Supported "Plasma membrane" "Plasma membrane" "CAB017632: AB_1127109, HPA043310: , HPA076091: " "unprognostic (1.29e-2)" "unprognostic (3.98e-2)" "unprognostic (8.91e-2)" "unprognostic (1.82e-1)" "unprognostic (7.00e-2)" "unprognostic (6.84e-2)" "unprognostic (1.54e-2)" "unprognostic (4.39e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-2)" "unprognostic (6.90e-2)" "unprognostic (2.41e-1)" "unprognostic (2.27e-2)" "unprognostic (1.64e-2)" "unprognostic (2.57e-2)" "unprognostic (1.67e-1)" "unprognostic (2.15e-1)" 6.4 2.5 9.0 4.2 13.9 3.4 6.3 15.0 38.5 8.4 4.3 3.2 0.4 2.0 4.4 1.1 3.1 4.8 5.0 4.1 12.4 6.9 2.8 1.9 7.7 2.0 5.3 19.4 1.7 9.8 17.3 2.3 4.9 34.7 3.7 3.0 3.1 7.1 4.0 26.1 2.2 2.7 4.7 3.6 4.1 6.1 31.8 4.5 0.0 5.4 1.0 1.9 4.6 3.5 0.2 3.3 5.9 4.4 5.3 2.0 1.3 0.0 1.4 0.3 3.9 11.4 6.8 2.2 3.2 6.5 0.4 1.1 3.4 3.1 1.4 9.6 8.4 0.3 2.2 0.4 0.2 3.7 3.2 13.4 4.7 3.7 7.4 2.2 21.6 5.0 0.4 3.6 0.0 3.1 10.5 3.2 2.3 0.9 1.3 24.9 1.7 2.8 8.8 2.2 11.5 0.5 0.8 2.5 0.9 0.2 0.1 3.5 0.5 4.4 6.5 4.9 6.3 3.3 2.0 6.4 0.5 7.1 2.1 0.1 3.9 5.9 2.6 5.1 1.5 4.4 0.8 0.2 0.5 2.0 3.3 0.1 0.1 0.7 0.2 5.3 4.4 0.2 1.2 1.3 9.0 13.9 15.0 38.5 12.4 6.9 5.3 19.4 34.7 4.5 PEBP1 "HCNP, PBP, PEBP, RKIP" ENSG00000089220 "Phosphatidylethanolamine binding protein 1" P30086 12 118135858-118145584 "Plasma proteins, Predicted intracellular proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "liver: 260.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "HPA008819, CAB013493, HPA063904" Enhanced Supported "Plasma membrane" 62000000 "Plasma membrane" "CAB013493: AB_2533305, HPA008819: AB_1855173, HPA063904: " "unprognostic (4.57e-1)" "unprognostic (1.03e-3)" "unprognostic (3.28e-2)" "unprognostic (3.39e-3)" "unprognostic (2.05e-1)" "unprognostic (1.59e-1)" "unprognostic (1.24e-2)" "unprognostic (7.35e-3)" "unprognostic (5.67e-2)" "unprognostic (3.55e-2)" "prognostic favourable (1.52e-4)" "unprognostic (1.63e-1)" "prognostic favourable (2.15e-13)" "unprognostic (2.17e-1)" "unprognostic (7.72e-2)" "unprognostic (7.96e-2)" "unprognostic (8.80e-2)" 26.8 207.3 83.0 15.2 82.3 13.5 32.3 63.3 102.7 35.5 50.4 58.0 18.9 75.3 22.9 52.8 24.3 28.5 22.6 57.6 77.6 69.7 132.7 260.7 22.1 16.0 77.8 71.5 43.5 46.2 139.2 30.8 16.5 59.1 35.4 25.4 41.2 43.6 33.1 65.1 20.9 75.4 23.4 79.1 15.3 20.6 22.7 43.5 8.7 94.9 26.1 19.7 20.2 17.8 45.2 37.3 3.0 12.1 20.9 45.3 36.4 31.7 27.1 38.5 40.0 60.7 29.8 59.9 25.3 29.6 40.0 20.6 16.2 11.0 51.2 25.5 37.9 22.9 56.9 23.5 31.3 12.8 54.4 25.7 30.6 112.6 35.1 46.5 11.3 29.4 39.1 23.6 16.5 18.6 42.6 19.1 40.0 37.6 25.3 94.2 37.3 32.9 50.1 28.7 93.4 49.0 31.0 46.1 35.8 52.6 36.6 49.5 52.5 31.7 20.1 30.8 17.5 30.0 25.4 18.7 33.2 26.4 36.1 34.8 33.2 0.7 11.0 3.0 26.9 12.1 42.4 45.2 45.3 33.3 33.3 32.5 43.9 35.3 1.2 20.9 10.3 37.3 41.2 36.4 83.0 82.3 63.3 102.7 77.6 69.7 77.8 71.5 59.1 43.5 PHACTR1 "dJ257A7.2, KIAA1733, RPEL1" ENSG00000112137 "Phosphatase and actin regulator 1" Q9C0D0 6 12716805-13290484 "Predicted intracellular proteins" "Actin-binding, Protein phosphatase inhibitor" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 25.9;brain: 80.3" "Cell line enhanced" "Detected in many" "HMC-1: 16.4;SK-MEL-30: 15.4;U-266/70: 40.3;U-266/84: 26.2" "Cancer enhanced" "Detected in many" "melanoma: 10.2" "Region enhanced" "Detected in all" "basal ganglia: 80.3" "Group enriched" "Detected in many" 13 "memory B-cell: 7.2;myeloid DC: 7.7;naive B-cell: 20.9;neutrophil: 10.1;plasmacytoid DC: 25.9" "Group enriched" "Detected in many" 17 "B-cells: 20.9;dendritic cells: 25.9;granulocytes: 10.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029755, HPA029756, HPA029757" Enhanced Uncertain "Plasma membrane" "Plasma membrane" "HPA029755: AB_10600089, HPA029756: AB_10601852, HPA029757: AB_10669870" "unprognostic (7.86e-2)" "unprognostic (7.49e-2)" "unprognostic (2.74e-2)" "unprognostic (2.80e-1)" "unprognostic (1.59e-1)" "unprognostic (1.29e-1)" "unprognostic (7.72e-2)" "unprognostic (4.80e-2)" "unprognostic (1.10e-1)" "unprognostic (1.22e-1)" "unprognostic (3.67e-4)" "unprognostic (1.53e-1)" "prognostic unfavourable (5.48e-6)" "unprognostic (1.31e-1)" "unprognostic (1.43e-1)" "unprognostic (5.00e-2)" "unprognostic (1.16e-1)" 3.5 1.6 11.6 7.2 80.3 22.6 1.6 4.9 31.4 1.4 1.4 1.3 0.3 2.0 1.3 2.6 1.5 1.9 4.2 9.2 10.9 4.4 3.9 1.9 9.0 8.7 2.7 16.6 1.8 4.2 0.5 6.0 1.7 2.2 1.4 1.5 0.6 1.4 0.7 1.2 2.6 2.9 1.7 2.6 6.5 2.0 2.2 7.2 0.4 1.3 0.0 13.4 3.4 1.4 20.9 25.9 10.1 1.1 0.4 0.2 1.1 0.0 0.1 1.1 0.2 0.0 0.0 3.2 0.3 1.2 1.2 2.1 0.0 0.0 0.2 0.4 0.1 0.1 0.0 0.0 1.5 4.1 0.3 8.2 0.1 0.1 0.1 7.7 16.4 0.4 0.0 0.0 0.1 1.5 3.8 7.0 1.1 0.0 0.1 6.0 1.1 0.0 3.9 2.1 0.7 0.9 0.1 4.9 1.4 0.0 3.1 15.4 9.4 1.8 1.6 0.1 0.3 0.0 0.0 40.3 26.2 6.8 0.6 2.2 6.2 0.1 1.1 0.6 0.1 0.9 0.0 7.2 0.1 0.0 7.7 20.9 0.1 0.2 10.1 0.4 0.3 25.9 0.0 1.1 11.6 80.3 4.9 31.4 10.9 4.4 2.7 16.6 2.2 7.2 PI3 "cementoin, ELAFIN, ESI, SKALP, WAP3, WFDC14" ENSG00000124102 "Peptidase inhibitor 3" P19957 20 45174876-45176544 "Plasma proteins, Predicted secreted proteins" "Protease inhibitor, Serine protease inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 157.1;esophagus: 200.8;lymphoid tissue: 173.5;tongue: 468.6" "Group enriched" "Detected in some" 6 "EFO-21: 27.0;HaCaT: 32.8;PC-3: 55.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 2666.5" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 1121 "neutrophil: 157.1" "Lineage enriched" "Detected in single" 1571 "granulocytes: 157.1" "CAB009449, HPA017737" Enhanced Approved "Plasma membrane" "Secreted to blood" 2100000 "Plasma membrane" "CAB009449: AB_2252354, HPA017737: AB_1848107" "prognostic favourable (6.94e-4)" "unprognostic (3.61e-2)" "unprognostic (1.00e-1)" "unprognostic (8.30e-2)" "unprognostic (7.34e-2)" "unprognostic (1.85e-1)" "unprognostic (3.20e-3)" "unprognostic (5.53e-3)" "unprognostic (1.75e-1)" "prognostic unfavourable (3.84e-6)" "prognostic unfavourable (6.89e-4)" "unprognostic (8.54e-3)" "prognostic unfavourable (1.94e-8)" "unprognostic (1.23e-1)" "unprognostic (7.38e-2)" "unprognostic (1.04e-2)" "unprognostic (5.91e-3)" 0.4 0.0 0.2 8.8 0.2 0.0 0.7 0.2 0.2 85.3 9.3 0.2 0.4 0.1 7.7 0.2 200.8 0.3 4.8 0.6 0.2 0.0 0.3 0.6 3.1 0.8 0.2 0.2 0.3 0.4 0.0 0.2 0.6 0.3 1.0 3.7 0.3 35.6 0.4 0.2 6.4 3.2 0.6 0.2 1.4 0.7 5.1 0.2 23.4 0.2 468.6 173.5 1.6 118.7 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.2 0.1 0.0 0.9 0.6 0.4 27.0 0.0 32.8 0.0 6.7 0.0 0.3 0.0 0.1 2.0 0.2 0.0 0.2 0.0 0.0 6.4 5.3 0.5 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 55.7 0.0 0.3 0.0 6.4 0.1 0.0 0.0 4.6 0.6 0.0 0.0 0.0 0.2 0.3 3.2 0.0 0.2 0.1 0.4 0.1 4.3 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 157.1 0.0 0.0 0.0 0.0 0.0 0.2 0.2 0.2 0.2 0.2 0.0 0.2 0.2 0.3 0.2 PI4K2A "DKFZP761G1923, PI4KII, PIK42A" ENSG00000155252 "Phosphatidylinositol 4-kinase type 2 alpha" Q9BTU6 10 97640686-97676434 "Enzymes, Predicted intracellular proteins" "Kinase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB030649, HPA076857" Approved Approved "Plasma membrane" "Plasma membrane" "CAB030649: , HPA076857: " "unprognostic (1.34e-1)" "unprognostic (3.50e-2)" "prognostic unfavourable (4.21e-5)" "unprognostic (1.80e-2)" "unprognostic (2.12e-1)" "unprognostic (1.75e-2)" "unprognostic (2.84e-3)" "unprognostic (1.60e-2)" "unprognostic (1.39e-3)" "unprognostic (1.38e-2)" "unprognostic (1.02e-2)" "unprognostic (1.65e-1)" "unprognostic (9.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.80e-1)" "unprognostic (1.45e-1)" "unprognostic (2.90e-1)" 17.2 23.0 13.8 10.7 21.2 22.8 9.5 16.8 33.8 12.0 9.1 16.8 9.5 10.9 12.8 15.5 18.3 8.9 16.1 15.2 14.5 17.9 14.7 17.1 15.0 11.0 15.9 15.7 10.6 9.5 23.2 15.5 19.9 30.7 10.3 10.2 23.8 10.1 12.7 11.3 15.3 9.9 15.0 9.9 14.4 8.8 14.9 7.5 8.2 12.0 8.8 11.8 13.6 11.2 4.1 3.7 1.1 3.4 1.9 4.0 1.6 12.0 9.1 7.5 13.4 16.2 11.7 6.1 12.1 26.7 19.1 20.3 8.2 12.0 4.4 7.2 15.3 11.7 8.4 24.1 15.9 5.3 7.1 3.9 6.4 7.4 15.5 3.5 5.6 12.3 20.6 20.0 35.6 9.7 6.1 7.2 13.2 6.1 7.6 2.7 4.8 8.6 3.6 7.8 4.3 13.1 11.3 2.5 8.4 10.2 2.6 15.0 7.1 5.6 10.7 9.1 6.8 10.8 9.3 6.4 7.5 7.2 16.9 2.1 2.9 0.0 3.4 0.0 4.0 2.3 2.8 4.1 1.7 3.4 3.7 1.9 1.4 2.6 1.1 1.9 1.6 1.7 3.1 1.6 13.8 21.2 16.8 33.8 14.5 17.9 15.9 15.7 30.7 7.5 PIGW "FLJ37433, Gwt1" ENSG00000277161 "Phosphatidylinositol glycan anchor biosynthesis class W" Q7Z7B1 17 36535020-36539310 "Disease related genes, Predicted membrane proteins" "GPI-anchor biosynthesis" "Acyltransferase, Transferase" "Disease mutation, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023499 Approved "Plasma membrane" "Plasma membrane" "HPA023499: " "unprognostic (4.96e-3)" "unprognostic (3.84e-2)" "unprognostic (5.40e-3)" "unprognostic (7.39e-2)" "unprognostic (2.32e-1)" "unprognostic (7.71e-2)" "unprognostic (8.14e-3)" "unprognostic (1.05e-1)" "unprognostic (1.89e-1)" "unprognostic (4.62e-2)" "unprognostic (1.98e-1)" "unprognostic (3.29e-1)" "unprognostic (1.73e-2)" "unprognostic (1.41e-1)" "unprognostic (8.96e-2)" "unprognostic (1.08e-3)" "unprognostic (1.88e-1)" 3.0 2.4 2.5 4.9 2.9 3.0 4.5 1.8 6.4 2.5 3.8 2.4 0.4 3.3 3.2 4.4 5.7 2.0 2.7 3.5 2.3 6.7 12.0 2.9 4.7 3.6 2.2 4.3 4.8 3.3 6.0 2.6 6.3 2.1 4.8 3.7 3.7 2.8 6.5 5.0 3.9 3.1 3.2 4.3 3.3 3.4 2.2 4.0 4.1 8.1 5.5 2.4 1.2 4.4 6.2 1.1 4.9 4.8 5.8 3.3 7.3 9.7 6.8 6.2 2.9 2.6 8.9 8.9 3.8 8.1 6.6 8.5 7.7 11.0 2.7 4.8 10.4 11.9 4.9 11.0 6.1 12.6 9.4 6.1 6.8 2.3 19.4 10.4 3.0 5.7 8.9 3.9 4.5 15.9 6.9 5.6 5.4 9.5 5.7 9.7 6.5 8.5 16.0 10.8 4.3 9.6 13.5 10.2 12.7 4.6 6.2 17.0 3.0 6.1 13.8 16.8 13.3 15.7 5.9 18.5 13.2 3.7 9.8 12.4 1.1 2.8 0.5 3.6 4.2 5.6 2.5 4.7 3.6 6.2 4.4 5.8 5.2 0.9 4.8 4.9 2.9 2.4 3.3 PITPNM3 "ACKR6, CORD5, NIR1, RDGBA3" ENSG00000091622 "PITPNM family member 3" Q9BZ71 17 6451264-6556494 "Disease related genes, Predicted intracellular proteins" "Cone-rod dystrophy, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2" "Cell line enhanced" "Detected in some" "HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 58 "neutrophil: 5.8" "Lineage enriched" "Detected in single" 58 "granulocytes: 5.8" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA022432, HPA059005" Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA022432: AB_2670936, HPA059005: AB_2683876" "unprognostic (2.97e-2)" "unprognostic (8.60e-3)" "unprognostic (1.45e-2)" "unprognostic (1.52e-1)" "unprognostic (2.69e-2)" "prognostic favourable (3.67e-6)" "unprognostic (1.25e-2)" "unprognostic (6.86e-2)" "unprognostic (3.66e-2)" "unprognostic (3.01e-2)" "unprognostic (2.99e-3)" "unprognostic (3.58e-2)" "unprognostic (2.41e-1)" "unprognostic (9.60e-2)" "unprognostic (1.61e-1)" "unprognostic (3.55e-1)" "unprognostic (2.63e-1)" 1.1 2.4 17.9 1.2 18.8 0.5 1.7 18.7 23.0 2.4 4.5 0.7 3.4 1.5 1.9 3.4 9.4 4.3 3.8 0.8 7.2 5.2 1.5 1.6 3.1 0.6 2.9 11.9 24.2 0.9 1.9 0.7 0.6 2.5 2.7 3.6 2.3 1.9 8.3 1.1 14.3 1.4 3.8 0.9 43.3 3.2 2.4 1.5 0.0 2.4 0.7 2.1 1.3 2.5 0.0 0.0 5.8 0.0 0.0 0.0 0.0 5.4 0.5 0.4 0.2 0.0 0.1 0.4 0.4 0.1 0.5 0.3 0.3 3.9 0.1 2.1 0.1 11.1 0.2 2.3 0.2 0.2 0.4 0.1 8.6 0.1 0.6 0.2 0.3 0.1 32.3 0.6 1.8 0.3 0.1 0.0 0.3 0.5 0.0 0.1 0.6 1.6 0.1 1.2 0.0 0.8 0.1 0.3 0.3 5.0 2.4 0.1 0.8 0.0 0.2 0.3 2.1 0.4 1.3 0.3 0.1 0.0 0.4 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 5.8 0.0 0.0 0.0 0.0 0.0 17.9 18.8 18.7 23.0 7.2 5.2 2.9 11.9 2.5 1.5 PLAUR "CD87, UPAR, URKR" ENSG00000011422 "Plasminogen activator, urokinase receptor" Q03405 19 43646095-43670547 "Cancer-related genes, CD markers, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 118.0;bone marrow: 165.0" "Cell line enhanced" "Detected in many" "hTEC/SVTERT24-B: 49.4;U-251 MG: 70.2;U-87 MG: 61.3;WM-115: 59.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 118.0" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" "HPA050843, CAB073533" Uncertain Supported "Plasma membrane" "Intracellular and membrane" 760000 "Plasma membrane" "CAB073533: , HPA050843: " "unprognostic (9.28e-2)" "unprognostic (9.65e-3)" "unprognostic (1.39e-1)" "unprognostic (1.29e-3)" "unprognostic (3.59e-3)" "unprognostic (1.50e-2)" "unprognostic (2.18e-3)" "prognostic unfavourable (2.33e-5)" "unprognostic (8.08e-3)" "unprognostic (4.30e-2)" "unprognostic (2.29e-3)" "unprognostic (5.30e-2)" "prognostic unfavourable (7.83e-9)" "unprognostic (4.99e-2)" "unprognostic (1.66e-1)" "unprognostic (5.45e-2)" "unprognostic (9.33e-2)" 25.2 3.6 3.0 23.6 4.8 165.0 6.3 2.2 6.1 10.7 7.5 4.4 1.8 3.3 9.5 6.0 8.6 10.6 23.0 11.5 4.5 3.2 5.1 6.1 39.4 8.1 6.0 1.1 11.9 4.3 2.5 4.4 12.2 6.9 6.1 6.0 4.6 11.0 3.7 7.9 3.5 7.3 7.2 7.1 12.6 12.0 6.3 6.3 2.5 4.4 7.7 7.0 22.7 14.9 0.2 21.3 118.0 50.5 0.6 0.9 21.0 14.0 4.9 4.5 0.3 4.0 14.4 2.7 29.6 30.1 18.7 23.5 0.4 16.6 0.5 7.5 18.3 6.0 1.2 7.3 20.9 0.9 0.9 2.6 7.4 0.6 5.1 3.1 34.3 14.8 1.4 49.4 7.4 20.6 2.7 0.6 17.9 1.0 3.4 8.4 1.4 10.6 3.9 3.0 1.0 5.8 0.7 0.2 3.9 13.2 3.0 3.9 0.6 9.8 21.1 41.3 21.2 18.9 70.2 0.6 1.4 0.1 61.3 5.8 59.7 7.2 48.9 72.4 0.7 41.5 0.8 0.2 0.9 0.6 21.3 0.1 0.3 0.4 118.0 0.6 50.5 6.8 0.3 21.0 3.0 4.8 2.2 6.1 4.5 3.2 6.0 1.1 6.9 6.3 PLCB1 "KIAA0581, PLC-I, PLC154" ENSG00000182621 "Phospholipase C beta 1" Q9NQ66 20 8077251-8968360 "Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" Epilepsy "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "parathyroid gland: 56.7" "Cell line enhanced" "Detected in many" "CACO-2: 21.6;Hep G2: 32.5" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB004275, CAB005334, HPA034743, HPA057910" Enhanced Approved "Plasma membrane" 5400 "Plasma membrane" "CAB004275: AB_628118, CAB005334: AB_632196, HPA034743: , HPA057910: " "unprognostic (2.32e-1)" "unprognostic (1.02e-1)" "unprognostic (6.63e-2)" "unprognostic (9.77e-2)" "unprognostic (9.87e-2)" "unprognostic (2.37e-1)" "unprognostic (1.27e-4)" "unprognostic (1.13e-1)" "unprognostic (3.16e-2)" "unprognostic (1.91e-1)" "unprognostic (7.12e-3)" "unprognostic (6.57e-2)" "unprognostic (2.87e-3)" "unprognostic (3.20e-2)" "unprognostic (4.41e-2)" "unprognostic (1.71e-2)" "unprognostic (2.12e-1)" 5.6 7.0 13.8 4.4 27.7 3.4 5.9 7.5 31.1 6.5 9.9 2.1 20.6 5.5 8.0 10.3 4.5 7.4 6.6 8.6 15.7 9.1 10.0 3.1 4.0 1.6 9.3 14.5 3.2 10.8 56.7 4.6 14.2 5.5 10.4 3.6 1.3 19.7 22.2 9.8 2.3 4.5 12.3 4.0 2.9 5.5 2.6 8.0 4.1 3.1 1.9 1.1 8.6 6.3 0.5 0.8 2.8 3.3 2.4 5.2 0.4 0.0 0.6 2.3 0.1 4.3 8.1 3.1 9.7 6.4 2.5 1.5 21.6 2.4 1.0 4.1 1.8 0.0 1.7 0.0 1.9 0.0 2.1 0.4 1.6 32.5 1.1 0.5 0.3 0.5 0.4 3.4 0.0 5.1 3.3 12.6 0.0 2.9 0.4 1.5 7.3 3.5 6.9 0.0 5.7 1.9 8.0 8.3 3.6 0.0 2.0 0.4 9.6 3.1 0.9 8.3 3.7 0.6 6.0 9.5 11.0 16.3 4.2 5.9 14.3 0.8 3.3 2.8 3.6 0.7 5.2 0.2 1.0 1.3 0.4 0.5 0.5 1.1 2.1 2.4 0.4 0.8 0.2 0.4 13.8 27.7 7.5 30.8 15.7 9.1 9.3 14.5 5.5 8.0 PLCD3 ENSG00000161714 "Phospholipase C delta 3" Q8N3E9 17 45108967-45133354 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Lipid degradation, Lipid metabolism" "Hydrolase, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 63.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA025711, HPA053665" Approved Approved "Plasma membrane" "Plasma membrane" "HPA025711: AB_1855320, HPA053665: " "unprognostic (3.58e-2)" "unprognostic (1.66e-1)" "unprognostic (2.77e-2)" "unprognostic (1.27e-2)" "unprognostic (2.66e-1)" "unprognostic (4.14e-3)" "unprognostic (8.13e-3)" "prognostic unfavourable (2.89e-6)" "unprognostic (2.96e-1)" "unprognostic (9.53e-2)" "unprognostic (1.34e-3)" "unprognostic (6.21e-2)" "unprognostic (3.18e-2)" "unprognostic (2.07e-1)" "unprognostic (1.62e-1)" "prognostic favourable (4.28e-4)" "unprognostic (3.34e-3)" 5.7 12.0 10.1 4.8 16.5 2.4 6.6 12.2 12.9 5.0 24.9 14.0 2.8 2.9 6.3 6.4 8.9 5.8 9.4 13.1 11.6 6.6 3.6 1.2 4.5 1.7 13.9 11.4 9.9 2.7 1.5 3.0 5.7 19.5 5.8 13.7 10.3 4.7 5.7 63.6 9.9 2.8 12.9 15.0 2.0 17.9 5.4 14.6 0.0 2.3 20.1 2.8 17.5 10.5 1.3 0.9 2.9 1.5 1.3 0.9 0.5 9.0 22.8 1.7 3.3 2.5 5.4 11.5 5.0 11.2 4.6 4.4 5.6 16.7 0.3 18.1 11.7 20.9 2.6 21.5 1.8 4.5 8.6 0.3 24.0 7.1 12.9 0.5 1.3 5.8 8.7 4.3 5.7 2.8 1.9 0.7 4.9 14.3 1.4 2.1 2.0 22.5 3.2 3.8 0.6 14.7 18.2 0.4 3.0 5.4 9.1 4.9 19.3 1.0 5.7 2.9 16.0 3.8 5.8 0.8 1.0 0.7 4.7 0.6 2.3 2.3 1.5 2.4 0.9 1.5 0.6 1.0 0.7 0.6 0.5 1.3 0.9 0.8 2.9 1.3 0.3 0.9 0.6 0.5 10.1 16.5 12.2 11.5 11.6 6.6 13.9 11.4 19.5 14.6 PLPP1 "LPP1, PAP-2a, PPAP2A" ENSG00000067113 "Phospholipid phosphatase 1" O14494 5 55424854-55535050 "Enzymes, Predicted membrane proteins" Hydrolase "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 91.2;fHDF/TERT166: 27.7;HMC-1: 47.8;HSkMC: 35.0" "Cancer enhanced" "Detected in all" "prostate cancer: 200.4" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB033331, HPA047815" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB033331: AB_2168044, HPA047815: " "unprognostic (1.22e-1)" "unprognostic (1.54e-1)" "unprognostic (1.74e-1)" "unprognostic (1.55e-2)" "unprognostic (2.52e-1)" "unprognostic (1.36e-1)" "prognostic favourable (6.06e-4)" "unprognostic (2.81e-1)" "unprognostic (2.20e-1)" "unprognostic (4.05e-3)" "unprognostic (2.43e-2)" "unprognostic (1.05e-1)" "unprognostic (4.37e-3)" "prognostic unfavourable (5.77e-4)" "unprognostic (3.94e-2)" "unprognostic (1.66e-1)" "unprognostic (3.11e-2)" 56.3 26.7 12.5 14.8 14.6 0.6 57.9 10.6 18.5 34.5 30.9 26.1 18.0 17.3 36.8 26.0 18.4 20.4 61.0 33.7 13.4 10.8 34.5 42.0 15.9 17.3 20.8 10.1 16.5 17.6 16.9 10.1 22.4 21.4 82.0 24.7 29.8 9.8 24.0 18.4 16.6 25.4 39.6 28.2 10.2 21.7 18.1 14.5 4.4 32.7 9.6 10.0 43.1 18.1 5.4 13.6 3.3 0.7 2.7 9.5 1.6 1.9 4.8 1.4 2.8 91.2 10.6 2.0 4.3 12.1 2.4 5.6 3.3 3.6 2.0 4.1 27.7 1.2 4.9 2.4 2.7 1.3 3.9 0.2 2.1 4.1 14.4 0.5 47.8 35.0 5.1 3.5 2.2 3.9 0.0 5.5 4.7 1.2 1.3 1.0 3.2 3.9 0.4 2.4 0.1 9.1 15.5 1.7 1.2 4.3 0.8 2.6 3.1 0.3 4.8 0.8 1.4 3.6 3.1 3.4 1.4 2.3 3.2 0.2 3.9 0.0 0.4 3.3 1.5 0.4 1.6 5.4 5.2 3.2 1.9 3.4 9.5 7.5 0.3 2.7 0.7 13.6 2.2 1.6 12.5 14.6 10.6 18.5 13.4 10.8 20.8 10.1 21.4 14.5 PLXNA4 "DKFZp434G0625PRO34003, FAYV2820, KIAA1550, PLXNA4A, PLXNA4B" ENSG00000221866 "Plexin A4" Q9HCM2 7 132123332-132648688 "Predicted intracellular proteins, Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 23.2;breast: 34.7" "Cell line enhanced" "Detected in some" "ASC diff: 14.9;HMC-1: 9.9;RH-30: 10.7;TIME: 32.6" "Cancer enhanced" "Detected in many" "glioma: 3.3" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in some" 5 "plasmacytoid DC: 6.1" "Lineage enriched" "Detected in many" 5 "dendritic cells: 6.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA029919, HPA052141, HPA075592" Approved Approved "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "HPA029919: AB_10671093, HPA052141: , HPA075592: " "unprognostic (2.05e-2)" "unprognostic (3.59e-2)" "unprognostic (2.08e-2)" "prognostic unfavourable (1.61e-6)" "unprognostic (5.76e-2)" "unprognostic (1.21e-2)" "unprognostic (1.28e-2)" "unprognostic (2.43e-2)" "unprognostic (2.19e-1)" "unprognostic (7.99e-2)" "unprognostic (7.64e-2)" "unprognostic (1.14e-1)" "unprognostic (1.69e-5)" "unprognostic (1.67e-1)" "unprognostic (2.28e-1)" "unprognostic (5.90e-2)" "unprognostic (1.42e-3)" 23.2 5.1 8.7 3.5 9.0 1.1 34.7 3.9 15.1 16.2 2.0 1.0 0.8 1.5 2.3 1.0 7.7 3.0 4.2 6.9 9.7 7.2 2.0 1.3 1.8 2.5 4.0 6.6 6.2 1.0 1.0 1.6 6.7 6.6 1.4 2.1 0.7 1.2 2.4 1.7 4.1 1.4 5.1 1.5 2.4 2.8 2.4 1.8 0.0 3.3 0.0 1.3 2.1 9.4 0.0 6.1 0.0 0.0 1.1 0.2 0.0 0.0 0.0 0.1 0.0 14.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 4.7 0.0 0.0 0.0 0.0 9.9 0.1 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 10.7 1.1 0.0 0.0 0.2 5.6 0.0 0.0 0.0 0.0 0.0 32.6 3.3 0.1 0.7 0.2 0.0 0.0 0.0 3.1 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 1.1 0.0 6.1 0.0 0.0 8.7 9.0 3.9 15.1 9.7 7.2 4.0 6.6 6.6 1.8 PPP1R16A "MGC14333, MYPT3" ENSG00000160972 "Protein phosphatase 1 regulatory subunit 16A" Q96I34 8 144477969-144502121 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "intestine: 23.3" "Cell line enhanced" "Detected in many" "MCF7: 25.7" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA023755 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA023755: AB_1854268" "unprognostic (9.63e-2)" "unprognostic (4.51e-2)" "unprognostic (5.45e-3)" "unprognostic (3.11e-1)" "unprognostic (5.60e-2)" "unprognostic (3.75e-2)" "unprognostic (4.64e-3)" "unprognostic (2.65e-1)" "unprognostic (3.68e-2)" "unprognostic (2.20e-2)" "unprognostic (1.52e-2)" "unprognostic (1.35e-1)" "unprognostic (1.05e-1)" "unprognostic (1.29e-2)" "unprognostic (1.03e-1)" "unprognostic (9.45e-2)" "unprognostic (2.79e-2)" 3.0 3.8 6.5 3.1 6.8 2.2 3.0 3.3 4.8 3.0 11.1 3.0 3.0 20.5 3.0 3.0 3.0 6.7 3.0 3.0 6.5 4.6 6.5 5.3 3.0 3.0 3.1 3.0 3.0 5.7 4.0 10.2 3.0 3.0 3.4 1.6 3.0 5.4 4.5 3.4 3.7 23.3 3.0 3.0 3.0 7.8 7.4 3.0 3.0 6.8 3.0 3.0 3.0 3.0 2.5 3.2 0.7 4.1 0.7 3.2 2.1 15.6 12.7 2.1 8.1 0.8 1.5 10.4 4.3 2.7 3.4 2.7 3.3 11.2 2.6 11.4 1.6 10.4 1.1 3.5 0.5 5.3 6.3 3.1 12.3 3.5 2.6 2.2 4.3 1.5 4.8 3.9 1.1 2.4 12.2 3.3 1.2 25.7 7.7 10.2 3.9 16.1 8.2 1.0 5.2 3.0 5.2 6.7 12.9 7.9 7.3 6.5 17.3 4.7 4.0 3.9 18.2 10.6 8.1 2.1 2.1 0.9 12.4 4.3 3.4 0.0 2.3 0.0 3.2 3.4 2.8 2.5 2.3 2.9 3.2 0.5 1.7 3.1 0.7 0.7 4.1 1.8 1.7 2.1 6.5 6.8 3.3 4.8 6.5 4.6 3.1 3.0 3.0 3.0 PPP1R9A "FLJ20068, KIAA1222, Neurabin-I" ENSG00000158528 "Protein phosphatase 1 regulatory subunit 9A" Q9ULJ8 7 94907202-95296415 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Actin-binding, Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "HAP1: 10.3;RH-30: 10.3" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 5.8;NK-cell: 10.9" "Group enriched" "Detected in many" 6 "granulocytes: 5.8;NK-cells: 10.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA027726, HPA075591" Approved Approved "Plasma membrane" "Plasma membrane" "HPA027726: AB_1855653, HPA075591: " "unprognostic (1.05e-1)" "unprognostic (6.59e-2)" "unprognostic (5.90e-2)" "unprognostic (1.63e-2)" "unprognostic (1.35e-1)" "unprognostic (1.12e-1)" "unprognostic (8.62e-2)" "unprognostic (6.19e-2)" "unprognostic (1.45e-1)" "prognostic favourable (7.17e-4)" "unprognostic (2.26e-2)" "unprognostic (1.89e-1)" "prognostic favourable (8.63e-6)" "unprognostic (2.74e-1)" "unprognostic (4.85e-2)" "unprognostic (8.47e-2)" "unprognostic (8.79e-3)" 2.9 11.7 11.0 1.9 23.5 0.8 8.1 10.9 19.7 5.2 8.7 7.4 7.7 3.0 5.4 9.2 3.2 9.6 4.4 8.2 11.5 9.7 8.2 1.1 6.4 0.9 8.1 13.7 5.0 14.3 16.5 15.5 4.5 12.7 4.2 6.8 5.7 14.2 5.3 6.7 1.1 3.0 5.1 9.1 3.2 6.2 10.0 11.2 0.0 10.9 1.3 1.0 4.2 1.4 1.3 0.3 5.8 0.1 10.9 0.2 0.2 0.0 9.3 5.8 6.5 0.0 0.0 4.7 0.4 0.1 0.8 0.7 5.1 3.1 0.0 7.9 0.4 0.0 10.3 0.0 1.2 0.0 4.0 9.5 3.8 5.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.7 4.0 0.1 0.0 4.8 1.7 0.0 10.3 0.0 9.6 7.6 6.2 6.5 0.0 0.8 1.3 1.9 0.0 0.0 0.1 3.8 0.1 3.3 6.3 9.1 0.0 0.1 0.0 0.7 5.8 0.0 0.5 0.0 0.0 0.2 0.9 0.0 0.0 0.0 1.3 0.0 0.0 0.0 10.9 0.1 0.3 0.0 0.2 11.0 23.5 10.9 18.3 11.5 9.7 8.1 13.7 12.7 11.2 PRRT2 "DKFZp547J199, DSPB3, DYT10, EKD1, FICCA, FLJ25513, ICCA, IFITMD1, PKC" ENSG00000167371 "Proline rich transmembrane protein 2" Q7Z6L0 16 29811382-29815892 "Disease related genes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Disease mutation, Dystonia, Epilepsy" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 86.7" "Cell line enhanced" "Detected in many" "AF22: 19.9;REH: 15.2;U-138 MG: 13.7" "Cancer enhanced" "Detected in many" "glioma: 5.8" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 11 "NK-cell: 7.3" "Lineage enriched" "Detected in single" 11 "NK-cells: 7.3" "HPA014447, HPA019203" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA014447: AB_1855786, HPA019203: " "unprognostic (7.60e-3)" "unprognostic (3.00e-1)" "unprognostic (8.32e-3)" "unprognostic (4.34e-2)" "unprognostic (3.72e-2)" "unprognostic (1.19e-3)" "unprognostic (2.85e-1)" "unprognostic (1.23e-1)" "unprognostic (9.30e-2)" "unprognostic (1.93e-1)" "unprognostic (4.45e-2)" "unprognostic (3.26e-2)" "unprognostic (3.43e-8)" "unprognostic (1.22e-1)" "unprognostic (1.17e-1)" "unprognostic (5.12e-2)" "unprognostic (2.44e-2)" 3.7 7.2 27.2 2.8 40.5 0.8 2.1 86.7 53.6 10.1 6.0 6.0 3.1 6.2 20.7 8.3 4.4 10.2 10.3 5.3 18.9 13.0 2.1 0.9 5.7 3.5 5.5 33.2 35.7 2.4 8.6 17.6 7.1 18.0 16.2 2.6 5.2 4.6 14.4 4.3 3.1 6.8 10.3 7.4 1.8 7.3 9.9 10.2 0.0 2.8 0.3 1.6 5.1 10.7 0.2 0.0 0.5 0.2 7.3 0.6 0.3 0.3 1.2 19.9 7.4 1.0 3.8 0.5 2.4 4.0 0.8 0.9 1.1 2.3 0.2 0.5 3.3 2.0 2.7 0.4 0.3 5.3 1.6 1.3 8.9 0.8 0.2 0.0 0.3 3.4 0.1 1.4 0.1 1.0 0.2 1.6 0.6 3.3 0.5 0.6 5.7 1.0 15.2 1.1 0.4 0.1 0.7 4.3 4.5 0.2 2.9 0.4 7.4 0.1 1.1 13.7 4.8 0.8 1.3 3.4 0.4 0.1 5.4 0.1 0.5 0.5 0.0 0.1 0.2 0.1 0.3 0.1 0.6 0.4 0.0 0.2 0.4 0.2 0.2 7.3 0.2 0.0 0.1 0.3 27.2 40.5 86.7 53.6 18.9 13.0 5.5 33.2 18.0 10.2 PSCA ENSG00000167653 "Prostate stem cell antigen" O43653 8 142670308-142682724 "Cancer-related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "esophagus: 72.6;stomach 1: 230.2;urinary bladder: 112.0" "Cell line enhanced" "Detected in some" "CAPAN-2: 11.5;HeLa: 22.2;RT4: 31.8;SK-BR-3: 8.1" "Cancer enriched" "Detected in many" 6 "urothelial cancer: 785.0" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "HPA030783, HPA056418" Approved Supported "Plasma membrane" "Plasma membrane" "HPA030783: , HPA056418: " "unprognostic (1.21e-3)" "unprognostic (1.76e-3)" "unprognostic (3.20e-1)" "unprognostic (2.24e-1)" "unprognostic (1.77e-2)" "unprognostic (7.57e-2)" "unprognostic (1.93e-2)" "unprognostic (7.81e-3)" "unprognostic (8.25e-3)" "unprognostic (2.13e-1)" "prognostic unfavourable (5.60e-5)" "unprognostic (6.82e-2)" "unprognostic (2.38e-3)" "unprognostic (4.93e-2)" "unprognostic (2.68e-1)" "unprognostic (3.07e-1)" "unprognostic (1.06e-3)" 0.4 0.2 0.0 0.2 0.0 0.2 0.3 0.0 0.2 7.0 2.4 0.7 0.1 0.6 0.3 0.2 72.6 1.1 21.2 0.1 0.0 0.0 2.6 0.1 3.0 0.2 0.0 0.0 0.1 0.3 0.1 0.5 17.2 0.0 30.1 0.7 0.1 11.7 0.6 0.1 0.8 1.5 18.9 0.0 0.2 230.2 0.2 0.0 0.0 0.1 9.3 35.1 112.0 54.5 0.0 0.8 0.0 0.3 0.0 0.0 0.0 5.3 0.3 0.0 0.0 1.1 3.7 5.5 2.5 0.5 1.1 0.9 0.0 11.5 0.0 0.2 0.2 1.1 0.0 0.2 0.6 0.3 0.0 0.0 22.2 0.0 0.0 0.0 0.7 3.2 4.1 2.4 0.0 0.0 0.0 0.0 0.8 2.9 0.8 0.3 0.6 0.6 0.3 0.0 0.4 0.5 31.8 0.1 0.2 2.6 8.1 1.7 0.1 0.1 0.5 0.8 0.9 1.5 0.0 1.0 0.0 0.0 1.5 0.4 0.4 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 PTPRG "PTPG, RPTPG" ENSG00000144724 "Protein tyrosine phosphatase, receptor type G" P23470 3 61561569-62297613 "Enzymes, Plasma proteins, Predicted membrane proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 35.5;HSkMC: 26.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "memory B-cell: 1.3" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA000546, HPA064237" Uncertain Approved "Plasma membrane" 520000000 "Plasma membrane" "HPA000546: , HPA064237: " "unprognostic (1.47e-1)" "unprognostic (1.03e-1)" "unprognostic (1.31e-2)" "unprognostic (1.93e-1)" "unprognostic (8.73e-2)" "unprognostic (3.26e-1)" "unprognostic (5.38e-2)" "unprognostic (1.18e-2)" "unprognostic (5.84e-2)" "unprognostic (2.28e-1)" "unprognostic (2.86e-1)" "unprognostic (1.14e-1)" "prognostic favourable (3.10e-6)" "unprognostic (9.91e-2)" "unprognostic (3.25e-1)" "unprognostic (1.19e-1)" "unprognostic (2.63e-2)" 22.2 18.0 12.9 10.1 10.7 1.2 26.1 8.1 16.4 17.2 13.9 5.2 12.0 5.6 15.8 19.0 6.4 13.1 15.7 12.4 24.5 9.9 20.2 8.2 38.9 10.2 8.3 10.5 16.6 6.0 58.6 11.9 13.1 15.1 11.3 8.9 23.3 7.9 17.2 19.2 6.6 8.4 17.4 12.7 9.2 8.7 11.4 5.0 0.1 21.7 7.0 3.2 10.0 14.6 1.3 0.9 0.0 0.0 0.0 0.0 0.0 0.0 2.1 11.4 0.0 35.5 18.1 5.5 7.0 11.6 7.5 10.2 5.3 0.2 0.2 4.1 8.3 0.1 5.5 5.5 12.0 0.6 3.1 0.5 0.0 6.1 11.9 2.9 0.0 26.3 2.2 10.7 13.0 8.1 0.0 7.0 6.8 3.0 0.0 0.0 7.0 0.0 4.6 3.5 0.2 7.8 3.3 0.8 1.8 1.7 0.0 2.7 0.0 0.1 18.5 10.6 10.1 16.9 5.9 2.2 2.6 0.0 8.1 1.3 12.7 0.0 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 12.9 10.7 8.1 16.4 24.5 9.9 8.3 10.5 15.1 5.0 PTPRM "hR-PTPu, PTPRL1, RPTPU" ENSG00000173482 "Protein tyrosine phosphatase, receptor type M" P28827 18 7566782-8406861 "Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" "Cell adhesion" "Hydrolase, Protein phosphatase, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC diff: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "memory CD8 T-cell: 7.2" "Group enriched" "Detected in many" 50 "dendritic cells: 2.7;T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA003891, CAB022442, CAB022443" Supported Approved "Plasma membrane" 76000000 "Plasma membrane" "CAB022442: , CAB022443: , HPA003891: " "unprognostic (2.59e-1)" "prognostic unfavourable (8.65e-5)" "unprognostic (4.89e-2)" "unprognostic (1.00e-1)" "unprognostic (1.13e-1)" "unprognostic (1.46e-1)" "unprognostic (1.80e-1)" "unprognostic (3.41e-2)" "unprognostic (7.62e-2)" "unprognostic (2.74e-2)" "unprognostic (1.56e-2)" "unprognostic (9.64e-2)" "unprognostic (5.63e-2)" "unprognostic (3.11e-3)" "unprognostic (9.41e-2)" "unprognostic (2.63e-2)" "prognostic favourable (1.07e-4)" 31.4 14.1 9.5 6.3 22.2 0.6 23.6 10.4 17.2 11.0 13.6 6.2 28.1 4.7 15.4 10.9 8.1 13.6 18.1 33.5 10.5 15.0 16.9 6.5 22.0 7.8 8.5 12.0 15.7 7.6 16.3 21.9 18.3 23.2 10.6 6.6 18.3 7.4 21.8 26.0 7.3 8.7 14.1 9.3 12.1 11.0 12.2 9.1 2.9 31.1 7.3 6.3 18.6 25.3 0.0 2.7 0.0 0.0 0.0 7.2 1.4 1.5 11.3 5.4 0.0 34.8 24.1 13.1 13.8 12.2 9.3 13.8 10.3 2.4 0.0 13.6 16.6 0.1 0.0 4.8 12.9 0.1 2.5 0.0 7.5 5.0 9.9 0.0 0.1 27.4 10.2 5.1 14.7 9.3 0.0 4.7 7.4 0.2 4.5 0.1 0.9 2.5 0.1 4.7 20.9 22.8 19.4 0.4 3.0 0.4 0.0 11.6 0.0 0.0 9.6 19.2 12.1 9.1 2.4 0.4 0.1 0.0 16.4 0.0 3.5 0.0 0.0 0.0 4.5 0.0 1.8 0.0 6.0 7.2 0.1 0.0 1.7 3.1 0.0 0.0 0.0 2.7 1.0 1.4 9.5 22.2 10.4 17.2 10.5 15.0 8.5 12.0 23.2 9.1 PTX3 "TNFAIP5, TSG-14" ENSG00000163661 "Pentraxin 3" P26022 3 157436789-157443628 "Plasma proteins, Predicted secreted proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "adipose tissue: 61.7;skeletal muscle: 67.7;urinary bladder: 77.0" "Cell line enhanced" "Detected in many" "ASC diff: 84.6;ASC TERT1: 122.6;BJ hTERT+: 80.5;HHSteC: 157.4;HSkMC: 163.9;hTEC/SVTERT24-B: 86.6;TIME: 116.7;U-2197: 108.8" "Cancer enhanced" "Detected in many" "glioma: 22.5" "Group enriched" "Detected in some" 6 "hippocampal formation: 1.1;pons and medulla: 3.6" "Cell type enhanced" "Detected in some" "eosinophil: 3.2" "Group enriched" "Detected in many" 20 "dendritic cells: 1.3;granulocytes: 3.2;monocytes: 1.2" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" HPA069320 Approved Approved "Plasma membrane" "Secreted to blood" 1090000 310000 "Plasma membrane" "HPA069320: " "unprognostic (1.93e-2)" "unprognostic (4.96e-3)" "unprognostic (1.35e-1)" "prognostic unfavourable (8.35e-9)" "unprognostic (5.79e-3)" "prognostic unfavourable (6.36e-4)" "unprognostic (6.03e-3)" "prognostic unfavourable (8.75e-6)" "unprognostic (2.45e-1)" "unprognostic (6.69e-2)" "unprognostic (7.60e-2)" "unprognostic (2.63e-1)" "unprognostic (2.76e-9)" "unprognostic (6.03e-3)" "unprognostic (5.98e-2)" "unprognostic (2.15e-4)" "unprognostic (1.92e-3)" 61.7 3.4 0.3 16.7 0.2 31.6 35.3 0.2 0.7 0.8 13.2 0.3 0.6 0.5 0.5 0.8 2.0 6.5 3.5 14.7 1.1 0.0 3.0 0.6 22.5 7.0 0.3 0.1 6.8 18.0 0.3 1.0 4.9 3.6 2.5 1.2 5.2 1.8 0.4 67.7 6.0 1.9 6.4 0.9 9.6 4.9 0.9 0.2 0.3 2.7 0.4 0.4 77.0 2.5 0.0 1.3 3.2 1.2 0.0 0.0 0.1 0.0 0.0 51.0 0.0 84.6 122.6 0.0 8.8 80.5 3.8 4.1 0.0 0.5 0.0 31.4 10.3 0.0 0.0 0.0 7.5 0.0 0.0 0.1 0.0 0.0 157.4 0.1 0.0 163.9 0.0 86.6 29.5 17.8 0.0 0.0 25.4 0.0 0.0 0.1 0.7 0.3 0.0 0.0 0.0 0.3 3.5 0.4 0.0 0.5 0.0 0.0 0.0 0.1 116.7 17.3 0.8 108.8 1.5 0.0 0.0 0.0 3.6 0.4 4.9 0.0 1.2 3.2 0.0 1.2 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.0 0.1 0.0 0.4 0.0 0.0 0.1 0.3 0.2 0.2 0.2 1.1 0.0 0.3 0.1 3.6 0.2 PXDC1 C6orf145 ENSG00000168994 "PX domain containing 1" Q5TGL8 6 3722614-3752026 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 79.6" "Cell line enhanced" "Detected in many" "HHSteC: 42.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 4 "memory B-cell: 4.2" "Lineage enriched" "Detected in single" 4 "B-cells: 4.2" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA019246 Approved "Plasma membrane" "Plasma membrane" "HPA019246: " "unprognostic (1.55e-1)" "unprognostic (1.87e-2)" "prognostic unfavourable (3.64e-4)" "prognostic unfavourable (1.14e-4)" "unprognostic (2.82e-2)" "unprognostic (3.80e-2)" "unprognostic (2.95e-1)" "unprognostic (1.48e-1)" "unprognostic (6.73e-2)" "unprognostic (6.08e-2)" "unprognostic (2.32e-1)" "unprognostic (2.13e-1)" "unprognostic (2.01e-2)" "unprognostic (6.17e-3)" "unprognostic (1.10e-1)" "unprognostic (2.97e-1)" "unprognostic (2.84e-1)" 26.3 5.5 5.9 5.9 6.5 0.4 30.6 3.2 6.6 11.1 10.3 6.4 5.3 10.7 10.1 14.4 13.9 8.3 18.5 10.8 6.5 4.4 13.4 79.6 14.2 5.8 7.5 3.1 6.2 10.0 3.4 4.3 32.9 6.2 9.1 3.1 7.5 12.3 8.1 11.9 11.7 16.9 20.6 7.0 6.1 8.9 3.9 6.9 1.0 16.8 11.5 5.8 14.9 21.0 4.2 0.3 0.5 0.0 0.0 0.9 0.3 11.5 4.9 8.1 5.4 25.6 19.3 26.0 21.0 16.2 18.0 13.9 8.1 2.3 0.0 13.7 34.4 8.7 1.6 5.8 8.6 11.7 1.6 0.0 3.5 7.2 42.8 0.0 0.0 17.5 19.0 11.1 24.0 19.6 0.0 1.5 14.0 0.7 0.0 0.1 0.3 5.9 0.6 4.3 0.4 6.8 9.7 0.9 0.4 14.0 14.4 28.3 1.1 0.7 20.5 15.3 6.5 5.9 14.3 0.0 0.0 0.0 3.4 0.0 9.9 0.0 0.0 0.0 0.0 0.0 0.3 4.2 0.1 0.0 0.3 0.2 0.0 0.0 0.5 0.0 0.0 0.0 0.9 0.3 5.9 6.5 3.2 6.6 6.5 4.4 7.5 3.1 6.2 6.9 RAB43 "ISY1, RAB11B, RAB41" ENSG00000172780 "RAB43, member RAS oncogene family" Q86YS6 3 129087569-129122801 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "liver: 73.9" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "neutrophil: 13.3" "Group enriched" "Detected in all" 5 "granulocytes: 13.3;T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046840, HPA060085" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA046840: , HPA060085: " "unprognostic (3.01e-1)" "unprognostic (1.14e-2)" "unprognostic (3.08e-1)" "unprognostic (1.01e-1)" "unprognostic (5.08e-2)" "unprognostic (1.91e-1)" "unprognostic (9.36e-2)" "unprognostic (3.17e-2)" "unprognostic (4.16e-1)" "unprognostic (8.68e-2)" "unprognostic (3.14e-1)" "unprognostic (3.08e-1)" "unprognostic (2.46e-2)" "unprognostic (9.32e-2)" "unprognostic (5.82e-3)" "unprognostic (1.42e-1)" "unprognostic (2.71e-2)" 5.4 6.2 3.9 8.0 3.3 14.6 5.3 6.0 3.6 6.4 7.0 3.2 7.2 5.8 5.4 6.8 4.1 5.3 12.0 3.8 2.8 2.0 9.1 73.9 11.4 12.1 2.7 1.6 7.8 7.4 2.5 8.0 4.7 3.7 7.3 1.7 7.7 7.4 4.7 1.9 3.0 5.9 4.9 2.7 9.9 5.7 5.2 2.1 17.3 17.1 2.6 13.6 6.6 6.0 1.3 1.1 13.3 1.6 1.5 3.5 1.3 15.4 4.3 1.0 4.1 1.9 0.9 6.1 5.4 3.5 3.0 2.6 6.6 6.7 0.4 12.4 3.9 6.5 0.4 6.1 0.7 7.8 4.1 1.0 0.7 8.6 19.1 3.5 9.2 5.2 3.8 1.5 0.4 6.1 1.7 7.8 4.3 6.6 3.4 6.8 4.9 7.0 7.4 2.3 4.4 9.9 13.2 0.3 1.9 2.3 5.0 9.9 2.1 3.7 8.8 6.8 4.8 5.5 2.0 12.2 6.4 2.4 6.2 0.7 7.3 0.5 1.5 2.6 1.9 1.6 0.9 0.6 1.8 1.5 0.7 1.3 3.5 3.0 13.3 1.5 0.7 1.1 2.7 1.3 3.9 3.3 6.0 3.6 2.8 2.0 2.7 1.6 3.7 2.1 RABEPK "bA65N13.1, RAB9P40" ENSG00000136933 "Rab9 effector protein with kelch motifs" Q7Z6M1 9 125200542-125234158 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA023920, HPA067106" Supported Uncertain "Plasma membrane" "Plasma membrane" "HPA023920: AB_1856023, HPA067106: " "unprognostic (8.72e-2)" "unprognostic (1.29e-1)" "unprognostic (1.76e-2)" "unprognostic (1.58e-1)" "unprognostic (3.24e-2)" "unprognostic (2.70e-2)" "unprognostic (3.47e-2)" "unprognostic (3.47e-2)" "unprognostic (9.74e-2)" "unprognostic (4.92e-2)" "unprognostic (1.27e-1)" "unprognostic (1.92e-1)" "unprognostic (1.52e-3)" "unprognostic (1.09e-1)" "unprognostic (1.63e-1)" "unprognostic (8.25e-2)" "unprognostic (2.69e-1)" 11.9 11.7 14.9 11.5 21.6 8.6 13.7 9.3 21.3 11.0 11.4 12.4 9.0 9.9 18.7 15.3 12.9 13.7 10.6 11.6 13.8 15.1 9.8 49.6 8.6 13.9 16.5 17.7 11.5 10.9 7.7 13.6 10.2 15.0 10.1 13.1 9.5 13.0 12.0 17.4 12.4 8.5 14.3 13.0 8.1 9.0 11.1 12.6 11.6 9.2 10.0 11.4 10.2 10.0 15.9 14.6 19.0 13.5 13.8 28.5 16.0 9.5 23.4 8.9 16.4 14.3 17.5 17.0 13.7 13.4 16.3 13.0 28.7 9.9 29.7 12.0 18.4 26.4 22.7 17.0 15.9 16.6 19.0 12.7 21.9 42.5 13.0 24.5 9.2 12.8 20.9 23.5 24.9 17.1 28.6 8.2 15.3 27.2 17.1 16.8 18.5 21.7 25.0 17.0 32.5 12.9 7.7 21.5 10.5 14.0 9.3 15.7 19.6 10.7 14.4 10.7 11.1 25.7 23.4 11.2 24.7 20.1 14.2 16.3 16.5 16.5 13.5 14.9 17.2 10.8 15.9 15.9 25.0 16.8 14.6 13.4 28.5 20.6 19.0 13.8 11.1 14.0 25.3 16.0 14.9 21.6 9.3 21.3 13.8 15.1 16.5 17.7 15.0 12.6 RAI2 ENSG00000131831 "Retinoic acid induced 2" Q9Y5P3 X 17800049-17861337 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enriched" "Detected in some" 10 "ASC diff: 48.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "naive CD4 T-cell: 1.5;naive CD8 T-cell: 5.1" "Lineage enriched" "Detected in single" 11 "T-cells: 5.1" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA051054 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA051054: " "unprognostic (3.45e-2)" "unprognostic (9.61e-2)" "unprognostic (2.41e-1)" "unprognostic (2.03e-2)" "unprognostic (1.98e-1)" "unprognostic (2.49e-2)" "unprognostic (4.10e-2)" "unprognostic (2.51e-2)" "unprognostic (1.44e-1)" "unprognostic (1.49e-1)" "prognostic favourable (2.77e-4)" "unprognostic (1.31e-2)" "prognostic favourable (3.39e-14)" "unprognostic (1.57e-2)" "unprognostic (2.33e-1)" "unprognostic (1.82e-2)" "unprognostic (2.80e-2)" 23.6 9.7 2.5 10.1 4.0 0.0 28.5 4.0 4.9 41.0 13.7 1.7 15.0 3.5 29.6 17.8 12.2 27.9 21.2 16.1 2.4 2.7 9.4 1.9 14.5 12.9 2.4 1.8 32.7 7.7 4.6 11.1 7.1 2.9 28.3 4.5 10.7 6.6 18.7 7.2 8.3 8.8 20.4 2.7 2.4 12.0 16.2 2.1 2.0 15.1 6.3 5.9 24.2 53.6 0.0 0.0 0.0 0.0 0.4 5.1 0.4 0.0 0.0 0.1 0.0 48.4 4.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 3.9 0.1 0.0 0.0 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.5 0.0 0.0 0.8 0.2 0.0 0.0 0.0 2.6 0.0 0.5 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 1.5 5.1 0.0 0.4 0.0 0.0 0.0 0.4 2.5 4.0 4.0 4.9 2.4 2.7 2.4 1.8 2.9 2.1 RCSD1 "CapZIP, MGC21854, MK2S4" ENSG00000198771 "RCSD domain containing 1" Q6JBY9 1 167630093-167706249 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 56.4;lymphoid tissue: 70.8;skeletal muscle: 52.3" "Cell line enhanced" "Detected in some" "Daudi: 47.6;REH: 47.7;RPMI-8226: 32.6;THP-1: 25.1;U-266/70: 31.9;U-698: 31.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA016597, HPA073490" Enhanced Approved "Plasma membrane" 150000 "Plasma membrane" "HPA016597: , HPA073490: " "unprognostic (2.13e-2)" "unprognostic (7.38e-3)" "unprognostic (6.50e-3)" "unprognostic (1.37e-3)" "unprognostic (1.08e-1)" "prognostic favourable (2.97e-4)" "unprognostic (5.51e-2)" "unprognostic (8.90e-3)" "unprognostic (3.65e-1)" "unprognostic (8.48e-2)" "unprognostic (1.01e-1)" "unprognostic (6.33e-2)" "unprognostic (2.53e-3)" "unprognostic (3.19e-1)" "unprognostic (3.58e-2)" "unprognostic (6.94e-2)" "unprognostic (3.97e-2)" 8.5 2.9 3.5 33.3 4.8 19.2 7.3 1.2 3.1 3.0 8.4 3.6 1.3 3.6 2.7 5.4 4.1 3.1 8.8 18.4 3.9 3.6 4.2 3.7 9.0 45.6 5.1 2.2 2.5 1.5 0.8 2.0 7.0 3.1 3.7 5.0 3.1 6.5 2.5 52.3 2.3 20.1 7.4 6.9 40.6 4.9 3.7 3.4 70.8 4.8 12.7 29.2 7.4 4.5 51.0 22.1 56.4 38.2 26.6 27.8 26.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 47.6 0.1 0.0 0.0 0.0 0.0 0.0 20.0 0.0 0.3 0.0 0.0 0.0 8.1 0.9 0.1 0.0 0.1 0.0 0.0 15.2 14.0 6.4 0.0 15.1 11.7 0.4 0.0 47.7 0.2 32.6 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 25.1 0.1 0.0 0.1 0.0 0.0 31.9 9.5 31.4 0.0 15.6 0.0 48.4 38.2 56.4 15.2 25.1 18.3 45.6 19.8 18.9 22.1 51.0 17.2 15.9 38.5 26.6 24.1 12.8 27.8 26.3 3.5 4.8 1.2 3.1 3.9 3.6 5.1 2.2 3.1 3.4 RECK "hRECK, ST15" ENSG00000122707 "Reversion inducing cysteine rich protein with kazal motifs" O95980 9 36036433-36124451 "Plasma proteins, Predicted membrane proteins" "Wnt signaling pathway" "Protease inhibitor, Serine protease inhibitor" "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 54.0;ASC TERT1: 43.3;BJ: 16.8;BJ hTERT+: 24.2;HSkMC: 19.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB025109, HPA071729" Supported Supported "Plasma membrane" 37000000 "Plasma membrane" "CAB025109: , HPA071729: " "unprognostic (3.42e-1)" "unprognostic (4.01e-3)" "unprognostic (5.50e-2)" "unprognostic (5.05e-4)" "unprognostic (8.87e-2)" "unprognostic (8.47e-2)" "unprognostic (2.24e-1)" "unprognostic (2.23e-1)" "unprognostic (3.75e-2)" "unprognostic (1.51e-2)" "unprognostic (9.06e-2)" "unprognostic (8.48e-2)" "unprognostic (7.45e-2)" "prognostic unfavourable (7.31e-4)" "unprognostic (2.68e-2)" "unprognostic (1.50e-2)" "unprognostic (3.60e-2)" 15.9 8.9 6.9 6.3 8.2 1.5 31.7 9.1 7.8 18.9 10.2 8.5 6.2 4.3 18.4 7.5 13.7 12.0 15.6 11.3 8.4 4.9 6.9 6.7 16.7 6.1 8.3 4.9 17.2 3.9 3.7 7.8 12.7 8.3 12.3 7.6 10.5 7.8 8.9 5.7 8.7 7.7 17.3 7.9 8.1 9.8 7.9 8.5 8.4 10.5 9.8 6.2 17.8 16.8 3.5 3.7 1.2 5.5 3.6 8.9 3.1 0.3 0.6 2.1 1.1 54.0 43.3 0.0 16.8 24.2 1.2 2.9 0.0 0.0 0.6 1.6 14.8 0.1 0.4 0.3 1.7 1.0 0.9 0.6 0.7 0.0 4.3 0.0 2.9 19.3 0.4 1.8 0.7 3.8 0.0 0.5 3.1 0.0 1.6 0.2 0.7 0.5 1.7 1.6 0.0 0.8 0.0 0.2 1.1 0.3 0.2 0.6 0.0 2.2 11.4 2.3 0.8 1.5 0.9 0.7 0.8 0.7 1.4 2.2 1.5 1.2 3.3 0.9 5.4 3.5 6.1 1.7 7.1 5.7 3.7 3.5 8.9 6.4 0.5 3.6 5.5 2.1 3.2 3.1 6.9 8.2 9.1 7.8 8.4 4.9 8.3 4.9 8.3 8.5 RGS3 "C2PA, FLJ20370, PDZ-RGS3" ENSG00000138835 "Regulator of G protein signaling 3" P49796 9 113444731-113597743 "Plasma proteins, Predicted intracellular proteins" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 52.5;HDLM-2: 84.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044234 Supported "Plasma membrane" "Plasma membrane" "HPA044234: " "prognostic unfavourable (9.93e-4)" "unprognostic (4.04e-2)" "unprognostic (5.33e-3)" "unprognostic (6.71e-3)" "unprognostic (1.49e-2)" "unprognostic (1.69e-2)" "prognostic unfavourable (6.62e-4)" "unprognostic (6.79e-2)" "unprognostic (9.17e-2)" "unprognostic (2.24e-1)" "unprognostic (8.59e-3)" "unprognostic (3.04e-1)" "unprognostic (2.51e-3)" "unprognostic (1.52e-2)" "unprognostic (1.45e-1)" "unprognostic (8.53e-2)" "unprognostic (2.90e-1)" 25.2 17.8 7.6 10.7 18.3 4.7 34.0 4.2 13.8 9.8 13.0 27.9 5.1 9.9 11.4 8.0 11.3 8.4 25.0 52.2 9.7 10.1 31.9 20.1 24.9 12.5 18.4 8.5 7.2 17.5 6.3 8.1 18.9 18.1 14.5 9.6 12.9 5.6 6.6 24.6 7.0 10.8 17.9 16.8 16.2 12.3 14.8 17.1 4.0 13.2 10.7 8.3 18.3 8.1 1.4 3.8 10.6 4.1 22.4 15.0 7.8 0.9 3.5 8.5 7.8 2.6 3.9 0.6 8.6 52.5 7.0 6.0 8.4 3.2 3.6 6.4 6.9 2.2 0.1 3.3 4.1 84.3 0.0 0.3 2.8 5.1 5.4 0.0 1.1 7.1 3.5 19.5 2.8 26.4 0.0 3.6 12.7 3.8 0.2 0.3 2.2 2.9 0.2 4.2 0.5 14.5 1.7 6.7 0.9 0.8 6.7 5.1 4.6 0.7 12.7 23.7 2.5 1.0 16.2 1.8 0.3 0.5 27.3 0.8 10.8 3.4 3.5 2.1 15.0 4.1 10.1 1.4 3.5 12.1 3.8 1.2 1.4 6.6 10.6 22.4 3.1 0.1 2.0 7.8 7.6 18.3 4.2 13.8 9.7 10.1 18.4 8.5 18.1 17.1 RGS9BP "FLJ45744, PERRS, R9AP, RGS9" ENSG00000186326 "Regulator of G protein signaling 9 binding protein" Q6ZS82 19 32675407-32678300 "Disease related genes, Predicted membrane proteins" "Sensory transduction, Vision" "Signal transduction inhibitor" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "retina: 38.3;skeletal muscle: 15.8" "Cell line enhanced" "Detected in some" "HEL: 10.4;HMC-1: 2.8" "Not detected" "Not detected" "Region enriched" "Detected in many" 6 "pons and medulla: 6.8" "Cell type enhanced" "Detected in some" "gdT-cell: 1.4;memory CD8 T-cell: 1.5" "Low lineage specificity" "Detected in single" "Not detected" "Not detected" "Not detected" "Not detected" HPA049791 Enhanced Approved "Plasma membrane" "Plasma membrane" "HPA049791: " "unprognostic (2.82e-2)" "unprognostic (6.99e-3)" "unprognostic (2.44e-3)" "unprognostic (1.20e-7)" "unprognostic (1.49e-1)" "unprognostic (1.21e-2)" "unprognostic (1.17e-2)" "unprognostic (1.32e-1)" "unprognostic (2.80e-1)" "unprognostic (6.71e-2)" "unprognostic (6.74e-2)" "unprognostic (3.89e-2)" "unprognostic (1.63e-3)" "unprognostic (2.29e-1)" "unprognostic (8.22e-2)" "unprognostic (5.23e-2)" "unprognostic (5.34e-2)" 0.4 0.5 0.8 0.3 1.1 0.3 0.4 0.2 0.7 0.3 0.4 1.4 0.2 0.4 0.3 0.6 1.1 0.4 0.3 6.7 1.0 0.8 0.9 0.3 0.9 0.3 1.1 0.3 0.3 0.4 0.4 0.6 0.4 6.8 1.3 0.3 38.3 0.5 0.6 15.8 0.6 0.3 7.4 1.3 0.4 0.4 0.9 0.9 0.1 0.4 4.3 0.3 2.3 1.0 0.0 0.3 0.0 0.9 0.5 1.5 0.0 0.2 0.2 0.0 0.9 0.5 0.2 0.5 0.0 0.5 0.3 0.2 0.2 0.3 0.4 0.5 0.1 0.0 1.8 0.1 0.1 0.5 0.2 10.4 0.3 0.0 0.2 0.3 2.8 0.0 0.5 0.0 0.4 0.0 0.9 1.5 0.2 0.4 0.0 1.7 0.0 2.0 0.1 0.4 0.2 0.0 0.1 0.3 0.1 0.0 1.1 0.1 1.0 0.5 0.0 0.5 0.7 0.2 0.3 0.6 0.7 0.1 0.3 0.6 0.8 0.0 0.3 0.0 1.4 0.9 0.0 0.0 0.2 1.5 0.3 0.0 0.0 0.4 0.0 0.5 0.3 0.0 0.0 0.0 0.8 1.1 0.2 0.7 1.0 0.8 1.1 0.3 6.8 0.9 RHEX "C1orf186, FLJ16052" ENSG00000263961 "Regulator of hemoglobinization and erythroid cell expansion" Q6ZWK4 1 206052723-206102459 "Predicted membrane proteins" "Differentiation, Erythrocyte maturation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 7 "blood: 117.7" "Cell line enriched" "Detected in some" 5 "HMC-1: 185.0" "Cancer enhanced" "Detected in many" "endometrial cancer: 42.8;ovarian cancer: 41.1" "Cell type enriched" "Detected in some" 51 "basophil: 117.7" "Lineage enriched" "Detected in many" 51 "granulocytes: 117.7" "Low region specificity" "Detected in all" HPA037859 Supported "Plasma membrane" "Plasma membrane" "HPA037859: AB_10697084" "unprognostic (9.26e-3)" "unprognostic (1.91e-2)" "unprognostic (9.66e-2)" "unprognostic (1.65e-2)" "unprognostic (2.06e-2)" "unprognostic (5.27e-3)" "unprognostic (9.55e-2)" "unprognostic (3.04e-3)" "unprognostic (2.36e-1)" "unprognostic (1.31e-2)" "unprognostic (1.35e-1)" "unprognostic (7.20e-3)" "unprognostic (1.89e-2)" "unprognostic (3.02e-2)" "unprognostic (1.35e-1)" "unprognostic (3.77e-2)" "unprognostic (2.80e-3)" 4.3 0.0 0.0 3.9 0.0 0.0 1.8 0.0 0.0 13.1 3.1 0.0 12.1 0.9 6.2 8.2 3.4 1.6 16.2 0.4 0.0 6.8 1.8 5.2 4.0 0.0 0.0 0.8 0.0 0.0 0.0 1.2 0.0 9.4 3.3 2.9 0.0 16.9 1.5 0.2 4.0 7.0 0.0 0.4 2.4 1.1 0.0 0.6 0.0 1.7 2.5 4.3 10.0 0.3 2.2 117.7 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 2.2 0.0 0.1 0.0 0.0 0.0 0.0 0.0 16.2 0.0 0.1 0.0 8.4 185.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.7 37.2 0.0 0.0 0.0 0.0 0.2 2.3 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 117.7 0.0 1.0 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 2.2 0.0 0.2 RHOBTB2 "DBC2, KIAA0717" ENSG00000008853 "Rho related BTB domain containing 2" Q9BYZ6 8 22987417-23020199 "Predicted intracellular proteins" "Disease mutation, Epilepsy" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "Daudi: 31.1;hTCEpi: 27.7;RT4: 46.6" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA060938 Approved Approved "Plasma membrane" "Plasma membrane" "HPA060938: " "unprognostic (2.67e-3)" "unprognostic (1.64e-1)" "unprognostic (1.64e-1)" "unprognostic (7.94e-2)" "unprognostic (7.83e-3)" "unprognostic (2.13e-2)" "unprognostic (8.13e-2)" "unprognostic (8.17e-2)" "unprognostic (3.47e-3)" "unprognostic (1.93e-2)" "unprognostic (1.60e-2)" "unprognostic (1.46e-2)" "prognostic favourable (2.98e-4)" "unprognostic (2.01e-1)" "unprognostic (1.09e-1)" "unprognostic (8.89e-3)" "unprognostic (2.43e-1)" 5.9 7.4 14.8 6.4 33.2 2.0 5.3 5.1 36.9 4.4 8.1 7.2 24.4 7.7 6.3 5.2 4.6 6.6 6.0 17.6 14.0 9.1 6.0 1.9 31.0 12.2 9.8 14.4 15.9 7.2 5.8 9.0 10.0 8.0 5.7 2.5 11.2 5.6 22.6 10.9 3.5 19.7 6.1 4.0 10.4 6.9 7.0 6.5 5.5 14.9 2.8 14.5 13.7 3.4 7.8 2.9 4.5 1.6 4.4 2.8 1.1 2.4 4.8 3.9 6.2 4.8 3.3 5.3 3.4 4.5 5.3 4.1 12.4 2.4 31.1 5.2 4.9 4.9 1.9 19.0 2.6 2.6 1.1 3.3 6.6 3.5 2.3 1.9 7.0 4.3 27.7 5.6 2.8 3.8 0.8 3.0 3.5 7.1 1.2 3.1 4.1 3.4 1.6 6.3 2.1 3.8 46.6 2.5 4.7 2.6 7.9 5.2 1.5 5.1 4.7 6.7 4.9 12.0 3.8 7.8 7.5 11.2 6.5 2.9 5.2 4.5 1.0 1.3 2.8 1.6 1.9 7.8 0.8 1.3 1.0 7.1 1.1 1.1 0.2 4.4 1.6 2.9 1.4 1.1 14.8 33.2 5.1 36.9 14.0 9.1 9.8 14.4 8.0 6.5 ROBO1 "DUTT1, FLJ21882, SAX3" ENSG00000169855 "Roundabout guidance receptor 1" Q9Y6N7 3 78597240-79767815 "Predicted intracellular proteins, Predicted membrane proteins" "Chemotaxis, Differentiation, Neurogenesis" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in some" "naive CD8 T-cell: 3.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB013524, HPA052968, HPA074461" Uncertain Enhanced "Plasma membrane" 6500000 "Plasma membrane" "CAB013524: , HPA052968: , HPA074461: " "unprognostic (2.89e-1)" "unprognostic (6.42e-2)" "unprognostic (2.29e-2)" "unprognostic (1.30e-1)" "unprognostic (4.77e-2)" "unprognostic (1.61e-3)" "prognostic unfavourable (9.88e-4)" "unprognostic (2.44e-1)" "unprognostic (2.92e-2)" "unprognostic (2.00e-1)" "unprognostic (6.40e-2)" "unprognostic (1.42e-1)" "unprognostic (1.65e-1)" "unprognostic (6.77e-2)" "unprognostic (1.91e-1)" "unprognostic (2.39e-2)" "unprognostic (1.16e-2)" 12.5 10.1 15.5 10.7 30.2 0.4 7.3 12.5 22.0 15.9 9.4 14.7 1.6 3.5 10.5 8.2 13.7 5.6 8.6 9.0 12.3 12.4 3.7 4.0 8.3 9.3 14.7 8.9 18.4 2.3 2.1 29.6 8.4 12.2 14.5 6.9 8.5 5.5 13.8 4.5 21.8 5.4 11.4 8.1 9.2 5.0 10.8 15.7 14.0 5.5 8.8 18.8 13.2 14.1 1.0 0.7 0.0 0.4 0.1 3.1 0.1 0.0 10.9 10.4 16.6 14.5 9.6 0.5 8.3 11.2 6.6 5.6 0.2 4.6 0.0 0.0 10.3 4.3 12.6 8.6 8.3 0.1 16.0 6.3 21.6 17.0 3.5 0.1 1.6 15.9 11.8 25.0 11.9 6.6 0.8 19.7 6.8 5.1 0.0 0.0 13.2 3.9 0.3 10.9 0.1 0.0 3.5 8.1 5.5 17.9 4.1 6.6 12.7 0.1 0.1 22.1 9.7 13.1 14.0 0.7 0.0 0.0 20.1 0.0 18.3 0.0 0.0 0.0 0.0 0.1 0.0 1.0 0.0 0.2 0.7 0.3 0.0 3.1 0.0 0.1 0.4 0.0 0.0 0.1 15.5 30.2 12.5 13.6 12.3 12.4 14.7 8.9 12.2 15.7 ROBO4 "ECSM4, FLJ20798, MRB" ENSG00000154133 "Roundabout guidance receptor 4" Q8WZ75 11 124883691-124898500 "Plasma proteins, Predicted membrane proteins" "Angiogenesis, Differentiation" "Developmental protein, Receptor" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Group enriched" "Detected in some" 10 "HUVEC TERT2: 63.4;TIME: 56.9" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "myeloid DC: 1.2" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA065212 Approved "Plasma membrane" 340000000 "Plasma membrane" "HPA065212: " "unprognostic (2.86e-1)" "unprognostic (9.35e-2)" "unprognostic (2.67e-1)" "unprognostic (1.07e-1)" "unprognostic (3.82e-2)" "unprognostic (6.97e-2)" "prognostic favourable (4.85e-4)" "unprognostic (7.94e-2)" "unprognostic (2.27e-1)" "unprognostic (1.43e-1)" "unprognostic (1.73e-3)" "unprognostic (2.17e-1)" "unprognostic (1.17e-2)" "prognostic unfavourable (8.73e-4)" "unprognostic (1.55e-1)" "unprognostic (4.63e-1)" "unprognostic (5.15e-2)" 33.3 4.5 4.0 5.6 4.5 0.6 21.6 2.0 5.5 11.1 4.4 4.3 3.7 2.8 10.8 7.8 5.3 7.7 8.5 15.5 4.9 3.0 10.6 6.5 24.9 5.8 4.7 2.8 5.9 3.5 3.8 3.8 23.6 5.5 6.0 1.8 9.2 2.9 4.5 12.5 4.5 4.7 8.4 3.6 33.3 4.3 3.9 3.3 1.0 11.6 9.8 2.5 6.2 5.9 0.0 1.2 0.5 0.2 0.0 0.0 0.0 0.1 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.8 0.1 0.3 0.0 0.0 0.0 6.1 0.0 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.0 0.0 0.1 0.0 0.0 0.0 0.0 2.3 0.7 63.4 0.0 0.0 2.1 0.0 0.0 0.0 0.0 0.8 0.0 2.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 56.9 0.3 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 4.0 4.5 2.0 5.5 4.9 3.0 4.7 2.8 5.5 3.3 S100A4 "18A2, 42A, CAPL, FSP1, MTS1, P9KA, PEL98" ENSG00000196154 "S100 calcium binding protein A4" P26447 1 153543613-153550136 "Cancer-related genes, Plasma proteins, Predicted intracellular proteins" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 419.2" "Cell line enhanced" "Detected in many" "A549: 112.8;ASC diff: 146.4;BJ hTERT+: 281.6;fHDF/TERT166: 201.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in many" "Not detected" "Not detected" "CAB002618, HPA007973, CAB027387, CAB058698, CAB068227, CAB068228" Enhanced Enhanced "Plasma membrane" 13000000 "Plasma membrane" "CAB002618: , CAB027387: , CAB058698: , CAB068227: , CAB068228: , HPA007973: AB_1079858" "unprognostic (1.56e-1)" "unprognostic (6.10e-2)" "unprognostic (2.84e-2)" "unprognostic (8.20e-2)" "unprognostic (6.21e-2)" "prognostic favourable (4.03e-5)" "unprognostic (8.35e-2)" "unprognostic (4.81e-2)" "unprognostic (1.50e-1)" "unprognostic (2.20e-1)" "unprognostic (2.78e-2)" "unprognostic (3.39e-2)" "prognostic unfavourable (2.90e-4)" "unprognostic (1.05e-1)" "unprognostic (3.05e-1)" "unprognostic (2.76e-2)" "unprognostic (3.16e-2)" 125.9 10.1 2.6 29.2 8.3 75.2 171.6 2.2 4.6 52.1 33.9 2.7 25.8 7.3 26.8 52.2 58.6 27.9 34.7 59.9 3.0 1.7 27.8 6.1 80.7 53.2 10.8 3.1 12.7 6.7 0.0 3.0 46.9 6.6 49.5 28.0 19.3 29.8 13.4 25.4 44.5 25.5 38.5 8.9 55.9 17.2 18.2 6.2 8.5 23.7 57.5 26.4 34.9 58.2 18.6 213.1 281.6 293.3 17.3 162.7 419.2 0.5 112.8 0.5 3.3 146.4 100.9 0.1 71.5 281.6 1.4 6.3 0.8 7.9 0.0 13.1 201.4 2.8 0.4 1.0 1.1 16.1 0.0 48.2 25.1 2.5 0.1 4.2 81.6 15.7 1.1 2.8 0.6 0.1 0.4 0.1 102.5 0.4 0.1 50.0 0.3 43.3 2.5 0.1 106.3 4.4 3.0 4.3 0.5 1.2 54.5 0.4 3.3 60.4 0.1 0.3 0.6 96.1 0.4 3.5 24.0 0.5 0.2 53.7 5.5 49.5 293.3 30.8 141.2 201.4 147.2 18.6 127.2 112.3 213.1 6.2 22.4 66.5 281.6 17.3 253.9 37.4 162.7 419.2 2.6 8.3 2.2 4.6 3.0 1.7 10.8 3.1 6.6 6.2 SCIN KIAA1905 ENSG00000006747 Scinderin Q9Y6U3 7 12570577-12660179 "Plasma proteins, Predicted intracellular proteins" "Actin capping, Actin-binding" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 30.3;intestine: 31.7;kidney: 30.3;placenta: 46.0" "Group enriched" "Detected in some" 5 "RPTEC TERT1: 37.7;SK-BR-3: 40.9" "Cancer enhanced" "Detected in many" "renal cancer: 13.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA020518, HPA024264" Enhanced Enhanced "Plasma membrane" "Plasma membrane" "HPA020518: AB_1856619, HPA024264: AB_1856621" "unprognostic (3.68e-1)" "unprognostic (4.98e-2)" "unprognostic (5.05e-1)" "unprognostic (2.47e-1)" "unprognostic (1.50e-1)" "unprognostic (5.98e-2)" "unprognostic (3.64e-5)" "unprognostic (1.31e-2)" "unprognostic (3.09e-1)" "unprognostic (3.77e-2)" "unprognostic (1.25e-1)" "unprognostic (1.24e-1)" "prognostic favourable (4.26e-8)" "unprognostic (3.87e-1)" "unprognostic (4.99e-2)" "unprognostic (3.13e-2)" "unprognostic (3.18e-1)" 4.1 1.0 14.5 2.3 30.3 1.0 0.9 1.5 13.3 1.2 11.2 7.5 1.0 16.2 1.2 0.7 14.5 3.6 2.0 0.5 11.1 4.2 30.3 0.6 3.4 0.6 22.8 2.3 0.8 0.9 1.1 3.1 46.0 20.0 2.3 10.2 0.6 9.0 1.0 0.6 2.5 31.7 1.0 27.9 0.6 12.2 4.3 23.4 0.0 1.0 2.7 8.2 5.5 1.1 4.5 1.5 3.5 1.5 2.1 1.9 0.8 0.0 0.0 0.1 0.3 0.0 0.0 0.2 0.1 0.0 0.0 0.2 0.1 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 4.2 0.0 0.5 0.0 0.0 0.2 0.1 0.1 0.5 0.1 0.0 0.0 0.1 8.3 0.2 0.2 0.1 0.6 0.1 1.3 0.1 0.2 0.0 37.7 1.4 1.7 0.0 0.4 40.9 0.0 4.3 0.3 0.0 0.1 0.3 0.8 0.0 1.4 0.1 0.1 0.0 0.1 0.1 3.5 1.5 1.0 1.7 1.3 1.5 4.5 1.5 1.4 1.0 2.5 1.6 1.9 2.5 2.1 1.4 1.5 1.0 0.8 14.5 30.3 1.5 13.3 11.1 4.2 22.8 2.3 20.0 23.4 SCUBE3 "CEGF3, FLJ34743" ENSG00000146197 "Signal peptide, CUB domain and EGF like domain containing 3" Q8IX30 6 35214419-35253079 "Predicted secreted proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "thyroid gland: 38.0" "Cell line enhanced" "Detected in some" "AF22: 10.4;ASC diff: 31.7;ASC TERT1: 42.6;HSkMC: 19.8;hTEC/SVTERT24-B: 12.1;U-138 MG: 11.8;WM-115: 10.0" "Cancer enhanced" "Detected in many" "thyroid cancer: 9.2" "Not detected" "Not detected" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" HPA040606 Uncertain Approved "Plasma membrane" "Secreted to blood" 1890000 110000 "Plasma membrane" "HPA040606: AB_10795383" "unprognostic (1.45e-1)" "unprognostic (1.79e-2)" "unprognostic (2.22e-1)" "unprognostic (2.41e-3)" "unprognostic (1.52e-1)" "unprognostic (1.27e-1)" "unprognostic (4.43e-2)" "unprognostic (5.01e-2)" "unprognostic (2.00e-2)" "unprognostic (7.41e-2)" "unprognostic (1.57e-1)" "unprognostic (2.64e-2)" "unprognostic (4.83e-8)" "unprognostic (1.54e-2)" "unprognostic (2.12e-1)" "prognostic unfavourable (1.38e-4)" "unprognostic (3.06e-3)" 1.6 2.6 0.5 1.1 0.4 0.2 0.3 0.3 0.7 1.6 3.3 0.0 2.8 0.2 1.3 7.0 1.5 0.7 0.7 6.4 0.3 0.5 2.3 0.2 1.3 0.2 0.4 0.6 0.9 0.2 0.3 1.6 0.9 0.6 7.0 1.1 6.8 1.1 5.3 0.8 0.7 0.8 13.8 0.6 0.3 1.2 1.7 0.0 0.0 38.0 0.3 0.3 11.4 2.5 1.1 1.6 2.5 0.7 1.1 1.1 0.1 0.0 0.0 10.4 0.1 31.7 42.6 0.1 2.6 1.3 0.0 0.0 0.2 0.0 0.0 0.3 6.1 0.0 2.1 0.0 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 19.8 0.0 12.1 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.5 0.1 0.0 0.0 0.0 0.0 1.1 0.2 0.0 0.0 0.2 0.7 0.2 0.0 0.6 11.8 0.5 0.0 0.1 0.0 0.0 0.0 1.8 0.0 10.0 1.4 0.7 1.3 1.1 0.5 0.3 0.8 0.7 0.3 0.1 1.1 0.8 0.8 2.5 1.1 0.5 1.6 0.8 0.1 0.5 0.4 0.3 0.7 0.3 0.5 0.4 0.6 0.6 0.0 SHANK1 "SPANK-1, SSTRIP, synamon" ENSG00000161681 "SH3 and multiple ankyrin repeat domains 1" Q9Y566 19 50661827-50719450 "Plasma proteins, Predicted intracellular proteins" "Differentiation, Neurogenesis" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 13 "brain: 35.7" "Cell line enhanced" "Detected in some" "REH: 7.3;SH-SY5Y: 3.5;U-138 MG: 4.1;U-2 OS: 10.4;U-87 MG: 3.9;U-937: 4.3" "Cancer enhanced" "Detected in some" "ovarian cancer: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "HPA032129, HPA032130" Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA032129: AB_10602796, HPA032130: " "unprognostic (1.62e-1)" "unprognostic (4.40e-2)" "unprognostic (7.83e-3)" "unprognostic (4.62e-2)" "unprognostic (1.70e-2)" "unprognostic (1.54e-1)" "unprognostic (1.76e-2)" "unprognostic (1.35e-2)" "unprognostic (5.02e-2)" "unprognostic (1.61e-1)" "unprognostic (7.51e-2)" "unprognostic (3.27e-1)" "unprognostic (3.65e-2)" "unprognostic (1.61e-2)" "unprognostic (5.14e-2)" "unprognostic (4.66e-3)" "unprognostic (1.29e-3)" 0.9 2.6 27.9 0.9 10.0 1.2 0.9 13.6 35.7 1.3 0.9 1.1 0.0 0.9 1.3 1.0 0.9 2.2 1.1 0.9 25.6 12.3 0.9 0.8 0.8 0.9 6.0 11.1 0.9 0.9 2.1 2.8 1.0 4.1 1.0 0.8 0.2 0.9 1.0 1.0 1.2 0.9 1.1 2.2 0.9 0.8 1.4 3.5 0.4 0.9 0.0 0.9 0.9 0.0 0.0 0.7 0.0 0.0 0.2 0.2 0.0 0.4 0.0 0.0 0.0 0.2 0.5 0.0 1.2 1.2 0.1 0.1 0.0 0.0 0.0 1.9 0.7 0.0 0.2 0.0 0.1 0.0 0.1 1.1 0.0 0.0 0.1 0.0 0.3 0.4 0.0 0.0 0.1 0.6 0.0 0.0 0.7 0.1 0.1 0.8 1.2 0.1 7.3 0.0 0.7 0.0 0.0 0.0 3.5 0.0 0.0 1.1 0.0 3.1 2.2 4.1 10.4 0.0 0.0 0.0 0.0 0.0 3.9 4.3 1.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.2 0.0 0.7 0.0 0.0 27.9 10.0 13.6 23.0 25.6 12.3 6.0 11.1 4.1 3.5 SLC10A5 ENSG00000253598 "Solute carrier family 10 member 5" Q5PT55 8 81693607-81696174 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Tissue enhanced" "Detected in some" "brain: 5.1;liver: 10.3" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in some" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA025966 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA025966: AB_1856959" "unprognostic (6.42e-2)" "unprognostic (3.89e-1)" "unprognostic (1.25e-2)" "unprognostic (2.34e-2)" "unprognostic (8.13e-3)" "unprognostic (1.91e-1)" "unprognostic (5.71e-2)" "unprognostic (5.63e-2)" "unprognostic (3.67e-1)" "unprognostic (2.41e-1)" "unprognostic (1.37e-1)" "unprognostic (3.22e-1)" "unprognostic (8.95e-2)" "unprognostic (2.51e-1)" "unprognostic (2.24e-1)" "unprognostic (1.67e-1)" "unprognostic (2.82e-7)" 0.0 0.3 0.9 0.1 2.3 0.0 0.2 5.1 1.8 0.3 2.5 2.9 0.3 0.9 0.2 0.3 1.4 0.1 0.9 2.1 1.8 10.3 0.3 0.0 0.8 0.4 1.0 0.3 1.9 0.0 0.5 3.5 0.3 0.2 0.1 0.4 3.5 0.2 0.3 0.3 3.4 0.0 0.8 0.0 0.3 0.1 0.0 0.5 0.0 0.0 0.3 0.4 0.0 0.9 0.4 1.0 1.1 0.9 1.7 0.9 1.1 0.5 0.4 0.7 0.4 0.6 1.1 1.6 0.3 1.1 1.3 0.9 1.6 0.8 2.9 2.2 3.0 1.7 0.5 0.1 0.3 0.4 2.6 0.8 2.0 0.5 1.9 1.4 1.6 0.8 0.6 1.4 0.5 0.6 0.4 0.4 0.7 1.4 3.7 2.6 1.1 0.8 0.8 0.4 1.9 0.7 1.1 1.3 1.8 1.7 1.7 1.8 2.6 0.2 1.3 0.1 1.3 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.3 0.0 0.5 0.0 0.0 SLC13A3 "NADC3, SDCT2" ENSG00000158296 "Solute carrier family 13 member 3" Q8WWT9 20 46557823-46684467 "Predicted membrane proteins, Transporters" "Ion transport, Sodium transport, Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 9 "kidney: 128.6" "Cell line enhanced" "Detected in many" "BEWO: 9.8;EFO-21: 11.2;Hep G2: 31.9;HHSteC: 11.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in some" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA014333, HPA014353, HPA014736" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA014333: , HPA014353: AB_1856968, HPA014736: AB_1856970" "unprognostic (1.07e-2)" "unprognostic (7.40e-2)" "unprognostic (5.59e-2)" "unprognostic (1.19e-2)" "unprognostic (3.34e-1)" "unprognostic (3.19e-2)" "unprognostic (2.15e-1)" "unprognostic (2.82e-2)" "unprognostic (1.66e-2)" "unprognostic (9.50e-2)" "unprognostic (1.92e-2)" "unprognostic (1.03e-1)" "unprognostic (8.94e-2)" "unprognostic (3.87e-1)" "unprognostic (1.17e-1)" "unprognostic (1.87e-1)" "unprognostic (2.05e-2)" 0.7 0.9 2.6 0.5 6.2 0.4 0.9 2.5 3.6 0.9 0.5 15.1 0.0 0.4 0.9 0.7 0.6 1.1 0.9 0.6 3.4 3.1 128.6 7.0 0.8 0.5 9.3 2.1 1.8 3.0 0.4 0.6 12.9 6.5 2.3 0.5 8.1 1.7 0.6 0.6 1.0 0.4 0.9 7.8 0.5 1.7 2.7 5.6 0.0 0.8 0.0 0.6 1.0 0.4 0.6 2.4 2.7 0.4 0.7 0.9 0.0 0.0 0.0 0.9 3.3 5.0 4.7 9.8 2.0 1.2 1.1 0.8 0.0 0.0 0.1 11.2 0.1 1.2 0.0 1.5 2.6 0.0 0.3 3.8 0.2 31.9 11.2 0.0 2.8 6.3 4.4 6.4 3.2 0.0 8.5 0.2 0.0 0.3 0.0 0.4 6.0 0.0 0.1 0.0 0.0 0.7 0.2 0.4 0.1 0.0 2.3 0.5 1.7 0.1 0.1 0.1 2.4 5.1 0.0 0.3 0.6 0.0 0.3 0.0 0.2 2.7 0.4 0.3 0.9 0.2 0.2 0.4 0.3 0.3 0.1 0.6 0.6 0.6 1.3 0.7 0.3 2.4 0.3 0.0 2.6 6.2 2.5 3.6 3.4 3.1 9.3 2.1 6.5 5.6 SLC14A1 "HsT1341, JK, RACH1, RACH2" ENSG00000141469 "Solute carrier family 14 member 1 (Kidd blood group)" Q13336 18 45687025-45752520 "Blood group antigen proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" Transport "Blood group antigen" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 4 "brain: 44.5;prostate: 64.7;urinary bladder: 29.6" "Cell line enriched" "Detected in some" 14 "RT4: 49.9" "Group enriched" "Detected in many" 5 "glioma: 5.3;prostate cancer: 8.6;urothelial cancer: 16.1" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 4 "eosinophil: 2.4;gdT-cell: 2.0;memory CD4 T-cell: 2.0;memory CD8 T-cell: 2.4;naive CD8 T-cell: 3.4;NK-cell: 1.8;T-reg: 7.2" "Group enriched" "Detected in many" 5 "granulocytes: 2.4;NK-cells: 1.8;T-cells: 7.2" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA059570, HPA077233" Supported Supported "Plasma membrane" "Plasma membrane" "HPA059570: , HPA077233: " "unprognostic (2.04e-1)" "unprognostic (2.56e-3)" "unprognostic (5.20e-2)" "unprognostic (1.27e-1)" "unprognostic (6.86e-2)" "unprognostic (1.84e-2)" "unprognostic (1.70e-2)" "unprognostic (7.97e-2)" "unprognostic (8.17e-2)" "unprognostic (9.99e-2)" "unprognostic (2.69e-1)" "unprognostic (1.42e-1)" "unprognostic (3.02e-2)" "unprognostic (2.31e-1)" "unprognostic (1.52e-1)" "unprognostic (9.09e-2)" "unprognostic (6.93e-2)" 2.2 2.1 15.6 1.5 21.5 10.3 2.4 4.6 24.2 2.9 1.6 33.7 0.0 1.9 1.1 1.4 1.1 1.0 8.7 8.2 33.7 11.7 10.1 1.5 4.1 2.4 28.0 23.4 1.0 1.5 1.2 0.4 2.0 44.5 64.7 1.8 0.0 2.6 3.2 3.4 1.7 2.1 3.9 34.9 2.6 2.0 1.0 44.0 0.0 3.6 0.0 2.6 29.6 3.0 0.7 0.3 2.4 0.1 1.8 7.2 1.1 0.0 0.1 0.0 0.0 0.0 0.1 0.3 0.1 3.6 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.3 0.1 0.0 0.1 0.0 0.0 0.0 1.3 49.9 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.8 0.2 0.4 0.0 1.9 0.0 0.0 1.1 0.5 0.5 0.1 0.1 2.4 2.0 0.0 0.1 0.6 2.0 2.4 0.0 0.7 0.5 3.4 0.4 1.8 0.0 0.3 7.2 1.1 15.6 21.5 4.6 24.2 33.7 11.7 28.0 23.4 44.5 44.0 SLC16A2 "AHDS, DXS128, MCT7, MCT8, MRX22, XPCT" ENSG00000147100 "Solute carrier family 16 member 2" P36021 X 74421461-74533917 "Disease related genes, Plasma proteins, Potential drug targets, Predicted membrane proteins, Transporters" "Symport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "liver: 43.6" "Cell line enhanced" "Detected in many" "BJ: 35.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in single" "gdT-cell: 1.0" "Lineage enriched" "Detected in single" 11 "T-cells: 1.0" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA072719 Approved "Plasma membrane" "Plasma membrane" "HPA072719: " "prognostic unfavourable (8.88e-5)" "unprognostic (2.48e-1)" "unprognostic (1.99e-1)" "unprognostic (2.90e-3)" "unprognostic (1.49e-1)" "unprognostic (1.58e-2)" "unprognostic (1.58e-3)" "unprognostic (2.47e-2)" "unprognostic (1.48e-1)" "unprognostic (2.54e-1)" "unprognostic (5.67e-2)" "unprognostic (3.51e-1)" "prognostic unfavourable (1.83e-4)" "unprognostic (2.15e-2)" "unprognostic (1.89e-1)" "unprognostic (6.89e-3)" "prognostic unfavourable (3.16e-4)" 13.5 24.4 10.9 5.4 12.2 0.7 4.9 5.9 14.3 9.9 5.5 8.4 1.8 4.1 9.4 2.7 5.2 6.7 10.5 10.7 8.0 5.9 9.4 43.6 6.0 1.6 4.2 8.0 14.7 6.6 12.7 12.6 10.0 8.2 9.2 2.6 11.1 5.8 7.0 3.5 2.2 3.0 7.6 4.1 1.9 4.2 1.8 5.1 6.4 13.6 4.3 3.0 5.0 5.8 0.0 0.0 0.0 0.0 0.0 1.0 0.0 3.3 4.1 3.0 16.9 8.1 4.2 0.0 35.2 10.9 14.3 8.2 0.0 0.3 0.0 0.5 13.6 0.6 0.4 14.9 8.4 2.3 1.3 0.0 0.0 0.0 0.6 0.0 0.0 6.3 3.6 7.4 8.7 0.0 0.0 0.0 3.3 0.0 0.2 1.0 11.2 3.1 6.7 8.1 0.0 7.0 0.0 0.7 5.3 3.9 19.7 0.1 0.2 0.4 0.0 13.9 3.7 15.2 17.4 0.0 0.0 0.0 15.3 0.0 0.3 0.0 0.0 0.0 1.0 0.0 0.0 0.0 0.2 0.3 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 10.9 12.2 5.9 14.3 8.0 5.9 4.2 8.0 8.2 5.1 SLC19A1 "FOLT, RFC1" ENSG00000173638 "Solute carrier family 19 member 1" P41440 21 45493572-45544411 "Cancer-related genes, Predicted membrane proteins, Transporters" "Antiport, Transport" "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "blood: 37.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in many" 4 "neutrophil: 37.6" "Lineage enriched" "Detected in many" 6 "granulocytes: 37.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA024802 Approved Approved "Plasma membrane" "Plasma membrane" "HPA024802: AB_10602892" "unprognostic (4.31e-3)" "prognostic unfavourable (4.15e-4)" "unprognostic (5.23e-2)" "unprognostic (2.02e-1)" "unprognostic (3.11e-1)" "unprognostic (3.04e-2)" "unprognostic (7.34e-2)" "unprognostic (2.87e-3)" "unprognostic (4.04e-2)" "unprognostic (4.09e-2)" "unprognostic (2.85e-1)" "unprognostic (2.39e-1)" "prognostic unfavourable (1.07e-10)" "unprognostic (1.44e-1)" "unprognostic (2.31e-1)" "unprognostic (7.97e-5)" "unprognostic (3.10e-1)" 9.0 7.8 7.1 8.2 13.5 10.5 12.5 9.6 8.9 5.0 9.7 6.0 9.4 31.2 4.3 4.6 2.3 4.6 3.5 3.2 7.1 6.1 4.7 14.1 13.9 14.1 8.7 4.4 8.1 5.4 1.8 3.5 32.9 11.5 4.7 2.0 17.8 6.0 3.5 3.5 6.1 16.5 2.3 5.9 11.7 5.7 3.4 3.4 11.8 9.6 2.8 4.1 3.1 3.1 0.9 4.9 37.6 6.4 0.4 1.1 2.4 10.4 9.5 1.9 7.8 0.6 0.8 15.6 4.9 0.8 4.5 2.9 22.0 9.7 9.7 9.8 1.2 5.4 3.9 3.6 1.1 8.9 19.0 20.5 5.2 15.3 2.7 13.3 3.2 1.0 2.7 4.9 1.6 3.7 24.4 4.3 1.6 11.7 18.1 12.4 11.2 11.2 24.6 2.2 28.3 2.0 6.3 11.7 10.3 5.5 9.1 4.2 6.9 15.8 4.5 5.9 7.4 1.6 8.0 1.8 6.5 8.8 2.6 21.8 4.7 0.6 6.4 8.5 0.3 6.0 1.1 0.9 0.5 0.7 4.9 0.3 0.8 0.5 37.6 0.4 3.7 1.5 1.0 2.4 7.1 13.5 9.6 8.9 7.1 6.1 8.7 4.4 11.5 3.4 SLC1A5 "AAAT, ASCT2, M7V1, RDRC" ENSG00000105281 "Solute carrier family 1 member 5" Q15758 19 46774883-46788594 "FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Amino-acid transport, Host-virus interaction, Symport, Transport" "Host cell receptor for virus entry, Receptor" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "plasmacytoid DC: 34.6" "Group enriched" "Detected in many" 4 "dendritic cells: 34.6;monocytes: 22.4" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "HPA035239, HPA035240" Enhanced Enhanced "Plasma membrane" "Plasma membrane" "HPA035239: AB_10670587, HPA035240: AB_10604092" "unprognostic (8.26e-3)" "unprognostic (6.38e-2)" "unprognostic (7.24e-2)" "unprognostic (7.94e-2)" "unprognostic (2.32e-1)" "unprognostic (1.24e-1)" "prognostic unfavourable (1.66e-8)" "unprognostic (2.08e-1)" "unprognostic (1.06e-2)" "unprognostic (9.82e-2)" "unprognostic (9.40e-3)" "unprognostic (9.57e-3)" "prognostic unfavourable (1.18e-7)" "unprognostic (1.28e-2)" "unprognostic (6.30e-2)" "unprognostic (1.06e-2)" "unprognostic (9.83e-2)" 39.3 5.7 3.4 16.0 5.4 16.2 45.0 0.9 3.0 20.7 15.8 5.0 50.4 4.9 14.3 33.7 33.9 18.1 31.2 10.0 4.5 2.2 23.7 4.1 23.4 17.7 8.2 0.9 33.3 24.6 0.2 9.1 25.8 4.9 35.2 13.8 5.2 99.0 55.7 6.9 18.6 12.1 23.1 5.3 19.8 17.9 21.7 6.1 14.9 6.5 28.4 25.9 48.3 44.9 7.0 34.6 0.9 22.4 6.9 5.6 7.4 24.2 44.9 10.8 16.3 28.2 24.0 25.6 34.7 39.7 26.1 37.9 40.7 27.5 26.6 17.0 86.1 39.2 31.5 41.2 19.5 17.6 28.5 44.2 17.2 38.1 73.0 30.7 26.1 39.0 103.2 30.6 77.6 13.8 46.6 70.6 13.9 41.3 14.0 82.7 18.9 19.8 16.0 12.2 37.9 14.6 53.1 16.7 12.2 17.1 46.8 37.2 26.9 40.6 10.3 15.7 25.1 12.2 28.2 43.8 42.3 22.2 29.5 38.4 38.4 0.0 11.5 0.9 5.3 19.9 4.4 7.0 3.1 3.7 17.8 2.5 0.7 2.3 0.3 6.9 22.4 34.6 5.6 7.4 3.4 5.4 0.9 3.0 4.5 2.2 8.2 0.9 4.9 6.1 SLC2A1 "CSE, DYT18, DYT9, GLUT, GLUT1, HTLVR" ENSG00000117394 "Solute carrier family 2 member 1" P11166 1 42925375-42959176 "Cancer-related genes, Disease related genes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Cancer-related genes, Cataract, Disease mutation, Dystonia, Epilepsy, Hereditary hemolytic anemia, Mental retardation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in all" 4 "placenta: 194.0" "Cell line enhanced" "Detected in many" "BEWO: 44.2;CACO-2: 71.8;Hep G2: 49.0" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "CAB002759, HPA031345, HPA058494" Enhanced Supported Enhanced "Plasma membrane" 36000000 "Plasma membrane" "CAB002759: , HPA031345: , HPA058494: " "unprognostic (3.60e-2)" "unprognostic (5.85e-3)" "unprognostic (7.59e-2)" "unprognostic (1.31e-2)" "unprognostic (4.10e-3)" "unprognostic (3.22e-2)" "prognostic unfavourable (3.65e-8)" "prognostic unfavourable (1.09e-4)" "unprognostic (1.10e-1)" "unprognostic (4.84e-2)" "prognostic unfavourable (4.39e-5)" "unprognostic (1.87e-1)" "prognostic unfavourable (4.55e-9)" "unprognostic (1.11e-1)" "unprognostic (9.49e-2)" "unprognostic (1.17e-1)" "prognostic unfavourable (4.05e-4)" 4.2 3.7 12.4 3.9 16.9 45.2 4.1 6.7 15.5 15.2 4.8 15.1 4.3 2.4 7.6 3.4 28.8 8.5 8.6 5.0 15.4 13.7 7.6 2.1 2.4 5.3 18.2 5.0 3.4 3.7 7.3 2.9 194.0 15.5 5.2 3.3 44.2 8.4 7.9 1.8 42.1 2.9 2.5 17.8 3.4 5.5 2.5 12.5 1.8 4.0 11.5 12.0 22.2 24.5 8.4 14.7 1.3 0.2 3.0 7.5 2.7 10.6 15.3 12.7 3.2 1.5 0.5 44.2 7.0 15.2 8.6 12.8 71.8 29.7 4.0 21.0 2.1 9.9 2.8 16.3 3.8 2.4 2.6 6.6 8.9 49.0 4.4 3.6 1.9 1.8 12.6 5.4 5.9 1.4 14.8 0.9 3.9 18.9 1.6 2.5 8.1 3.9 1.6 4.1 5.6 7.9 5.2 6.7 4.7 8.2 26.0 3.0 1.1 4.6 3.2 7.9 5.7 1.4 15.8 0.7 1.5 2.4 15.6 2.5 6.4 0.3 0.2 1.3 7.5 0.2 6.9 8.4 4.1 5.1 2.9 7.3 3.2 4.7 1.0 3.0 0.1 14.7 4.7 2.7 12.4 16.9 6.7 15.5 15.4 13.7 18.2 5.0 15.5 12.5 SLC2A14 "GLUT14, SLC2A3P3" ENSG00000173262 "Solute carrier family 2 member 14" Q8TDB8 12 7812512-7891148 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Differentiation, Spermatogenesis, Sugar transport, Transport" "Developmental protein" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 7 "testis: 52.4" "Group enriched" "Detected in some" 4 "BEWO: 14.6;CACO-2: 23.7;Hep G2: 6.1" "Cancer enriched" "Detected in single" 35 "testis cancer: 7.1" "Not detected" "Not detected" "Cell type enhanced" "Detected in many" "neutrophil: 6.9" "Lineage enriched" "Detected in many" 4 "granulocytes: 6.9" HPA006539 Supported Approved "Plasma membrane" "Plasma membrane" "HPA006539: AB_1078984" "unprognostic (2.52e-1)" "unprognostic (4.74e-3)" "unprognostic (1.79e-1)" "unprognostic (1.29e-1)" "unprognostic (3.35e-2)" "unprognostic (1.82e-3)" "unprognostic (8.62e-2)" "unprognostic (7.15e-2)" "unprognostic (1.89e-1)" "unprognostic (9.91e-3)" "unprognostic (1.23e-1)" "unprognostic (1.27e-1)" "unprognostic (8.46e-4)" "unprognostic (3.92e-2)" "unprognostic (3.41e-1)" "unprognostic (3.26e-2)" "unprognostic (1.22e-2)" 0.4 3.1 0.1 0.1 0.6 3.0 0.4 0.1 0.2 0.4 0.4 0.3 0.1 0.0 0.3 0.8 0.8 0.1 0.3 0.1 0.2 0.3 0.1 2.0 0.2 0.2 0.1 0.1 2.7 7.4 0.0 0.6 0.5 0.3 0.6 0.2 0.1 0.1 0.1 0.1 0.1 0.7 0.2 0.1 0.1 0.0 52.4 0.2 0.1 0.1 0.1 0.1 0.6 0.1 0.6 0.4 6.9 0.7 1.3 1.7 0.2 0.0 0.4 0.3 0.3 0.2 0.8 14.6 0.0 0.0 0.0 0.2 23.7 0.1 0.0 0.2 0.0 0.1 0.0 0.0 0.0 0.2 0.0 2.4 0.6 6.1 0.0 0.0 3.5 0.0 0.1 0.0 0.0 0.0 1.0 0.1 0.0 0.1 0.1 0.1 2.7 0.0 0.2 0.1 0.1 0.0 0.4 0.1 0.0 0.0 0.4 0.0 0.0 1.5 0.3 0.1 0.6 0.4 0.1 0.1 0.1 0.3 0.3 0.0 0.3 5.5 0.7 1.8 1.0 0.2 1.2 0.5 1.0 0.8 0.4 0.6 0.7 0.9 6.9 1.3 0.2 0.3 1.7 0.2 0.1 0.6 0.1 0.2 0.2 0.3 0.1 0.1 0.3 0.2 SLC2A2 GLUT2 ENSG00000163581 "Solute carrier family 2 member 2" P11168 3 170996348-171026750 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in some" 8 "intestine: 77.4;liver: 172.8" "Group enriched" "Detected in some" 68 "CACO-2: 7.1;Hep G2: 23.7" "Cancer enriched" "Detected in some" 12 "liver cancer: 105.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "CAB010444, HPA028997" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB010444: AB_641068, HPA028997: " "unprognostic (9.56e-2)" "unprognostic (1.24e-1)" "prognostic favourable (2.63e-5)" "unprognostic (3.10e-1)" "unprognostic (1.02e-1)" "unprognostic (2.95e-2)" "unprognostic (6.31e-2)" 0.1 0.1 0.1 0.0 0.1 0.0 0.1 0.1 0.1 0.1 27.9 0.0 0.0 10.8 0.1 0.2 0.1 0.1 3.8 0.1 0.1 0.1 15.3 172.8 0.1 0.0 0.1 0.0 0.1 0.6 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.1 0.1 77.4 0.0 0.1 0.1 0.1 0.1 0.0 0.0 0.1 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 7.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 23.7 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 SLC2A3 GLUT3 ENSG00000059804 "Solute carrier family 2 member 3" P11169 12 7919230-7936275 "Predicted membrane proteins, Transporters" "Sugar transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "bone marrow: 166.3" "Group enriched" "Detected in many" 5 "BEWO: 148.6;CACO-2: 159.4" "Cancer enriched" "Detected in all" 7 "testis cancer: 107.9" "Low region specificity" "Detected in all" "Group enriched" "Detected in many" 6 "basophil: 30.2;neutrophil: 55.6" "Lineage enriched" "Detected in all" 9 "granulocytes: 55.6" "CAB002763, HPA006539" Approved Approved "Plasma membrane" 33000000 "Plasma membrane" "CAB002763: , HPA006539: AB_1078984" "unprognostic (9.20e-2)" "unprognostic (9.63e-3)" "prognostic unfavourable (8.58e-4)" "unprognostic (2.65e-1)" "unprognostic (5.29e-3)" "unprognostic (2.16e-3)" "unprognostic (1.12e-1)" "unprognostic (8.27e-2)" "unprognostic (2.35e-1)" "unprognostic (3.83e-2)" "unprognostic (8.47e-3)" "unprognostic (5.40e-2)" "prognostic unfavourable (6.36e-8)" "prognostic unfavourable (2.89e-5)" "unprognostic (1.70e-1)" "unprognostic (1.14e-2)" "unprognostic (2.91e-3)" 48.8 10.0 9.5 25.2 10.5 166.3 26.4 13.1 24.3 9.4 10.0 6.8 1.8 4.2 10.3 8.2 13.2 8.0 25.6 22.8 10.8 13.6 10.3 14.1 32.4 12.8 13.3 3.3 18.8 6.1 6.9 10.9 43.9 13.7 15.0 6.9 14.8 3.8 3.9 13.6 7.4 5.8 18.7 15.4 16.4 7.0 10.6 12.5 3.3 15.7 7.0 13.6 51.8 10.5 1.8 2.4 55.6 4.6 3.6 6.4 3.5 0.0 0.7 6.8 2.6 2.5 8.9 148.6 2.4 2.6 2.4 5.6 159.4 1.0 0.1 0.0 1.6 0.0 0.2 0.3 4.3 4.6 0.2 9.2 0.6 21.0 6.9 3.3 13.5 3.6 0.2 6.3 2.9 2.2 4.2 2.2 2.1 0.0 0.2 3.6 30.1 0.0 0.2 0.8 0.1 0.0 0.0 0.0 0.0 0.0 0.2 3.1 0.0 0.4 2.2 3.0 1.6 5.8 0.2 0.0 6.4 0.5 8.8 1.5 1.6 30.2 4.6 7.0 6.4 0.5 5.3 1.8 4.4 4.9 2.4 1.7 2.8 3.8 55.6 3.6 0.2 0.1 5.8 3.5 9.5 10.5 13.1 13.3 10.8 13.6 13.3 3.3 13.7 12.5 SLC35F5 FLJ22004 ENSG00000115084 "Solute carrier family 35 member F5" Q8WV83 2 113705011-113756823 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA034828, HPA049229" Uncertain Uncertain "Plasma membrane" "Plasma membrane" "HPA034828: AB_2674350, HPA049229: AB_2680682" "unprognostic (1.59e-2)" "prognostic unfavourable (2.60e-4)" "unprognostic (8.37e-2)" "unprognostic (3.87e-3)" "unprognostic (5.62e-2)" "unprognostic (4.73e-3)" "unprognostic (3.94e-2)" "unprognostic (5.68e-2)" "unprognostic (1.19e-1)" "unprognostic (1.63e-2)" "unprognostic (1.93e-2)" "unprognostic (1.77e-1)" "prognostic favourable (1.71e-5)" "unprognostic (1.64e-1)" "unprognostic (1.84e-1)" "unprognostic (2.33e-1)" "unprognostic (4.83e-2)" 20.0 46.8 7.9 11.7 9.2 3.6 13.8 10.6 9.0 16.9 18.1 15.0 18.9 14.5 14.2 12.6 20.4 10.7 14.9 20.0 8.2 7.9 44.7 29.5 15.0 12.7 10.4 5.0 19.1 23.6 21.6 20.6 24.6 11.7 16.1 16.5 14.1 23.4 16.9 20.0 15.1 32.4 13.1 9.6 12.6 13.7 12.6 10.3 9.2 33.1 14.6 16.7 14.1 16.7 3.4 6.8 5.8 9.1 6.2 4.3 3.2 9.8 9.3 5.1 2.8 47.5 33.1 15.1 16.4 17.3 10.6 15.7 18.6 18.3 9.3 21.2 21.1 9.1 9.0 8.5 14.6 3.7 3.7 6.5 6.5 16.4 16.3 9.4 17.6 28.6 11.4 13.5 19.1 11.1 8.2 9.1 22.4 6.8 2.8 4.8 5.0 7.6 3.9 10.3 5.8 37.2 13.5 1.6 3.8 12.1 13.1 9.1 10.3 5.4 9.9 16.7 8.9 8.7 5.2 6.0 8.1 6.3 12.9 5.3 10.9 5.8 5.4 3.7 2.9 8.0 3.8 3.3 2.6 3.1 6.8 3.4 2.9 2.1 4.3 6.2 9.1 3.0 4.3 3.2 7.9 9.2 10.6 9.0 8.2 7.9 10.4 5.0 11.7 10.3 SLC35G2 "DKFZp564K2464, MGC3295, TMEM22" ENSG00000168917 "Solute carrier family 35 member G2" Q8TBE7 3 136818647-136855892 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "BJ hTERT+: 34.1" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "gdT-cell: 1.6;memory CD8 T-cell: 3.5;naive CD8 T-cell: 2.4" "Lineage enriched" "Detected in single" 16 "T-cells: 3.5" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA052054, HPA064728" Approved Supported "Plasma membrane" "Plasma membrane" "HPA052054: , HPA064728: " "unprognostic (1.04e-1)" "unprognostic (1.46e-2)" "unprognostic (6.91e-4)" "unprognostic (2.56e-4)" "unprognostic (5.34e-2)" "unprognostic (6.73e-2)" "unprognostic (1.16e-5)" "unprognostic (1.83e-3)" "unprognostic (1.12e-1)" "unprognostic (6.39e-2)" "unprognostic (1.49e-2)" "unprognostic (3.32e-1)" "prognostic unfavourable (1.16e-7)" "unprognostic (1.00e-2)" "unprognostic (1.69e-1)" "unprognostic (1.07e-2)" "unprognostic (2.30e-2)" 20.2 24.6 10.6 3.7 12.0 1.3 18.3 16.6 17.4 8.1 3.6 6.4 6.6 2.2 6.7 8.1 4.1 5.0 8.7 7.6 11.6 15.2 4.3 7.1 6.0 3.3 10.9 10.5 5.3 13.3 6.7 15.9 11.7 11.3 4.8 3.8 3.2 2.7 4.8 2.8 3.0 2.4 8.5 12.4 3.1 3.1 17.2 4.9 0.9 8.8 2.1 2.5 8.2 9.3 0.2 0.0 0.0 0.1 0.0 3.5 0.3 1.7 4.9 5.0 2.2 10.1 8.2 0.0 7.8 34.1 11.7 17.7 4.6 2.7 0.0 6.0 8.0 0.6 5.9 0.3 10.9 0.0 1.6 1.4 6.0 2.8 12.9 0.0 0.0 11.7 0.9 10.2 2.8 8.8 0.8 0.0 15.0 0.0 2.1 1.5 1.1 3.7 1.8 3.3 0.0 10.0 0.4 8.3 5.5 6.3 0.0 10.7 0.0 0.8 5.9 8.7 2.2 3.8 8.4 0.0 0.0 0.0 12.1 0.0 0.0 0.0 0.1 0.0 1.6 0.0 0.5 0.0 0.1 3.5 0.0 0.2 0.1 2.4 0.0 0.0 0.0 0.0 0.0 0.3 10.6 12.0 16.6 17.0 11.6 15.2 10.9 10.5 11.3 4.9 SLC41A3 FLJ20473 ENSG00000114544 "Solute carrier family 41 member 3" Q96GZ6 3 126006355-126101561 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA045847 Approved Supported "Plasma membrane" "Plasma membrane" "HPA045847: " "unprognostic (1.77e-1)" "unprognostic (3.35e-2)" "unprognostic (1.11e-1)" "unprognostic (3.37e-2)" "unprognostic (7.68e-3)" "unprognostic (2.20e-1)" "prognostic unfavourable (1.49e-7)" "unprognostic (1.36e-1)" "unprognostic (3.23e-2)" "unprognostic (2.82e-3)" "unprognostic (5.74e-2)" "unprognostic (3.57e-1)" "prognostic favourable (6.04e-7)" "unprognostic (1.26e-1)" "unprognostic (5.88e-2)" "unprognostic (2.85e-1)" "unprognostic (7.54e-2)" 11.2 20.2 21.3 10.7 20.7 5.3 22.2 29.8 43.4 18.6 10.6 12.6 12.1 10.1 21.1 32.9 10.8 24.0 16.3 17.1 17.9 20.6 14.0 8.5 9.5 14.3 17.1 16.5 31.2 17.6 19.7 16.9 10.9 21.4 12.5 10.9 18.6 16.7 14.5 25.5 10.7 8.9 17.1 11.7 8.8 10.7 30.5 6.0 27.7 18.0 11.5 10.4 12.3 11.9 9.0 8.6 9.3 8.2 13.0 18.8 5.6 17.5 7.3 12.0 10.1 34.2 20.1 18.1 10.0 17.5 14.0 16.6 9.6 16.0 12.9 19.1 19.8 13.8 4.4 17.5 12.3 12.4 13.8 7.0 13.6 13.8 28.3 12.7 7.8 19.4 21.5 8.4 17.4 19.3 5.8 10.8 18.4 9.4 14.0 10.4 9.1 11.3 7.4 12.4 17.4 16.7 13.0 9.3 10.1 15.5 5.0 42.6 5.1 17.1 13.2 13.1 10.1 19.8 11.3 8.2 6.7 6.3 11.9 5.7 11.9 9.3 5.7 3.9 11.2 8.2 9.1 9.0 10.6 11.5 8.6 8.4 9.2 8.7 1.2 13.0 5.1 8.4 18.8 5.6 21.3 20.7 29.8 43.4 17.9 20.6 17.1 16.5 21.4 6.0 SLC45A4 KIAA1126 ENSG00000022567 "Solute carrier family 45 member 4" Q5BKX6 8 141207166-141308305 "Predicted membrane proteins, Transporters" Transport "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 17.1" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 7 "eosinophil: 9.4;neutrophil: 8.6" "Lineage enriched" "Detected in single" 19 "granulocytes: 9.4" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA023154 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA023154: AB_2191204" "unprognostic (7.79e-3)" "unprognostic (1.06e-1)" "unprognostic (4.30e-2)" "unprognostic (1.44e-1)" "unprognostic (6.06e-2)" "unprognostic (3.96e-2)" "unprognostic (1.26e-1)" "unprognostic (4.49e-3)" "unprognostic (1.02e-1)" "unprognostic (5.31e-2)" "unprognostic (2.12e-1)" "unprognostic (1.84e-1)" "prognostic favourable (1.73e-6)" "unprognostic (8.79e-3)" "unprognostic (1.13e-1)" "unprognostic (1.77e-2)" "unprognostic (2.40e-2)" 5.6 3.9 6.9 7.6 7.0 10.2 4.3 10.0 19.1 14.2 6.6 2.7 8.5 5.4 6.7 8.9 5.0 11.6 6.9 9.3 8.2 5.9 12.2 1.6 10.1 7.6 5.1 8.4 5.0 14.2 5.4 20.6 17.8 11.5 9.5 3.9 11.4 15.6 16.3 6.4 7.4 6.0 4.3 3.0 6.8 24.4 28.5 2.9 6.6 8.7 1.8 6.4 7.8 4.4 0.0 0.4 9.4 0.1 0.2 0.5 0.1 4.1 9.5 3.4 5.4 0.2 0.3 15.1 2.3 1.5 2.1 1.7 5.9 10.9 0.9 10.3 0.9 3.4 1.8 1.1 1.0 6.5 2.8 2.6 2.7 0.0 1.7 1.0 17.1 0.8 1.5 1.6 0.8 1.4 5.0 0.7 0.6 10.0 9.2 2.1 4.5 3.8 2.8 0.2 2.7 7.4 7.4 5.3 4.3 2.5 0.8 4.0 1.7 6.2 0.7 0.0 2.3 3.6 4.5 3.4 10.8 1.1 2.1 4.0 4.0 1.3 0.1 9.4 0.2 0.1 0.2 0.0 0.2 0.5 0.1 0.0 0.2 0.2 8.6 0.2 0.1 0.4 0.2 0.1 6.9 7.0 10.0 19.1 8.2 5.9 5.1 8.4 11.5 2.9 SLC4A8 NBC3 ENSG00000050438 "Solute carrier family 4 member 8" Q2Y0W8 12 51391317-51515763 "Predicted membrane proteins" "Anion exchange, Antiport, Ion transport, Sodium transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 28.6;pituitary gland: 20.0;testis: 15.3" "Cell line enhanced" "Detected in many" "BEWO: 17.2;HMC-1: 12.1;SCLC-21H: 12.9" "Group enriched" "Detected in some" 6 "breast cancer: 1.7;glioma: 2.7;testis cancer: 4.2" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA077895 Approved "Plasma membrane" "Plasma membrane" "HPA077895: " "unprognostic (4.01e-1)" "unprognostic (8.15e-2)" "unprognostic (2.49e-2)" "unprognostic (6.39e-2)" "unprognostic (1.29e-1)" "unprognostic (1.96e-2)" "unprognostic (3.46e-2)" "unprognostic (7.72e-4)" "unprognostic (3.13e-2)" "unprognostic (7.03e-3)" "unprognostic (1.07e-4)" "unprognostic (1.70e-1)" "unprognostic (9.60e-6)" "unprognostic (1.35e-1)" "unprognostic (2.57e-1)" "unprognostic (3.21e-2)" "unprognostic (2.47e-1)" 1.0 6.5 5.8 2.2 13.3 1.7 3.1 9.2 22.9 2.7 1.1 9.8 0.0 1.4 1.2 5.4 0.7 3.7 1.1 1.0 10.9 5.6 3.2 0.8 2.8 3.0 6.0 9.3 7.3 2.4 1.0 20.0 1.0 28.6 1.4 1.4 2.2 1.5 1.7 0.8 1.0 2.0 1.1 4.7 2.2 3.0 15.3 5.1 0.0 0.8 0.0 2.7 1.0 0.7 1.1 2.6 3.4 3.1 1.7 1.7 0.7 0.2 0.8 9.7 0.1 0.4 0.5 17.2 2.6 4.4 4.3 2.7 5.7 0.2 3.5 0.4 3.5 0.1 3.8 0.2 4.0 0.7 0.5 1.7 0.3 0.0 0.0 0.6 12.1 0.1 0.2 2.1 0.4 4.9 0.1 6.3 2.1 2.0 5.1 1.1 4.2 2.9 0.1 0.0 0.0 0.5 0.1 12.9 8.7 1.0 1.3 0.0 1.6 0.4 4.6 2.7 1.5 0.2 3.3 3.2 1.0 0.2 3.8 0.5 0.4 1.3 2.1 3.4 1.7 1.4 0.4 0.6 0.6 1.6 2.6 1.1 0.6 1.0 2.3 1.7 3.1 1.0 0.3 0.7 5.8 13.3 9.2 22.9 10.9 5.6 6.0 9.3 28.6 5.1 SLC9A1 "APNH, NHE1, PPP1R143" ENSG00000090020 "Solute carrier family 9 member A1" P19634 1 27098815-27166981 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" Calmodulin-binding "Deafness, Disease mutation, Neurodegeneration" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "salivary gland: 60.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB022371, HPA048532, HPA052891" Enhanced Supported "Plasma membrane" "Plasma membrane" "CAB022371: , HPA048532: AB_2680431, HPA052891: AB_2681981" "unprognostic (6.18e-2)" "unprognostic (1.59e-1)" "unprognostic (2.21e-1)" "unprognostic (8.48e-2)" "prognostic unfavourable (7.47e-4)" "unprognostic (2.70e-2)" "unprognostic (4.33e-3)" "unprognostic (3.18e-2)" "unprognostic (9.74e-2)" "prognostic unfavourable (7.10e-4)" "unprognostic (3.44e-2)" "unprognostic (6.95e-2)" "unprognostic (2.05e-2)" "unprognostic (1.27e-2)" "unprognostic (1.60e-1)" "unprognostic (3.34e-1)" "unprognostic (1.16e-2)" 7.1 11.3 7.5 9.9 10.1 7.3 8.4 11.7 18.9 8.7 14.0 5.0 26.9 20.7 10.6 6.8 10.3 7.1 24.4 13.4 4.6 5.3 7.3 2.4 11.2 5.8 5.0 6.7 6.9 6.4 13.4 8.0 42.5 14.8 8.5 10.2 10.1 60.7 55.4 3.8 9.2 24.7 8.1 3.9 10.5 45.6 8.3 4.9 6.0 8.0 6.5 9.0 18.8 8.4 0.9 0.6 5.5 1.5 0.4 4.2 1.8 13.5 4.7 4.4 4.5 10.1 7.3 27.3 11.1 17.1 9.8 10.7 5.6 8.8 6.1 9.6 14.6 17.0 4.3 27.7 6.1 7.3 4.0 9.3 3.0 2.4 30.7 5.5 7.1 9.1 13.4 16.5 23.0 16.2 2.6 6.0 14.4 8.1 2.8 2.9 6.2 9.7 5.0 3.9 2.8 5.1 20.5 5.1 1.6 9.4 12.8 5.6 5.9 3.4 17.4 10.4 4.2 9.7 6.1 5.4 3.4 1.8 11.2 6.1 6.0 0.1 1.5 1.5 1.9 0.9 4.2 0.2 2.2 2.0 0.6 0.9 1.4 1.7 5.5 0.4 1.5 0.1 0.8 1.8 7.5 10.1 11.7 18.9 4.6 5.3 5.0 6.7 14.8 4.9 SLC9A3 NHE3 ENSG00000066230 "Solute carrier family 9 member A3" P48764 5 470458-524332 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Antiport, Ion transport, Sodium transport, Transport" "Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "gallbladder: 65.8;intestine: 85.1;kidney: 43.6" "Cell line enhanced" "Detected in all" "HDLM-2: 27.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in some" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Region enriched" "Detected in single" 14 "cerebellum: 4.6" "Low region specificity" "Detected in many" "HPA036493, HPA036669" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA036493: AB_10673353, HPA036669: AB_10670843" "unprognostic (1.27e-1)" "unprognostic (4.88e-1)" "unprognostic (9.35e-3)" "unprognostic (1.11e-1)" "unprognostic (2.37e-1)" "unprognostic (3.35e-1)" "unprognostic (2.51e-1)" "unprognostic (9.40e-2)" "prognostic unfavourable (8.49e-4)" "unprognostic (5.18e-2)" "unprognostic (1.29e-1)" "unprognostic (3.69e-2)" "unprognostic (3.84e-1)" "unprognostic (1.30e-1)" "unprognostic (1.04e-1)" "unprognostic (1.24e-2)" "unprognostic (1.32e-1)" 0.6 0.6 0.5 16.2 1.0 0.0 0.6 4.2 0.9 0.9 27.5 0.7 1.1 12.7 0.9 3.4 2.4 0.8 65.8 0.6 0.6 0.6 43.6 0.5 0.5 0.9 0.9 0.7 0.8 1.1 0.6 0.9 0.5 1.2 1.4 2.3 1.2 2.1 0.8 0.7 4.2 85.1 1.1 0.6 0.5 22.7 1.1 0.5 0.6 0.7 2.4 2.7 0.8 2.0 1.9 2.0 0.2 1.2 3.5 6.8 2.9 4.2 3.8 6.9 7.3 1.6 1.9 5.5 4.2 2.4 5.1 3.2 9.2 4.8 10.1 5.5 1.8 6.9 3.8 2.5 2.5 27.9 7.2 4.6 16.3 3.3 2.6 3.4 5.9 2.7 5.2 2.2 3.5 1.5 6.0 5.3 1.8 6.5 3.7 16.5 2.6 6.2 5.5 6.5 5.3 1.7 3.6 7.8 3.3 12.5 3.5 2.6 7.9 2.6 1.9 5.9 5.3 4.0 2.6 8.9 3.6 5.7 3.7 15.1 3.7 0.0 1.2 0.1 4.3 0.5 3.8 1.6 5.6 4.1 1.4 1.9 6.8 5.2 0.2 3.5 0.4 2.0 4.2 2.9 0.5 1.0 4.2 0.9 0.6 0.6 0.9 0.7 1.2 0.5 SLC9A3R2 "E3KARP, NHERF-2, SIP-1, TKA-1" ENSG00000065054 "SLC9A3 regulator 2" Q15599 16 2025356-2039026 "Predicted intracellular proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "MCF7: 59.5;PC-3: 56.1;WM-115: 40.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 5 "classical monocyte: 3.6;intermediate monocyte: 2.7;myeloid DC: 6.8;plasmacytoid DC: 5.0" "Group enriched" "Detected in many" 5 "dendritic cells: 6.8;monocytes: 3.6" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001672, HPA066520" Enhanced Supported "Plasma membrane" 120000 "Plasma membrane" "HPA001672: AB_1080017, HPA066520: " "unprognostic (6.99e-2)" "unprognostic (4.56e-2)" "unprognostic (2.06e-2)" "prognostic favourable (1.03e-4)" "unprognostic (1.41e-2)" "unprognostic (1.54e-1)" "unprognostic (2.94e-3)" "unprognostic (9.17e-2)" "unprognostic (1.68e-2)" "unprognostic (1.56e-2)" "unprognostic (2.17e-2)" "unprognostic (1.70e-2)" "unprognostic (2.20e-2)" "unprognostic (6.20e-3)" "unprognostic (9.10e-2)" "unprognostic (2.40e-1)" "unprognostic (2.80e-2)" 51.5 19.4 20.0 10.0 25.4 1.1 41.0 15.5 26.6 29.7 13.1 15.2 13.5 13.5 28.7 10.3 16.1 20.9 30.4 65.1 18.4 15.7 40.7 80.9 51.2 11.1 21.0 15.9 18.3 14.0 5.3 17.4 25.1 17.8 25.5 6.5 37.5 76.3 22.9 60.9 7.1 15.7 9.9 12.2 39.0 35.0 8.8 13.5 2.5 32.7 21.5 12.3 13.3 25.0 0.1 6.8 0.0 3.6 0.1 0.9 1.0 6.2 37.3 1.0 7.7 1.2 1.7 1.1 27.2 16.5 13.8 4.5 4.9 8.3 0.0 12.9 11.6 6.1 2.9 2.7 1.4 0.0 8.9 0.6 16.1 11.8 9.2 0.1 2.8 1.9 2.7 4.0 1.2 13.7 4.5 0.5 0.9 59.5 0.1 6.9 1.5 56.1 5.3 1.6 9.8 3.0 0.5 7.1 6.7 1.9 37.8 2.4 30.6 3.2 34.8 4.3 6.3 0.3 37.6 1.0 0.8 0.1 0.5 0.7 40.3 0.0 3.6 0.0 0.9 2.7 0.3 0.0 0.2 0.2 6.8 0.1 0.9 0.9 0.0 0.1 0.9 5.0 0.2 1.0 20.0 25.4 15.5 26.6 18.4 15.7 21.0 15.9 17.8 13.5 SLCO1A2 "OATP, OATP-A, OATP1A2, SLC21A3" ENSG00000084453 "Solute carrier organic anion transporter family member 1A2" P46721 12 21264600-21419594 "Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 17.9;liver: 11.2;retina: 14.2;salivary gland: 14.5" "Cell line enhanced" "Detected in some" "NTERA-2: 13.7;RPMI-8226: 9.5;U-266/70: 20.5;U-266/84: 8.2" "Cancer enhanced" "Detected in some" "testis cancer: 2.5" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" HPA071152 Supported "Plasma membrane" "Plasma membrane" "HPA071152: " "unprognostic (5.43e-3)" "unprognostic (2.33e-1)" "unprognostic (1.28e-1)" "unprognostic (8.59e-2)" "unprognostic (1.08e-1)" "unprognostic (6.36e-2)" "unprognostic (7.63e-2)" "unprognostic (1.53e-1)" "unprognostic (3.82e-2)" "unprognostic (1.54e-2)" "unprognostic (1.51e-1)" "unprognostic (8.82e-2)" "unprognostic (1.66e-4)" "unprognostic (2.52e-2)" "unprognostic (3.20e-1)" "unprognostic (1.24e-1)" 0.2 0.1 3.3 0.0 3.4 0.0 3.6 3.4 17.9 0.1 0.1 1.9 0.0 0.0 0.1 0.1 0.2 0.3 0.1 0.9 4.1 2.5 1.1 11.2 2.7 0.6 3.0 4.0 0.2 2.3 0.5 0.5 1.2 9.7 0.7 0.0 14.2 14.5 0.0 0.4 0.4 0.2 0.0 2.9 0.4 0.4 1.6 1.4 0.0 0.3 0.0 0.3 0.4 0.1 1.3 0.7 4.3 0.4 1.1 2.3 0.2 2.1 0.5 0.8 0.2 0.0 0.0 2.8 0.0 0.0 0.0 0.0 3.0 1.7 0.1 2.1 0.1 0.2 0.2 0.1 0.4 0.5 0.7 0.0 0.5 1.1 0.0 0.3 0.2 0.0 1.4 0.1 0.1 0.1 3.5 1.4 0.0 2.1 0.3 0.1 13.7 0.1 0.1 0.2 9.5 0.0 2.1 1.9 2.3 0.0 0.2 0.2 2.7 0.7 0.0 0.0 1.4 0.7 0.3 20.5 8.2 0.1 0.2 0.2 0.1 0.6 0.4 0.3 1.4 0.3 2.3 1.3 2.2 1.5 0.1 1.0 2.1 1.6 4.3 1.1 0.1 0.7 1.8 0.2 3.3 3.4 3.4 5.0 4.1 2.5 3.0 4.0 9.7 1.4 SLCO1B3 "OATP1B3, OATP8, SLC21A8" ENSG00000111700 "Solute carrier organic anion transporter family member 1B3" Q9NPD5 12 20810702-20916911 "Disease related genes, Potential drug targets, Predicted membrane proteins, Transporters" "Ion transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 21 "liver: 88.1" "Cell line enhanced" "Detected in some" "A-431: 35.2;A549: 9.7;CAPAN-2: 7.0;HeLa: 8.0;PC-3: 9.7;U-2 OS: 8.3" "Cancer enhanced" "Detected in many" "liver cancer: 5.4" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "HPA004943, HPA050892" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA004943: AB_1854758, HPA050892: " "unprognostic (5.36e-2)" "unprognostic (1.25e-1)" "unprognostic (6.95e-2)" "unprognostic (1.63e-2)" "unprognostic (1.89e-2)" "unprognostic (7.09e-2)" "unprognostic (3.08e-2)" "unprognostic (1.54e-2)" "unprognostic (7.37e-2)" "unprognostic (1.50e-1)" "unprognostic (6.61e-3)" "unprognostic (2.36e-3)" 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 4.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.0 0.1 88.1 0.1 0.1 0.1 0.1 0.1 0.2 0.0 0.1 0.1 0.1 0.1 0.0 0.1 0.4 0.1 0.1 0.0 0.1 0.1 0.1 0.1 0.0 0.2 0.1 0.1 0.1 0.1 0.1 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 35.2 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 7.0 0.0 2.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 8.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 1.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 9.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 8.3 0.0 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.1 0.1 0.1 0.0 0.1 0.1 0.1 0.1 SLIT1 "MEGF4, SLIL1, Slit-1, slit1, SLIT3" ENSG00000187122 "Slit guidance ligand 1" O75093 10 96998038-97185920 "Predicted secreted proteins" "Differentiation, Neurogenesis" "Developmental protein" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "brain: 44.3" "Cell line enriched" "Detected in some" 15 "MOLT-4: 41.2" "Group enriched" "Detected in many" 10 "glioma: 9.2;prostate cancer: 2.2;thyroid cancer: 10.2" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in some" "myeloid DC: 1.6;plasmacytoid DC: 1.6" "Low lineage specificity" "Detected in single" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" HPA006879 Approved "Plasma membrane" "Secreted in brain" "Plasma membrane" "HPA006879: AB_1078197" "unprognostic (2.72e-1)" "unprognostic (2.25e-2)" "unprognostic (5.67e-3)" "unprognostic (1.43e-5)" "unprognostic (8.40e-2)" "unprognostic (2.60e-3)" "unprognostic (4.57e-2)" "unprognostic (1.81e-2)" "unprognostic (3.53e-1)" "unprognostic (6.06e-2)" "unprognostic (2.28e-3)" "unprognostic (1.46e-1)" "unprognostic (1.08e-5)" "unprognostic (1.66e-1)" "unprognostic (2.18e-1)" "unprognostic (1.21e-1)" "unprognostic (4.39e-3)" 1.2 0.8 13.4 0.9 16.1 0.9 0.8 0.4 44.3 0.8 0.9 0.5 0.0 0.9 0.8 0.7 0.8 1.0 0.8 0.8 13.9 10.5 0.8 0.7 1.0 0.9 4.6 13.2 0.8 1.4 0.8 8.0 0.8 2.2 1.1 0.8 0.3 0.8 0.7 0.9 0.8 0.9 0.8 1.4 0.9 1.1 2.0 0.3 3.3 3.6 0.0 0.9 0.8 0.0 0.0 1.6 0.4 0.7 0.0 0.0 0.2 0.0 0.0 2.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.8 0.0 0.0 0.2 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.1 41.2 0.1 0.1 0.0 0.0 0.0 0.1 0.0 0.0 2.6 1.1 0.0 0.0 0.4 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.9 0.0 0.0 0.0 0.7 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.0 1.6 0.0 0.0 0.0 0.4 0.0 0.4 1.6 0.0 0.2 13.4 16.1 0.4 24.8 13.9 10.5 4.6 13.2 2.2 0.3 SLITRK6 FLJ22774 ENSG00000184564 "SLIT and NTRK like family member 6" Q9H5Y7 13 85792787-85806683 "Disease related genes, Predicted membrane proteins" "Hearing, Sensory transduction, Vision" Deafness "Evidence at protein level" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "prostate: 24.2;salivary gland: 22.8;smooth muscle: 22.4;urinary bladder: 27.8" "Cell line enhanced" "Detected in some" "hTCEpi: 13.3;RT4: 45.6;WM-115: 10.7" "Cancer enhanced" "Detected in many" "breast cancer: 21.1" "Group enriched" "Detected in many" 4 "basal ganglia: 11.1;cerebellum: 4.9" "Not detected" "Not detected" "Not detected" "Not detected" "Region enhanced" "Detected in many" "thalamus: 24.7" "Low region specificity" "Detected in many" "HPA014491, HPA014513" Uncertain Supported "Plasma membrane" 9500 "Plasma membrane" "HPA014491: AB_10601603, HPA014513: " "unprognostic (6.14e-2)" "unprognostic (5.21e-3)" "unprognostic (1.40e-1)" "unprognostic (2.66e-2)" "unprognostic (2.46e-2)" "prognostic unfavourable (8.52e-4)" "unprognostic (6.10e-2)" "unprognostic (1.72e-2)" "unprognostic (1.69e-1)" "unprognostic (4.82e-2)" "unprognostic (7.60e-2)" "unprognostic (7.92e-2)" "unprognostic (3.31e-5)" "unprognostic (5.60e-2)" "unprognostic (1.81e-1)" "unprognostic (1.83e-1)" "unprognostic (2.51e-2)" 0.4 0.3 0.3 2.7 11.1 0.0 2.9 4.9 0.3 1.0 4.5 0.0 0.2 2.8 0.7 3.4 3.6 0.3 1.1 1.9 0.3 1.3 0.3 1.1 3.1 0.0 0.6 0.0 0.3 0.4 0.0 0.4 4.1 0.8 24.2 5.8 1.7 22.8 1.8 0.3 4.5 7.2 22.4 0.4 0.2 1.2 0.5 1.8 0.0 0.6 3.4 0.7 27.8 5.3 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 1.3 0.0 0.2 0.0 0.0 0.0 1.2 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 2.2 0.0 0.0 0.0 0.0 0.3 0.0 0.3 0.0 0.0 0.0 13.3 0.0 1.5 0.0 0.0 0.0 0.0 1.4 0.0 0.0 0.0 0.8 0.1 0.0 0.0 0.0 45.6 0.4 0.5 0.2 0.0 0.0 0.2 0.0 0.0 0.1 0.5 0.0 0.0 0.0 0.0 0.0 0.4 0.0 10.7 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 11.1 4.9 0.3 0.3 1.3 0.6 0.0 0.8 1.8 SMOC1 ENSG00000198732 "SPARC related modular calcium binding 1" Q9H4F8 14 69854131-70032366 "Disease related genes, Predicted secreted proteins" Differentiation "Developmental protein" "Disease mutation, Microphthalmia" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 62.2;liver: 48.0" "Cell line enhanced" "Detected in some" "AF22: 19.4;HeLa: 53.3;HSkMC: 15.6;SiHa: 31.4;SK-BR-3: 13.8;U-266/70: 19.9;U-87 MG: 19.9" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Cell type enriched" "Detected in single" 12 "plasmacytoid DC: 4.9" "Lineage enriched" "Detected in single" 50 "dendritic cells: 4.9" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA004153, CAB034427" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" 27000 "Plasma membrane" "CAB034427: AB_2193382, HPA004153: AB_1080035" "unprognostic (3.31e-1)" "unprognostic (2.17e-3)" "unprognostic (8.17e-2)" "unprognostic (1.96e-2)" "unprognostic (1.89e-2)" "unprognostic (4.04e-1)" "unprognostic (6.75e-3)" "unprognostic (2.09e-3)" "unprognostic (4.76e-2)" "unprognostic (2.80e-2)" "unprognostic (5.10e-2)" "unprognostic (5.63e-2)" "unprognostic (4.09e-2)" "unprognostic (3.92e-1)" "unprognostic (2.57e-1)" "unprognostic (1.34e-1)" "unprognostic (1.87e-1)" 7.4 10.7 23.0 1.4 10.8 1.1 2.9 5.2 62.2 8.6 2.2 32.0 19.4 3.0 2.2 10.3 1.3 7.1 1.5 4.7 22.6 16.2 2.1 48.0 1.4 1.8 23.8 8.5 1.8 26.4 1.1 2.4 9.0 21.7 42.9 2.0 14.7 3.6 35.8 8.7 1.2 2.3 1.9 15.0 19.5 3.5 24.7 16.9 0.0 2.9 0.6 1.5 1.7 3.6 0.0 4.9 0.0 0.0 0.0 0.0 0.0 0.0 1.4 19.4 0.0 3.9 2.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.4 0.0 0.0 7.5 0.0 53.3 7.8 0.0 0.0 0.0 15.6 4.5 0.6 0.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.1 0.0 0.0 0.7 0.0 0.0 0.0 0.7 0.1 31.4 13.8 0.0 0.0 0.0 0.1 0.1 1.4 0.0 0.0 19.9 0.0 0.0 19.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 4.9 0.0 0.0 23.0 10.8 5.2 11.2 22.6 16.2 23.8 8.5 21.7 16.9 SMPX "DFN6, DFNX4" ENSG00000091482 "Small muscle protein, X-linked" Q9UHP9 X 21705972-21758163 "Disease related genes, Predicted intracellular proteins" "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 23 "heart muscle: 108.8;skeletal muscle: 155.8;tongue: 74.5" "Cell line enhanced" "Detected in some" "CACO-2: 2.6;Hep G2: 6.7;HSkMC: 7.3;Karpas-707: 5.0;U-266/70: 7.4;U-266/84: 2.7" "Cancer enhanced" "Detected in many" "head and neck cancer: 7.2" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in some" "Low region specificity" "Detected in all" HPA077360 Approved "Plasma membrane" 45000 "Plasma membrane" "HPA077360: " "unprognostic (7.29e-2)" "unprognostic (1.78e-1)" "unprognostic (2.63e-1)" "unprognostic (1.28e-1)" "unprognostic (1.45e-1)" "prognostic unfavourable (3.04e-5)" "unprognostic (1.39e-2)" "unprognostic (7.46e-2)" "unprognostic (5.27e-1)" "unprognostic (1.96e-2)" "unprognostic (3.97e-2)" "unprognostic (3.58e-2)" "unprognostic (2.67e-2)" "unprognostic (2.82e-1)" "unprognostic (8.38e-2)" 1.4 0.0 0.1 0.6 0.1 0.0 0.2 0.6 0.9 0.1 4.0 0.0 0.0 0.1 0.1 4.7 4.0 0.1 0.1 108.8 0.1 0.2 0.0 0.2 0.0 0.1 0.7 0.3 0.2 0.1 0.0 0.0 0.0 0.0 1.6 0.5 0.0 3.6 0.1 155.8 0.0 0.9 1.8 0.1 0.0 1.5 0.1 0.0 0.0 1.0 74.5 4.9 1.1 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 6.7 0.0 0.0 0.0 7.3 0.0 0.0 0.0 0.0 0.0 5.0 0.4 0.0 0.0 0.0 0.6 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 7.4 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.6 0.9 0.1 0.2 0.7 0.3 0.0 0.0 SNAP23 "HsT17016, SNAP23A, SNAP23B" ENSG00000092531 "Synaptosome associated protein 23" O00161 15 42491233-42545356 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in all" "eosinophil: 102.0" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA001214, CAB037083, CAB037317" Approved Supported "Plasma membrane" 12000000 "Plasma membrane" "CAB037083: AB_477494, CAB037317: AB_261925, HPA001214: AB_1080037" "unprognostic (1.77e-1)" "unprognostic (1.37e-1)" "unprognostic (1.18e-1)" "unprognostic (3.76e-3)" "unprognostic (2.42e-2)" "unprognostic (1.65e-1)" "unprognostic (9.67e-3)" "unprognostic (1.60e-1)" "unprognostic (2.60e-1)" "unprognostic (2.93e-1)" "unprognostic (7.31e-2)" "unprognostic (1.36e-1)" "unprognostic (2.04e-2)" "unprognostic (1.59e-1)" "unprognostic (8.95e-2)" "unprognostic (1.10e-1)" "unprognostic (3.93e-2)" 29.9 24.0 15.2 28.4 20.5 14.3 28.6 11.1 17.5 20.8 30.8 21.6 27.7 23.0 38.9 18.6 20.3 21.3 18.7 24.6 16.6 11.7 22.8 23.0 28.0 35.4 27.3 10.5 24.6 19.8 10.4 17.7 81.6 18.9 24.1 24.5 16.3 37.0 25.8 32.8 15.3 40.8 22.8 23.4 41.6 22.1 25.1 21.3 20.1 20.3 18.1 35.1 25.5 53.7 17.2 22.9 102.0 36.3 10.3 11.5 23.0 17.1 7.7 14.7 14.3 24.1 19.1 22.6 21.7 16.4 12.8 15.6 25.2 6.8 8.4 28.6 13.3 14.7 16.3 12.7 18.3 14.1 9.4 39.8 8.4 23.6 17.5 15.9 38.3 15.2 10.0 11.5 19.6 49.1 29.8 8.7 17.4 5.9 19.0 16.5 12.4 6.0 35.0 8.7 13.7 18.0 15.5 2.3 9.4 15.6 14.3 13.7 20.5 23.0 38.6 13.0 17.7 15.6 21.3 18.7 33.1 44.6 15.7 32.5 16.7 30.2 24.7 102.0 8.4 36.3 9.8 17.2 8.9 8.2 22.9 15.4 11.5 8.8 56.2 10.3 34.4 9.5 9.8 23.0 15.2 20.5 11.1 17.5 16.6 11.7 27.3 10.5 18.9 21.3 SPN "CD43, GPL115, LSN" ENSG00000197471 Sialophorin P16150 16 29662979-29670876 "CD markers, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Group enriched" "Detected in many" 7 "blood: 52.1;bone marrow: 33.1;lung: 25.0;lymphoid tissue: 79.7" "Cell line enhanced" "Detected in some" "HEL: 54.9;HL-60: 48.8;HMC-1: 27.5;MOLT-4: 18.9;THP-1: 26.4;U-937: 34.8" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in many" "Cell type enhanced" "Detected in many" "non-classical monocyte: 52.1" "Low lineage specificity" "Detected in all" "CAB002666, HPA055244" Enhanced Approved "Plasma membrane" "Plasma membrane" "CAB002666: , HPA055244: " "prognostic favourable (1.40e-4)" "unprognostic (1.63e-3)" "unprognostic (3.14e-2)" "prognostic favourable (3.08e-5)" "unprognostic (2.68e-2)" "unprognostic (2.49e-3)" "unprognostic (4.02e-2)" "unprognostic (4.17e-2)" "prognostic favourable (1.88e-4)" "unprognostic (1.70e-1)" "unprognostic (4.67e-2)" "unprognostic (2.68e-1)" "unprognostic (2.61e-2)" "unprognostic (4.52e-2)" "unprognostic (4.14e-2)" "unprognostic (5.85e-2)" "unprognostic (4.72e-2)" 5.7 1.0 1.2 12.9 2.7 33.1 1.6 0.7 1.5 1.3 2.8 2.6 0.0 2.3 1.5 0.6 1.9 1.7 2.8 3.9 1.2 1.4 1.8 1.9 25.0 18.3 3.7 0.2 1.0 1.6 0.2 1.0 0.8 2.3 1.6 2.6 1.6 5.0 0.6 0.8 1.6 6.8 1.0 4.6 15.9 2.0 0.6 1.9 79.7 1.6 1.7 17.4 2.6 1.4 1.0 8.8 3.5 52.1 17.5 26.5 10.7 0.0 0.0 0.0 0.1 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.2 0.0 0.1 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.9 0.0 0.4 0.0 48.8 27.5 0.0 0.0 0.0 0.0 0.0 17.1 13.4 0.1 0.0 18.9 12.2 0.0 0.0 17.1 0.2 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 26.4 0.1 0.0 0.0 0.0 0.0 0.0 0.9 7.2 0.0 34.8 0.0 2.4 5.5 3.5 26.5 24.3 14.5 1.0 10.7 18.1 8.8 0.3 7.6 13.2 0.9 17.5 52.1 7.0 9.1 10.7 1.2 2.7 0.7 1.5 1.2 1.4 3.7 0.2 2.3 1.9 SRPRB "APMCF1, SR-beta" ENSG00000144867 "SRP receptor beta subunit" Q9Y5M8 3 133784033-133825772 "Predicted membrane proteins" Receptor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "pancreas: 104.0" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA011173 Approved Approved "Plasma membrane" 54000 "Plasma membrane" "HPA011173: AB_1857484" "unprognostic (5.44e-2)" "unprognostic (1.32e-1)" "unprognostic (6.40e-2)" "unprognostic (1.58e-2)" "unprognostic (2.61e-1)" "unprognostic (2.02e-2)" "prognostic unfavourable (3.12e-5)" "unprognostic (1.99e-1)" "unprognostic (3.60e-2)" "unprognostic (6.07e-3)" "unprognostic (8.45e-2)" "unprognostic (1.31e-2)" "unprognostic (3.79e-2)" "unprognostic (5.08e-2)" "unprognostic (7.37e-2)" "unprognostic (6.47e-2)" "unprognostic (2.26e-2)" 10.4 15.7 8.7 10.2 9.3 5.8 12.5 5.2 10.2 14.4 11.3 5.1 33.2 8.9 8.0 25.6 16.8 9.1 11.0 10.9 9.0 10.7 17.2 56.3 9.2 17.3 10.4 7.7 8.9 104.0 11.7 15.6 7.7 8.8 9.5 13.4 7.6 53.3 29.9 10.6 8.6 7.4 10.3 7.4 9.5 12.5 14.7 5.4 6.3 16.5 10.2 13.7 8.7 10.4 15.4 20.0 3.8 15.2 14.3 29.0 18.0 12.2 9.9 6.3 20.0 26.4 18.3 11.8 25.9 13.5 14.4 12.5 18.0 9.5 23.2 38.4 19.8 17.9 19.6 14.0 13.7 15.7 15.8 20.7 9.8 17.1 32.1 32.4 16.9 16.5 23.6 13.1 38.9 12.2 17.6 27.0 15.4 17.8 11.1 15.4 12.0 17.1 13.6 11.8 49.5 17.4 8.4 20.9 8.7 19.8 18.5 7.2 21.0 15.1 12.1 14.2 8.4 22.4 13.8 34.8 34.6 35.0 12.7 21.6 15.9 3.8 11.6 1.4 21.4 15.2 29.0 15.4 18.3 19.0 13.2 13.4 18.0 21.2 0.8 14.3 9.9 20.0 10.6 18.0 8.7 9.3 5.2 10.2 9.0 10.7 10.4 7.7 8.8 5.4 SSTR1 ENSG00000139874 "Somatostatin receptor 1" P30872 14 38207999-38213067 "FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 15.0;intestine: 14.3;stomach 1: 22.8" "Cell line enhanced" "Detected in some" "BJ: 46.8;BJ hTERT+: 13.0;BJ hTERT+ SV40 Large T+: 8.6;fHDF/TERT166: 27.6;HeLa: 10.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA003207, HPA031506" Approved Supported "Plasma membrane" "Plasma membrane" "HPA003207: , HPA031506: " "unprognostic (1.40e-1)" "unprognostic (1.37e-1)" "unprognostic (3.36e-1)" "unprognostic (2.50e-3)" "unprognostic (4.34e-2)" "unprognostic (9.90e-2)" "unprognostic (3.66e-3)" "unprognostic (1.91e-1)" "unprognostic (6.16e-3)" "unprognostic (3.20e-2)" "unprognostic (1.72e-2)" "unprognostic (9.19e-2)" "prognostic favourable (4.28e-4)" "unprognostic (2.17e-1)" "unprognostic (1.67e-1)" "unprognostic (4.71e-2)" "unprognostic (3.28e-2)" 0.7 0.4 6.8 0.6 6.9 0.0 0.6 0.5 15.0 0.9 3.7 0.6 0.1 14.3 1.0 0.6 0.4 0.7 0.5 0.8 4.3 10.4 2.2 6.7 5.5 0.1 6.8 4.0 0.6 3.8 0.1 1.4 2.8 2.8 1.2 2.5 0.2 0.2 0.5 0.7 0.4 8.2 0.6 1.3 0.7 22.8 0.1 0.7 0.1 0.3 0.1 0.1 1.3 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 46.8 13.0 8.6 0.7 0.4 0.0 0.0 0.0 27.6 0.1 0.0 0.0 6.3 0.0 0.0 0.0 10.6 0.0 2.6 0.0 0.0 0.1 0.0 0.0 0.1 0.6 0.0 0.0 5.5 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 1.9 0.0 1.3 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.8 6.9 0.5 15.0 4.3 10.4 6.8 4.0 2.8 0.7 SSTR5 ENSG00000162009 "Somatostatin receptor 5" P35346 16 1078781-1080142 "FDA approved drug targets, G-protein coupled receptors, Plasma proteins, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "gallbladder: 8.2;lymphoid tissue: 5.2;pituitary gland: 9.0" "Group enriched" "Detected in some" 15 "Hep G2: 9.2;PC-3: 34.1" "Low cancer specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Not detected" "Group enriched" "Detected in some" 5 "basal ganglia: 4.2;hypothalamus: 2.7" "Low region specificity" "Detected in many" HPA066503 Supported "Plasma membrane" "Plasma membrane" "HPA066503: " "unprognostic (2.16e-2)" "unprognostic (7.31e-2)" "unprognostic (3.69e-2)" "unprognostic (2.39e-2)" "unprognostic (2.14e-1)" "unprognostic (9.89e-3)" "unprognostic (1.72e-2)" "unprognostic (1.72e-2)" "unprognostic (2.06e-1)" "unprognostic (2.05e-1)" "unprognostic (4.09e-2)" 0.0 4.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 1.4 0.4 0.0 0.7 0.6 0.9 0.5 0.0 8.2 2.9 0.0 0.2 3.3 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 9.0 0.0 0.0 1.1 0.0 0.0 1.1 0.9 0.1 0.1 0.8 0.0 0.0 0.0 1.7 0.3 0.0 0.0 0.0 0.0 5.2 1.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.0 0.0 1.4 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 9.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 34.1 0.0 1.3 0.3 0.0 1.3 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 STAC2 24b2 ENSG00000141750 "SH3 and cysteine rich domain 2" Q6ZMT1 17 39210536-39225872 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "ductus deferens: 94.0;seminal vesicle: 101.5" "Group enriched" "Detected in some" 5 "HeLa: 25.6;U-87 MG: 11.7" "Group enriched" "Detected in many" 7 "breast cancer: 15.0;endometrial cancer: 3.2;glioma: 10.4;ovarian cancer: 4.2;renal cancer: 10.7" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA076925 Approved "Plasma membrane" "Plasma membrane" "HPA076925: " "unprognostic (1.70e-3)" "unprognostic (1.05e-1)" "unprognostic (3.09e-2)" "prognostic unfavourable (4.05e-5)" "prognostic unfavourable (5.61e-4)" "unprognostic (1.42e-1)" "unprognostic (8.66e-2)" "unprognostic (2.94e-2)" "unprognostic (1.17e-2)" "prognostic unfavourable (6.66e-4)" "unprognostic (1.12e-2)" "unprognostic (5.16e-2)" "unprognostic (2.35e-3)" "unprognostic (2.05e-2)" "unprognostic (1.94e-1)" "unprognostic (3.54e-2)" "unprognostic (3.17e-1)" 2.4 0.9 4.2 1.0 7.4 0.7 29.7 9.5 21.9 4.0 0.9 0.0 94.0 0.9 2.5 13.9 0.8 1.4 0.8 1.0 6.8 3.2 4.8 0.7 0.9 0.8 3.5 6.6 1.2 1.1 0.7 0.5 1.0 13.1 1.8 0.9 8.2 7.8 101.5 0.8 20.1 0.8 1.7 1.4 0.8 0.8 0.9 0.2 0.0 0.7 0.0 0.8 0.8 0.9 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.7 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.4 0.0 0.0 3.2 0.0 0.0 0.0 0.4 0.0 25.6 0.0 0.0 0.0 0.0 0.0 0.0 3.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.2 2.0 0.2 2.7 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 11.7 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.2 7.4 9.5 21.7 6.8 3.2 3.5 6.6 13.1 0.2 STAMBPL1 "ALMalpha, AMSH-FP, AMSH-LP, bA399O19.2, FLJ31524, KIAA1373" ENSG00000138134 "STAM binding protein like 1" Q96FJ0 10 88879734-88975153 "Enzymes, Predicted intracellular proteins" "Ubl conjugation pathway" "Hydrolase, Metalloprotease, Protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "testis: 18.6" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA040202 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA040202: AB_10805708" "unprognostic (2.73e-1)" "unprognostic (1.95e-1)" "unprognostic (7.56e-2)" "unprognostic (4.25e-2)" "unprognostic (6.46e-2)" "unprognostic (6.27e-2)" "unprognostic (1.68e-2)" "unprognostic (1.05e-2)" "unprognostic (4.67e-2)" "unprognostic (8.20e-2)" "unprognostic (2.78e-1)" "unprognostic (6.57e-2)" "prognostic unfavourable (1.08e-5)" "unprognostic (4.41e-2)" "unprognostic (4.06e-2)" "unprognostic (1.50e-1)" "unprognostic (4.40e-3)" 3.9 15.9 3.7 6.8 5.1 2.8 2.1 12.4 8.9 2.0 5.8 3.4 1.5 4.5 2.7 1.5 2.7 1.2 2.9 4.8 3.3 3.4 1.5 1.7 2.9 11.3 2.6 14.8 8.5 1.8 2.2 6.6 1.5 4.1 1.9 8.0 1.5 1.5 1.5 1.5 3.4 6.1 1.8 3.1 6.0 3.1 18.6 3.2 1.5 1.5 1.5 9.5 3.9 2.7 10.5 15.2 4.3 0.6 13.1 14.7 4.5 6.7 8.0 0.5 0.3 8.0 15.3 0.0 14.2 14.0 9.1 8.2 0.3 12.9 8.2 1.0 7.7 3.3 2.0 2.9 9.3 7.3 5.0 2.1 5.7 0.4 5.4 9.0 2.9 5.5 0.7 15.3 4.9 0.2 0.0 3.7 24.5 1.4 15.1 10.8 3.0 6.2 1.5 6.0 1.8 3.5 2.6 4.6 5.5 1.8 0.6 16.1 1.0 1.9 2.0 8.1 5.9 9.8 8.8 8.7 8.2 7.6 8.9 9.2 7.7 4.3 0.6 4.2 6.3 0.6 8.2 10.5 9.2 7.9 0.9 7.0 9.9 5.9 0.9 13.1 0.3 15.2 14.7 4.5 3.7 5.1 12.4 8.9 3.3 3.4 2.6 14.8 4.1 3.2 STARD4 ENSG00000164211 "StAR related lipid transfer domain containing 4" Q96DR4 5 111496033-111512590 "Predicted intracellular proteins" "Lipid transport, Transport" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA046177, HPA048081" Approved Approved "Plasma membrane" "Plasma membrane" "HPA046177: , HPA048081: " "unprognostic (1.13e-1)" "unprognostic (7.07e-3)" "unprognostic (1.53e-2)" "unprognostic (1.64e-1)" "unprognostic (1.01e-1)" "unprognostic (1.21e-2)" "prognostic unfavourable (4.80e-5)" "unprognostic (1.31e-1)" "unprognostic (1.11e-1)" "unprognostic (4.26e-1)" "unprognostic (6.27e-2)" "unprognostic (1.39e-1)" "prognostic unfavourable (5.89e-5)" "unprognostic (2.00e-1)" "unprognostic (3.82e-3)" "unprognostic (4.01e-3)" "prognostic unfavourable (2.84e-4)" 5.2 12.4 9.7 11.2 27.3 12.6 3.2 20.7 17.5 8.5 11.0 6.8 5.5 30.0 6.4 12.9 8.4 4.6 7.6 11.0 12.5 12.5 8.2 25.3 22.0 8.8 10.5 7.3 6.6 4.7 17.2 10.8 27.8 25.5 16.5 13.1 7.1 5.9 8.0 1.6 2.6 29.9 5.4 17.0 8.8 13.2 5.1 16.3 5.1 7.7 5.7 7.4 5.2 8.8 2.8 2.8 11.0 3.1 2.9 4.2 2.1 6.9 3.4 16.8 10.1 15.1 30.3 5.7 7.1 16.1 10.7 31.9 12.7 20.6 8.3 2.9 4.5 3.1 8.5 24.6 10.2 7.9 3.6 6.4 11.0 7.6 16.8 3.1 4.1 16.1 16.9 22.6 16.8 19.6 3.5 16.0 7.1 1.3 7.7 5.7 5.7 1.9 1.8 18.8 7.5 15.6 2.2 9.6 37.3 0.0 4.2 6.4 5.5 10.2 28.9 9.0 8.2 6.0 3.0 5.5 5.1 7.3 8.5 11.9 4.5 11.0 2.1 1.5 4.2 3.1 2.2 2.8 2.0 3.0 2.8 2.7 2.1 3.1 0.0 2.9 2.2 1.9 1.2 2.1 9.7 27.3 20.7 17.5 12.5 12.5 10.5 7.3 25.5 16.3 STOML3 "Epb7.2l, SRO" ENSG00000133115 "Stomatin like 3" Q8TAV4 13 38965925-38991066 "Predicted membrane proteins, Transporters" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 9.7;epididymis: 8.1;fallopian tube: 31.7;lung: 9.2" "Cell line enriched" "Detected in single" 39 "AF22: 18.6" "Cancer enhanced" "Detected in some" "endometrial cancer: 2.4" "Low region specificity" "Detected in many" "Not detected" "Not detected" "Not detected" "Not detected" "Region enriched" "Detected in some" 6 "olfactory region: 29.0" "Low region specificity" "Detected in all" "HPA012892, HPA071011" Enhanced Supported "Plasma membrane" "Plasma membrane" "HPA012892: AB_1857610, HPA071011: " "unprognostic (2.64e-1)" "unprognostic (1.91e-2)" "prognostic favourable (1.49e-4)" "unprognostic (1.82e-1)" "unprognostic (1.17e-1)" "unprognostic (4.24e-2)" "unprognostic (1.19e-1)" "unprognostic (2.14e-1)" "unprognostic (2.14e-1)" "unprognostic (1.07e-2)" "unprognostic (1.35e-2)" "unprognostic (3.07e-2)" "unprognostic (1.74e-1)" "unprognostic (1.22e-1)" 0.1 0.1 2.9 0.1 3.8 0.1 0.2 0.0 0.2 1.7 0.2 6.6 0.0 0.2 1.1 8.1 0.1 31.7 0.1 0.1 4.4 4.1 0.1 0.1 9.2 0.1 0.0 0.0 7.6 0.1 0.1 0.0 0.3 9.7 0.2 0.2 0.0 0.1 0.1 0.1 0.2 0.1 0.1 0.3 0.1 0.1 0.6 2.1 0.0 0.1 0.4 0.1 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 18.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 2.9 3.8 0.0 0.2 4.4 4.1 0.0 0.0 9.7 2.1 STX18 Ufe1 ENSG00000168818 "Syntaxin 18" Q9P2W9 4 4415742-4542346 "Predicted intracellular proteins, Predicted membrane proteins" "ER-Golgi transport, Protein transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "cervix, uterine: 98.6" "Low cell line specificity" "Detected in all" "Cancer enhanced" "Detected in all" "endometrial cancer: 43.1" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA003019 Approved Approved "Plasma membrane" "Plasma membrane" "HPA003019: AB_1857622" "unprognostic (2.33e-1)" "unprognostic (1.65e-1)" "prognostic favourable (2.84e-4)" "prognostic favourable (6.33e-8)" "unprognostic (4.21e-1)" "unprognostic (6.77e-2)" "unprognostic (6.17e-3)" "unprognostic (2.95e-2)" "unprognostic (7.53e-2)" "unprognostic (3.22e-3)" "unprognostic (1.21e-1)" "unprognostic (1.07e-2)" "prognostic favourable (7.03e-4)" "unprognostic (1.92e-2)" "unprognostic (1.55e-1)" "unprognostic (7.44e-2)" "prognostic favourable (4.69e-4)" 14.0 17.6 12.4 16.0 18.4 9.2 11.0 11.2 15.9 98.6 19.7 19.5 12.2 15.0 46.5 11.9 11.5 38.9 16.1 11.0 11.3 14.2 24.2 14.0 9.8 10.4 14.5 12.3 12.4 18.5 12.2 24.1 17.5 17.3 12.3 11.9 12.7 12.2 14.7 19.0 11.0 19.6 13.5 14.8 14.2 15.0 28.5 10.3 18.1 10.1 9.8 15.0 11.8 12.3 11.2 25.5 7.1 13.0 10.8 13.4 9.3 14.0 9.2 10.9 11.1 9.4 13.8 14.6 16.2 14.9 15.6 13.0 19.3 20.6 18.8 39.2 15.0 7.6 19.3 9.5 15.4 7.8 9.6 11.8 12.1 23.3 14.1 20.4 10.0 12.9 8.3 13.2 9.6 13.1 11.3 16.7 11.1 7.5 18.5 14.5 14.5 19.1 16.7 8.2 14.9 16.0 8.6 13.9 12.3 12.2 8.2 14.2 12.0 10.0 14.8 9.4 10.3 8.6 17.4 12.0 18.2 21.7 11.5 15.8 11.7 4.8 10.6 7.1 10.9 10.4 13.4 11.2 10.1 9.9 16.0 9.3 8.5 9.8 2.1 10.8 13.0 25.5 9.1 9.3 12.4 18.4 11.2 15.9 11.3 14.2 14.5 12.3 17.3 10.3 STX4 "p35-2, STX4A" ENSG00000103496 "Syntaxin 4" Q12846 16 31032889-31042975 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Neurotransmitter transport, Transport" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA001330 Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA001330: AB_1080167" "unprognostic (2.31e-3)" "prognostic favourable (3.65e-4)" "unprognostic (3.25e-2)" "unprognostic (4.76e-2)" "unprognostic (1.74e-2)" "unprognostic (1.63e-1)" "unprognostic (3.75e-3)" "unprognostic (5.64e-3)" "unprognostic (2.93e-2)" "unprognostic (1.01e-2)" "unprognostic (3.12e-1)" "unprognostic (1.16e-2)" "prognostic unfavourable (2.88e-9)" "unprognostic (6.90e-2)" "unprognostic (7.91e-2)" "unprognostic (1.52e-1)" "unprognostic (3.26e-2)" 26.5 28.2 28.6 23.8 29.6 14.1 23.5 24.2 28.0 21.4 24.0 24.4 16.9 28.3 24.1 19.8 26.4 19.6 23.7 24.6 26.7 18.0 21.7 25.2 25.8 22.5 38.1 22.3 22.7 19.3 33.6 14.9 27.0 32.4 19.8 22.0 14.0 21.3 21.8 30.3 32.7 26.7 27.7 26.1 31.4 22.7 10.7 31.5 19.2 21.3 17.3 26.7 25.4 29.4 11.9 14.8 20.6 18.2 18.2 14.9 8.6 18.2 26.2 5.9 13.2 20.0 20.4 12.7 16.9 29.9 18.1 18.7 8.0 19.9 12.4 22.0 29.9 13.3 5.5 19.7 17.4 22.2 16.8 8.9 18.3 21.8 22.7 10.3 30.1 19.4 13.8 31.3 23.4 24.0 10.4 14.5 32.1 28.7 9.7 15.9 12.3 14.1 8.3 17.8 16.1 18.0 13.6 4.9 9.3 14.9 15.4 6.2 12.3 13.7 25.7 18.4 8.2 20.6 9.4 15.6 12.6 5.4 27.7 16.7 11.1 14.6 17.7 20.6 14.9 18.2 12.9 9.7 12.5 14.5 14.8 11.9 9.5 12.2 18.5 18.2 15.8 8.6 6.8 8.6 28.6 29.6 24.2 28.0 26.7 18.0 38.1 22.3 32.4 31.5 SUSD2 "BK65A6.2, FLJ22778" ENSG00000099994 "Sushi domain containing 2" Q9UGT4 22 24181259-24189110 "Predicted membrane proteins" Receptor "Tumor suppressor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "lung: 100.1" "Cell line enriched" "Detected in some" 31 "SK-BR-3: 135.7" "Cancer enhanced" "Detected in all" "testis cancer: 64.5" "Region enhanced" "Detected in many" "pons and medulla: 9.6" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" HPA004117 Enhanced Approved "Plasma membrane" 3600000 "Plasma membrane" "HPA004117: AB_1857674" "unprognostic (5.24e-3)" "unprognostic (1.60e-1)" "unprognostic (1.74e-1)" "unprognostic (7.30e-2)" "unprognostic (1.27e-2)" "unprognostic (5.40e-2)" "unprognostic (5.20e-2)" "unprognostic (1.89e-2)" "unprognostic (5.87e-2)" "unprognostic (1.20e-2)" "unprognostic (9.74e-3)" "unprognostic (8.97e-2)" "prognostic unfavourable (3.29e-5)" "unprognostic (2.72e-2)" "unprognostic (2.82e-2)" "unprognostic (1.88e-2)" "unprognostic (3.33e-3)" 6.0 4.2 0.3 1.4 0.9 0.5 11.3 3.8 1.4 10.5 10.5 2.5 1.3 7.8 7.1 8.3 2.8 6.9 5.3 10.8 0.6 2.9 19.5 1.2 100.1 1.4 0.6 2.6 2.6 2.4 1.3 3.6 3.5 9.6 2.8 1.0 2.2 7.9 4.0 3.0 11.8 32.4 2.4 3.0 1.6 2.5 1.9 0.7 0.1 12.7 5.9 1.5 2.3 4.7 0.7 0.2 0.0 0.0 0.0 0.2 0.0 0.7 1.5 0.0 0.0 2.9 3.8 0.1 0.3 0.0 0.0 0.0 1.1 0.0 0.2 3.2 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 4.4 1.2 0.0 0.0 3.3 0.0 0.0 0.9 0.0 0.0 0.0 0.0 1.3 0.0 0.0 0.1 0.0 0.0 0.0 0.3 0.0 0.0 0.2 2.0 0.1 135.7 0.0 0.4 0.0 0.0 0.0 0.1 0.1 0.0 0.1 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.2 0.7 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.9 3.8 1.4 0.6 2.9 0.6 2.6 9.6 0.7 SYNGR3 ENSG00000127561 "Synaptogyrin 3" O43761 16 1989660-1994275 "Predicted intracellular proteins, Predicted membrane proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 5 "brain: 55.3" "Cell line enhanced" "Detected in many" "HDLM-2: 25.1;HMC-1: 16.2;Karpas-707: 13.7;SK-BR-3: 17.1;U-266/70: 21.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Group enriched" "Detected in many" 4 "B-cells: 3.7;NK-cells: 4.6;T-cells: 2.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB034278, HPA042842" Enhanced Approved "Plasma membrane" "Plasma membrane" "CAB034278: AB_2200905, HPA042842: " "unprognostic (8.89e-3)" "prognostic favourable (6.92e-4)" "unprognostic (6.07e-3)" "unprognostic (2.94e-3)" "unprognostic (2.92e-2)" "unprognostic (8.06e-3)" "unprognostic (2.52e-1)" "unprognostic (5.70e-2)" "unprognostic (2.84e-2)" "unprognostic (1.06e-1)" "unprognostic (3.69e-3)" "unprognostic (1.05e-1)" "prognostic favourable (7.12e-7)" "unprognostic (1.03e-1)" "unprognostic (1.19e-1)" "unprognostic (2.79e-1)" "unprognostic (8.78e-2)" 1.1 11.1 20.3 3.7 21.8 1.6 1.1 24.2 55.3 1.5 2.3 2.6 0.0 2.2 1.0 1.0 1.3 1.1 1.3 1.4 14.6 40.8 1.7 1.0 1.3 4.0 27.1 20.1 1.5 1.0 9.4 3.1 5.4 28.2 1.3 2.2 0.9 2.1 1.1 0.9 1.1 2.5 1.7 4.4 2.2 2.1 4.2 2.0 0.0 1.0 0.0 4.7 1.4 0.2 3.7 0.7 0.0 0.8 4.6 2.7 0.9 0.4 2.1 1.9 0.2 0.2 0.2 2.4 0.9 1.6 0.8 0.6 3.2 1.5 3.1 0.7 0.7 1.8 2.1 0.3 0.2 25.1 1.5 0.0 2.7 1.5 1.1 0.0 16.2 0.5 0.1 0.0 0.5 0.2 9.0 13.7 0.4 2.4 0.1 0.1 10.1 0.9 0.0 0.2 2.4 1.3 0.0 4.5 5.7 2.3 17.1 0.2 2.3 0.2 0.3 0.5 7.9 0.0 0.3 21.6 2.5 3.6 0.3 2.8 0.3 0.0 0.8 0.0 0.9 0.3 2.1 3.2 1.7 2.7 0.7 3.7 2.0 0.8 0.0 4.6 0.7 0.0 1.6 0.9 20.3 21.8 24.2 39.3 14.6 40.8 27.1 20.1 28.2 2.0 TACR2 "NK2R, NKNAR, SKR, TAC2R" ENSG00000075073 "Tachykinin receptor 2" P21452 10 69403903-69416867 "G-protein coupled receptors, Predicted membrane proteins" "G-protein coupled receptor, Receptor, Transducer" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "intestine: 56.3;smooth muscle: 35.5" "Cell line enhanced" "Detected in some" "SK-MEL-30: 8.5;U-87 MG: 4.9" "Cancer enhanced" "Detected in many" "stomach cancer: 6.7" "Low region specificity" "Detected in single" "Cell type enhanced" "Detected in some" "intermediate monocyte: 4.2" "Low lineage specificity" "Detected in many" "Not detected" "Not detected" "Low region specificity" "Detected in all" HPA076573 Approved "Plasma membrane" "Plasma membrane" "HPA076573: " "unprognostic (2.83e-1)" "unprognostic (1.58e-3)" "unprognostic (2.48e-2)" "unprognostic (1.67e-1)" "unprognostic (4.22e-1)" "unprognostic (2.30e-1)" "unprognostic (1.30e-2)" "unprognostic (1.96e-2)" "unprognostic (3.72e-1)" "unprognostic (6.14e-2)" "unprognostic (2.45e-2)" "unprognostic (3.16e-2)" "unprognostic (9.88e-4)" "unprognostic (5.59e-3)" "unprognostic (4.31e-3)" "unprognostic (1.25e-3)" "unprognostic (1.32e-1)" 1.6 0.1 0.5 3.1 0.5 0.1 1.2 0.5 1.1 11.1 56.3 0.2 0.4 4.1 12.3 0.9 19.6 7.2 1.2 1.9 0.5 0.3 0.2 0.5 0.8 0.5 0.2 0.4 2.0 0.8 0.0 0.1 0.1 0.4 14.9 8.2 0.2 0.4 0.9 1.1 0.4 14.2 35.5 0.8 0.5 16.5 0.9 0.5 0.1 0.4 0.8 0.4 19.4 3.1 1.2 2.0 0.5 4.2 0.1 0.8 0.3 1.9 1.2 0.4 0.6 3.0 0.2 0.2 0.5 0.3 0.5 0.7 0.7 0.3 0.2 0.5 0.5 0.7 0.1 0.1 0.0 0.4 0.5 1.6 0.6 1.9 0.3 0.0 3.0 0.5 0.7 0.0 0.0 0.2 0.4 2.5 0.0 0.8 0.1 0.5 0.4 1.9 0.1 0.0 0.0 0.0 1.0 0.8 0.6 1.3 2.6 8.5 1.1 0.2 0.8 3.0 0.4 1.2 1.0 1.2 1.3 0.2 4.9 0.3 1.7 0.5 1.5 0.1 0.3 4.2 0.4 1.2 0.8 0.3 2.0 0.6 0.4 0.2 0.2 0.1 1.7 0.3 0.1 0.3 0.5 0.5 0.5 1.1 0.5 0.3 0.2 0.4 0.4 0.5 TASP1 "C20orf13, dJ585I14.2, FLJ20212" ENSG00000089123 "Taspase 1" Q9H6P5 20 13389392-13638940 "Predicted intracellular proteins" "Hydrolase, Protease, Threonine protease" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA030824, HPA030825" Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA030824: AB_10600327, HPA030825: AB_10601575" "unprognostic (1.29e-1)" "unprognostic (1.68e-1)" "unprognostic (8.61e-2)" "unprognostic (1.20e-1)" "unprognostic (2.47e-1)" "unprognostic (6.46e-2)" "unprognostic (3.44e-3)" "unprognostic (9.85e-2)" "unprognostic (9.85e-2)" "unprognostic (6.95e-2)" "unprognostic (1.59e-1)" "unprognostic (3.13e-2)" "unprognostic (2.21e-1)" "unprognostic (1.04e-1)" "unprognostic (2.70e-1)" "prognostic unfavourable (6.78e-4)" "unprognostic (1.67e-2)" 12.1 8.0 6.0 9.1 11.9 6.8 11.4 8.9 15.3 10.7 8.3 6.3 13.4 5.7 21.7 14.2 8.7 13.4 7.2 9.1 6.8 6.4 9.9 7.2 10.5 8.7 4.8 8.1 10.1 11.1 14.6 28.5 10.3 8.2 8.9 9.6 10.8 16.3 11.1 5.0 9.6 9.6 8.4 5.2 9.1 8.9 11.3 4.4 31.3 12.9 9.0 12.2 8.5 11.1 9.7 15.1 3.5 4.8 10.7 15.8 5.6 9.2 5.6 2.3 2.9 2.8 4.2 4.4 3.8 5.5 4.5 5.4 11.4 9.7 4.2 2.7 5.1 12.5 3.6 13.3 5.4 2.4 4.5 8.4 3.6 14.6 5.6 11.3 3.0 4.8 9.1 4.7 11.2 4.4 7.4 0.2 3.9 11.2 21.4 6.3 3.1 2.5 3.4 9.4 6.4 6.3 7.3 6.1 4.2 6.0 11.6 6.8 6.1 4.3 4.3 4.4 3.1 4.3 5.4 8.4 11.7 2.9 2.4 2.6 4.0 1.7 3.5 3.5 10.3 4.8 7.3 9.7 10.7 8.1 3.9 8.6 15.8 12.2 1.9 10.7 4.7 15.1 9.8 5.6 6.0 11.9 8.9 15.3 6.8 6.4 4.8 8.1 8.2 4.4 TAZ "BTHS, CMD3A, EFE, EFE2, G4.5, TAZ1, XAP-2" ENSG00000102125 Tafazzin Q16635 X 154411518-154421726 "Disease related genes, Predicted intracellular proteins, Predicted membrane proteins" "Cardiomyopathy, Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA039557 Approved Approved "Plasma membrane" "Plasma membrane" "HPA039557: AB_10672899" "unprognostic (1.14e-1)" "prognostic favourable (5.70e-4)" "unprognostic (4.94e-3)" "unprognostic (1.43e-1)" "unprognostic (8.29e-2)" "unprognostic (7.84e-2)" "unprognostic (1.56e-2)" "unprognostic (8.21e-3)" "unprognostic (1.69e-1)" "unprognostic (1.62e-1)" "unprognostic (4.68e-2)" "unprognostic (8.39e-2)" "prognostic unfavourable (1.22e-7)" "unprognostic (4.00e-3)" "unprognostic (4.20e-1)" "unprognostic (1.41e-1)" "unprognostic (3.79e-2)" 11.9 8.7 12.1 15.0 13.6 36.8 11.7 12.4 13.5 10.9 15.4 15.6 12.1 13.9 10.8 13.0 15.1 9.9 14.1 25.9 11.0 8.4 13.3 14.0 14.3 17.3 16.7 9.6 12.6 16.3 10.7 8.9 9.1 13.1 11.1 10.8 12.2 12.7 14.5 27.9 18.6 15.0 11.7 12.8 25.4 12.8 3.4 15.1 17.2 11.8 13.4 14.4 10.8 19.5 16.7 14.7 13.8 10.3 12.3 17.2 7.8 11.0 12.5 4.6 5.1 9.0 5.4 8.8 3.9 7.7 6.0 8.3 4.1 13.8 13.1 21.3 5.7 16.8 6.5 7.2 4.2 11.2 9.6 2.6 8.0 6.4 10.1 5.0 6.2 5.5 13.2 5.2 11.8 9.0 5.2 13.9 5.2 6.7 12.7 15.8 1.3 13.1 10.5 7.0 17.6 8.2 3.2 5.8 8.2 2.5 7.4 10.7 4.5 8.9 6.5 4.9 6.3 12.0 5.9 32.5 12.8 27.3 6.0 17.6 5.6 5.7 10.3 13.8 12.1 9.3 11.0 11.3 17.2 15.5 14.7 16.7 14.4 12.5 9.4 12.3 7.4 7.3 12.2 7.8 12.1 13.6 12.4 13.5 11.0 8.4 16.7 9.6 13.1 15.1 TBC1D10A "AC004997.C22.2, EPI64, TBC1D10" ENSG00000099992 "TBC1 domain family member 10A" Q9BXI6 22 30291990-30327046 "Predicted intracellular proteins" "GTPase activation, Guanine-nucleotide releasing factor" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "HPA007725, HPA008142, HPA076041" Approved Enhanced "Plasma membrane" "Plasma membrane" "HPA007725: , HPA008142: AB_1080209, HPA076041: " "unprognostic (3.37e-2)" "unprognostic (2.44e-3)" "unprognostic (1.13e-1)" "unprognostic (1.10e-2)" "unprognostic (2.11e-3)" "unprognostic (1.20e-1)" "unprognostic (4.96e-2)" "unprognostic (5.07e-2)" "unprognostic (4.28e-1)" "unprognostic (6.40e-2)" "unprognostic (1.08e-1)" "unprognostic (2.45e-1)" "unprognostic (3.02e-1)" "unprognostic (7.92e-2)" "unprognostic (3.89e-2)" "unprognostic (1.05e-2)" "unprognostic (7.52e-2)" 13.5 10.7 8.4 14.5 13.4 7.8 14.8 10.5 13.6 16.5 12.0 4.6 17.6 9.3 9.7 16.0 31.5 11.6 13.8 6.4 8.4 6.6 16.0 10.8 14.3 15.6 6.0 6.5 16.2 12.7 8.9 13.0 35.7 8.1 13.6 6.1 17.3 15.0 19.4 4.3 27.1 10.4 10.5 7.0 15.8 10.6 17.5 6.1 19.8 14.6 10.2 22.7 12.7 23.2 13.3 22.3 21.0 23.9 12.9 26.1 17.1 11.5 4.6 1.9 6.1 5.8 7.3 15.1 6.8 10.1 8.0 12.9 5.3 4.6 5.8 6.6 11.9 11.5 2.9 6.4 4.3 4.4 7.8 1.6 4.0 3.8 14.9 2.3 8.3 9.7 10.6 15.9 2.7 3.6 3.0 5.7 6.0 14.1 16.7 5.0 1.2 6.0 7.5 8.2 5.3 8.0 11.6 3.2 2.5 6.9 10.7 15.8 9.1 1.5 6.6 15.2 6.8 8.3 3.6 5.6 2.4 5.3 10.6 3.5 8.6 17.0 8.9 21.0 16.5 17.1 18.2 8.4 19.3 16.9 12.8 13.3 26.1 21.3 6.0 12.9 23.9 22.3 16.2 17.1 8.4 13.4 10.5 10.5 8.4 6.6 6.0 6.5 8.1 6.1 TEC PSCTK4 ENSG00000135605 "Tec protein tyrosine kinase" P42680 4 48135783-48269864 "Enzymes, Plasma proteins, Predicted intracellular proteins" "Adaptive immunity, Immunity" "Kinase, Transferase, Tyrosine-protein kinase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HEL: 10.4;HMC-1: 16.4;U-266/70: 16.3;U-266/84: 11.6" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in many" "Group enriched" "Detected in some" 4 "basophil: 13.3;eosinophil: 11.0" "Lineage enriched" "Detected in many" 5 "granulocytes: 13.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in many" "HPA005733, HPA024657" Approved Supported "Plasma membrane" "Plasma membrane" "HPA005733: AB_1857878, HPA024657: " "unprognostic (7.19e-2)" "unprognostic (1.44e-1)" "unprognostic (1.41e-2)" "unprognostic (4.07e-3)" "unprognostic (4.21e-2)" "unprognostic (8.57e-2)" "unprognostic (3.14e-1)" "unprognostic (1.67e-1)" "unprognostic (8.36e-2)" "prognostic favourable (7.12e-4)" "unprognostic (7.46e-3)" "unprognostic (7.83e-2)" "unprognostic (1.01e-4)" "unprognostic (4.24e-2)" "unprognostic (2.16e-1)" "unprognostic (7.39e-2)" "unprognostic (4.96e-3)" 3.9 4.5 0.8 7.2 1.1 9.8 5.1 0.6 2.0 3.4 4.8 0.5 8.4 2.8 3.0 21.6 9.5 3.6 2.1 3.3 0.9 0.9 4.0 5.7 6.4 7.0 1.5 0.3 2.9 2.9 2.6 6.4 2.0 3.2 2.0 2.5 3.0 6.8 4.7 2.1 8.1 6.5 3.0 1.2 6.7 2.2 5.5 0.6 4.4 4.4 5.8 11.1 3.2 6.5 0.9 1.3 13.3 0.6 2.9 0.4 0.3 2.3 0.6 0.0 0.0 0.0 0.0 0.1 0.4 1.8 1.0 2.2 0.0 1.7 1.5 1.6 0.0 0.5 0.9 0.0 1.5 0.1 0.7 10.4 0.7 0.1 0.0 1.7 16.4 0.0 0.2 1.4 0.0 0.0 5.7 0.4 3.2 0.7 1.0 3.7 0.3 0.7 2.4 2.2 0.0 2.8 0.7 0.0 0.2 0.5 0.2 0.4 0.6 3.3 0.0 0.0 0.0 2.2 0.0 16.3 11.6 2.1 0.0 2.3 0.1 13.3 0.5 11.0 0.1 0.6 0.3 0.9 0.1 0.4 1.3 0.6 0.4 0.4 0.4 2.9 0.1 0.1 0.0 0.3 0.8 1.1 0.6 2.0 0.9 0.9 1.5 0.3 3.2 0.6 TGFBR1 "ACVRLK4, ALK-5, ALK5, ESS1, MSSE, TBR-i, TBRI" ENSG00000106799 "Transforming growth factor beta receptor 1" P36897 9 99104038-99154192 "Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Craniosynostosis, Disease mutation" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "RH-30: 67.2" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "CAB002441, CAB031481, HPA056473" Uncertain Supported "Plasma membrane" "Intracellular and membrane" "Plasma membrane" "CAB002441: AB_564029, CAB031481: AB_2202455, HPA056473: " "unprognostic (2.58e-3)" "unprognostic (1.20e-2)" "unprognostic (3.64e-3)" "unprognostic (2.80e-1)" "unprognostic (8.63e-2)" "unprognostic (3.36e-2)" "unprognostic (1.97e-2)" "unprognostic (1.32e-3)" "unprognostic (1.97e-1)" "unprognostic (1.45e-1)" "unprognostic (8.21e-3)" "unprognostic (1.82e-1)" "unprognostic (1.18e-1)" "unprognostic (1.01e-3)" "unprognostic (3.40e-2)" "unprognostic (3.19e-2)" "unprognostic (1.14e-2)" 11.1 6.9 10.3 11.5 14.6 20.0 15.4 12.6 11.3 14.4 20.0 11.0 5.5 7.4 18.8 8.0 13.2 10.9 14.9 9.7 7.8 7.5 16.0 9.8 19.2 18.9 15.8 4.3 13.3 8.8 6.5 13.5 50.9 14.1 12.3 9.2 10.4 10.2 12.2 8.4 6.6 11.0 28.6 17.9 13.9 25.5 11.4 12.4 10.8 7.7 8.1 11.5 13.0 10.2 1.6 2.0 13.1 2.4 4.0 8.3 1.9 3.3 5.0 30.8 9.5 7.2 5.3 4.6 11.5 12.6 10.7 12.1 5.1 2.4 7.5 3.6 9.0 8.0 10.4 8.9 14.6 19.5 3.2 11.2 5.6 4.5 11.9 6.9 27.3 11.0 9.6 16.8 7.9 1.9 15.5 3.2 14.7 5.2 1.0 7.8 6.5 3.0 2.8 67.2 3.2 2.6 0.8 8.3 9.7 8.9 39.9 11.9 7.4 9.4 3.5 8.0 6.9 34.3 7.0 3.2 3.2 5.1 16.8 11.9 6.9 13.1 2.4 9.1 8.3 1.6 7.2 1.6 3.6 6.1 2.0 1.3 3.5 6.7 4.9 4.0 1.9 1.4 2.2 1.9 10.3 14.6 12.6 11.3 7.8 7.5 15.8 4.3 14.1 12.4 TGFBR2 "MFS2, TBR-ii, TBRII" ENSG00000163513 "Transforming growth factor beta receptor 2" P37173 3 30606502-30694142 "Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted membrane proteins" "Apoptosis, Differentiation, Growth regulation" "Kinase, Receptor, Serine/threonine-protein kinase, Transferase" "Aortic aneurysm, Cancer-related genes, Disease mutation, Hereditary nonpolyposis colorectal cancer" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "ASC diff: 53.4;ASC TERT1: 80.5;HSkMC: 69.5;LHCN-M2: 65.8;TIME: 60.3" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" CAB073537 Supported "Plasma membrane" 560000 "Plasma membrane" "CAB073537: " "unprognostic (1.74e-1)" "unprognostic (1.84e-2)" "unprognostic (3.70e-1)" "unprognostic (3.02e-2)" "unprognostic (1.92e-1)" "unprognostic (2.26e-1)" "unprognostic (1.96e-1)" "unprognostic (1.62e-1)" "unprognostic (1.40e-1)" "unprognostic (2.24e-2)" "unprognostic (7.36e-2)" "unprognostic (1.12e-1)" "unprognostic (1.65e-2)" "unprognostic (4.72e-2)" "unprognostic (1.81e-2)" "unprognostic (8.81e-2)" "unprognostic (8.02e-2)" 91.8 24.6 6.7 24.6 10.3 7.3 88.3 3.6 7.3 36.5 42.6 9.8 18.6 13.2 42.6 23.3 36.2 28.4 42.6 73.5 6.9 5.2 32.6 21.9 52.6 75.7 12.6 3.7 22.2 26.0 17.4 10.3 24.2 9.9 35.2 17.5 27.9 22.5 19.5 34.9 17.0 31.3 37.2 12.0 68.7 26.8 15.4 8.2 19.3 40.9 16.8 26.9 48.0 82.0 5.3 6.8 20.0 6.6 1.4 19.7 3.9 2.4 14.4 0.9 0.0 53.4 80.5 2.4 12.5 17.6 4.3 4.3 3.2 13.3 0.3 45.3 16.8 5.0 0.6 18.3 7.2 1.0 1.3 1.4 1.6 16.2 22.8 2.2 11.8 69.5 16.3 18.6 18.0 46.7 0.2 0.0 65.8 0.2 2.3 1.6 0.4 5.8 2.0 5.8 0.3 23.2 5.8 0.0 0.9 3.7 1.0 3.5 0.0 2.4 60.3 21.2 5.2 9.6 4.7 0.4 0.0 2.0 12.7 2.5 8.5 6.9 2.9 20.0 3.5 3.0 3.2 4.0 5.4 4.2 2.6 5.3 19.7 9.1 12.6 1.4 6.6 6.8 1.2 3.9 6.7 10.3 3.6 7.3 6.9 5.2 12.6 3.7 9.9 8.2 THBS1 "THBS, THBS-1, TSP, TSP-1, TSP1" ENSG00000137801 "Thrombospondin 1" P07996 15 39581079-39599466 "Cancer-related genes, Candidate cardiovascular disease genes, Plasma proteins, Predicted secreted proteins" "Cell adhesion, Unfolded protein response" Heparin-binding "Cancer-related genes" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "fHDF/TERT166: 162.1;HUVEC TERT2: 157.6;LHCN-M2: 117.7;TIME: 229.8" "Low cancer specificity" "Detected in all" "Group enriched" "Detected in many" 5 "basal ganglia: 3.4;pons and medulla: 8.1" "Cell type enhanced" "Detected in some" "eosinophil: 14.1" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in many" "Low region specificity" "Detected in single" "CAB033678, HPA059756" Approved Approved "Plasma membrane" "Secreted to extracellular matrix" 1600000000 "Plasma membrane" "CAB033678: AB_793044, HPA059756: " "unprognostic (1.72e-2)" "unprognostic (9.55e-3)" "unprognostic (7.49e-2)" "unprognostic (3.31e-1)" "unprognostic (4.34e-2)" "unprognostic (1.03e-3)" "unprognostic (3.60e-1)" "unprognostic (1.53e-2)" "unprognostic (1.22e-1)" "unprognostic (2.07e-1)" "unprognostic (6.40e-2)" "unprognostic (9.16e-2)" "prognostic unfavourable (8.47e-5)" "prognostic unfavourable (8.50e-4)" "unprognostic (1.00e-1)" "unprognostic (9.25e-3)" "unprognostic (1.48e-3)" 79.6 15.2 0.9 81.4 3.4 19.3 41.0 0.7 1.3 25.7 42.7 2.5 6.6 5.0 72.8 30.5 22.7 40.8 57.7 49.0 1.0 1.0 23.4 27.2 118.4 38.8 1.1 0.8 60.9 14.0 1.3 7.7 38.1 8.1 31.9 18.3 8.4 38.0 13.2 22.6 9.2 23.0 63.5 4.5 58.0 46.5 27.5 0.2 0.6 14.0 21.4 18.4 111.8 78.9 0.0 0.5 14.1 7.4 7.5 2.6 8.6 11.5 3.9 3.1 1.1 13.1 15.4 0.0 67.0 54.8 18.4 12.1 11.4 8.7 0.0 25.3 162.1 41.2 0.1 32.7 9.3 3.0 0.0 2.9 2.3 2.9 2.9 0.0 0.8 34.5 2.4 15.3 34.5 157.6 0.0 0.1 117.7 0.8 0.0 0.2 0.5 1.4 0.0 8.1 0.0 27.6 29.4 0.0 0.0 19.0 1.0 1.1 11.7 0.2 229.8 64.5 15.3 75.9 76.9 0.1 0.1 0.1 2.1 0.0 68.9 0.2 7.4 14.1 0.8 0.8 2.6 0.0 0.4 0.5 0.5 0.0 0.1 0.1 1.4 7.5 0.1 0.3 0.0 8.6 0.9 3.4 0.7 1.0 1.0 1.0 1.1 0.8 8.1 0.2 TMEM229A ENSG00000234224 "Transmembrane protein 229A" B2RXF0 7 124030916-124033023 "Predicted membrane proteins" "Evidence at protein level" "Evidence at transcript level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in some" "brain: 10.6;intestine: 16.4;testis: 10.6" "Cell line enriched" "Detected in some" 44 "SH-SY5Y: 54.6" "Cancer enhanced" "Detected in some" "glioma: 2.2" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in all" "Low region specificity" "Detected in many" HPA056391 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA056391: " "unprognostic (2.52e-2)" "unprognostic (3.04e-2)" "unprognostic (2.30e-1)" "unprognostic (2.50e-1)" "unprognostic (2.89e-2)" "unprognostic (8.21e-2)" "unprognostic (4.74e-2)" "unprognostic (2.31e-1)" "unprognostic (4.31e-3)" 0.4 1.5 6.9 0.5 7.6 0.4 0.4 1.3 9.0 0.8 0.5 7.6 0.0 16.4 0.7 1.2 0.4 1.7 0.6 0.9 8.0 4.6 0.5 0.4 0.5 0.4 10.6 4.9 1.0 0.4 2.5 1.0 0.6 5.6 0.8 0.6 0.6 0.7 0.5 0.4 0.4 7.7 0.7 7.3 0.6 3.7 10.6 8.7 0.0 0.5 0.0 0.4 1.1 0.1 0.0 0.0 0.3 0.0 0.2 0.2 0.0 0.0 0.0 0.5 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 1.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 54.6 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.1 0.1 0.0 0.0 0.0 0.2 0.3 0.2 0.0 0.0 0.1 0.0 6.9 7.6 1.3 6.1 8.0 4.6 10.6 4.9 5.6 8.7 TNFRSF8 "CD30, D1S166E, KI-1" ENSG00000120949 "TNF receptor superfamily member 8" P28908 1 12063377-12144207 "Cancer-related genes, CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins" Receptor "Cancer-related genes, FDA approved drug targets" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "blood: 33.3" "Cell line enriched" "Detected in some" 21 "HDLM-2: 109.9" "Cancer enriched" "Detected in some" 12 "testis cancer: 9.3" "Region enriched" "Detected in single" 14 "basal ganglia: 13.1" "Cell type enhanced" "Detected in some" "intermediate monocyte: 21.7;non-classical monocyte: 33.3" "Lineage enriched" "Detected in many" 5 "monocytes: 33.3" "Low region specificity" "Detected in many" "CAB000016, HPA014823, HPA032081, HPA032082" Approved Supported "Plasma membrane" "Plasma membrane" "CAB000016: AB_563546, HPA014823: , HPA032081: , HPA032082: " "unprognostic (1.07e-2)" "unprognostic (2.06e-2)" "unprognostic (2.52e-2)" "unprognostic (5.98e-2)" "unprognostic (2.50e-1)" "unprognostic (1.46e-3)" "unprognostic (2.19e-1)" "unprognostic (3.93e-2)" "unprognostic (1.18e-1)" "unprognostic (9.18e-3)" "unprognostic (1.86e-1)" "unprognostic (2.06e-1)" "unprognostic (3.17e-8)" "unprognostic (3.31e-1)" "unprognostic (8.56e-2)" "unprognostic (2.07e-1)" "unprognostic (2.31e-2)" 10.7 0.2 0.1 7.2 13.1 1.4 5.8 0.2 0.4 1.1 0.8 0.0 1.5 0.2 1.7 1.3 0.9 2.1 1.4 3.8 0.1 0.2 0.9 0.2 3.9 2.9 0.5 0.5 1.2 0.4 0.0 0.1 6.2 0.5 1.0 0.5 0.0 0.7 0.3 3.1 1.6 1.3 1.3 1.4 2.9 6.4 2.5 0.9 3.0 0.7 2.7 5.3 2.6 3.8 0.0 3.2 6.8 33.3 0.0 0.3 2.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.1 2.4 0.0 0.0 0.0 0.0 0.0 109.9 0.0 0.0 0.0 0.0 0.0 2.0 0.0 0.0 0.0 0.3 0.0 0.0 5.1 0.3 0.0 0.0 0.2 0.0 4.4 0.0 0.0 0.0 1.7 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.3 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 6.5 0.3 0.0 21.7 0.1 0.0 0.0 0.0 3.2 0.0 0.0 0.0 6.8 0.0 33.3 0.8 0.3 2.7 0.1 13.1 0.2 0.4 0.1 0.2 0.5 0.5 0.5 0.9 TPRN "C9orf75, DFNB79, FLJ90254" ENSG00000176058 Taperin Q4KMQ1 9 137191617-137204193 "Disease related genes, Predicted intracellular proteins" Hearing "Deafness, Non-syndromic deafness" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "brain: 32.8;pancreas: 45.3" "Cell line enhanced" "Detected in many" "MCF7: 28.4;T-47d: 27.4" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in many" "Low region specificity" "Detected in all" "Region enriched" "Detected in many" 5 "cerebellum: 40.9" "HPA020899, HPA076667" Approved Approved "Plasma membrane" "Plasma membrane" "HPA020899: AB_1845835, HPA076667: " "unprognostic (5.41e-2)" "prognostic favourable (2.13e-4)" "unprognostic (2.94e-1)" "unprognostic (9.28e-2)" "unprognostic (1.68e-1)" "unprognostic (2.61e-2)" "unprognostic (3.59e-3)" "unprognostic (8.20e-2)" "unprognostic (9.96e-2)" "unprognostic (1.21e-1)" "unprognostic (1.89e-2)" "unprognostic (4.77e-2)" "prognostic favourable (5.16e-9)" "unprognostic (1.96e-3)" "unprognostic (6.35e-2)" "unprognostic (1.51e-1)" "unprognostic (5.44e-2)" 3.2 3.8 8.5 5.0 16.8 3.2 3.3 26.1 17.9 3.4 18.5 32.8 2.3 23.6 2.8 1.8 8.2 4.2 4.8 3.6 11.2 7.0 12.1 10.0 5.8 3.0 25.3 7.1 4.7 45.3 2.8 2.7 4.3 11.0 4.4 8.1 13.1 8.7 4.8 5.0 8.0 29.0 2.4 11.9 3.7 10.8 4.7 21.7 0.2 2.5 2.3 3.5 3.8 2.7 1.2 2.3 0.2 2.9 2.9 2.2 0.6 4.6 5.3 1.8 8.1 2.5 2.7 14.4 3.3 2.0 3.3 1.8 17.8 5.7 8.6 4.9 1.6 14.2 3.7 1.8 0.4 5.4 5.2 4.0 8.0 11.6 3.8 6.1 5.2 2.3 3.6 3.0 2.0 2.1 7.2 3.0 1.0 28.4 4.0 13.2 6.4 7.0 12.0 4.3 13.0 7.5 9.8 11.7 4.3 5.0 23.6 5.8 27.4 9.7 2.3 6.2 2.9 9.6 6.9 2.5 4.9 4.4 4.4 5.6 3.4 0.0 2.9 0.2 1.3 2.6 0.4 1.1 1.3 1.8 2.1 1.2 0.6 1.2 0.0 2.9 1.5 2.3 2.2 0.6 8.5 16.8 26.1 17.9 11.2 7.0 25.3 7.1 11.0 21.7 TRPV2 "VRL, VRL-1, VRL1" ENSG00000187688 "Transient receptor potential cation channel subfamily V member 2" Q9Y5S1 17 16415542-16437003 "Predicted intracellular proteins, Predicted membrane proteins, Transporters" "Calcium transport, Ion transport, Transport" "Calcium channel, Ion channel" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in many" "Cell line enhanced" "Detected in many" "ASC TERT1: 26.6;fHDF/TERT166: 34.8;HMC-1: 29.3;SK-MEL-30: 30.2;TIME: 27.2" "Cancer enriched" "Detected in all" 8 "melanoma: 59.8" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA044993 Uncertain Supported "Plasma membrane" "Plasma membrane" "HPA044993: AB_10960889" "unprognostic (1.57e-1)" "unprognostic (4.34e-3)" "unprognostic (2.05e-2)" "unprognostic (1.58e-2)" "unprognostic (2.85e-2)" "unprognostic (6.16e-3)" "unprognostic (5.25e-2)" "unprognostic (1.25e-1)" "unprognostic (8.40e-3)" "unprognostic (2.43e-1)" "unprognostic (3.11e-2)" "unprognostic (1.02e-1)" "prognostic unfavourable (1.19e-6)" "unprognostic (7.94e-2)" "prognostic unfavourable (5.53e-4)" "unprognostic (8.07e-2)" "unprognostic (1.23e-1)" 25.4 17.6 5.9 14.3 4.9 15.6 11.3 1.9 7.6 6.7 6.0 4.2 0.5 5.4 8.2 6.1 5.7 6.8 6.7 8.9 5.0 8.1 4.4 4.5 25.8 24.9 6.0 4.2 8.9 8.4 7.7 1.8 15.6 8.1 6.3 5.0 4.9 4.4 2.1 3.8 5.0 8.8 9.2 4.1 23.4 5.3 2.8 2.5 23.4 5.7 4.2 18.0 8.1 6.7 9.0 25.9 20.4 22.3 26.5 29.8 17.4 0.0 0.5 0.0 0.0 8.5 26.6 1.6 2.6 3.0 3.0 2.9 0.1 0.0 3.0 0.7 34.8 0.0 0.0 0.0 1.7 13.5 0.2 3.3 0.0 8.2 10.2 4.6 29.3 11.8 0.0 17.9 0.2 1.2 11.4 8.5 14.1 0.1 5.9 6.4 0.0 0.0 3.5 0.1 1.3 13.2 0.3 0.4 0.0 0.0 0.0 30.2 0.0 4.0 27.2 0.0 0.1 0.1 0.3 0.0 0.1 1.5 2.7 6.8 4.1 20.4 12.2 15.2 29.8 22.3 25.9 9.0 21.9 27.6 25.9 8.7 12.5 21.7 3.0 26.5 19.8 22.7 21.2 17.4 5.9 4.9 1.9 7.6 5.0 8.1 6.0 4.2 8.1 2.5 TTC7B TTC7L1 ENSG00000165914 "Tetratricopeptide repeat domain 7B" Q86TV6 14 90524564-90816479 "Predicted intracellular proteins" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Cell line enhanced" "Detected in many" "HMC-1: 33.2" "Low cancer specificity" "Detected in many" "Low region specificity" "Detected in all" "Group enriched" "Detected in some" 6 "basophil: 7.0;eosinophil: 9.7" "Lineage enriched" "Detected in many" 8 "granulocytes: 9.7" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA058363, HPA059577" Enhanced Supported "Plasma membrane" 11000 "Plasma membrane" "HPA058363: , HPA059577: " "unprognostic (9.37e-2)" "unprognostic (4.20e-2)" "unprognostic (1.01e-2)" "unprognostic (2.41e-2)" "unprognostic (2.58e-1)" "unprognostic (2.67e-4)" "unprognostic (9.42e-2)" "unprognostic (2.17e-1)" "unprognostic (5.38e-2)" "unprognostic (7.60e-2)" "unprognostic (2.75e-3)" "unprognostic (2.87e-2)" "prognostic favourable (3.20e-6)" "unprognostic (2.74e-2)" "unprognostic (7.41e-2)" "unprognostic (4.48e-2)" "unprognostic (1.07e-2)" 16.2 9.0 29.1 6.6 20.1 6.7 7.1 40.6 33.7 10.0 7.9 10.9 5.6 3.8 11.0 5.0 11.8 5.7 7.0 23.8 26.0 15.9 7.7 6.7 8.9 2.8 14.7 18.3 9.9 17.2 6.7 7.0 19.2 20.3 10.1 3.6 8.8 8.6 11.1 37.4 3.2 4.2 13.1 8.8 10.6 6.1 2.7 8.1 0.3 5.9 2.5 2.1 8.1 4.8 0.4 0.7 9.7 0.6 0.5 1.2 0.7 8.3 7.6 9.0 6.6 8.4 10.0 29.7 6.8 5.9 9.2 9.9 2.0 2.2 0.1 10.8 7.7 0.1 5.8 4.8 8.9 15.3 6.3 18.9 3.9 1.8 8.5 0.4 33.2 7.4 3.2 4.9 6.1 13.1 10.5 15.7 8.8 9.0 0.2 7.4 5.1 6.6 16.4 14.9 2.8 2.9 6.3 13.8 9.5 6.8 2.8 14.5 4.0 5.8 14.9 9.4 7.5 6.8 11.1 5.4 2.6 0.1 13.6 1.8 9.2 7.0 0.3 9.7 0.2 0.6 0.3 0.3 0.3 0.2 0.4 0.4 0.3 0.2 1.4 0.5 0.2 0.7 1.2 0.7 29.1 20.1 40.6 27.8 26.0 15.9 14.7 18.3 20.3 8.1 TWF2 "A6r, A6RP, PTK9L" ENSG00000247596 "Twinfilin actin binding protein 2" Q6IBS0 3 52228610-52239260 "Plasma proteins, Predicted intracellular proteins" "Cilium biogenesis/degradation" Actin-binding "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in all" "skeletal muscle: 81.7" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA053874 Uncertain Supported "Plasma membrane" 14000000 "Plasma membrane" "HPA053874: " "unprognostic (4.24e-2)" "unprognostic (8.61e-2)" "unprognostic (2.18e-1)" "unprognostic (2.62e-2)" "unprognostic (2.70e-2)" "unprognostic (3.51e-2)" "unprognostic (5.46e-3)" "unprognostic (2.76e-1)" "unprognostic (6.56e-2)" "unprognostic (1.97e-1)" "unprognostic (2.58e-2)" "unprognostic (5.07e-2)" "unprognostic (4.31e-3)" "unprognostic (4.40e-1)" "unprognostic (1.03e-1)" "unprognostic (1.09e-1)" "unprognostic (7.07e-2)" 25.0 13.0 10.4 21.0 10.9 17.0 22.3 17.5 21.1 13.8 15.2 7.7 10.4 12.1 14.3 13.1 17.2 11.4 18.7 38.8 13.2 9.4 13.9 11.7 16.5 39.4 9.2 13.2 14.4 10.9 5.4 7.5 11.0 9.1 13.4 7.1 10.4 18.2 13.5 81.7 11.9 13.5 13.5 8.4 23.3 13.4 7.9 7.3 34.5 9.4 15.4 19.5 18.7 14.3 32.3 46.8 72.5 50.1 26.9 40.9 38.7 6.5 16.9 5.9 10.3 19.3 23.6 10.5 15.5 25.1 18.6 16.7 8.8 18.1 23.6 10.3 18.2 11.6 7.4 21.7 4.2 14.9 9.7 24.2 12.7 21.2 16.7 14.6 40.8 21.9 10.4 22.0 7.5 28.2 5.6 12.3 13.9 5.7 20.1 33.6 9.2 47.9 7.8 6.1 24.7 14.6 10.6 4.6 17.7 5.5 23.4 30.7 5.3 15.9 29.0 18.2 19.9 14.1 13.3 11.1 9.8 11.5 35.9 41.4 21.9 26.8 50.1 39.6 33.7 48.9 30.6 32.3 35.9 35.8 46.8 25.4 28.9 35.6 72.5 26.9 49.5 42.3 40.9 38.7 10.4 10.9 17.5 21.1 13.2 9.4 9.2 13.2 9.1 7.3 UBASH3B "KIAA1959, STS-1, TULA-2, TULA2" ENSG00000154127 "Ubiquitin associated and SH3 domain containing B" Q8TF42 11 122655675-122814473 "Enzymes, Predicted intracellular proteins" "Hydrolase, Protein phosphatase" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enhanced" "Detected in many" "brain: 32.5;lymphoid tissue: 27.7" "Cell line enhanced" "Detected in many" "HEL: 41.7;HMC-1: 31.7;hTEC/SVTERT24-B: 25.9;REH: 24.9" "Low cancer specificity" "Detected in many" "Group enriched" "Detected in many" 5 "cerebellum: 32.5;pons and medulla: 21.2" "Low cell type specificity" "Detected in many" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" "HPA038605, HPA038607" Approved Approved "Plasma membrane" 2200000 "Plasma membrane" "HPA038605: AB_10669648, HPA038607: " "unprognostic (4.94e-2)" "unprognostic (6.03e-3)" "unprognostic (1.34e-1)" "unprognostic (2.98e-1)" "unprognostic (2.02e-1)" "unprognostic (1.49e-1)" "unprognostic (9.09e-2)" "unprognostic (4.67e-3)" "unprognostic (1.21e-1)" "unprognostic (1.95e-1)" "unprognostic (1.46e-3)" "unprognostic (6.20e-2)" "unprognostic (9.02e-3)" "unprognostic (1.54e-1)" "unprognostic (3.22e-2)" "unprognostic (2.72e-3)" "unprognostic (1.53e-1)" 4.3 1.3 2.8 5.5 4.0 7.2 1.5 32.5 4.9 4.0 1.5 0.7 0.0 1.7 1.3 0.3 1.8 1.1 2.4 1.3 3.4 3.5 1.5 1.7 5.5 10.9 5.1 1.9 0.8 1.2 0.6 0.9 16.8 21.2 1.3 1.8 0.9 1.3 0.9 1.8 4.1 2.4 2.3 2.1 27.7 1.7 2.1 0.2 23.9 2.9 1.7 3.8 3.4 1.3 1.0 1.7 9.8 11.0 6.5 4.9 1.8 4.4 10.9 2.0 2.6 0.8 1.6 10.3 15.8 8.8 6.4 5.0 4.3 2.4 1.8 1.2 8.4 2.2 0.0 5.6 10.3 0.0 0.3 41.7 0.3 3.6 2.4 5.0 31.7 1.4 0.3 25.9 9.6 4.3 0.0 0.0 6.2 0.1 6.1 3.2 0.8 2.6 24.9 1.2 0.2 10.2 3.8 4.5 0.1 4.2 0.3 3.5 0.0 1.3 11.2 8.4 4.5 4.9 6.5 0.3 0.0 5.3 4.4 7.1 15.2 0.0 1.3 9.8 2.0 6.5 2.2 0.3 2.6 1.8 1.7 1.0 3.0 1.6 2.8 6.5 11.0 0.2 4.9 1.8 2.8 4.0 32.5 4.9 3.4 3.5 5.1 1.9 21.2 0.2 VANGL1 STB2 ENSG00000173218 "VANGL planar cell polarity protein 1" Q8TAA9 1 115641953-115698224 "Disease related genes, Predicted membrane proteins" "Disease mutation" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Cell type enhanced" "Detected in many" "NK-cell: 8.9" "Group enriched" "Detected in many" 7 "dendritic cells: 3.5;NK-cells: 8.9;T-cells: 4.3" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA025235, CAB076375" Approved Approved "Plasma membrane" "Plasma membrane" "CAB076375: , HPA025235: AB_1858718" "unprognostic (1.04e-2)" "unprognostic (2.04e-2)" "prognostic favourable (7.53e-4)" "unprognostic (9.94e-2)" "unprognostic (1.71e-2)" "unprognostic (5.18e-2)" "unprognostic (2.18e-3)" "unprognostic (5.11e-3)" "unprognostic (2.11e-1)" "unprognostic (6.43e-3)" "prognostic unfavourable (7.89e-4)" "unprognostic (1.88e-2)" "unprognostic (1.74e-2)" "unprognostic (7.71e-3)" "unprognostic (1.21e-1)" "unprognostic (4.50e-3)" "unprognostic (9.06e-3)" 7.0 8.6 2.2 5.8 3.1 2.0 16.4 1.2 2.5 14.0 9.3 5.3 8.3 4.0 13.2 8.8 14.4 13.7 5.3 12.7 3.2 2.3 11.8 7.1 12.1 7.4 2.1 1.9 8.9 11.5 5.5 2.2 5.3 2.4 9.4 7.1 6.6 9.5 11.0 2.1 9.8 6.6 15.9 2.0 4.7 6.6 7.9 2.6 18.0 11.8 10.0 10.0 10.2 9.4 0.3 3.5 0.0 0.8 8.9 4.3 1.4 21.3 9.1 3.0 4.0 11.2 10.1 5.9 8.3 6.0 10.9 8.7 5.2 10.7 0.0 14.4 9.6 27.1 5.0 14.7 7.2 25.0 6.1 11.9 8.5 4.2 4.1 3.5 5.2 5.3 10.5 7.8 8.3 10.8 7.2 6.6 11.0 28.6 17.5 1.4 7.5 8.7 0.0 8.6 6.2 5.0 14.4 2.7 3.6 15.0 10.0 7.1 5.1 3.8 11.6 7.5 11.9 16.4 15.1 0.9 1.0 0.0 10.2 6.3 18.4 0.0 0.8 0.0 3.0 0.5 0.8 0.3 1.9 2.9 3.5 0.0 0.7 3.3 0.0 8.9 0.8 3.0 4.3 1.4 2.2 3.1 1.2 2.5 3.2 2.3 2.1 1.9 2.4 2.6 VIL1 "D2S1471, VIL" ENSG00000127831 "Villin 1" P09327 2 218419092-218453295 "Cancer-related genes, Disease related genes, Plasma proteins, Predicted intracellular proteins" Apoptosis "Actin capping, Actin-binding" "Cancer-related genes" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in some" 6 "intestine: 129.3" "Group enriched" "Detected in some" 106 "CACO-2: 122.1;Hep G2: 57.3" "Cancer enhanced" "Detected in many" "colorectal cancer: 56.4" "Not detected" "Not detected" "Cell type enriched" "Detected in single" 6 "neutrophil: 2.5" "Lineage enriched" "Detected in single" 6 "granulocytes: 2.5" "Low region specificity" "Detected in single" "Low region specificity" "Detected in many" "CAB002452, HPA006884, HPA006885" Enhanced Enhanced "Plasma membrane" 41000000 "Plasma membrane" "CAB002452: AB_564052, HPA006884: AB_1080566, HPA006885: AB_1080564" "unprognostic (1.28e-1)" "unprognostic (1.91e-2)" "unprognostic (1.61e-2)" "unprognostic (1.09e-1)" "unprognostic (1.83e-1)" "unprognostic (3.36e-1)" "unprognostic (3.03e-1)" "unprognostic (5.90e-2)" "unprognostic (2.44e-2)" "unprognostic (7.06e-2)" "unprognostic (4.14e-1)" "unprognostic (1.03e-1)" "unprognostic (2.25e-3)" "unprognostic (3.90e-1)" "unprognostic (2.58e-1)" "unprognostic (4.79e-2)" "unprognostic (4.65e-2)" 0.3 0.2 0.6 5.7 0.8 0.0 0.3 0.7 0.4 0.3 36.6 0.3 0.3 68.9 0.3 1.2 0.3 0.2 22.6 0.3 0.5 0.5 4.6 6.1 0.3 0.3 0.5 0.3 0.3 7.2 0.0 0.4 0.3 0.3 0.3 32.6 0.3 0.5 0.3 0.3 0.3 129.3 1.2 0.5 0.4 0.9 0.6 0.3 0.3 0.3 0.3 0.3 0.3 0.3 0.1 0.4 2.5 0.1 0.1 0.1 7.8 0.0 0.2 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 122.1 0.0 0.0 0.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 57.3 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.4 0.1 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 2.5 0.1 0.0 0.4 0.0 7.8 0.6 0.8 0.7 0.4 0.5 0.5 0.5 0.3 0.3 0.3 ZBTB8OS ARCH ENSG00000176261 "Zinc finger and BTB domain containing 8 opposite strand" Q8IWT0 1 32600172-32650903 "Predicted intracellular proteins" "tRNA processing" "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA046315 Approved Approved "Plasma membrane" "Plasma membrane" "HPA046315: " "unprognostic (3.41e-2)" "unprognostic (1.39e-2)" "unprognostic (1.08e-1)" "unprognostic (9.08e-2)" "unprognostic (1.82e-1)" "unprognostic (8.14e-2)" "prognostic unfavourable (4.25e-4)" "unprognostic (9.63e-2)" "prognostic unfavourable (8.56e-4)" "unprognostic (5.18e-2)" "unprognostic (3.84e-1)" "unprognostic (1.40e-1)" "prognostic unfavourable (7.11e-8)" "unprognostic (1.94e-2)" "unprognostic (2.79e-1)" "unprognostic (1.68e-1)" "unprognostic (1.42e-1)" 16.1 18.8 20.9 21.2 22.3 14.5 16.7 21.7 21.1 13.1 25.6 11.9 21.4 24.9 13.9 29.5 20.6 15.5 12.2 20.7 16.9 15.8 23.2 26.6 15.5 25.9 23.5 18.6 10.4 20.3 9.2 36.6 13.6 20.9 15.9 26.8 15.3 19.0 18.5 29.5 13.4 28.6 16.2 18.0 22.3 20.6 11.1 23.0 8.4 18.7 20.3 32.5 14.8 13.5 36.0 26.1 33.8 35.4 22.4 40.1 18.0 18.2 10.6 9.4 16.0 16.7 15.2 13.0 20.8 21.0 16.6 16.9 25.0 20.5 20.3 19.2 15.1 13.7 16.4 16.2 22.2 27.1 15.1 16.5 22.0 41.5 13.7 23.7 15.3 15.1 17.8 14.6 17.6 18.0 16.3 27.7 21.2 14.4 18.1 13.8 29.3 16.4 14.6 20.4 19.8 19.7 21.8 19.1 14.8 16.8 16.9 26.0 11.6 19.7 12.8 23.2 14.0 18.6 25.8 42.1 41.2 57.4 16.6 29.6 22.9 15.8 29.2 33.8 24.4 33.9 23.5 36.0 27.0 28.9 20.4 23.1 22.5 24.2 32.5 22.4 35.4 26.1 40.1 18.0 20.9 22.3 21.7 21.1 16.9 15.8 23.5 18.6 20.9 23.0 ZDHHC22 C14orf59 ENSG00000177108 "Zinc finger DHHC-type containing 22" Q8N966 14 77131270-77142734 "Enzymes, Predicted intracellular proteins, Predicted membrane proteins" "Acyltransferase, Transferase" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Tissue enriched" "Detected in many" 17 "brain: 52.3" "Group enriched" "Detected in some" 4 "AF22: 5.2;NTERA-2: 5.5;RH-30: 9.2;SCLC-21H: 10.2" "Cancer enriched" "Detected in single" 40 "glioma: 7.7" "Low region specificity" "Detected in all" "Not detected" "Not detected" "Not detected" "Not detected" "Low region specificity" "Detected in many" "Low region specificity" "Detected in all" "HPA049471, HPA072213" Enhanced "Plasma membrane" "Plasma membrane" "HPA049471: , HPA072213: " "unprognostic (1.02e-1)" "unprognostic (3.42e-1)" "unprognostic (1.22e-4)" "unprognostic (1.66e-1)" "unprognostic (8.86e-2)" "unprognostic (2.68e-1)" "unprognostic (3.41e-1)" "unprognostic (1.87e-1)" "unprognostic (6.94e-4)" "unprognostic (3.05e-1)" "unprognostic (6.30e-2)" "unprognostic (1.16e-1)" "unprognostic (4.02e-1)" "unprognostic (1.95e-1)" "unprognostic (4.79e-1)" 1.1 1.5 11.2 1.1 12.6 1.1 1.1 8.4 52.3 1.1 1.2 6.7 0.0 1.1 1.1 1.4 1.3 1.2 1.1 1.2 14.5 18.4 1.1 1.1 1.1 1.1 10.7 19.5 1.1 1.1 1.1 3.1 1.1 9.2 1.1 1.3 0.5 1.1 1.1 1.3 1.1 1.1 1.2 3.6 1.1 1.3 1.4 5.1 0.0 1.3 0.0 1.1 1.4 0.0 0.0 0.0 0.1 0.0 0.2 0.1 0.0 0.0 0.0 5.2 0.2 0.0 0.0 0.0 0.0 0.0 0.1 0.1 0.0 0.0 0.0 0.0 0.1 0.1 0.4 0.0 0.0 0.0 0.2 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.0 0.6 0.0 0.0 5.5 0.7 0.0 9.2 0.0 0.0 0.0 10.2 1.8 0.1 0.0 0.0 0.0 0.0 0.0 0.0 1.8 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.2 0.1 0.0 0.0 0.0 0.0 0.1 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.1 0.2 0.0 0.0 0.0 0.0 11.2 12.6 8.4 29.5 14.5 18.4 10.7 19.5 9.2 5.1 ZNF227 ENSG00000131115 "Zinc finger protein 227" Q86WZ6 19 44207547-44237268 "Plasma proteins, Predicted intracellular proteins, Transcription factors" "Transcription, Transcription regulation" DNA-binding "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in many" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" HPA030573 Uncertain Approved "Plasma membrane" "Plasma membrane" "HPA030573: AB_10610702" "unprognostic (3.01e-2)" "unprognostic (1.79e-2)" "unprognostic (7.14e-2)" "unprognostic (2.77e-2)" "unprognostic (4.74e-2)" "unprognostic (1.66e-2)" "unprognostic (8.05e-2)" "unprognostic (7.89e-2)" "unprognostic (1.52e-2)" "unprognostic (1.08e-1)" "unprognostic (5.68e-3)" "unprognostic (1.94e-1)" "unprognostic (4.88e-2)" "unprognostic (1.27e-1)" "unprognostic (2.21e-2)" "unprognostic (9.91e-2)" "prognostic favourable (2.64e-4)" 10.4 11.5 13.6 8.3 13.3 6.3 12.7 24.7 14.4 12.9 10.3 13.0 8.7 8.0 15.4 12.1 10.1 12.6 9.0 8.9 12.3 11.7 10.0 11.0 9.4 14.0 13.5 12.5 17.6 9.9 18.5 28.0 11.4 15.7 13.3 9.0 9.6 9.3 11.2 10.0 9.6 8.9 12.8 15.3 13.4 12.6 10.7 17.6 20.8 12.7 4.3 16.2 12.3 13.2 12.1 5.8 13.0 4.5 10.6 13.1 4.9 5.1 7.4 8.9 11.1 7.3 6.4 4.2 5.1 7.4 5.0 9.7 3.6 4.1 9.1 7.9 4.7 3.0 10.1 5.4 6.7 11.8 12.8 15.9 8.0 4.4 5.2 13.8 7.0 5.7 6.0 4.8 9.2 7.3 1.5 0.2 5.3 2.8 13.0 3.7 14.3 3.9 7.8 9.0 7.7 5.1 9.5 15.2 15.6 11.4 5.2 4.0 4.3 7.5 6.2 5.5 9.1 4.1 6.5 21.3 28.2 20.0 3.6 5.8 7.3 13.0 4.5 8.6 10.7 3.2 11.7 11.4 10.0 10.3 5.4 12.1 13.1 11.1 4.1 10.6 2.9 5.8 11.8 4.9 13.6 13.3 24.7 14.4 12.3 11.7 13.5 12.5 15.7 17.6 ZNF706 HSPC038 ENSG00000120963 "Zinc finger protein 706" Q9Y5V0 8 101177878-101206193 "Predicted intracellular proteins" "Translation regulation" Repressor "Evidence at protein level" "Evidence at transcript level" "Evidence at protein level" "Evidence at protein level" "Evidence at protein level" "Low tissue specificity" "Detected in all" "Low cell line specificity" "Detected in all" "Low cancer specificity" "Detected in all" "Low region specificity" "Detected in all" "Low cell type specificity" "Detected in all" "Low lineage specificity" "Detected in all" "Low region specificity" "Detected in all" "Low region specificity" "Detected in all" HPA042793 Approved "Plasma membrane" "Plasma membrane" "HPA042793: AB_10795710" "unprognostic (2.05e-2)" "unprognostic (3.29e-2)" "unprognostic (2.04e-1)" "prognostic unfavourable (3.12e-5)" "unprognostic (1.60e-1)" "unprognostic (1.26e-1)" "unprognostic (2.48e-3)" "unprognostic (5.22e-2)" "unprognostic (3.19e-2)" "unprognostic (1.21e-2)" "unprognostic (1.35e-1)" "unprognostic (1.19e-1)" "prognostic unfavourable (5.90e-11)" "unprognostic (9.65e-2)" "unprognostic (1.59e-1)" "unprognostic (3.57e-1)" "unprognostic (2.17e-2)" 28.0 24.6 38.4 34.5 40.8 26.3 39.4 35.5 39.0 21.8 35.9 34.5 21.5 37.1 23.0 38.5 42.4 20.5 29.9 27.8 37.0 25.4 23.4 34.6 34.1 45.5 32.8 40.0 23.9 82.3 26.9 28.9 30.1 29.3 21.6 36.1 20.9 29.4 21.2 31.6 53.6 50.4 25.7 32.6 30.1 34.5 31.1 32.1 21.2 25.1 33.6 39.4 23.9 28.7 63.6 85.4 32.4 73.1 19.3 46.4 38.1 41.8 24.1 42.3 13.4 15.2 17.6 27.1 17.5 22.6 18.1 19.5 17.2 25.9 25.4 30.6 20.8 23.0 24.2 23.6 21.0 18.8 21.0 25.4 14.9 33.0 20.1 18.9 24.8 15.3 37.1 17.1 37.4 30.8 27.5 49.7 16.0 29.5 39.6 52.3 12.8 59.8 16.7 14.1 52.0 24.0 21.7 28.1 12.6 12.2 20.4 75.0 21.3 20.1 20.4 10.0 20.5 26.3 18.1 42.2 40.5 40.8 26.9 41.8 46.0 32.4 45.9 24.9 23.7 71.9 24.3 63.6 33.1 30.1 42.3 49.0 37.5 35.8 6.2 19.3 73.1 85.4 46.4 38.1 38.4 40.8 35.5 39.0 37.0 25.4 32.8 40.0 29.3 32.1